0001102993-22-000035.txt : 20220502 0001102993-22-000035.hdr.sgml : 20220502 20220502172705 ACCESSION NUMBER: 0001102993-22-000035 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 21 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220502 DATE AS OF CHANGE: 20220502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LIVEPERSON INC CENTRAL INDEX KEY: 0001102993 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 133861628 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-30141 FILM NUMBER: 22883419 BUSINESS ADDRESS: STREET 1: 475 10TH AVENUE STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 2126094200 MAIL ADDRESS: STREET 1: 475 10TH AVENUE STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 10-K/A 1 lpsn-20211231.htm 10-K/A lpsn-20211231
0001102993--12-312021FYfalse00011029932021-01-012021-12-3100011029932021-06-30iso4217:USD00011029932022-02-25xbrli:shares


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K/A
(Amendment No. 1)
    ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Fiscal Year Ended December 31, 2021
OR
    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period from _____ to _____
Commission File Number 000-30141
LIVEPERSON, INC.
(Exact name of registrant as specified in its charter)
Delaware13-3861628
(State or other jurisdiction of incorporation)(IRS Employer Identification No.)
530 7th Ave, Floor M1
New York, New York
10018
(Address of Principal Executive Offices)(Zip Code)
Registrant’s telephone Number, including area Code: (212) 609-4200
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.001 per shareLPSNThe Nasdaq Stock Market LLC
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated FilerAccelerated Filer
Non-accelerated FilerSmaller Reporting Company
Emerging Growth Company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No ☒
The aggregate market value of the voting common stock held by non-affiliates of the registrant as of June 30, 2021 (the last business day of the registrant’s most recently completed second fiscal quarter) was approximately $4,035,402,834 (computed by reference to the last reported sale price on The Nasdaq Global Select Market on that date). The registrant does not have any non-voting common stock outstanding.
On February 10, 2022, 72,570,760 shares of the registrant’s common stock were outstanding.
Auditor NameAuditor LocationAuditor Firm ID
BDO USA, LLPNew York, New York23




LIVEPERSON, INC.
AMENDMENT NO. 1 TO 2021 ANNUAL REPORT ON FORM 10-K/A
TABLE OF CONTENTS
Page
Explanatory Note
Cautionary Statement Concerning Forward-Looking Statements
PART III
Item 10. Directors, Executive Officers and Corporate Governance
Item 11. Executive Compensation
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Item 13. Certain Relationships and Related Transactions, and Director Independence
Item 14. Principal Accountant Fees and Services
PART IV
Item 15. Exhibits and Financial Statement Schedules

1



EXPLANATORY NOTE

LivePerson, Inc. (“LivePerson”, the “Company”, “we” or “us”) is filing this Amendment No. 1 on Form 10-K/A (this “Amendment”) to amend the Annual Report on Form 10-K for the fiscal year ended December 31, 2021 originally filed with the Securities and Exchange Commission (the “SEC”) by the Company on February 28, 2022 (the “Original Form 10‑K”), solely for the purpose of including the information required by Items 10 through 14 of Part III of Form 10-K. This information was omitted from the Original Form 10‑K in reliance on General Instruction G(3) to Form 10-K, which permits such information to be incorporated by reference from a registrant’s definitive proxy statement, if filed with the SEC not later than 120 days after the end of the fiscal year covered by a Form 10-K (or as such deadline may be extended pursuant to Rule 0-3 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the “Filing Deadline”). We will not have filed our definitive proxy statement by the Filing Deadline and are therefore amending and restating in their entirety Items 10, 11, 12, 13 and 14 of Part III of the Original Form 10-K. The reference on the cover page of the Original Form 10-K to the incorporation by reference of portions of our definitive proxy statement into Part III of the Original Form 10-K is hereby deleted.

In addition, as required by Rule 12b-15 under the Exchange Act, certifications by LivePerson’s principal executive officer and principal financial officer are filed as exhibits to this Amendment under Item 15 of Part IV hereof. Because no financial statements have been included in this Amendment and this Amendment does not contain or amend any disclosure with respect to Items 307 and 308 of Regulation S-K, paragraphs 3, 4 and 5 of the certifications have been omitted. We are not including certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 as no financial statements are being filed with this Amendment.

This Amendment does not reflect events occurring after the filing of the Original Form 10-K or modify or update the disclosure contained in the Original Form 10‑K in any way other than as required to reflect the amendments discussed above and reflected below. Accordingly, this Amendment should be read in conjunction with the Original Form 10-K and with the Company’s filings with the SEC subsequent to the filing of the Original Form 10-K. Capitalized terms used but not defined herein have the meanings assigned to them in the Original Form 10-K.
2



CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS

Statements in this Amendment about LivePerson that are not historical facts are forward-looking statements. These forward-looking statements are based on our current expectations, assumptions, estimates and projections about LivePerson and our industry. Our expectations, assumptions, estimates and projections are expressed in good faith, and we believe there is a reasonable basis for them, but we cannot assure you that our expectations, assumptions, estimates and projections will be realized. Examples of forward-looking statements include, but are not limited to, statements regarding future business, future results of operations or financial condition (including based on examinations of historical operating trends), management strategies and the COVID-19 pandemic. Many of these statements are found in the “Business” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Original Form 10-K. When used in this Amendment, the words “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes” and variations of such words or similar expressions are intended to identify forward-looking statements. However, not all forward-looking statements contain these words. Forward-looking statements are subject to risks and uncertainties that could cause actual future events or results to differ materially from those expressed or implied in the forward-looking statements. Important factors that could cause our actual results to differ materially from the forward-looking statements we make in this Amendment include those set forth in the section of the Original Form 10-K entitled “Risk Factors.” It is routine for our internal projections and expectations to change as the year or each quarter in the year progress, and therefore it should be clearly understood that the internal projections and beliefs upon which we base our expectations may change prior to the end of each quarter or the year. Although these expectations may change, we are under no obligation to inform you if they do. Our policy is generally to provide our expectations only once per quarter, and not to update that information until the next quarter. We do not undertake any obligation to revise forward-looking statements to reflect future events or circumstances. All forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
3



PART III

Item 10. Directors, Executive Officers and Corporate Governance

The following is a brief biographical summary of the experience of our directors, including their ages as of December 31, 2021.

Peter Block, 82, has served as a member of our board of directors (the “Board”) since July 2010. Mr. Block brings experience in management consulting and organizational development, and has been President of Peter Block Inc., a management consulting group, and a partner in Designed Learning, a training company that offers both in-person and virtual workshops designed by Mr. Block to build organizational development skills, since 1997. Mr. Block is also a best-selling author of several books about organizational dynamics, community, and accountability. Among other awards, Mr. Block has received the Organizational Development Network’s Lifetime Achievement Award, the American Society for Training and Development Award for Distinguished Contributions, and the Association for Quality and Participation President’s Award. He is also a member of Training Magazine’s HRD Hall of Fame. Mr. Block holds a B.S. degree in Industrial Administration from the University of Kansas and an M.S. degree in Industrial Administration from Yale University. Mr. Block serves on the Compensation Committee and Social Impact and Culture Committee.

Mr. Block brings to the Board significant expertise on hiring, enabling and retaining talent, building high-performance internal teams and maintaining a diverse, inclusive and engaged workforce and unique perspective on organizational design.

Ernest Cu, 61, has served as a member of the Board since April 2021. Mr. Cu brings a long history of executive leadership experience, having served as Executive Director, President, and Chief Executive Officer (“CEO”) of Globe Telecom, Inc. (PSE:GLO), a major publicly traded telecommunications provider in the Philippines, since April 2009, and as President and CEO of SPi Technologies from 1997 to 2008. He is considered to be one of the founding originators of the business process outsourcing (“BPO”) business model in the Philippines in recognition of his immense contributions to the telecommunications industry. Mr. Cu also brings valuable finance experience as a former executive at Bank of America and former director of Maybank ATR Kim Eng Financial Corp. Mr. Cu has extensive experience as a director of a variety of private companies, including AF Payments (Beep), a financial services company. Mr. Cu has previously been recognized by Ernst & Young as ICT Entrepreneur of the Year, and, on two occasions each, was recognized by Finance Asia as the Philippines’ Best CEO and by Frost & Sullivan as CEO of the Year. He was also recognized as one of the 100 most influential telecom leaders worldwide by London-based Global-Telecoms Business Magazine Power 100 for five consecutive years. Mr. Cu holds a B.S. degree in Industrial Management Engineering from De La Salle University in Manila and an M.B.A. degree from the J.L. Kellogg Graduate School of Management at Northwestern University. Mr. Cu serves on the Social Impact and Culture Committee.

Mr. Cu brings to the Board a global perspective in areas such as infrastructure modernization, sustainability, and product innovation, with particular expertise in communications and consumer offerings, and extensive expertise in financial and operational management and business transformation.

Kevin Lavan, 69, has served as a member of the Board since January 2000. Mr. Lavan currently serves as Chief Financial Officer (“CFO”) of Autoclear LLC, a designer, builder, and distributor of security systems, a role he has held since February 2016. Prior to his current role, Mr. Lavan was an independent consultant to the media and entertainment industries, building on his leadership experience across entertainment, media, and direct and digital marketing. Between April 2010 and December 2014, Mr. Lavan was a Senior Vice President, Worldwide Controller of IMG, an international and diversified sports, entertainment and media company. He also served in various executive roles at Paradysz Matera Company, Inc., MDCPartners, Inc., Now Marketing, Inc., and Wunderman, a marketing division of Young & Rubicam Inc., and previously served as an independent consultant to marketing services organizations. Earlier in Mr. Lavan’s career, he held various finance roles at Young & Rubicam, Viacom Inc. and Viacom’s subsidiary, MTV Networks. Mr. Lavan holds a B.S. degree from Manhattan College, and is a Certified Public Accountant. Mr. Lavan is Chair of the Audit Committee and also serves on the Compensation Committee, Nominating and Corporate Governance Committee, and Social Impact and Culture Committee.

Mr. Lavan brings to the Board highly relevant perspective in digital marketing and advertising, as well as extensive operating, financial senior management experience.

Jill Layfield, 47, has served as a member of the Board since November 2016. Ms. Layfield co-founded Tamara Mellon, a digitally-native, luxury retail company, where she served as CEO from July 2016 to December 2021 and assisted in launching the first-ever digitally led, direct-to-consumer luxury footwear brand. From November 2004 until July 2016, Ms. Layfield served in various roles at Backcountry.com, including as President and CEO from January 2011 to December 2015. During her time at Backcountry.com, she grew the company from $25 million to $515 million in revenue and successfully sold the business to TSG Consumer Partners for $350 million. Ms. Layfield also held various marketing positions at several Silicon Valley companies including Shutterfly, a photography and image sharing company; Cisco Systems, a developer, manufacturer, and seller of technology and
4



telecommunications equipment; Infogear, a start-up focused on marketing for internet appliances; and 8x8, a manufacturer of videoconferences products and a VOIP service provider. Ms. Layfield currently sits on the board of directors for The Orvis Company. Additionally, Ms. Layfield previously sat on the boards of directors of Camber Outdoors and SmartPak Equine. Ms. Layfield received a B.A. degree in Communications - Journalism from Santa Clara University. Ms. Layfield is recognized as an innovator and industry expert in combining organizational change and advanced technologies to retool customer care for the digital, mobile era. Ms. Layfield is Chair of the Compensation Committee and also serves on the Audit Committee, Nominating and Corporate Governance Committee, and Social Impact and Culture Committee.

Ms. Layfield brings to the Board a deep experience in the retail and technology sector, operational expertise and unique expertise transforming customer experience and forging meaningful, high-quality connections between brands and consumers.

Robert P. LoCascio, 53, has served as a member of our Board since LivePerson’s inception in November 1995. He has been CEO and Chairman since founding the Company, and also served as President until January 2001. As founder and CEO, Mr. LoCascio deeply understands the technology and business of LivePerson and has been an integral part of driving the Company’s market leadership in Conversational Artificial Intelligence and building its best-in-class AI platform. In addition to his role at LivePerson, Mr. LoCascio is a founding board member of EqualAI, an organization which works with companies, policy makers, and experts to reduce bias in AI. Mr. LoCascio has been widely recognized for his leadership in the technology space and was the winner of the 2015 Smart CEO Circle of Evidence Award and was named a New York City Ernst & Young Entrepreneur of the Year finalist in 2001 and 2008. Mr. LoCascio is also a founding member of the NYC Entrepreneurs Council of the Partnership for New York City. In 2001, Mr. LoCascio started the Dream Big Foundation with its first program, FeedingNYC, which gives families in need a Thanksgiving dinner. To date, FeedingNYC has delivered meals to approximately 90,000 families. Its second program, the Dream Big Entrepreneurship Initiative, launched in 2014 to fund, mentor, coach, and empower local entrepreneurs in underserved communities. Mr. LoCascio received a B.B.A. degree from Loyola College. Mr. LoCascio currently serves on the Board’s Social Impact and Culture Committee.

Mr. LoCascio brings to the Board a unique perspective of LivePerson’s business and his strategic vision and operational insights as the Company founder and CEO. In addition, the Company values Mr. LoCascio’s extensive technology experience, specifically in the cloud-based technologies space, as well as his strong entrepreneurial background.

Fred Mossler, 55, has served as a member of the Board since May 2017. Mr. Mossler brings experience as an executive, investor, and entrepreneur. He has been an independent consultant, entrepreneur, and philanthropist since June 2016. From August 1999 until June 2016, Mr. Mossler worked in various senior leadership positions at Zappos, including Senior Vice President of Merchandising, and helped Zappos grow into a company with more than $1 billion in gross merchandise sales before it was bought by Amazon in 2009. From September 1991 to August 1999, Mr. Mossler worked in various positions at Nordstrom. In addition to Mr. Mossler’s career in e-commerce and retail, he assisted with the launch and building of, and previously served on the board of, Downtown Project, a company dedicated to helping revitalize part of downtown Las Vegas through investment in small businesses, tech startups, real estate, arts, culture, and education. Mr. Mossler founded Honus Capital LLC, a hands-on investment fund for Las Vegas-area entrepreneurs. He also co-founded the popular Mexican restaurant chain Nacho Daddy. Mr. Mossler graduated from Southern Oregon University with a B.S. degree in Business. Mr. Mossler serves on the Compensation Committee, Nominating and Corporate Governance Committee, and Social Impact and Culture Committee.

Mr. Mossler brings to the Board significant expertise in call center services, in addition to extensive experience in consumer-facing industries and consumer experience more broadly. Mr. Mossler also has extensive experience in assisting with business growth and providing both technology, e-commerce, and product merchandising knowledge.

William G. Wesemann, 65, has served as a member of the Board since November 2004. Mr. Wesemann brings experience as an executive, board member and investor in various technology companies. Mr. Wesemann has been an independent consultant and an independent investor since 2002. In addition to his role as a member of the Board, Mr. Wesemann has served on the board of directors of Aclarion, Inc. (Nasdaq:ACON), a medical SAAS company that listed on Nasdaq in 2022, since 2016. He also serves on the boards of directors of several privately held companies, including STATIONHEAD, a social audio company, and Mylio, a photo management company. From March 2016 until January 2019, Mr. Wesemann was CEO of LARC Networks Inc., a communication, security, and privacy technology developer. Earlier in his career, Mr. Wesemann was CEO of NextPage, Inc., a provider of document management systems, CEO of netLens Inc., a peer-to-peer platform for creating distributed applications that was acquired by NextPage, and Vice President of Sales of Genesys Telecommunications Laboratories, Inc., a leader in computer-telephony integration. Mr. Wesemann received a B.A. degree from Glassboro State College (now called Rowan University). Mr. Wesemann serves as Chair of the Nominating and Corporate Governance Committee and also serves on the Compensation Committee, Audit Committee, and Social Impact and Culture Committee.

Mr. Wesemann brings to the Board notable technology, software and sales experience, in addition to extensive CEO, management and board experience at public and private software and technology companies.
5



The following is a brief biographical summary of the experience of the executive officers of LivePerson, including their ages as of December 31, 2021.
NameAgePosition(s)
Robert P. LoCascio53Chief Executive Officer & Chairman of the Board
John D. Collins40Chief Financial Officer
Monica L. Greenberg53Executive Vice President of Public Policy & General Counsel
Norman M. Osumi (1)
57Senior Vice President, Chief Accounting Officer
(1)Mr. Osumi assumed the role of Senior Vice President, Chief Accounting Officer on March 2, 2021.

Robert P. LoCascio’s biography can be found above in this Amendment, and is included with the biographies of the other members of the Board. Biographies for our other executive officers are listed below.

John D. Collins has served as our CFO since February 2020. Mr. Collins joined LivePerson in September 2019 to lead the development of automations and machine learning to support strategic decision making and predictive analytics as SVP of Quantitative Strategy. In 2013, Mr. Collins co-founded Thasos, a New York City-based predictive intelligence company powering large scale equity trading platforms. Mr. Collins served in various capacities at Thasos, including, most recently, as an Advisory Board Member, as its Chief Product Officer (2016-2019) and as its Portfolio Manager (2013-2016). Prior to that, Mr. Collins held roles in the financial services industry, including regulating financial firms at the NYSE, and structuring transactions in leveraged finance at Credit Suisse. Mr. Collins received his J.D. from Chicago-Kent College of Law at Illinois Institute of Technology, his M.B.A. from the Massachusetts Institute of Technology and a B.S. from the University of Central Florida.

Monica L. Greenberg has been our Executive Vice President of Public Policy and General Counsel since April 2019, our Executive Vice President, Corporate Development, Strategic Alliances and General Counsel from December 2017 to April 2019, our Executive Vice President, Business Affairs and General Counsel from February 2014 to December 2017, and our Senior Vice President, Business Affairs and General Counsel from November 2006 to February 2014. From May 2004 until October 2006, Ms. Greenberg was an independent consultant. From April 2000 until April 2004, Ms. Greenberg served as Vice President, General Counsel and Senior Corporate Counsel of Nuance Communications, Inc. Previously, from January 1999 to March 2000, Ms. Greenberg was the principal of a small business. From July 1996 to December 1998, Ms. Greenberg was associated with the law firm of Wilson Sonsini Goodrich & Rosati in Palo Alto, California. From September 1994 to July 1996, Ms. Greenberg was associated with the law firm of Willkie Farr & Gallagher in New York, NY. Ms. Greenberg received a J.D. from Boston University School of Law where she was a member of the Boston University Law Review, and a B.A. from the University of Pennsylvania.

Norman M. Osumi has served as our Senior Vice President and Chief Accounting Officer since March 9, 2021. Prior to joining LivePerson, Mr. Osumi served in senior finance and accounting roles at Symantec, now known as NortonLifeLock, from October 2007 to February 2021. Prior to that, Mr. Osumi held the position of Vice President of Finance at VeriSign, Inc. from 2004 to 2007, Associate Vice President & Corporate Controller at NEC Electronics America, Inc from 1998 to 2004, and served as Director of Finance at Gymboree Corporation from 1996 to 1998. Mr. Osumi started his career at PricewaterhouseCoopers and received a B.S. from Loyola Marymount University.

Audit Committee

The Audit Committee appoints our independent registered public accounting firm, reviews the plan for and the results of the independent audit, approves the fees of our independent registered public accounting firm, reviews with management and the independent registered public accounting firm our quarterly and annual financial statements and our internal accounting, financial and disclosure controls, reviews and approves transactions between LivePerson and its officers, directors and affiliates, oversees whistle-blower procedures and performs other duties and responsibilities as set forth in a charter approved by the Board. The charter of the Audit Committee is available at https://ir.liveperson.com/corporate-governance/governance-overview. Each member of the Audit Committee is independent, as independence is defined for purposes of Audit Committee membership by the listing standards of The Nasdaq Stock Market (“Nasdaq”) and the applicable rules and regulations of the SEC. The Audit Committee held four meetings during the fiscal year ended December 31, 2021 (the “ 2021 Fiscal Year” or “fiscal 2021”).

The Board has determined that each member of the Audit Committee is able to read and understand fundamental financial statements, including LivePerson’s balance sheet, income statement and cash flow statement, as required by Nasdaq rules. In addition, the Board has determined that Mr. Lavan satisfies the Nasdaq rule requiring that at least one member of our Board’s Audit Committee have past employment experience in finance or accounting, requisite professional certification in accounting or any other comparable experience or background which results in the member’s financial sophistication, including being, or having been, a chief executive officer, chief financial officer or other senior officer with financial oversight responsibilities. The Board has also determined that Mr. Lavan is the Audit Committee’s “audit committee financial expert” as defined by the SEC.

6



Delinquent Section 16(a) Reports

The members of our Board, our executive officers and persons who hold more than ten percent of our outstanding common stock are subject to the reporting requirements of Section 16(a) of the Exchange Act, which requires them to file reports with respect to their ownership of our common stock and their transactions in such common stock. Based solely upon a review of the copies of Section 16(a) reports which LivePerson has received from such persons or entities, and the written representations received from the reporting persons that no other reports were required, for transactions in our common stock and their common stock holdings for the 2021 Fiscal Year, LivePerson believes that all reporting requirements under Section 16(a) for such fiscal year were met in a timely manner by its directors, executive officers and beneficial owners of more than ten percent of its common stock, other than one late Form 4 filed by each of Messrs. Block and Lavan with respect to one transaction each; Messrs. Cu, Mossler, Osumi and Wesemann and Ms. Layfield with regard to two related transactions each; and Mr. Collins with respect to three related transactions.

Codes of Conduct and Corporate Governance Documents

The Company monitors developments in the area of corporate governance and routinely reviews its processes and procedures in light of such developments. Accordingly, the Company reviews federal laws affecting corporate governance as well as various rules promulgated by the SEC and Nasdaq. The Company believes that it has procedures and practices in place which are designed to enhance and protect the interests of its stockholders.

The Board has adopted a Code of Conduct that applies to all officers, directors and employees, and a Code of Ethics for the Chief Executive Officer and Senior Financial Officers that applies to the Company’s Chief Executive Officer and executives who are deemed to be Senior Financial Officers of the Company.

Both codes of conduct can be accessed at https://ir.liveperson.com/corporate-governance/governance-overview and disclosures of any amendments to, or waivers under, the Code of Ethics for the Chief Executive Officer and Senior Financial Officers will be made on our website.

The charters of our Board’s Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee, and LivePerson’s current Amended and Restated Certificate of Incorporation, and Amended and Restated Bylaws can be accessed at https://ir.liveperson.com/corporate-governance/governance-overview. Copies may also be obtained at no charge by writing to LivePerson, Inc., 530 7th Avenue, Floor M1, New York, New York 10018, Attention: Investor Relations.

Item 11. Executive Compensation

Compensation Discussion and Analysis

This Compensation Discussion and Analysis (“CD&A”) describes our executive compensation program for our Named Executive Officers (“NEOs”) for 2021, listed below. The CD&A also describes the process followed by the Compensation Committee of the Board (referred to as the Compensation Committee or the Committee in this CD&A) for making pay decisions in respect of our NEOs, as well as its rationale for specific decisions related to 2021 NEO compensation matters. For 2021, our NEOs included:

Robert P. LoCascio, our Chief Executive Officer;
John D. Collins, our Chief Financial Officer;
Monica L. Greenberg, our Executive Vice President of Public Policy and General Counsel;
Norman M. Osumi, our Senior Vice President and Chief Accounting Officer; and
Alexander Spinelli, our former Global Chief Technology Officer.

Our Company

LivePerson, Inc. is the market leader in Conversational Artificial Intelligence with a best-in-class platform used by thousands of the world’s top brands to better understand customer intents, connect across channels and deliver meaningful outcomes. The Conversational Cloud, our cloud-based platform, enables businesses to become conversational by securely deploying AI-powered messaging at scale for brands with tens of millions of customers and many thousands of agents across each brand’s primary digital channels, including mobile apps, mobile and desktop web browsers, SMS, social media, and third-party consumer messaging
7



platforms. More than 18,000 businesses use our conversational solutions to create a convenient, deeply personal relationship with their customers and nearly a billion conversational interactions are powered by our Conversational Cloud each month.
2021 Financial and Strategic Performance Highlights

Delivered strong financial performance in 2021. Reflecting the strength of our core conversational AI platform and expansion of our customer base, in 2021, our revenue grew 28% to $469.6 million, setting a new record for the company. We drove total messaging volume growth by nearly 50%, while our focus on profitable and leverageable growth enabled us to achieve an adjusted EBITDA margin of 6.2%.

Accelerated the momentum of our core AI platform. We continued to execute our strategy of becoming one of the leading AI and automation companies in the world. In 2021, AI-powered messaging volume increased 60% year-over-year with our AI solutions for customer care and commerce powering approximately 75% of interactions across our platform and entire businesses across retail, healthcare, financial services, travel and hospitality sectors.

Unlocked new growth opportunities in healthcare vertical. Expanding upon our traction in the healthcare vertical for digital customer care, we leveraged our technology and innovation capabilities to pursue brand-to-employee solutions in response to client demand, unlocking additional go-forward opportunities in the healthcare sector for digital solutions on our platform.

Completed acquisitions of VoiceBase and Tenfold to deliver integrated voice, digital, and AI offerings in response to market demand. These acquisitions are enabling us to meet client demand for integrated voice and digital engagement solutions, analytics and AI, and are opening new opportunities for strategic relationships to expand our indirect distribution capabilities.

2021 Executive Compensation Program Highlights

Compensation Program Aligned with Growth. Approximately 88% of our CEO and almost 80% of the compensation for our other NEOs is variable and at risk. To align the long-term interests of our CEO and NEOs with our stockholders, options represented 50% of the 2021 long-term incentive opportunity for our executives and deliver value only if our stock price meaningfully appreciates.

Annual incentives paid out 90% of target. Performance metrics for the annual incentive program include revenue to incentivize top line growth and EBITDA to emphasize disciplined profitability, two of the key drivers of our long-term growth.

Eliminated stock payment premium for the executive annual incentive program. We continued to deliver annual bonus program payouts in the form of vested restricted stock units (“RSUs”) to foster a culture of ownership throughout the company for all bonus plan participants, including our NEOs. For our senior executives, we eliminated the additional premium on bonus RSUs paid in prior years.

Enhanced equity risk mitigation policies. Consistent with our commitment to best governance practices, we adopted robust stock ownership guidelines for our executives, including 5x base salary for the CEO and 2x base salary for other NEOs.

In response to stockholder feedback, we introduced performance RSUs to the 2022 long-term incentive program for executives. Commencing in 2022, long-term incentive equity grants for our NEOs will include performance RSUs with vesting tied to a three-year performance period and the achievement of financial performance and relative TSR metrics. Together with our use of stock options in our executive equity program, we believe the introduction of our performance RSUs further strengthens alignment between the interests of our executives with those of our stockholders, as we continue to evolve our compensation program.

Stockholder Engagement and Say on Pay

We believe that regular, transparent communications with our stockholders are essential to our long-term success. We value the opinions of our stockholders and we are committed to a robust stockholder engagement program to solicit feedback and encourage open, transparent and candid discussion about our strategic priorities, governance programs and sustainability priorities that are important to our stockholders.

Each year, we carefully consider the results of our stockholder advisory say-on-pay vote from the preceding year. In 2021 and 2020, over 92% and 96%, respectively, of the votes cast supported our executive compensation program and decisions. We are pleased with the support we have received in these recent votes as we continue to evolve our executive compensation program with the interests and perspectives of our stockholders in mind. In this regard, based on stockholder feedback, as part of the 2022 long-term incentive program design, the Board adopted a new long-term incentive program structure that will incorporate a performance-based RSU component as part of our annual equity grants to NEOs. We will continue to evaluate and evolve our performance compensation programs over time in response to stockholder feedback and consistent with best practices.

8



We engage with our stockholders in a variety of ways, including as follows:

We regularly speak with stockholders, prospective stockholders and investment analysts.
We participate in equity conferences and investor events across the United States.
We also directly engage with stockholders to solicit feedback on the following matters: executive compensation, environmental, social and governance (“ESG”) strategies and practices, governance, and other topics of interest related to our business.

As part of our engagement efforts, we seek to provide our investors with insight into our business and practices, answers to their questions, and responses to the valuable insight and feedback they share. We also review and discuss stockholder feedback internally to help ensure we are proactively assessing and informing our policies, programs and areas of focus, as well as balancing the priorities of our stockholders. We intend to continue our efforts to engage with, and solicit feedback from, our stockholders and will, in turn, carefully consider, and may implement, revisions to our compensation programs as a result of that feedback, as we have done for our 2022 program with the adoption of performance-based RSUs.

Compensation Governance

We believe the following practices and policies, embedded in our current NEO compensation plans and programs, promote sound compensation governance and are in the best interests of our stockholders and executives:
What We DoWhat We Don’t Do
üEmphasize variable incentive pay ûNo excise tax gross ups
üMaintain a clawback policy covering all incentive awards
ûNo guaranteed bonuses
üMaintain fully independent Compensation CommitteeûNo excessive perquisites
üRetain an independent compensation consultantûNo option repricing, without stockholder approval
üDesign compensation programs that would not encourage risk-takingûNo hedging
üCap bonus payoutsûNo dividends paid on unvested equity awards

What Guides Our Program

Compensation Philosophy, Strategy and Objectives

The philosophy underlying our executive compensation program is to employ and retain the best leaders in our industry to ensure we execute on our business goals, and to reward both individual and company performance in order to promote continued growth and profitability, and to effectively create long-term stockholder value. Our executive compensation program strategy is therefore driven by the following objectives:
Pay for Performance
A significant portion of an executive’s total compensation should be variable and at risk and aligned with our short- and long-term performance results.
Stockholder AlignmentExecutives should be compensated through pay elements (annual- and long-term incentives) designed to align executive compensation to the creation of long-term value for our stockholders.
CompetitivenessTarget compensation should be set at a level that is competitive with that being offered to individuals holding comparable positions at other companies with which we compete for business and leadership talent.
Attraction and RetentionThe executive compensation program should enable the Company to attract and retain high-potential team players with exceptional leadership capabilities and who want to build a long-term career with LivePerson.

9



Elements of Compensation

In order to achieve our compensation objectives and to support our strategy and compensation philosophy, each as outlined above, our compensation program has been designed to include the following principal pay elements:
ElementForm of PaymentPurpose
Base SalaryCash
(Fixed)
• Provides a competitive fixed rate of pay relative to similar positions in the market.
• Enables the Company to attract and retain critical executive talent.
• Based on job scope, level of responsibilities, individual performance, experience, and market levels.
Annual IncentiveCash or
Equity
(Variable)
• Focuses executives on achieving important annual financial and strategic goals that drive stockholder value.
• Rewards attainment of annual business goals.
• Allows for assessment of individual performance and contribution.
• Form of award settlement determined by the Compensation Committee as part of annual bonus plan design determination.
Long-Term IncentivesEquity
(Variable)
• Provides incentives for executives to execute on longer-term financial and strategic growth goals to maintain focus on long-term stockholder value creation.
• Supports the Company’s executive retention strategy.

The Company also offers certain benefits, including medical, dental and life insurance benefits, a deferred compensation program, and retirement savings that it considers to be consistent with industry practices and important for competitive recruitment and retention. The NEOs are eligible to participate in these programs on the same basis as our other employees. The Company does not offer special benefits such as supplemental executive retirement plans, perquisites, tax gross-ups or tax equalization.

Pay Mix

In accordance with our executive compensation philosophy, the charts below illustrate the target annual total direct compensation (base salary, target annual incentive opportunity and the grant date fair value of long-term equity-based incentives awarded in 2021) of our CEO and all other NEOs for fiscal year 2021, which shows our emphasis on variable, at-risk compensation.
lpsn-20211231_g1.jpg
As illustrated by the charts above, a majority of the CEO’s, and other NEOs’ target pay is incentive-based, and therefore is considered “at risk.” This incentive-based compensation, for each executive, includes an annual bonus award, determined based on the Company’s success over certain financial metrics and paid in the first quarter of 2022 in fully-vested RSUs, and long-term
10



incentive awards delivered in a mix of 50% stock options and 50% restricted stock unit awards. In each case, the value of the compensation package increases as the value of our shares increase, and the value of the compensation package decreases as our share value decreases. This approach directly aligns our CEO’s interests with those of our stockholders in both times of share price growth, as well as when the Company faces share price pressure.

The Role of the Compensation Committee

The Compensation Committee, comprised of independent, non-employee members of the Board, oversees the executive compensation program for our NEOs. The Compensation Committee works very closely with an independent compensation consultant, having engaged Pearl Meyer through August 2021, at which time it entered into a new engagement with Compensia. The Committee also seeks the input of management to examine the effectiveness of the Company’s executive compensation program throughout the year. The Compensation Committee reviews executive compensation and market and peer compensation data annually, in conjunction with annual operational and financial planning for the current fiscal year and periodically as needed for specific executive compensation issues that may arise at other times. The Compensation Committee makes final determinations regarding compensation for the CEO and our other executive officers in its sole discretion. Details of the Compensation Committee’s authority and responsibilities are specified in the Compensation Committee’s charter, which may be accessed at our website, www.liveperson.com, by selecting “Investor Relations,” and then “Governance,” and then “Governance Overview.”

The Role of Management

Our CEO, with input from a committee of senior executives, assists the Compensation Committee by presenting it with proposals and recommendations for NEO compensation levels (other than for himself), information on Company and individual performance of each NEO and management’s perspective and recommendations on compensation design matters (except that the CEO and senior executives, to the extent present, recuse themselves from that portion of the Compensation Committee meetings involving their own compensation).

The Role of the Independent Compensation Consultant

Under its Charter, the Compensation Committee has the authority to retain an independent compensation consultant to provide expertise on competitive pay practices, program design, and an objective assessment of the inherent risks of any compensation programs. During 2020 and until August 2021, the Committee worked with Pearl Meyer, an independent compensation consulting firm, to assist the Committee in evaluating the elements and levels of our executive compensation for 2021, including base salaries, annual cash incentive awards and equity-based incentives for our CEO and other executive officers.. During this time, Pearl Meyer advised the Committee on a variety of compensation matters, completed a competitive market assessment for executive and non-employee director compensation levels, conducted a compensation peer group review, reviewed governance matters pertaining to executive and employee compensation with the Committee, and reviewed strategies regarding equity grants pursuant to the Company’s short- and long-term incentive programs. During the time of their services, Pearl Meyer also advised and assisted the Committee with other ad hoc requests related to executive compensation. .

In August 2021, the Committee ended its engagement with Pearl Meyer and transitioned to using Compensia as the Committee’s independent compensation consultant. Since its engagement, Compensia has refreshed the Company’s market benchmarking analysis utilizing the previously determined peer group, worked with the Company to review bonus awards under the 2021 short-term incentive bonus program, and focused on development and implementation of an updated long-term equity compensation program that introduces the use of performance share units as part of the annual equity grant mix for executive officers (as more fully described below in the sections of this Amendment entitled “2022 Compensation Design Updates”).

The Compensation Committee conducted an independence assessment of both Pearl Meyer and Compensia in accordance with SEC and Nasdaq rules. Based on this review, the Committee is not aware of any conflicts of interest raised by the work performed by either Pearl Meyer or Compensia that would prevent them from having served, or serving, as applicable, as an independent consultant to the Compensation Committee. The Committee’s compensation consultant reports directly to the Compensation Committee, and neither Pearl Meyer nor Compensia provided any additional services to the Company or management in 2021.

The Role of Competitive Pay Positioning/2021 Benchmarking

As part of the compensation setting process for 2021, the Compensation Committee reviewed surveys and market data provided by Pearl Meyer to evaluate compensation levels and practices for the NEOs. After consideration of the data collected on external competitive levels of compensation and internal relationships within the executive group, the Compensation Committee reviewed and approved 2021 target total compensation opportunities for executives based on the need to attract, motivate and retain an experienced and effective management team.

Pay levels for each of our NEOs are determined based on a number of factors, including the individual’s roles and responsibilities within the Company, the individual’s experience and expertise, the pay levels for peers within the Company, pay levels in the
11



marketplace for similar positions and performance of the individual and the Company as a whole. The Compensation Committee is responsible for approving pay levels for our NEOs. In determining the pay levels, the Compensation Committee considers all forms of compensation and benefits.

Relative to the general competitive industry market data, the Compensation Committee generally intends that total target compensation (salary, annual incentive and long-term incentive opportunity) is calibrated to be within a reasonable range of the median of the competitive market. As noted above, notwithstanding the Company’s overall pay positioning objectives, pay opportunities for specific individuals vary based on several factors such as scope of duties, tenure, institutional knowledge and/or difficulty in recruiting a new executive. Given that a majority of our compensation consists of variable, at-risk elements, actual total compensation in a given year will vary above or below the target compensation levels based primarily on the attainment of operating goals and the creation of stockholder value.

For purposes of setting compensation for 2021, together with Pearl Meyer and input from management, the Compensation Committee approved a compensation peer group of 17 companies. In developing an appropriate comparator group, the following criteria served as key drivers: industry (inclusive of business scope and business mix), size (market capitalization and revenue), revenue growth rate, gross margin, number of employees and location. The 2021 peer group remained consistent with the peer group utilized for compensation determinations in 2020 as originally adopted in Q4 2019 and includes the following companies:
BlackLine, Inc.MongoDB, Inc.Twilio, Inc.
Box, Inc.New Relic, Inc.Varonis Systems, Inc.
Datadog, Inc.Nuance Communications, Inc.Yext, Inc.
8x8, Inc.PROS Holdings, Inc.Zendesk, Inc.
Five9, Inc.Slack Technologies, Inc.Zuora, Inc.
HubSpot, Inc.Momentive Global (formerly SVMK, Inc.)

2021 Compensation Program In Detail

Base Salary

The Compensation Committee believes that executive base salaries should reflect competitive levels of pay and factors unique to each executive such as experience and breadth of responsibilities, performance, individual skill set, time in the role and internal pay parity. Salary adjustments are generally approved during the first quarter of the calendar year and implemented during the second quarter. For 2021, no base salary increases were made for the NEOs, as set forth in the table below.
NEOBase salary as of
December 31, 2020 ($)
Base salary as of
December 31, 2021 ($)
% Adjustment
Robert P. LoCascio611,820 611,820 — %
John D. Collins450,000 450,000 — %
Monica L. Greenberg400,000 400,000 — %
Norman M. Osumi (1)
— 340,000 N/A
Alexander Spinelli (2)
450,000 — N/A
(1)Mr. Osumi’s first date of employment with the Company was February 22, 2021.
(2)Mr. Spinelli’s last day of employment with the Company was October 22, 2021. His base salary for 2021 was consistent with the level in effect as of December 31, 2020.

Annual Incentive Compensation

Our NEOs are provided the opportunity to earn a performance-based annual bonus. The annual bonus plan is designed to provide awards to such individuals as an incentive to contribute to and reward revenue growth, profitability, and execution on our strategic corporate objectives.

Actual bonus payouts depend on the achievement of pre-established financial performance objectives and the Compensation Committee’s assessment of contributions toward our strategic corporate objectives, as well as the individual’s target bonus amount.

12



Target annual bonus opportunities are expressed as a percentage of base salary and were established by the Compensation Committee in consideration of the NEO’s level of responsibility and his or her ability to impact overall results. The Compensation Committee also considers market data in setting target award amounts. For 2021, target award opportunities were as follows:
NEOTarget Bonus
as a % of Salary
Target Bonus
($)
Robert P. LoCascio100 %611,820 
John D. Collins (1)
55 %236,250 
Monica L. Greenberg50 %200,000 
Norman M. Osumi (2)
35 %109,083 
Alexander Spinelli (3)
100 %450,000 
(1)Mr. Collins’s target bonus opportunity increased from 45% to 55% as of April 1, 2021. The target bonus listed above represents the blended target bonus amount taking into action the April 1, 2021 adjustment.
(2)Mr. Osumi’s first date of employment with the Company was in February 2021 and therefore, his bonus opportunity was prorated for 11 months.
(3)Mr. Spinelli’s employment with the Company terminated prior to the end of fiscal 2021 and the bonus payout date, and he was therefore not entitled to a bonus payment in respect of the 2021 performance year pursuant to the Company’s bonus program and policies.

Annual bonus payouts are based on achievement of financial objectives, and the related threshold, target and maximum performance goals for each objective established by the Compensation Committee in consultation with the CEO. The Company believes it is important to focus on both top line growth (revenue), as well as profitability. The Compensation Committee therefore chose Revenue and Adjusted EBITDA (defined below) as the relevant financial performance metrics for 2021 annual bonuses, consistent with the financial metrics used in prior years. For this purpose, “Adjusted EBITDA” means net (loss) income, before provision for (benefit from) income taxes, interest expense, net, other (expense) income, depreciation and amortization, stock-based compensation, restructuring costs, transaction-based acquisition costs and other non-cash charges. Under the annual bonus program, the Compensation Committee also may, in its discretion, make an assessment of individual performance based on the Company’s execution of its strategic objectives and apply an additional modifier to adjust a recipient’s bonus amount up or down. The Compensation Committee also annually sets a cap on the potential bonus payout under the program. For 2021, bonus payout potential was capped at 150% of target for all NEOs.

While maintaining consistent use of Revenue and Adjusted EBITDA as the financial metrics for the annual bonus program over the last several years, the Committee reevaluates the applicable weightings each year in order to emphasize the measure best suited to drive desired business outcomes. For 2021, the Compensation Committee set the weighting at 80% for the Revenue metric and 20% for the Adjusted EBITDA metric.

Following the determination of the relevant performance goals for 2021, the Company, with the Board’s approval, modified its fiscal plan to make strategic investments directed to driving sustainable growth and creating long term stockholder value (such as investments in strategic acquisitions as well as go-to-market investments). Based on the Company’s actual performance in 2021, the applicable Revenue target was achieved at 100%. However, in light of the strategic investments described above, the associated unplanned expenses materially impacted our EBITDA performance that fell below the performance threshold set at the start of the year. This outcome would have resulted in a combined performance payout at 80% of target.

To account for the shift in our business plan for the year, the Committee determined that it was reasonable and appropriate to assess performance results for the year based on the performance levels that would have otherwise been earned absent the Company’s mid-year strategic investments. The Committee believed that this approach would provide a fair and more comparable determination of the Company’s performance achievement for the year, which would have translated to a bonus payout at 98% of target. To foster alignment of our annual incentive program with the experience of our stockholders in fiscal 2021, the Compensation Committee approved a reduction of the bonus payout down to 90% of target.

13



The table below summarizes the Revenue and Adjusted EBITDA performance goals and outcomes with respect to the 2021 annual bonus program:
GoalWeightingGoals
Threshold/
Target/
Maximum
($M)
Achievement Level
($M)
Payout % AchievementWeighted Average Achievement
2021 Revenue80 %454.6/466.1/505.9469.5100 %80 %
2021 Adjusted EBITDA 20 %39.7/50.6/65.346.9
(1)
90 %18 %
Total for Financial Metrics100 %98 %
(1)
Compensation Committee Adjustment for Final Payout Percentage90 %
(1)The Adjusted EBITDA achievement level excludes the impact of the strategic investments, which results in a final weighted average achievement of 98%. The actual Adjusted EBITDA achievement level, without excluding the impact of the strategic investments, was $29.2 million.

The Compensation Committee did not revise any NEO bonuses based on individual performance or strategic objectives, other than for Mr. Osumi. In recognition of superior performance and significant achievements in execution of his role since joining the Company in February 2021, including, in part, Mr. Osumi’s efforts in delivering on key strategic and operational goals, the Compensation Committee determined that it was appropriate to apply an individual performance modifier of 120% to Mr. Osumi’s bonus payout for 2021, which when applied to the 90% payout rate set by the Compensation Committee, translated to a payout for Mr. Osumi at 108%. The table below sets forth the target bonus and earned bonus for each NEO for 2021.
NEO (1)
Target Bonus
($)
Earned Bonus
($)
Earned Bonus
(as a % of Target)
Robert P. LoCascio611,820 550,638 90 %
John D. Collins (2)
236,250 212,625 90 %
Monica L. Greenberg200,000 180,000 90 %
Norman M. Osumi (3)
109,083 117,810 108 %
(1)Mr. Spinelli was not employed by the Company at the end of fiscal 2021 and was therefore not entitled to a bonus payment.
(2)Mr. Collins’s target bonus opportunity increased from 45% to 55% as of April 1, 2021. The target bonus listed above represents the blended target bonus amount taking into action the April 1, 2021 adjustment.
(3)Mr. Osumi’s first date of employment with the Company was in February 2021, and therefore, his bonus was prorated for 11 months. In addition to Company achievement of 90%, Mr. Osumi achieved an individual performance modifier of 120%, resulting in an aggregate payout percentage of 108%.

Prior to payment of bonuses for the 2019 performance period, annual bonuses were generally paid entirely in cash. In an effort to further our objective to foster an ownership culture throughout the Company and focus on long-term value creation, beginning in 2020 all annual bonus plan participants, encompassing approximately 84% of employees, including the NEOs, received their annual bonus payout in the form of vested restricted stock units (“Bonus RSUs”). This program continued with respect to 2021 bonus payouts. For the NEOs, the Company calculated the number of Bonus RSUs paid to the NEO by dividing the NEO’s earned bonus amount by the fair market value of a share of Company common stock on the date of settlement of the Bonus RSUs, and no additional premium was applied to the NEOs’ Bonus RSU grants to account for the settlement in shares rather than in cash, as had been the practice in prior years.

Long-Term Incentives - Annual Equity-Based Awards

Equity-based awards are an important factor in aligning the long-term financial interests of our NEOs and our stockholders. The Compensation Committee continually evaluates the use of equity-based awards and intends to continue to use such awards in the future as part of designing and administering the Company’s compensation program. The Compensation Committee may grant equity incentives under the Company’s 2019 Stock Incentive Plan in the form of stock options (non-qualified and incentive stock options), stock appreciation rights, restricted stock, performance shares and other stock-based awards, including, without limitation, RSUs and deferred stock units. The Compensation Committee approves equity grants at one of its regularly scheduled meetings, or at such other times as appropriate or necessary, and generally after the Compensation Committee has its annual compensation review process for the CEO and other NEOs. In 2019, the Company adopted internal grant-making guidelines which contemplate, in part, that the Committee would consider the timing of “open trading windows” as set in accordance with the
14



Company’s Insider Trading Policy as a factor for alignment with stockholder interests when determining the exercise price methodology for stock options.

In March 2021, the Compensation Committee granted equity awards to the NEOs using a mix of stock options and RSUs. In granting these equity awards, the Compensation Committee considered market data regarding equity compensation awards for executive officers of comparable companies. The Compensation Committee also considered the significant roles each of the NEOs play in driving the Company’s performance and executing on its strategic priorities, as well as their overall level of performance, tenure and existing equity holdings.

The stock options and restricted stock units granted in spring 2021 as part of the Company’s annual long-term incentive program each provide for service-based vesting in four equal annual installments beginning on the first anniversary of the grant date.

The following table describes the equity awards made to the NEOs as described above:
NEO
Value of Options at Grant ($) (1)
Stock Options
(# of shares)
Value of RSUs at Grant ($)RSUs
(# of units)
Total Value of Equity Awards at Grant ($)
Robert P. LoCascio (2)
$2,000,00082,700$2,000,00038,700$4,000,000
John D. Collins (2)
$700,00029,000$700,00013,600$1,400,000
Monica L. Greenberg (2)
$550,00022,800$550,00010,700$1,100,000
Norman M. Osumi (3)
$601,00023,300$303,0005,500$904,000
Alexander Spinelli (4)
$850,00035,200$850,00016,500$1,700,000
(1)The “Value of Options at Grant” represents the approved target value of the award when approved by the Board (at which time a grant date was set during the next “open trading” window). The actual grant date fair value set forth in the Summary Compensation Table may differ because of the mechanics of converting the dollar target value into a number of shares on the pre-determined grant date, rounding as appropriate, and then calculating the grant date fair value of the resulting number of shares under the applicable accounting principles.
(2)Other than for Mr. Osumi, the total value of each NEO grant was approved by the Committee on April 9, 2021, which amount was to be attributed 50% to stock options and 50% to RSUs. In connection with this grant, as described above, the number of shares subject to each award, and the exercise price for the stock options, was calculated based on the price of a share of Company common stock on May 7, 2021, the first day of the first “open trading window” following the grant approval date, and in the case of stock options, the applicable Black-Scholes value.
(3)Mr. Osumi received the equity awards as part of a new hire grant. The number of shares was calculated on the grant date of April 21, 2021.
(4)Mr. Spinelli was granted equity awards in 2021 but they were forfeited upon his departure from the Company on October 22, 2021.


15



2022 Compensation Incentive Program Design Updates

In response to our stockholders’ feedback, we introduced performance RSUs into our 2022 long-term incentive program to further foster alignment with our stockholders and long-term financial and relative performance results.

Starting in 2022, our long-term equity incentives for NEOs will be issued in an equal mix of performance RSUs, stock options, and service RSUs. With the introduction of performance RSUs, two-thirds of the long-term incentive opportunities for our CEO and other NEOs will be performance-based with the value only realized upon the achievement of pre-set performance goals and/or increases in our stock price.
lpsn-20211231_g2.jpg

The vesting of performance RSUs will be tied to our performance results over a three-year performance period, achieved against preset revenue and EBITDA targets for 2022, together with a modifier based on year over year EBITDA margin performance in 2023, and an additional modifier based on relative Total Shareholder Return to be measured over the three-year performance period ending in 2024. The targets are set at the start of the three-year performance period and are aligned with our operating plan and key drivers of our long-term stockholder value. The program design motivates our executives to maximize both absolute and relative performance results throughout the full performance cycle in support of our sustained long-term growth objectives. Earned performance RSUs, if any, cliff-vest at the end of the three-year performance period, without any interim vesting opportunities.

Other Compensation Practices, Policies, and Guidelines

Stock Ownership

We strongly encourage our executives and non-employee directors to hold an equity interest in our Company, and adopted formal executive stock ownership guidelines in April 2022. Under the new policy, each of our executive officers and non-employee directors is required to build and maintain their share ownership to the levels listed below within a period of five years from start of service with the Company:
CEO: 5x current base salary.
Other NEOs: 2x current base salary.
16



Non-employee directors: 5x annual cash retainer.
Shares owned outright (including shares from vested RSUs and performance-based RSUs) will count toward the ownership goals, while shares associated with unvested RSUs, performance-based RSUs and unexercised stock options do not count toward compliance with the policy. It is anticipated that all of the executive officers will be in compliance with the suggested ownership levels within the requisite timeframes. If the ownership goals are not achieved within the applicable five-year compliance period, the executive officer would be required to hold all net shares issued upon exercise of stock options or settlement of RSUs and performance-based RSUs (in each case, after payment of any applicable withholding tax obligations) until the guidelines are met.

Compensation Recovery Policy

In April 2020, the Company adopted a policy under which, in the event of an accounting restatement of the Company’s financial statements due to the Company’s material noncompliance with any financial reporting requirements under federal securities laws, the Board could, in its sole discretion, seek to recover cash or equity-based incentive compensation paid to our current and former executive officers in the three years prior to the year of the accounting restatement where the payments were predicated upon the achievement of financial results that were subsequently changed in light of the accounting restatement. The policy may be applied whether or not the accounting restatement was the result of any wrongdoing on the part of the impacted executive officers, in the sole discretion of the Board.

Other Benefits

We do not offer special perquisites to our NEOs. The Company’s executive compensation program includes standard benefits that are also offered to all employees. These benefits include participation in the Company’s 401(k) plan accounts, including Company matching contributions, and Company-paid medical benefits and life insurance coverage. The Company annually reviews these other benefits and perquisites and makes adjustments as warranted based on competitive practices, the Company’s performance and the individual’s responsibilities and performance. The Company’s 401(k) has a Safe Harbor Plan and, in accordance with IRS rules, the Company matches 100% of the first 3% of eligible compensation and 50% of the next 2% of eligible compensation, subject to IRS limitations.

Deferred Compensation Plan

In 2015, the Compensation Committee adopted the Deferred Compensation Plan. Certain key employees of the Company, including our NEOs and members of our Board, are eligible to participate in the Deferred Compensation Plan and generally may elect to defer the receipt of a portion of their base salary, bonus and/or directors’ fees until distribution (which may occur upon the following events: a specified time, a separation from service, death, disability, change of control, or financial hardship that arises in connection with an unforeseeable emergency). To date, none of our current NEOs have elected to make any deferrals under the Deferred Compensation Plan. The Company may make discretionary or matching contributions to the Deferred Compensation Plan, which may or may not be subject to vesting, but has not done so to date.

Post-Termination Compensation and Benefits

Certain employment agreements with our executive officers provide for severance payments and benefits upon an involuntary termination of employment, or resignation for “good reason” (as defined in the agreement). In addition, certain executives are entitled to vesting acceleration in the event they are involuntary terminated or resign for good reason in connection with a change in control. Additional details regarding the employment agreements with our executives, including a description of the severance payments and benefits payable to our executives as well as estimates of amounts payable upon termination of employment, are disclosed in the sections of this Amendment entitled “Employment Agreements for our Named Executive Officers” and “Potential Payments Upon Termination or Change-in-Control.”

Prohibition Against Hedging and Certain Equity Transactions

Our Insider Trading Policy prohibits those officers subject to Section 16 reporting from engaging in hedging or derivative transactions, such as “cashless” collars, forward contracts, equity swaps or other similar or related transactions. In addition, all officers and employees of the Company and all the members of our Board, are prohibited from engaging in “short” sales or other transactions involving LivePerson stock which could reasonably cause our officers to have interests adverse to our stockholders. “Short” sales, which are sales of shares of common stock by a person that does not own the shares at the time of the sale, evidence an expectation that the value of the shares will decline. We prohibit our officers from entering into “short” sales because such transactions signal to the market that the officer has no confidence in us or our short-term prospects and may reduce the officer’s incentive to improve our performance. In addition, Section 16(c) of the Exchange Act expressly prohibits executive officers and directors from engaging in short sales. Our officers are also prohibited from trading in LivePerson-based put and call option
17



contracts, transacting in straddles and similar transactions without Board approval. These transactions would allow someone to continue to own the covered securities, but without the full risks and rewards of ownership. If an officer were to enter into such a transaction, the officer would no longer have the same objectives as our other stockholders. Under the Insider Trading Policy, officers, employees and all of the members of our Board are also prohibited from margining or pledging their common stock to secure a loan, or from purchasing Company stock “on margin” (that is, borrow funds to purchase stock, including in connection with exercising any Company stock options).

Tax and Accounting Considerations

In determining executive compensation, the Compensation Committee also considers, among other factors, the possible tax consequences to the Company and to its executives. However, to maintain maximum flexibility in designing compensation programs, the Compensation Committee will not limit compensation to those levels or types of compensation that are intended to be deductible.

Section 162(m) of the Internal Revenue Code of 1986, as amended (the “Code”), and as further amended by the Tax Cuts and Jobs Act of 2017, denies a federal income tax deduction for certain compensation in excess of $1.0 million per year paid to certain executive officers of a publicly-traded corporation, with no exception for “performance-based” compensation (other than under limited transition relief). Under Section 162(m), as amended, the Company will be denied a deduction for any compensation exceeding $1.0 million for those considered covered individuals under the rules, unless the transition rules for certain compensation that qualified as performance-based compensation apply. However, to retain highly skilled executives and remain competitive with other employers, the Compensation Committee may authorize compensation that will not be deductible under Section 162(m) or otherwise if it determines that such compensation is in the best interests of the Company and its stockholders.

Sections 280G and 4999 of the Code provide that executive officers, persons who hold significant equity interests and certain other highly-compensated service providers may be subject to an excise tax if they receive payments or benefits in connection with a change in control of the Company that exceeds certain prescribed limits, and that the Company (or a successor) may forfeit a deduction on the amounts subject to this additional tax. Further, Section 409A of the Code imposes certain additional taxes on service providers who enter into certain deferred compensation arrangements that do not comply with the requirements of Section 409A. We have not agreed to pay any NEO a “gross-up” or other reimbursement payment for any tax liability that he or she might owe as a result of the application of Sections 280G, 4999 or 409A.

The Compensation Committee also considers the accounting consequences to the Company of different compensation decisions and the impact of certain arrangements on stockholder dilution. However, neither of these factors by themselves will compel a particular compensation decision.

Compensation Committee Report

The Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis with management and based on the review and discussions, the Compensation Committee recommended to our Board that the Compensation Discussion and Analysis be included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021.

Submitted by the Compensation Committee of the Company’s Board:
Jill Layfield (Chair)
Peter Block
Kevin C. Lavan
Fred Mossler
William G. Wesemann

The Compensation Committee Report above does not constitute “soliciting material” and will not be deemed “filed” or incorporated by reference into any of our future filings under the Securities Act of 1933, as amended, (the “Securities Act”) or the Exchange Act that might incorporate our SEC filings by reference, in whole or in part, notwithstanding anything to the contrary set forth in those filings.

18



Summary Compensation Table

The following table sets forth the compensation earned for all services rendered to the Company in all capacities in each of the last three fiscal years, by our NEOs.

Following the table is a discussion of material factors related to the information disclosed in the table.
Name and Principal PositionYearSalary
($)
Stock
Awards (1)
($)
Option
Awards (1)
($)
Non-Equity Incentive Plan Compensation (2)
($)
All Other Compensation
($)
Total
($)
Robert P. LoCascio
Chief Executive Officer
2021611,820 2,002,338 
(3)
2,001,340 550,638 28,943 
(4)
5,195,079 
2020611,820 1,613,271 
(3)
1,613,290 917,730 27,612 4,783,723 
2019611,820 1,250,029 1,250,243 688,302 35,844 3,836,238 
John D. Collins
Chief Financial Officer
2021450,000 703,664 
(3)
701,800 212,625 39,179 
(4)
2,107,268 
2020441,667 655,081 
(3)
600,435 303,750 37,713 2,038,646 
Monica L. Greenberg
Executive Vice President, Public Policy and General Counsel
2021400,000 553,618 
(3)
551,760 180,000 19,682 
(4)
1,705,060 
2020400,000 501,237 
(3)
500,969 300,000 19,670 1,721,876 
2019390,625 295,500 605,000 225,024 22,882 1,539,031 
Norman M. Osumi
Chief Accounting Officer (5)
2021289,872 303,435 
(3)
601,373 117,810 26,935 
(4)
1,339,425 
Alexander Spinelli
Former Global Chief Technology Officer (6)
2021337,336 853,710 
(6)
851,840 
(6)
— 30,561 
(4)
2,073,447 
2020450,000 851,829 
(3)
850,313 675,000 32,822 2,859,964 
2019450,000 591,000 726,000 506,254 40,913 2,314,167 
(1)Amounts represent the aggregate grant date fair value for restricted stock units and stock options granted in the fiscal year computed in accordance with Financial Accounting Standards Board’s Accounting Standards Codification Topic 718, or ASC Topic 718, and in accordance with SEC rules. Generally, the aggregate grant date fair value is the amount that the Company expects to expense in its financial statements over the award’s vesting schedule. These amounts reflect the Company’s accounting expense and do not correspond to the actual value that will be realized by the NEOs and there is no assurance that these grant date fair values will ever be realized by the NEOs. Pursuant to SEC rules, the amounts shown exclude the impact of estimated forfeitures related to service-based vesting conditions. For additional information on the valuation assumptions with respect to the grants, refer to Note 11 of LivePerson’s consolidated financial statements contained in our Annual Report on Form 10-K for the 2021 Fiscal Year, as filed with the SEC.
(2)The performance-based, annual incentive bonuses earned in 2021 and paid in 2022 are reflected in the column entitled “Non-Equity Incentive Plan Compensation” for 2021. All bonuses were paid in the form of vested restricted stock units, in lieu of a cash payment, as further described above in the CD&A. Due to his termination, Mr. Spinelli was not eligible to receive a bonus for 2021.
(3)These amounts do not include the value of restricted stock units granted on March 1, 2022 and March 3, 2021, due to the decision to distribute fully vested restricted stock units in lieu of annual cash bonus payments in respect of performance for 2021 and 2020, which amounts are included in the column “Non-Equity Incentive Plan Compensation.”
(4)Amounts include: (i) $720, $648, $540, $576, and $408 for Mr. LoCascio, Mr. Collins, Mr. Spinelli, Ms. Greenberg, and Mr. Osumi, respectively, for premiums for term life insurance, (ii) $6,118 for Mr. LoCascio, $11,333 each for Ms. Greenberg and Mr. Osumi, and $11,600 each for Mr. Collins and Mr. Spinelli for matching contributions to 401(k) plans, and (iii) $22,105, $26,931, $18,421, $7,773, and $15,194 for Mr. LoCascio, Mr. Collins, Mr. Spinelli, Ms. Greenberg, and Mr. Osumi, respectively, for health, dental, vision and disability insurance.
(5)Mr. Osumi’s first date of employment with the Company was February 22, 2021, and he assumed his current role as of March 2, 2021.
(6)Mr. Spinelli’s last day of employment with the Company was October 22, 2021. In connection with his termination of employment, Mr. Spinelli forfeited all unvested equity awards, including the restricted stock units and stock options he received in 2021 which are disclosed on this “Summary Compensation Table.” The amount reported in the “Stock Award” column does not include the value of restricted stock units granted on March 3, 2021, due to the decision to distribute fully vested restricted stock units in lieu of annual cash bonus payments in respect of performance for 2020, which amounts are included in the column “Non-Equity Incentive Plan Compensation” for 2020.


19



Employment Agreements for our Named Executive Officers

Robert P. LoCascio, our CEO, was originally employed pursuant to an employment agreement entered into as of January 1, 1999. Following a comprehensive review by the Compensation Committee of the Board of applicable market and benchmarking data, with advice and input from the Compensation Committee’s independent executive compensation consultant at the time, together with a review of certain strategic achievements by the Company, the Compensation Committee determined that it was in the best interest of the Company to enter into an updated employment agreement with Mr. LoCascio. Accordingly, an updated employment agreement was entered into with an effective date of December 27, 2017 (the “CEO Agreement”).

The CEO Agreement provides, among other terms and conditions, for an updated compensation package for Mr. LoCascio. Pursuant to the CEO Agreement, Mr. LoCascio is entitled to receive a base salary of $611,820, subject to annual review and increase by the Board in its discretion. Mr. LoCascio is also eligible to receive a target annual bonus equal to 100% of his base salary, which target percentage is subject to annual increase by the Board in its discretion, and a maximum potential payment of 200% of target. The actual amount of the annual bonus for a given year is to be determined by the Board based on achievement of the relevant performance goals and metrics established by the Compensation Committee on an annual basis, the overall financial performance of the Company and such other factors as the Compensation Committee in its sole discretion shall deem reasonable and appropriate (the “CEO Bonus”). At the written election of Mr. LoCascio, the CEO Bonus, if any, (or portion thereof) may be paid in fully vested shares of common stock of the Company having a fair market value at the time of issuance equivalent in an amount equal to the portion of the CEO Bonus that Mr. LoCascio elects to convert into shares. In the event Mr. LoCascio remains employed by the Company or a successor entity following a Change of Control (as such term is defined in the CEO Agreement), the CEO Bonus for the then-current year shall be equal to the greater of (i) 100% of the amount of the CEO Bonus actually paid to Mr. LoCascio for the immediately preceding calendar year or (ii) the bonus target amount for the CEO Bonus for the then current year; provided that if the CEO Bonus for the calendar year preceding the Change of Control has not been determined prior to the Change of Control, the amount of such bonus shall be determined by the Board and shall not be less than the target bonus for such year. In no event will the Company be obligated to pay more than one CEO Bonus for the same annual period.

The CEO Agreement also provides that during the Term and for a period of (A) 12 months following a termination or cessation of employment in the event of a termination or cessation for which Mr. LoCascio is not receiving the base salary continuation portion of any severance or (B) 18 months following a termination or cessation of employment in the event of a termination or cessation for which Mr. LoCascio is receiving the base salary continuation portion of his severance, Mr. LoCascio is subject to restrictive covenants of (i) noncompetition, (ii) nonsolicitation of employees and independent contractors, and (iii) noninterference with customers, clients, prospective customers or clients. Additionally the CEO Agreement provides that payments may be subject to forfeiture or recoupment if required by law or regulation to which the Company becomes subject, or in the event of the Mr. LoCascio’s acts of embezzlement, fraud or dishonesty involving the Company or its affiliates that result in financial loss to the Company or its affiliates.

The CEO Agreement provides for certain payments upon Mr. LoCascio’s termination. Please refer to the next section “Potential Payments Upon Termination or Change in Control” for additional description of those termination payments.

John D. Collins, our CFO, was originally employed pursuant to an employment agreement entered into as of September 19, 2019 as our SVP of Predictive Products, which covers the terms and conditions of his employment. Prior to his promotion, Mr. Collins was entitled to a base salary of $350,000 and a target incentive compensation of 40% of his base salary. Any bonus amount is targeted to be paid in the first quarter of the subsequent fiscal year, and will be determined by the Company in its sole discretion based on revenue and profitability and personal contributions to the Company. Mr. Collins was promoted to CFO effective March 3, 2020, and in connection with his promotion, his employment agreement was modified to reflect his change in title, a base salary of $450,000, and a target incentive compensation of 45% of his base salary, which percentage was raised as of April 1, 2021 to 55%.

Monica L. Greenberg, our Executive Vice President, Public Policy and General Counsel, is party to an employment agreement with us, dated as of October 25, 2006, that covers the terms and conditions of Ms. Greenberg’s employment. Upon annual review in April 2021, Ms. Greenberg’s annual salary and target annual incentive compensation remained unchanged. The employment agreement we entered into with Ms. Greenberg provides for certain payments upon termination. Please refer to the next section “Potential Payments Upon Termination or Change in Control” for a description of those termination payments.

Norman M. Osumi, our Senior Vice President and Chief Accounting Officer, is party to an offer letter with us, dated as of January 25, 2021, that covers the terms and conditions of Mr. Osumi’s employment. Pursuant to the offer letter, Mr. Osumi is entitled to a base salary of $340,000 and a target incentive compensation of $119,000, prorated for his first year of employment. The offer letter we entered into with Mr. Osumi provides for certain payments upon termination. Please refer to the next section “Potential Payments Upon Termination or Change in Control” for a description of those termination payments.

Alexander Spinelli, our former Global Chief Technology Officer, was party to an employment agreement with us effective March 1, 2018, that covered the terms and conditions of Mr. Spinelli’s employment. Pursuant to the agreement, Mr. Spinelli was entitled to a base salary of $450,000 and a target incentive compensation of $450,000. Upon annual review in April 2021, Mr. Spinelli’s annual salary and target incentive compensation remained the same. While Mr. Spinelli’s employment agreement provided for certain
20



payments and benefits to be made to Mr. Spinelli upon his constructive termination or termination by the Company without cause, as Mr. Spinelli voluntarily terminated his employment, he did not receive any severance payments or benefits in connection with his termination.

Grants of Plan-Based Awards in 2021 Fiscal Year

The following table sets forth information concerning awards under our equity and non-equity incentive plans granted to each of the NEOs in 2021, including performance-based awards.
NameGrant
Date
Committee Approval Date
Estimated Future Payouts Under
Non-Equity Incentive Plan
Awards (1)
All Other Stock Awards: Number of Shares of Stock or Units
(#)
All Other
Option
Awards:
Number of
Securities
Underlying
Options
(#)
Exercise
or
Base
Price of
Option Awards
($/Sh)
Grant Date
Fair Value
of Stock and
Option
Awards (2)
($)
Threshold
($)
Target
($)
Maximum
($)
Robert P. LoCascio305,910 611,820 1,223,640 
5/7/20214/9/2021— 82,700 51.74 2,001,340 
5/7/20214/9/202138,700 — — 2,002,338 
John D. Collins123,750 247,500 371,250 
5/7/20214/9/2021— 29,000 51.74 701,800 
5/7/20214/9/202113,600 — — 703,664 
Monica L. Greenberg100,000 200,000 300,000 
5/7/20214/9/2021— 22,800 51.74 551,760 
5/7/20214/9/202110,700 — — 553,618 
Norman M. Osumi (3)
59,500 119,000 178,500 
4/21/20214/21/2021— 23,300 55.17 601,373 
4/21/20214/21/20215,500 — — 303,435 
Alexander Spinelli (4)
225,000 450,000 675,000 
5/7/20214/9/2021— 35,200 51.74 851,840 
5/7/20214/9/202116,500 — — 853,710 
(1)Amounts shown represent the target and maximum awards that could have been earned by the NEOs under the Company’s annual incentive bonus plan for these executives. The target amount could be exceeded based on performance metrics. Awards are based on Company performance as measured by revenue and Adjusted EBITDA and the achievement of individual performance and strategic objectives. The Compensation Committee retains discretion to adjust the bonus amount paid to any employee or executive up or down, regardless of that person’s target bonus or specific corporate performance metrics. Additional information about these bonus opportunities appear in the section of this Amendment entitled “Compensation Discussion and Analysis.” The actual incentives earned in 2021 and paid in 2022 are reflected in the “Summary Compensation Table” in the “Non-Equity Incentive Plan Compensation” column. The actual incentives earned in 2021 were paid in the form of vested restricted stock units, in lieu of a cash payment, as further described above in the CD&A.
(2)Amounts represent the aggregate grant date fair value for restricted stock units and stock options granted in the fiscal year computed in accordance with Financial Accounting Standards Board’s Accounting Standards Codification Topic 718, or ASC Topic 718, and in accordance with SEC rules.
(3)Mr. Osumi received the equity awards as part of a new hire grant.
(4)Mr. Spinelli was granted equity awards in 2021 but they were forfeited upon his departure from the Company on October 22, 2021.

Narrative Disclosure to Grants of Plan-Based Awards in 2021 Fiscal Year

As described in detail above in the section titled “2021 Compensation Program in Detail – Long-Term Incentives – Annual Equity-Based Awards,” at a Compensation Committee meeting on April 9, 2021, the Committee granted equity awards to employees, including all of the NEOs except for Mr. Osumi, based on specific individual total award values, which amounts for the NEOs were attributed 50% to stock options and 50% to RSUs. In connection with this grant, as described above, the number of shares subject to each award, and the exercise price for the stock options, was calculated based on the price of a share of Company common stock on May 7, 2021, the first day of the first “open trading window” following the grant approval date, and in the case of stock options, the applicable Black-Scholes value. Mr. Osumi received a new-hire grant of stock options and RSUs pursuant to the terms of his offer letter with the Company.

21



Outstanding Equity Awards at End of 2021 Fiscal Year

The following table sets forth information concerning outstanding equity awards held by each of the NEOs as of the end of the 2021 Fiscal Year.
Option AwardsStock Awards
Name (1)
Grant Date
Number of Securities Underlying Unexercised
Options (#)
Exercisable (2)
Number of Securities Underlying Unexercised
Options (#)
Unexercisable (2)
Option Exercise Price ($)Option Expiration Date
Number of Shares or Units of Stock That Have Not Vested (#) (3)
Market Value of Shares or Units of Stock That Have Not Vested ($) (4)
Robert P. LoCascio9/4/2012100,000 — 16.98 9/4/2022— — 
7/1/201370,000 — 9.24 7/1/2023— — 
4/25/2014100,000 — 10.13 4/25/2024— — 
5/5/201780,000 — 7.60 5/5/2027— — 
2/16/2018234,375 15,625 12.45 2/16/2028— — 
2/21/201977,607 38,803 25.95 2/21/2029— — 
5/15/202033,250 99,750 27.39 5/15/2030— — 
5/7/2021— 82,700 51.74 5/7/2031— — 
2/21/2019— — — — 27,845 994,623 
5/15/2020— — — — 44,175 1,577,931 
5/7/2021— — — — 38,700 1,382,364 
John D. Collins10/29/20194,924 22,894 40.61 10/29/2029— — 
5/15/202037,125 27.39 5/15/2030— — 
5/7/2021— 29,000 51.74 5/7/2031— — 
10/29/2019— — — — 2,462 87,943 
5/15/2020— — — — 16,500 589,380 
5/7/2021— — — — 13,600 485,792 
Monica L. Greenberg9/4/201225,000 — 16.98 9/4/2022— — 
7/1/20136,250 — 9.24 7/1/2023— — 
4/25/201412,920 — 10.13 4/25/2024— — 
5/5/201739,520 — 7.60 5/5/2027— — 
2/16/2018150,000 10,000 12.45 2/16/2028— — 
4/11/201925,000 25,000 29.55 4/11/2029— — 
5/15/202010,325 30,975 27.39 5/15/2030— — 
5/7/2021— 22,800 51.74 5/7/2031— — 
4/11/2019— — — — 5,000 178,600 
5/15/2020— — — — 13,725 490,257 
5/7/2021— — — — 10,700 382,204 
Norman M. Osumi4/21/2021— 23,300 55.17 4/21/2031— — 
4/21/2021— — — — 5,500 196,460 
(1)Mr. Spinelli’s last day of employment with the Company was October 22, 2021. Mr. Spinelli forfeited all of his outstanding options, both vested and unvested, effective October 22, 2021, and therefore had no outstanding equity awards as of the end of the 2021 Fiscal Year.
(2)Unless otherwise noted, the total original number of shares subject to each stock option grant listed in the table vests as to 25% of the original number of shares covered by each stock option grant on the first anniversary of the grant date of each stock option (the “Grant Date”) and as to an additional 25% of the original number of shares at the end of each successive anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the executive’s continued service with the Company through each vesting date and any acceleration provisions set forth in each executive’s employment agreement as described above in “Employment Agreement for our Named Executive Officers.” Options granted in 2017 and on February 16, 2018, however, vested as to 25% of the original number of shares covered by each stock option grant on the first anniversary of the grant date and as to 6.25% of the original number of shares at the end of each quarter thereafter.
(3)The total original number of units subject to each restricted stock unit award listed in the table vests over four years, with 25% of the units vesting on the first anniversary of the grant date and the balance vesting in equal annual installments on each anniversary of the grant date.
22



(4)The market value of unvested restricted stock units is based on the closing market price of the Company’s Common Stock on December 31, 2021 of $35.72.

Option Exercises and Stock Vested in 2021 Fiscal Year

The following table sets forth information concerning the number of shares acquired and the value realized by the NEOs as a result of stock option exercises and stock awards vesting in 2021.
Option AwardsStock Awards
Name (1)
Number of Shares Acquired on Exercise (#)Value Realized on Exercise
($)
Number of Shares Acquired on
Vesting (2)
(#)
Value Realized on Vesting (3)
($)
Robert P. LoCascio78,8704,875,081
John D. Collins20,0311,120,048
Monica L. Greenberg57,1313,619,31320,3751,151,974
Alexander Spinelli81,8755,229,005
(1)Mr. Osumi did not acquire any shares on exercise or vesting in 2021.
(2)Of the gross number of shares reported as vested, 10,242, 3,723, 4,577, and 3,385, were withheld by the Company to cover the executives’ tax withholding obligation for Mr. LoCascio, Mr. Collins, Ms. Greenberg, and Mr. Spinelli, respectively.
(3)Represents the aggregate gross value realized on vesting of restricted stock units based on the closing market price of the Company’s common stock on the vesting date for the specific grant.

CEO Pay Ratio Disclosure

Under the Dodd-Frank Wall Street Reform and Consumer Protection Act, we are required to disclose the median of the annual total compensation of our employees, the annual total compensation of our CEO, and the ratio of these two amounts.

Using the methodology described below, and calculated in accordance to Item 402(u) of Regulation S-K, the ratio of the total annual compensation for the CEO to our estimated median employee was approximately 44 to 1.

We identified our median employee by examining the total cash compensation paid during the 2021 Fiscal Year to employees who were employed by us on December 31, 2021. This included our full-time, part-time and seasonal employees, subject to certain exceptions for employees in foreign jurisdictions as described below. We believe that total cash compensation reasonably reflects the annual compensation of our employee population worldwide. We examined our internal payroll and similar records in order to determine total cash compensation paid to our employees included in our calculations. For employees in foreign jurisdictions, we converted amounts paid in foreign currencies to U.S. dollars using the exchange rates we utilized in connection with the preparation of our 2021 annual financial statements.

23



The total number of employees in the jurisdictions identified below as excluded under the de minimis exception are less than 5% of the total workforce of 1,540 employees and have been excluded from the analysis as permitted by the SEC’s disclosure rules, while the employees in the U.S., the U.K., Israel, Australia and Germany jurisdictions have been included in the analysis.
LocationTotal% of Total
Excluded due to de minimis exemption
Canada171.10 %
France30.19 %
Italy70.45 %
Japan140.92 %
Netherlands100.65 %
Singapore80.52 %
Spain20.13 %
Subtotal613.96 %
Included in basis for identification of median employee
Australia946.10 %
Germany17411.30 %
Israel20413.25 %
United Kingdom1489.61 %
United States85955.78 %
Subtotal1,47996.04 %
Grand Total1,540100.00 %

After identifying the estimated median employee using total cash compensation, we calculated annual total compensation for such employee using the same methodology we use for our named executive officers as set forth in the Summary Compensation Table in this Amendment. The median employee is an Australian resident.

Total compensation for the CEO as reported in the Summary Compensation Table was $5,195,079 and the reasonably estimated total compensation of the median employee was $119,104. Therefore, our 2021 CEO to median employee estimated pay ratio is 44 to 1.

The SEC rules for identifying the median employee and calculating that employee’s annual total compensation allows companies to make reasonable assumptions and estimates, and to apply a variety of methodologies and exclusions that reflect their compensation practices. We believe the pay ratio provides a reasonable estimate of the required information calculated in a manner consistent with Item 402(u) of Regulation S-K.

This information is being provided for compliance purposes. Neither the Compensation Committee nor management of the company used the pay ratio measure in making compensation decisions. In light of the various assumptions, estimates, methodologies and exclusions that may be used in accordance with the pay ratio disclosure rules, the pay ratio reported by other companies may not be comparable to the pay ratio reported above, as other companies may have different compensation practices, and may utilize different assumptions, estimates, methodologies and exclusions in calculating their own pay ratios.

Potential Payments Upon Termination or Change in Control

The following table, footnotes and narrative disclosure describe and quantify the additional compensation that would have become payable to certain of our NEOs in connection with an involuntary termination of their employment or a change in control of LivePerson on December 31, 2021 pursuant to the employment agreements entered into with our NEOs. Where applicable, the amounts payable assume a $35.72 fair value of our common stock (the closing price of our common stock on December 31, 2021).
24



Mr. Collins does not have any contractual right to severance payments or benefits upon termination or change of control and as a result, is not included within the table below.
Named Executive OfficerReason for PaymentSalary-Related Payments
($)
Bonus-Related Payments
($)
Accelerated
Vesting of Equity
Awards
($)
Other Benefits
($)
Robert P. LoCascioTermination (i) without cause, (ii) for good reason or (iii) by Company notice of nonrenewal (not in connection with a change of control)917,730 
(1)
825,957 
(2)
4,034,403 
(3)
46,694 
(4)
Termination by reason of (i) death, (ii) disability or (iii) notice of nonrenewal by Mr. LoCascio after reaching retirement age.— 825,957 
(2)
4,034,403 
(3)
46,694 
(4)
Termination without cause or for good reason (in connection with a change of control)917,730 
(1)
825,957 
(2)
5,528,535 
(3)
46,694 
(4)
Change of control— — 2,764,267 
(5)
— 
Monica L. GreenbergTermination without cause or constructively terminated, not following a change of control200,000 
(6)
— 644,972 
(7)
5,158 
(8)
Termination without cause or constructively terminated, following a change in control300,000 
(9)
— 644,972 
(7)
5,158 
(8)
Norman M. OsumiTermination without cause or constructively terminated85,000 
(10)
— 
(11)
— — 
(1)Represents 18 months of Mr. LoCascio’s annual base salary as of December 31, 2021.
(2)Represents 1.5 times Mr. LoCascio’s 2021 Fiscal Year bonus.    
(3)Represents the closing price of our common stock on December 31, 2021 less the exercise price, for the options, and stock awards held by Mr. LoCascio, multiplied by (a) for a qualifying termination not in connection with a change of control or as a result of death or disability, the number of unvested shares underlying the options or stock awards that would otherwise have vested in the two year period following termination of employment; and (b) for a qualifying termination in connection with a change of control, the total number of unvested shares underlying the options or stock awards.
(4)Represents 18 months of company contributions toward premium payments for health insurance coverage under COBRA.
(5)Represents the closing price of our common stock on December 31, 2021 less the exercise price, for the options, and stock awards held by Mr. LoCascio, multiplied by 50% the total number of unvested shares underlying the options or stock awards.
(6)Represents Ms. Greenberg’s base salary as of December 31, 2021 for six months.
(7)Represents the closing price of our common stock on December 31, 2021 less the exercise price, for the options held by Ms. Greenberg, multiplied by the total number of unvested shares underlying the options.
(8)Represents up to six months of company contributions toward premium payments for health insurance coverage under COBRA.
(9)Represents Ms. Greenberg’s base salary as of December 31, 2021 for nine months.
(10)Represents Mr. Osumi’s base salary as of December 31, 2021 for three months.
(11)If Mr. Osumi is terminated on or before bonuses are paid for the fiscal year prior to termination, he is entitled to receive a payment equal to the bonus that he would have received, had he been employed on the date bonuses for such fiscal year are paid.
Robert P. LoCascio

Pursuant to the CEO Agreement, in the event of a termination of Mr. LoCascio’s employment by the Company for Cause (as such term is defined in the CEO Agreement), Mr. LoCascio would be entitled to the following: (i) his unpaid base salary and reimbursable expenses through date of termination; (ii) accrued benefits under Company plans and programs; and (iii) continued coverage under indemnification agreements and Company directors’ and officers’ liability (“D&O”) insurance applicable to Mr. LoCascio ((i), (ii) and (iii) collectively, the “Accrued Benefits”). In the event of a termination of employment by Mr. LoCascio without Good Reason (as such term is defined in the Employment Agreement), or pursuant to a notice of nonrenewal delivered by Mr. LoCascio (prior to his reaching normal retirement age), Mr. LoCascio would be entitled to the Accrued Benefits plus (i) payment of his annual bonus for the prior year to the extent not yet paid; and (ii) all vested stock options held on the date of termination will remain exercisable for 18 months following termination, or until the original expiration date of the option.

25



In the event of a termination of Mr. LoCascio’s employment by the Company without Cause, by Mr. LoCascio for Good Reason (as such term is defined in the CEO Agreement), or pursuant to a notice of nonrenewal delivered by the Company (each, a “Qualifying Termination”), Mr. LoCascio would be entitled to the following: (i) the Accrued Benefits; (ii) his annual bonus for the prior year to the extent not paid; (iii) 18 months base salary continuation (“Base Salary Continuation”); (iv) a pro-rated annual bonus for the year of termination based on days worked, calculated as 1.5x the highest bonus paid for the three proceeding years, payable in a lump sum; (v) payment of what would have been the employer portion of the premiums for the Company’s group health insurance coverage to be put toward Mr. LoCascio’s COBRA continuation payments for 18 months (or until he is eligible for coverage through another employer) (the “COBRA Premium Contribution”); (vi) any stock options or restricted stock units held by Mr. LoCascio on the date of termination that would have vested in the two years following termination had he remained employed will immediately vest; and (vii) any stock options held on the date of termination will remain exercisable for 18 months following termination, or until the original expiration date of the option. In the event of a termination of Mr. LoCascio’s employment by reason of his death or Disability (as such term is defined in the Employment Agreement), or pursuant to a notice of nonrenewal delivered by Mr. LoCascio (after his reaching normal retirement age), Mr. LoCascio would be entitled to the same benefits payable upon a Qualifying Termination, except that the Base Salary Continuation will not be provided.

In the event a Qualifying Termination occurs within the 12 month period immediately following a Change in Control, Mr. LoCascio would be entitled to the following: (i) the Accrued Benefits; (ii) his annual bonus for the prior year to the extent not paid; (iii) Base Salary Continuation; (iv) his annual bonus for the current year calculated as 150% of the highest annual bonus actually paid for the three proceeding years, payable in a lump sum; (v) the COBRA Premium Contribution; (vi) any unvested stock options or restricted stock units held by Mr. LoCascio on the date of termination will immediately vest; and (vii) any stock options held on the date of termination will remain exercisable for 18 months following termination, or until the original expiration date of the option.

The CEO Agreement also provides that, in the event of a Change in Control, 50% of each of the unvested stock options and unvested restricted stock units held by Mr. LoCascio on the date of the Change in Control shall fully vest, subject to Mr. LoCascio’s employment on such date. In addition, in the event of a Change in Control, in the event that any of the payments or benefits provided by the Company to Mr. LoCascio would constitute “parachute payments” (“Parachute Payments”) within the meaning of Section 280G of the Internal Revenue Code of 1986, as amended (the “Code”), and would be subject to the excise tax imposed under Section 4999 of the Code or any interest or penalties with respect to such excise tax (collectively, the “Excise Tax”), then such Parachute Payments to be made to Mr. LoCascio shall be payable either (1) in full or (2) as to such lesser amount which would result in no portion of such Parachute Payments being subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the Excise Tax, results in Mr. LoCascio’s receipt on an after-tax basis, of the greatest amount of economic benefits under the CEO Agreement, notwithstanding that all or some portion of such benefits may be subject to the Excise Tax.

Alexander Spinelli

Mr. Spinelli did not receive any severance benefits in connection with his voluntary termination of employment from the Company on October 22, 2021.

Monica L. Greenberg

If Ms. Greenberg is terminated by us without Cause (as defined in the employment agreement) or Ms. Greenberg is “constructively terminated,” (as defined in the employment agreement) then, subject to executing a release of claims, she is entitled to receive the following severance: (i) a lump sum severance payment equal to six months of her then current base salary, (ii) all of her outstanding options will accelerate and become exercisable upon such termination and will remain exercisable for up to 12 months following her termination, and (iii) up to six months of premium payments for health insurance coverage under COBRA.

If there is a change of control of the Company and Ms. Greenberg is terminated by us without Cause or Ms. Greenberg is “constructively terminated,” in each case within 12 months following the change of control, then subject to executing a release of claims, she will be entitled to receive the same severance benefits as described above except the lump sum severance payment will be equal to nine months of her then current base salary.

26



Compensation of Directors in 2021 Fiscal Year

The following table sets forth information concerning the compensation of our non-employee directors in the 2021 Fiscal Year.

Following the table is a discussion of material factors related to the information disclosed in the table.
Name
Fees
Earned
or Paid
in Cash
($) (1)
Stock Awards
($) (1)(2)
Option
Awards
($) (1)(2)(3)
Total
($)
Peter Block— 257,684 — 257,684 
Ernest Cu— 117,627 117,550 235,177 
Kevin C. Lavan67,500 — 200,014 267,514 
Jill Layfield65,000 100,119 100,135 265,254 
Fred Mossler— 129,116 128,818 257,934 
William G. Wesemann62,500 100,119 100,135 262,754 

(1)In April 2021, the Compensation Committee, based on the recommendations of Pearl Meyer, its compensation consultant at that time, determined to allow directors to receive their annual equity award in one of the following forms, at their election: (1) 100% in stock options, (2) 100% in RSUs, or (3) 50% in stock options and 50% in RSUs. This election was applicable for director equity grants made in 2021 and will be applicable for director equity awards in 2022. In addition, directors may elect to receive their annual cash retainer in the form of equity, the form of which will be based on the same options described above. This will apply to their services in respect of years 2021 and 2022.
(2)These columns represent the aggregate grant date fair value of stock options and restricted stock units granted to each non-employee director in the 2021 Fiscal Year computed in accordance with FASB ASC Topic 718, and in accordance with SEC rules. Generally, the aggregate grant date fair value is the amount that the Company expects to expense in its financial statements over the award’s vesting schedule. These amounts reflect the company’s accounting expense and do not correspond to the actual value that will be realized by the non-employee directors and there is no assurance that these grant date fair values will ever be realized by the non-employee directors. Pursuant to SEC rules, the amounts shown exclude the impact of estimated forfeitures related to service-based vesting conditions. For additional information on the valuation assumptions with respect to the grants, refer to Note 11 of LivePerson’s consolidated financial statements contained in our Annual Report on Form 10-K for the 2021 Fiscal Year, as filed with the SEC.
(3)As of December 31, 2021, the number of shares underlying unexercised stock options for each director were: Mr. Block, 112,107; Mr. Cu 4,590; Mr. Lavan, 204,917; Ms. Layfield, 141,017; Mr. Mossler 77,137; and Mr. Wesemann, 221,017.

The Company’s non-employee directors are compensated in accordance with a fee schedule that is approved by the Compensation Committee. Directors who are also our employees receive no additional compensation for their services as directors. The Compensation Committee reviews and recommends to the Board appropriate director compensation programs for service as directors, committee chair, and committee members. In order to determine the Board compensation framework, the Compensation Committee reviewed comparative market composite data provided by the Committee’s independent consultant.

Consistent with the Company’s compensation philosophy, non-employee director compensation is positioned competitively against companies of similar size, complexity and growth trajectory. In general, total compensation for our non-employee directors is targeted within the competitive range (+/-15%) of the peer group median.

For their services in 2021, each non-employee director receives compensation in accordance with the following:
Annual Cash Retainer$35,000 
Annual Stock Option Grant$200,000 
(1)
Members of our Committees, other than the Chairpersons, receive the following additional compensation:
Audit Committee$10,000 
Compensation Committee$7,500 
Nominating and Corporate Governance Committee$5,000 
27



The Chairpersons of our Committees receive the following additional compensation:
Audit Committee$20,000 
Compensation Committee$15,000 
Nominating and Corporate Governance Committee$10,000 
Social Impact and Culture Committee$5,000 
(2)
(1)Newly appointed directors to the Board receive an initial stock option grant equal to the annual equity retainer of $200,000 at the time of their appointment, followed by subsequent annual equity grants for each year of service following the year of appointment.
(2)In April 2021, we combined the Social Impact Committee and the Culture Committee into the Social Impact and Culture Committee.

In April 2021, the Compensation Committee, based on the recommendations of Pearl Meyer, its compensation consultant at the time, determined to allow directors to receive their annual equity award in one of the following forms, at their election: (1) 100% in stock options, (2) 100% in RSUs, or (3) 50% in stock options and 50% in RSUs. This election was applicable for director equity grants to be made in 2021 and will be applicable for director equity awards made in 2022. In addition, directors may elect to receive their annual cash retainer in the form of equity, the form of which will be based on the same options described above. This will apply to their services in respect of years 2021 and 2022.

Compensation Committee Interlocks and Insider Participation

The members of the Compensation Committee of our Board during the 2021 Fiscal Year were Ms. Layfield (Chair), Mr. Block, Mr. Lavan, Mr. Mossler and Mr. Wesemann.

During the 2021 Fiscal Year:
•    none of the members of the Compensation Committee was an officer (or former officer) or employee of the Company or any of its subsidiaries;
•    none of the members of the Compensation Committee had a direct or indirect material interest in any transaction in which the Company was a participant and the amount involved exceeded $120,000;
•    none of our executive officers served on the compensation committee (or another board committee with similar functions or, if none, the entire board of directors) of another entity where one of that entity’s executive officers served on our Compensation Committee;
•    none of our executive officers was a director of another entity where one of that entity’s executive officers served on our Compensation Committee; and
•    none of our executive officers served on the compensation committee (or another board committee with similar functions or, if none, the entire board of directors) of another entity where one of that entity’s executive officers served as a director on our Board.

28



Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Equity Compensation Plan Information

The following table summarizes the number of securities underlying outstanding options and restricted stock units granted to employees and directors, as well as the number of securities remaining available for future issuance, under LivePerson’s equity compensation awards as of December 31, 2021.
Plan category
Number of securities to be issued upon exercise of outstanding options, warrants and rights (1)
Weighted-average exercise price of outstanding options, warrants and rights (2)
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))
Equity compensation plans approved by security holders6,944,234$24.565,736,029
(3)
Equity compensation plans not approved by security holders1,489,500$48.19
(4)
Total8,433,7345,736,029
(1)Consists of options to purchase shares of our common stock, as well as restricted stock unit awards, each representing the right to acquire shares of our common stock. In respect of the plans approved by security holders, including the 2000 Stock Incentive Plan, 2009 Stock Incentive Plan, and 2019 Stock Incentive Plan, the number of shares reported represents 4,234,512 shares subject to stock options and 2,709,722 restricted stock units. In respect of the plan not approved by security holders, including the Inducement Plan (described below), number of shares reported represents 600,175 shares subject to stock options, and 889,325 restricted stock units.
(2)The weighted average exercise price is calculated based solely on the outstanding stock options. It does not take into account the shares issuable upon vesting of outstanding restricted stock unit awards or performance stock units, which have no exercise price.
(3)Consists of 4,988,580 shares remaining available for issuance under the 2019 Stock Incentive Plan and 747,449 shares remaining available for issuance under the 2019 Employee Stock Purchase Plan.
(4)Represents shares under the Inducement Plan, which is intended to qualify as an inducement plan under Nasdaq rule 5635(c)(4). As of December 31, 2021, no more shares of common stock remained available for issuance under the Inducement Plan.

LivePerson, Inc. 2018 Inducement Plan

On January 19, 2018, the Board adopted the LivePerson, Inc. 2018 Inducement Plan (the “Inducement Plan”), which provides for the grants of awards of stock options, stock appreciation rights, restricted stock, restricted stock units and other stock and cash-based awards to persons who have not previously been an employee or director of the Company, or an individual following a bona fide period of non-employment with the Company, as an inducement for the individual’s entering into employment with the Company. The purpose of the Inducement Plan is to help the Company provide an inducement to attract and retain the employment services of new employees, to motivate those new employees whose potential contributions are important to the success of the Company to accept an offer of employment by providing them with equity ownership opportunities, and to advance the interests of the Company’s stockholders by providing incentives to those eligible individuals who are expected to make important contributions to the Company.

In the event of any stock split, reverse stock split, stock dividend, recapitalization, combination of shares, reclassification of shares, spin-off or other similar change in capitalization or event, or any dividend or distribution to holders of our common stock other than an ordinary cash dividend, the Board will make equitable adjustments to the maximum number and type of shares or other securities that may be issued under the Inducement Plan, the maximum number and type of shares that may be granted to any participant in any calendar year, the number and type of shares subject to outstanding awards, the exercise price or grant price of outstanding awards and other necessary adjustments in connection with the Inducement Plan.

The Inducement Plan is administered by the Board. Pursuant to the terms of the Inducement Plan, subject to applicable law, the Board may delegate certain authority under the Inducement Plan to one or more committees or subcommittees of the Board or one or more officers of the Company satisfying applicable laws. Subject to the provisions of the Inducement Plan, the Board has the power to select the recipients of awards, to determine the number of shares subject to any award, to establish and verify the extent of satisfaction of any performance goals or other conditions applicable to awards, to determine whether, and the extent to which, adjustments are required under the Inducement Plan, and to determine the terms and conditions of awards. The Board may also modify awards granted to participants who are foreign nationals or employed outside the United States or establish subplans or
29



procedures under the Inducement Plan to recognize differences in laws, rules, regulations or customs of such foreign jurisdictions with respect to tax, securities, currency, employee benefit or other matters.

The Inducement Plan permits the granting of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards and other stock and cash-based awards to persons who have not previously been an employee or director of the Company, or an individual following a bona fide period of non-employment with the Company, as an inducement for the individual’s entering into employment with the Company.

Stock Options

The Board may grant stock options under the Inducement Plan. The number of shares covered by each stock option granted to a participant (subject to the Inducement Plan’s stated limit) and all other terms and conditions will be determined by the Board. The stock option exercise price is established by the Board and must be at least 100% of the fair market value of a share on the date of grant. Consistent with applicable laws, regulations and rules, and to the extent authorized by the Board, payment of the exercise price of stock options may be made in one of more of the following: (i) cash or check, (ii) broker assisted cashless exercise, (iii) shares of our common stock, (iv) net exercise, (v) delivery to the Company of a promissory note, (vi) any other lawful means, or (vii) any combination of these permitted forms of payment. The Inducement Plan prohibits decreasing the exercise price of an option or cancelling an option and replacing it with an award with a lower exercise price.

After a termination of service with the Company, a participant will be able to exercise the vested portion of his or her option for the period of time stated in the applicable stock option agreement. Unless otherwise provided by the Board, unvested stock options will generally expire upon termination of the participant’s employment and vested stock options will generally expire immediately following a termination for cause. In no event, however, may a stock option be exercised beyond its original expiration date. The term of a stock option will not exceed 10 years from the date of grant.

Stock Appreciation Rights

The Board may grant stock appreciation rights under the Inducement Plan. Stock appreciation rights typically provide for the right to receive the appreciation in the fair market value of our common stock between the grant date and the exercise date. The Board may grant stock appreciation rights either alone or in tandem with a stock option granted under the Inducement Plan. The number of shares of Company common stock covered by each stock appreciation right (subject to the Inducement Plan’s stated limit) and all other terms and conditions will be determined by the Board. Stock appreciation rights are generally subject to the same terms and limitations applicable to options or, when granted in tandem with an option, to the same terms as the option. Stock appreciation rights may be paid in cash or shares or any combination of both, as determined by the Board, in its sole discretion. Unless otherwise approved by the Company’s stockholders, the Inducement Plan prohibits decreasing the exercise price of a stock appreciation right or canceling a stock appreciation right and replacing it with an award with a lower exercise price.

Restricted Stock

The Board may award shares of restricted stock under the Inducement Plan. Shares of restricted stock are shares that vest in accordance with the terms and conditions established by the Board in its sole discretion. The Board will determine the terms of any restricted stock award, including the number of shares subject to such award (subject to the Inducement Plan’s stated limit), and the minimum period over which the award may vest. Specifically, with respect to restricted stock awards with solely time-based vesting, generally no portion of the award may vest until the first anniversary of the date of grant, no more than one-third of the award may be vested prior to the second anniversary of the date of grant, and no more than two-thirds of the award may be vested prior to the third anniversary of the date of grant. With respect to restricted stock awards that do not vest solely based on the passage of time, generally no portion of the award may vest prior to the first anniversary of the date of grant (or, in the case of awards to non-employee directors, if earlier, the date of the first annual meeting held after the date of grant). These minimum vesting schedules do not apply to awards granted, in the aggregate, for up to 5% of the maximum number of authorized shares under the Inducement Plan. Participants holding restricted stock will be entitled to all ordinary cash dividends paid with respect to such shares, which dividends shall be accrued and become payable when and if the restricted stock vests. When the restricted stock award conditions are satisfied, the shares will no longer be subject to forfeiture as the participant is vested in the shares and has complete ownership of the shares.

Restricted Stock Units

The Board may also grant an award of restricted stock units under the Inducement Plan. A restricted stock unit is a bookkeeping entry representing an amount equivalent to the fair market value of one share of our common stock. Participants are not required to pay any consideration to the Company at the time of grant of a restricted stock unit award. The Board will determine the terms of any restricted stock unit award, including the number of shares covered by such award (subject to the Inducement Plan’s stated limit), and the minimum period over which the award may vest, which is subject to the same minimum vesting requirements and exceptions described above for restricted stock awards. Restricted stock unit awards may include a dividend equivalent right
30



feature, but any dividends payable to stockholders will accrue with respect to the restricted stock unit and become payable only when and if the underlying restricted stock unit vests. When the participant satisfies the conditions of a restricted stock unit award, the Company will pay the participant cash or shares of our common stock to settle the vested restricted stock units. The Board may permit a participant to elect to defer the settlement of his or her vested restricted stock unit award until a later date; provided that such deferral election must be made pursuant to an exemption from, or in compliance with, Code Section 409A.

Other Stock-Based and Cash-Based Awards

Under the Inducement Plan, the Board may also grant awards of shares of our common stock or other awards denominated in cash. The Board will determine the terms of any such stock-based or cash-based award, including the number of shares or amount of cash, as applicable, covered by such award (subject to the Inducement Plan’s stated limit), and the minimum period over which the award may vest, which is subject to the same minimum vesting requirements and exceptions described above for restricted stock awards.

Performance Awards

The Board may grant performance awards under the Inducement Plan. Performance awards provide participants with the opportunity to earn a payout subject to the award only if certain performance goals or other vesting criteria are achieved. The Board will establish the performance goals or other vesting in its discretion, which, depending on the extent to which they are met, will determine the number and/or the value of performance shares to be paid out to participants. The Board has discretion to determine other terms of the performance award, including the number of shares or value subject to a performance award (subject to the Inducement Plan’s stated limit), the period as to which performance is to be measured (which may be no shorter than a one-year period), any applicable forfeiture provisions, and any other terms and conditions consistent with the Inducement Plan. After the completion of the performance period applicable to the award, the Board will measure performance against the applicable goals and other vesting criteria and determine whether any payment will be made under the award. If the participant satisfies the conditions of the performance share award, the Company will pay the participant cash or shares or any combination of both to settle the award.

Performance Goals

The Compensation Committee may establish performance criteria and level of achievement versus such criteria that will determine the number of shares to be granted, retained, vested, issued or issuable under or in settlement of or the amount payable pursuant to an award, which criteria may be based on certain performance goals (as described below). The performance criteria for each such performance award will be based on one or more of the following measurable performance goals: (a) net income, (b) earnings before or after discontinued operations, interest, taxes, depreciation and/or amortization, (c) operating profit before or after discontinued operations and/ or taxes, (d) sales, (e) sales growth, (f) earnings growth, (g) cash flow or cash position, (h) gross margins, (i) stock price, (j) market share, (k) return on sales, assets, equity or investment, (l) improvement of financial ratings, (m) achievement of balance sheet or income statement objectives, (n) total shareholder return, (o) introduction of new products, (p) expansion into new markets or (o) achievement of any other strategic, operational goals or such other individual performance measures as the Board may determine.

These performance goals may reflect absolute entity or business unit performance or a relative comparison to the performance of a peer group of entities or other external measure of the selected performance criteria and may be absolute in their terms or measured against or in relationship to other companies comparably, similarly or otherwise situated. The Compensation Committee may specify that such performance measures shall be adjusted to exclude any one or more of (i) extraordinary items, (ii) gains or losses on the dispositions of discontinued operations, (iii) the cumulative effects of changes in accounting principles, (iv) the writedown of any asset, and (v) charges for restructuring and rationalization programs. Such performance goals: (i) may vary by participant and may be different for different awards; (ii) may be particular to a participant or the department, branch, line of business, subsidiary or other unit in which the participant works and may cover such period as may be specified by the Board; and (iii) shall be set by the Compensation Committee at a time that the accomplishment of such goals is reasonably uncertain. The Compensation Committee may adjust downwards or upwards, the cash or number of shares payable pursuant to such awards, and the Compensation Committee may waive the achievement of the applicable performance measures in its discretion.

Transferability of Awards

Awards granted under the Inducement Plan generally may not be transferred other than by will or the laws of descent and distribution or pursuant to a qualified domestic relations order. During the life of the participant, awards are exercisable only by the participant. The Board may in its sole discretion permit and subject to certain conditions provide for the gratuitous transfer of an award to or for the benefit of any immediate family member, family trust or other entity established for the benefit of the participant and/or an immediate family member thereof to the extent permitted under Form S-8 under the Securities Act.

31



Reorganization Event

In the event of a reorganization event, each outstanding award will be treated as the Board determines, including, without limitation, that each award may be assumed or an equivalent option or right substituted by the successor corporation, or in the case of stock options, may be terminated after giving holders notice of such pending termination and a change to exercise the option prior to the reorganization event. In addition, the vesting of awards that are unvested at the time of a reorganization event does not automatically accelerate, but the Board may cause any vesting to accelerate or restrictions lapse in connection with the reorganization event. In the case that stockholders are receiving a cash payment for each share in a reorganization event, the Board may also provide that all awards will be cancelled in connection with the reorganization event in exchange for the holder of such award receiving a cash payment for each share underlying the award in the same amount as the stockholders receive, or, in the case of options, the excess, if any, between the amount a stockholder is receiving and the exercise price of the stock option. The Board will generally not be required to treat all awards, all awards held by a participant, or all awards of the same type, similarly in the transaction. Upon the occurrence of a liquidation or dissolution of the Company, except to the extent specifically provided otherwise in the restricted stock or restricted stock unit award agreement or any other agreement between a participant and the Company, all restrictions and conditions on all restricted stock and restricted stock unit awards then outstanding will automatically be deemed terminated or satisfied.

Amendment and Termination; Forfeiture Events

The Board may amend the Inducement Plan at any time and for any reason. The Board may also suspend or terminate the Inducement Plan at any time and for any reason. The Inducement Plan will terminate on January 19, 2028 unless terminated earlier by the Board. The termination or amendment of the Inducement Plan may not materially and adversely affect the rights of participants under the Inducement Plan.

The Board may specify in any award agreement that the participant’s rights, payments and benefits with respect to the award shall be subject to reduction, cancellation, forfeiture, clawback or recoupment upon the occurrence of certain specified events or as required by law, in addition to any otherwise applicable forfeiture provisions that apply to the award.

Ownership of Securities

The following table sets forth information with respect to the beneficial ownership of our outstanding common stock as of April 1, 2022, by:
•    each person or group of affiliated persons whom we know to beneficially own more than five percent of our common stock;
•    each of our named executive officers identified in the “Summary Compensation Table” included in this Amendment on page 19;
•    each of our directors; and
•    all of our directors and executive officers as a group.

A person is deemed to be a beneficial owner of any securities of which that person has a right to acquire beneficial ownership within 60 days after April 1, 2022, including any shares of our common stock subject to an option that are exercisable or will be exercisable, or RSUs that have vested or will vest, within 60 days after April 1, 2022.

32



Beneficial ownership is determined in accordance with the rules of the SEC and includes voting and investment power with respect to shares. Percentage of beneficial ownership is based on 74,803,853 shares of common stock outstanding at April 1, 2022 (excluding shares held in treasury). Unless otherwise indicated, the persons named in the table directly own the shares and have sole voting and sole investment control with respect to all shares beneficially owned.
Name of Beneficial Owner (1)
Number of
Shares Beneficially
Owned (2)
Percentage of
Common Stock
Outstanding
(%)
5% Stockholders
BlackRock, Inc. (3)
11,064,38814.8%
The Vanguard Group. (4)
7,368,4869.9%
Starboard Value LP (5)
7,005,0009.4%
FMR LLC (6)
5,557,5477.4%
Named Executive Officers and Directors
Robert P. LoCascio (7)
5,381,7277.2%
John D. Collins (8)
34,104*
Alexander Spinelli (9)
317,817*
Monica L. Greenberg (10)
292,312*
Norman M. Osumi (11)
10,410*
Peter Block (12)
122,817*
Ernest Cu (13)
6,740*
Kevin C. Lavan (14)
212,727*
Jill Layfield (15)
148,837*
Fred Mossler (16)
142,425*
William G. Wesemann (17)
391,757*
Directors and Executive Officers as a group (11 persons) (18)
7,061,6739.4%
*    Less than 1%.
(1)Unless noted otherwise, the business address of each beneficial owner is c/o LivePerson, Inc., 530 7th Avenue, Floor M1, New York, New York 10018.
(2)Beneficial ownership is determined in accordance with the rules of the SEC and includes voting and/or investment power with respect to the shares shown as beneficially owned.
(3)Based solely on our review of the Schedule 13G/A filed with the SEC on February 8, 2022 by BlackRock, Inc., whose address is 55 East 52nd Street, New York, New York 10022. BlackRock, Inc. reported that it has sole voting power as to 11,010,844 shares and sole dispositive power as to 11,064,388 shares.
(4)Based solely on our review of the Schedule 13G/A filed with the SEC on March 9, 2022 by The Vanguard Group, whose address is 100 Vanguard Blvd., Malvern, Pennsylvania 19355. The Vanguard Group reported that it has shared voting power as to 126,794 shares, sole dispositive power as to 7,181,571 shares and shared dispositive power as to 186,915 shares.
(5)Based solely on our review of the Schedule 13D/A filed with the SEC on March 1, 2022 by Starboard Value LP, whose address is 777 Third Avenue, 18th Floor, New York, New York 10017. Starboard Value LP reported that it has sole voting and dispositive power as to 7,005,000 shares; Starboard Value and Opportunity Master Fund Ltd reported that it has sole voting and dispositive power as to 4,092,292 shares; Starboard Value and Opportunity S LLC reported that it has sole voting and dispositive power as to 596,677 shares; Starboard Value and Opportunity C LP reported that it has sole voting and dispositive power as to 364,260 shares; Starboard Value R LP reported that it has sole voting and dispositive power with respect to 364,260 shares; Starboard Value and Opportunity Master Fund L LP reported that it has sole voting and dispositive power as to 253,180 shares; Starboard Value L LP reported that it has sole voting and dispositive power as to 253,180 shares; Starboard Value R GP LLC reported that it has sole voting and dipositive power as to 617,440 shares; Starboard X Master Fund Ltd reported that it has sole voting and dispositive power as to 944,049 shares; Starboard Value GP LLC reported that it has sole voting and dipositive power as to 7,005,000 shares; Starboard Principal Co LP reported that it has sole voting and dispositive power as to 7,005,000 shares; Starboard Principal Co GP LLC reported that it has sole voting and dispositive power as 7,005,000 shares; Jeffrey C. Smith reported that he has shared voting and dispositive power as to 7,005,000 shares; Peter A. Feld reported that he has shared voting and dispositive power as to 7,005,000 shares; John R. McCormack reported that he has voting and dispositive power as to 0 shares; Vanessa Pegueros reported that she has sole voting and dispositive power as to 1,349 shares; and Yael Zheng reported that she has shared voting and dispositive power as to 3,000 shares. The address of the principal office of each of these stockholders is c/o Starboard Value LP, 201 E Las Olas Boulevard, Suite 1000, Fort Lauderdale, Florida 33301.
(6)Based solely on our review of the Schedule 13G/A filed with the SEC on February 9, 2022 by FMR LLC, whose address is 245 Summer Street, Boston, Massachusetts 02210. FMR LLC reported that it has sole voting power as to 2,077,376 shares and sole dispositive power as to 5,557,547 shares.
33



(7)Of the total shares held by Mr. LoCascio, 4,226,983 shares of common stock are held indirectly by Mr. LoCascio through Ikon LP, a limited partnership of which Mr. LoCascio is the sole owner. Includes 813,260 shares underlying options that are currently exercisable or that will be exercisable and/or RSUs that have vested or that will vest, in each case, at or within 60 days of April 1, 2022. In January 2012, 2,000,000 shares of common stock beneficially owned by Mr. LoCascio were pledged as collateral in connection with a line of credit extended to Mr. LoCascio by UBS, and such pledge is currently in effect with regards to those shares.
(8)Includes 17,300 shares underlying options that are currently exercisable or that will be exercisable and/or RSUs that have vested or that will vest, in each case, at or within 60 days of April 1, 2022.
(9)Includes 122,525 shares underlying options that are currently exercisable or that will be exercisable and/or RSUs that have vested or that will vest, in each case, at or within 60 days of April 1, 2022.
(10)Includes 280,840 shares underlying options that are currently exercisable or that will be exercisable and/or RSUs that have vested or that will vest, in each case, at or within 60 days of April 1, 2022.
(11)Includes 7,200 shares underlying options that are currently exercisable or that will be exercisable and/or RSUs that have vested or that will vest, in each case, at or within 60 days of April 1, 2022.
(12)Includes 116,817 shares underlying options that are currently exercisable or that will be exercisable and/or RSUs that have vested or that will vest, in each case, at or within 60 days of April 1, 2022.
(13)Includes 6,740 shares underlying options that are currently exercisable or that will be exercisable and/or RSUs that have vested or that will vest, in each case, at or within 60 days of April 1, 2022.
(14)Includes 204,917 shares underlying options that are currently exercisable or that will be exercisable at or within 60 days of April 1, 2022.
(15)Includes 146,757 shares underlying options that are currently exercisable or that will be exercisable and/or RSUs that have vested or that will vest, in each case, at or within 60 days of April 1, 2022.
(16)Includes 84,527 shares underlying options that are currently exercisable or that will be exercisable and/or RSUs that have vested or that will vest, in each case, at or within 60 days of April 1, 2022.
(17)Includes 226,757 shares underlying options that are currently exercisable or that will be exercisable and/or RSUs that have vested or that will vest, in each case, at or within 60 days of April 1, 2022.
(18)Includes 2,027,640 shares underlying options that are currently exercisable or that will be exercisable and/or RSUs that have vested or that will vest, in each case at or within 60 days of April 1, 2022 and shares over which the directors and executive officers are indirect beneficial owners.

Item 13. Certain Relationships and Related Transactions, and Director Independence

Certain Relationships and Related Party Transactions

Any transaction or series of transactions, of which the aggregate amount involved exceeded or may be reasonably expected to exceed $120,000, in which we participate and a related person has a material interest would require the prior approval by our Board. In such cases, the Board would review all of the relevant facts and circumstances and would take into account, among other factors, whether the transaction is on terms no less favorable than terms generally available to an unaffiliated third-party under the same or similar circumstances and the extent of the related person’s interest in the transaction. If a transaction relates to a director, that director would not participate in the Board’ deliberations.

Related persons would include a member of our Board and our executive officers and their immediate family members. It would also include persons controlling over five percent of our outstanding common stock. Under our written policy on conflicts of interest, all of our directors, executive officers and employees have a duty to report to the appropriate level of management potential conflicts of interests, including transactions with related persons.

Pursuant to our Audit Committee Charter, our Audit Committee is responsible for reviewing potential conflict of interest situations and approving, on an ongoing basis, all related party transactions required to be disclosed pursuant to Item 404 of Regulation S-K. In particular, our Audit Committee Charter requires that our Audit Committee approve all transactions between the Company and one or more directors, executive officers, major stockholders or firms that employ directors, as well as any other material related party transactions that are identified in a periodic review of our transactions. In considering a related party transaction, the Audit Committee will consider such factors as it deems appropriate, including, without limitation, the commercial reasonableness of the terms, if the terms are judged to be the same as a transaction made on an arm’s-length basis, the benefit or perceived benefit (or lack thereof) to the Company, the impact on a director’s independence in the event the related person is a director, an immediate family member of a director or an entity in which a director has a position or relationship, opportunity costs and availability of alternate transactions, the materiality and character of the related person’s direct or indirect interest, and any actual or apparent conflict of interest of the related person.

34



Since the beginning of the 2021 Fiscal Year, the Company has not been a participant in any transaction with a related person.

Indemnification Agreements with Directors and Executive Officers

Our Fourth Amended and Restated Certificate of Incorporation and our Second Amended and Restated Bylaws, as amended, provide that we will indemnify each of our directors and officers to the fullest extent permitted by the Delaware General Corporation Law. In addition, we have entered into indemnification agreements with our directors and officers. We monitor developments in Delaware law in order to provide our directors and officers the highest level of protection under the law. Our Board approved an updated form of indemnification agreement which was filed as an exhibit to our 2011 Annual Report on Form 10-K. The form of indemnification agreement used by the Company contains provisions that require us, among other things, to indemnify our directors and executive officers against certain liabilities (other than liabilities arising from intentional or knowing and culpable violations of law) that may arise by reason of their status or service as our directors or executive officers or other entities to which they provide service at our request and to advance expenses they may incur as a result of any proceeding against them as to which they could be indemnified. We believe that these provisions and agreements are necessary to attract and retain highly qualified individuals to serve the Company. We also have obtained an insurance policy covering our directors and officers for claims that such directors and officers may otherwise be required to pay or for which we are required to indemnify them, subject to certain exclusions.

Director Independence

The Board has determined that Messrs. Block, Cu, Lavan, Mossler, and Wesemann, and Ms. Layfield are “independent” under the Nasdaq listing requirements and the applicable rules and regulations of the SEC. As part of the Board’s process in making such determination, each such director provided confirmation that (a) the objective criteria for independence pursuant to the Nasdaq rules are satisfied and (b) each such director has no other relationship with the Company that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. Mr. LoCascio, our CEO and Chairman of the Board, is an employee and therefore not “independent.”
35



Item 14. Principal Accountant Fees and Services

Fees Billed to the Company for Services Rendered during the Fiscal Years Ended December 31, 2021 and 2020

BDO USA, LLP served as the Company’s independent registered public accounting firm for the fiscal years ended December 31, 2021 and 2020.
Fiscal Years 2021 and 2020 Accounting Fees
Fees2021 Fiscal Year2020 Fiscal Year
Audit Fees (1)
$912,588 $1,096,948 
Audit-Related Fees (2)
418,178 — 
Tax Fees (3)
— — 
All Other Fees (4)
— — 
(1)Audit Fees” consist of fees for professional services rendered in connection with the audit of the Company’s consolidated annual financial statements, the review of the Company’s interim condensed consolidated financial statements included in quarterly reports, the audits in connection with statutory and regulatory filings or engagements and the audit of the Company’s internal controls over financial reporting.
(2)Audit-Related Fees” consist primarily of fees for professional services rendered in connection with the audits of the Company’s acquisition accounting due diligence.
(3)Tax Fees” consist of fees billed for professional services rendered for tax compliance, tax consulting and tax planning services.
(4)All Other Fees” - none.
Pre-Approval Policies and Procedures
The Audit Committee pre-approves all audit and permissible non-audit services. The Audit Committee has authorized each of its members to pre-approve audit, audit-related, tax and non-audit services, provided that such approved service is reviewed with the full Audit Committee at its next meeting.

As early as practicable in each fiscal year, the independent registered public accounting firm provides to the Audit Committee a schedule of the audit and other services that they expect to provide or may provide during the year. The schedule is specific as to the nature of the proposed services, the proposed fees, and other details that the Audit Committee may request. The Audit Committee by resolution authorizes or declines the proposed services. Upon approval, this schedule serves as the budget for fees by specific activity or service for the year.

A schedule of additional services proposed to be provided by the independent registered public accounting firm or proposed revisions to services already approved, along with associated proposed fees, may be presented to the Audit Committee for their consideration and approval at any time. The schedule is required to be specific as to the nature of the proposed service, the proposed fee, and other details that the Audit Committee may request. The Audit Committee intends by resolution to authorize or decline authorization for each proposed new service.

PART IV

Item 15. Exhibits and Financial Statement Schedules

The following documents are filed as part of this Amendment No.1 on Form 10-K/A:
1.Financial Statements. Incorporated by reference to the index of consolidated financial statements included in Item 8 of the Original Form 10-K.
2.Financial Statements Schedules. None.
3.Exhibits. Incorporated by reference to the Exhibit Index immediately preceding the signature page to this Amendment No. 1 on Form 10-K/A.
36



EXHIBIT INDEX
NumberDescription
2.1
2.2

3.1(a)
3.1(b)
3.2
4.1
4.2
4.3

4.4
4.5
4.6
4.7
10.1(a)*

10.1(b)*
10.2*

10.3*
10.4*


10.5*
37



10.6*
10.7*
10.8*



10.9*

10.10*
10.11*
10.12*
10.13*
10.14*
10.15*
10.16*

10.17*

10.18*

10.19

10.20

10.21*

10.22*

10.23*

38



10.24*

10.25
10.26
10.27
21.1
23.1
31.1
31.2
31.3
31.4
32.1**
32.2**
101.INS†Inline XBRL Instance Document - The instance document does not appear in the interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH†Inline XBRL Taxonomy Extension Schema Document
101.CAL†Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF†Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB†Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE†Inline XBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File (formatted as inline XBRL)
*    Management contract or compensatory plan or arrangement
**    The certifications furnished as Exhibit 32.1 and Exhibit 32.2 accompany the Original Form 10-K pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed “filed” by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
†    Pursuant to applicable securities laws and regulations, the Registrant is deemed to have complied with the reporting obligation relating to the submission of interactive data files in such exhibits and is not subject to liability under any anti-fraud provisions of the federal securities laws as long as the Registrant has made a good faith attempt to comply with the submission requirements and promptly amends the interactive data files after becoming aware that the interactive data files fail to comply with the submission requirements. These interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under these Sections.
39



SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on May 2, 2022.
LIVEPERSON, INC.
By:/s/ Robert P. LoCascio
Name: Robert P. LoCascio
Title: Chief Executive Officer


40
EX-10.27 2 normanosumiofferletter.htm EX-10.27 Document
image_0.jpg
January 25, 2021

To: Norman Osumi
nosumi22@gmail.com
408 821 1325

Dear Norm,

I am pleased to offer you the position of SVP, Chief Accounting Officer, working remotely. You are scheduled to start on February 22, 2021, reporting to John Collins, the Company’s CFO. This letter confirms the terms and conditions of our employment offer to you:
    
You will be paid a salary at an initial annualized salary rate of $340,000 per year, to be paid in accordance with our then-current payroll practices (we currently pay salary on a semi-monthly basis on the 15th and last day of each month).

You will be eligible to participate in the LivePerson bonus plan as it exists from time to time under terms comparable to other LivePerson employees of similar role and responsibility. Your target annual bonus for 2021 will be 35% of your annual base salary which will be prorated for the portion of 2021 that you are employed at LivePerson based on your actual start date. Your actual bonus payout, if any, is anticipated to be paid during the first quarter of the subsequent fiscal year, and will be determined in the sole discretion of LivePerson based on the profitability of the company as compared to Plan, your individual bonus target and your personal contribution to the company’s efforts as determined by the Company in its sole discretion. Eligibility for and payment of such bonus, if any, is conditioned on your being actively employed by LivePerson as of the date the bonus, if any, is paid. Your actual bonus payment is likely to be either greater or less than your target amount based on these criteria. In any year, LivePerson may determine not to pay any bonus based on the above criteria. LivePerson reserves the right to amend or terminate its bonus plan at any time.

You will be granted new hire equity as follows: (a) $600,000 in unvested options to purchase shares of LivePerson common stock at a strike price determined by the LivePerson Board of Directors, and (b) $300,000 in unvested LivePerson Restricted Stock Units, in each case on the first Board equity grant date following your employment start date.

This grant date typically occurs within 3 months of the employment start date. The equity grants described above will be granted in accordance with our then-current standard policies and under the terms and conditions of the LivePerson Incentive Stock Plan together with the corresponding grant document issued to you at the time of the grant. Unvested option and RSU grants made to new hires vest in equal increments of 25% annually over four (4) years, beginning on the first anniversary of the grant date.

You will be eligible for vacation in accordance with LivePerson’s vacation policy as it exists from time to time. Under the current policy, you will accrue vacation at the approximate rate of 1.66 vacation days per month (20 days per year).

                                        Page 1


image_0.jpg
You will be eligible to enroll in the LivePerson health and disability insurance program on the first day of the first full calendar month of your employment subject to the terms and conditions of the applicable plans and policies, as they exist from time to time. You will be eligible to participate in the company’s 401(k) savings plan following your employment start date subject to the terms and conditions of the plan.
    
You will receive further orientation regarding benefits you are eligible for and company policies on or shortly after your start date.

This offer is made contingent upon your successful completion of the Company’s pre-employment procedures, including reference and background verification of your prior employment and other information provided by you during the interview process, as well as proof of identity and authorization to work in the United States, as required by law.

You will receive further orientation regarding benefits you are eligible for and company policies on or shortly after your start date.
Your employment with LivePerson is at-will and may be terminated by you or LivePerson at any time with or without cause and with or without notice.

In the event that your employment is terminated (a) by the Company without Cause (as defined below), or (b) by you for Good Reason (as defined below), and provided that within thirty (30) days following your termination date you timely execute and do not revoke a separation and release agreement drafted by and satisfactory to the Company (a “Release”), the Company will provide you with severance pay equal to three (3) months pay at your then current base salary rate and, if such termination occurs on or before the date that bonuses are paid for the fiscal year prior to termination, a payment equal to the bonus you would have received for the prior fiscal year had you remained employed on the date bonuses for such fiscal year are paid.  All payments hereunder shall be payable in accordance with the payment procedures described below.   For the avoidance of doubt, the foregoing severance shall not be paid in the event that your employment is terminated by reason of your voluntary resignation (other than for Good Reason).

Severance payments described above shall commence on the Company's first regularly scheduled payroll date that occurs as soon as practicable after the conditions set forth above are satisfied, and with respect to bonus payments, on the date bonuses are paid by the Company but in any event all severance and bonus payments hereunder shall be paid in full no later than the fifteenth (15th) day of the third (3rd) month following the end of your first tax year in which your termination of employment occurs, or, if later, the fifteenth (15th) day of the third (3rd) month following the end of the Company's first tax year in which your termination of employment occurs, as provided in Treasury Regulation Section 1.409A-1(b)(4).  The parties intend that the payments and benefits provided pursuant to this letter are exempt from the requirements of Section 409A of the Internal Revenue Code of 1986, as amended, the regulations and other guidance under and any state law of similar effect ("Section 409A") and any ambiguities herein will be interpreted to be so exempt.  Each payment and benefit payable under this letter is intended to constitute separate payments for purposes of Treasury Regulation Section 1.409A-2(b)(2).  Notwithstanding anything herein to the contrary, the Company

                                        Page 2


image_0.jpg
shall have no liability to you or to any other person, for any taxes, penalties or otherwise, if the payments and benefits provided pursuant to this letter that are intended to be exempt from Section 409A are not so exempt.

In the event that your employment is voluntarily terminated at any time by you or by the Company for Cause, you will be entitled only to your earned and unpaid compensation earned through the date of your termination of employment in accordance with applicable law.  You will not be entitled to severance or any other compensation or consideration that you might have received had your employment with the Company not been terminated.

For purposes hereof, “Cause” shall mean a determination by the Company (which determination shall not be arbitrary or capricious)  that:  (i) you materially failed to perform your specified or fundamental duties to the Company or any of its subsidiaries,  (ii) you were convicted of, or pled nolo contendere to, a felony (regardless of the nature of the felony), or any other crime involving dishonesty, fraud, or moral turpitude, (iii) you engaged in or acted with gross negligence or willful misconduct (including but not limited to acts of fraud, criminal activity or professional misconduct) in connection with the performance of your duties and responsibilities to the Company or any of its subsidiaries, (iv) you failed to substantially comply with the written rules and policies of the Company or any of its subsidiaries governing employee conduct or with the lawful directives of the Board of Directors, or (v) you breached any non-disclosure, non-solicitation or other restrictive covenant obligation to the Company or any of its subsidiaries.  If the Company in its reasonable discretion determines that an event or incident described in subparagraph (i) or (iv) of the definition of Cause is curable, then in order to terminate your employment for Cause pursuant to subparagraph (i) or (iv) of the definition of Cause, the Company shall (a) provide you with written notice of the event or incident that it considers to be “Cause” within 30 calendar days following its occurrence, (b) provide you with a period of at least 15 calendar days to cure the event or incident, and (c) if the Cause persists following the cure period, terminate your employment by written termination letter any time within 60 calendar days following the date that notice to cure was delivered to you.

For purposes hereof, “Good Reason” shall mean one or all of the following conditions arising without your consent: (i) a material reduction in your annual base salary by the Company, other than as part of an across-the-board reduction in parity with a reduction applicable to all employees or to other employees of similar role and responsibility or (ii) a material diminution by the Company of your role. To be entitled to terminate your employment for Good Reason, you must (a) provide written notice to the Company of the event or change that you consider constitutes “Good Reason” within 30 calendar days following its occurrence, (b) provide the Company with a period of at least 30 calendar days to cure the event or change, and (c) if the Good Reason persists following the cure period, actually resign by written resignation letter within 60 calendar days following the event or change.

This letter shall not be construed as an agreement (either express or implied) to employ you, or for any guaranteed term of employment, and shall in no way alter the Company’s policy of employment at-will, under which both the Company and you remain free to end the employment relationship for any reason, at any time, with or without cause or notice. Your employment with LivePerson is at-will and may be terminated by you or LivePerson at any time with or without cause and with or without notice.



                                        Page 3


image_0.jpg
This offer is made contingent upon your successful completion of the Company’s pre-employment procedures, including reference and background verification of your prior employment and other information provided by you during the interview process, as well as proof of identity and authorization to work in the United States, as required by law.

By signing this letter you confirm that you are not subject to any agreement, with a prior employer or otherwise, which would prohibit, limit or otherwise be inconsistent with your employment at LivePerson or prevent you from performing your obligations to LivePerson.  Additionally, please be advised that it is LivePerson’s corporate policy not to obtain or use any confidential, proprietary information or trade secrets of its competitors or others, unless it is properly obtained from sources permitted to disclose such information.  By signing this letter below, you are acknowledging that you have been advised of this policy and that you accept and will abide by it, and you are also agreeing that you will not use or disclose any confidential or proprietary information of LivePerson to any third party, including any previous or subsequent employer.

Please indicate your acceptance of this offer by signing and dating below. You will also receive additional information about LivePerson as well as some forms and documents that you must complete prior to your start date. Your employment is contingent upon the return of the requested material. The terms of this offer cannot be changed unless in writing signed by LivePerson.

LivePerson is a dynamic organization with tremendous growth opportunities. We look forward to you joining us and hope that you share our excitement for the opportunity it presents to everyone on the team.

Signatures are on the following page.

                                        Page 4


image_0.jpg


Sincerely,

/s/ John Collins
__________________________________
John Collins, CFO
LivePerson, Inc.

January 25, 2021
Date
Accepted By:

/s/ Norman Osumi
______________________________
Norman Osumi


January 25, 2021
Date


                                        Page 5

EX-31.3 3 a2021q4livepersonex313.htm EX-31.3 Document
Exhibit 31.3
CERTIFICATIONS
I, Robert P. LoCascio, certify that:
1.I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of LivePerson, Inc.; and
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
Date:May 2, 2022By:/s/ ROBERT P. LOCASCIO
Name:Robert P. LoCascio
Title:Chief Executive Officer (principal executive officer)


EX-31.4 4 a2021q4livepersonex314.htm EX-31.4 Document
Exhibit 31.4
CERTIFICATIONS
I, John Collins, certify that:
1.I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of LivePerson, Inc.; and
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
Date:May 2, 2022By:/s/ John Collins
Name:John Collins
Title:Chief Financial Officer (principal financial officer)



EX-101.SCH 5 lpsn-20211231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 0402401 - Document - Auditor Information link:presentationLink link:calculationLink link:definitionLink 1001002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1002003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 1004005 - Statement - Consolidated Statements of Operations (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005006 - Statement - Consolidated Statements of Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 1006007 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 1007008 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 2101101 - Disclosure - Description of Business and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2202201 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Description of Business and Summary of Significant Accounting Policies - Schedule of Activity in the Allowance for Doubtful Accounts (Details) link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - Description of Business and Summary of Significant Accounting Policies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2106102 - Disclosure - Revenue from Contract with Customer link:presentationLink link:calculationLink link:definitionLink 2307302 - Disclosure - Revenue from Contract with Customer (Tables) link:presentationLink link:calculationLink link:definitionLink 2408404 - Disclosure - Revenue from Contract with Customer (Schedule of Deferred Revenues and Contract Balances) (Details) link:presentationLink link:calculationLink link:definitionLink 2409405 - Disclosure - Revenue from Contract with Customer (Schedule of Disaggregation of Revenue) (Details) link:presentationLink link:calculationLink link:definitionLink 2410406 - Disclosure - Revenue from Contract with Customer (Schedule of Revenue by Geographic Region) (Details) link:presentationLink link:calculationLink link:definitionLink 2411407 - Disclosure - Revenue from Contract with Customer (Schedule of Receivables, Contract Acquisition Costs, and Deferred Revenue) (Details) link:presentationLink link:calculationLink link:definitionLink 2412408 - Disclosure - Revenue from Contract with Customer (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2113103 - Disclosure - Net Loss per Share link:presentationLink link:calculationLink link:definitionLink 2314303 - Disclosure - Net Loss per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2415409 - Disclosure - Earnings Per Share (Reconciliation of Shares Used in Calculating Basic and Diluted Earnings Per Share) (Details) link:presentationLink link:calculationLink link:definitionLink 2416410 - Disclosure - Earnings Per Share (Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share) (Details) link:presentationLink link:calculationLink link:definitionLink 2417411 - Disclosure - Net Loss per Share (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2118104 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 2319304 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2420412 - Disclosure - Segment Information - Financial Information by Segment (Details) link:presentationLink link:calculationLink link:definitionLink 2421413 - Disclosure - Segment Information - Long-Lived Assets by Geographic Region (Details) link:presentationLink link:calculationLink link:definitionLink 2422414 - Disclosure - Segment Information - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2123105 - Disclosure - Goodwill and Intangible Assets link:presentationLink link:calculationLink link:definitionLink 2324305 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 2425415 - Disclosure - Goodwill and Intangible Assets - (Schedule of Changes in Goodwill) (Details) link:presentationLink link:calculationLink link:definitionLink 2426416 - Disclosure - Goodwill and Intangible Assets - Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2427417 - Disclosure - Goodwill and Intangible Assets - Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2428418 - Disclosure - Goodwill and Intangible Assets - (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2129106 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 2330306 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 2431419 - Disclosure - Property and Equipment - (Schedule of Property and Equipment) (Details) link:presentationLink link:calculationLink link:definitionLink 2432420 - Disclosure - Property and Equipment - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2133107 - Disclosure - Accrued Liabilities and Other Current Liabilities link:presentationLink link:calculationLink link:definitionLink 2334307 - Disclosure - Accrued Liabilities and Other Current Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 2435421 - Disclosure - Accrued Liabilities and Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2136108 - Disclosure - Convertible Senior Notes and Capped Call Transactions link:presentationLink link:calculationLink link:definitionLink 2337308 - Disclosure - Convertible Senior Notes and Capped Call Transactions (Tables) link:presentationLink link:calculationLink link:definitionLink 2438422 - Disclosure - Convertible Senior Notes and Capped Call Transactions - Schedule of Carrying Amount of Liability Component of Convertible Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2439423 - Disclosure - Convertible Senior Notes and Capped Call Transactions - Schedule of Carrying Amount of Equity Component of Convertible Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2440424 - Disclosure - Convertible Senior Notes and Capped Call Transactions - Schedule of Interest Expense Incurred (Details) link:presentationLink link:calculationLink link:definitionLink 2441425 - Disclosure - Convertible Senior Notes and Capped Call Transactions - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2142109 - Disclosure - Acquisitions link:presentationLink link:calculationLink link:definitionLink 2343309 - Disclosure - Acquisitions (Tables) link:presentationLink link:calculationLink link:definitionLink 2444426 - Disclosure - Acquisitions - Schedule of Business Acquisitions, by Acquisition (Details) link:presentationLink link:calculationLink link:definitionLink 2445427 - Disclosure - Acquisitions - Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination (Details) link:presentationLink link:calculationLink link:definitionLink 2446428 - Disclosure - Acquisitions - Business Acquisition, Pro Forma Information (Details) link:presentationLink link:calculationLink link:definitionLink 2447429 - Disclosure - Acquisitions - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2148110 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 2349310 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 2450430 - Disclosure - Leases (Supplemental cash flow information related to leases) (Details) link:presentationLink link:calculationLink link:definitionLink 2451431 - Disclosure - Leases (Schedule of components of lease costs) (Details) link:presentationLink link:calculationLink link:definitionLink 2452432 - Disclosure - Leases (Supplemental balance sheet information related to leases) (Details) link:presentationLink link:calculationLink link:definitionLink 2453433 - Disclosure - Leases (Schedule of future minimum lease payments) (Details) link:presentationLink link:calculationLink link:definitionLink 2454434 - Disclosure - Leases (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2155111 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2356311 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2457435 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 2458436 - Disclosure - Fair Value Measurements - Level 3 Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2459437 - Disclosure - Fair Value Measurements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2160112 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2461438 - Disclosure - Commitments and Contingencies - Employee Benefit Plans, Letters of Credit, and Non-Income Related Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2162113 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 2363312 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 2464439 - Disclosure - Stockholders' Equity - Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2465440 - Disclosure - Stockholders' Equity - Restricted Stock Unit Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2466441 - Disclosure - Stockholders' Equity - Weighted Average Assumption (Details) link:presentationLink link:calculationLink link:definitionLink 2467442 - Disclosure - Stockholders' Equity - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2168114 - Disclosure - Restructuring Costs link:presentationLink link:calculationLink link:definitionLink 2369313 - Disclosure - Restructuring Costs (Tables) link:presentationLink link:calculationLink link:definitionLink 2470443 - Disclosure - Restructuring Costs -Liability for Restructuring Charges (Details) link:presentationLink link:calculationLink link:definitionLink 2471444 - Disclosure - Restructuring Costs - Restructuring Charges (Details) link:presentationLink link:calculationLink link:definitionLink 2472445 - Disclosure - Restructuring Costs - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2173115 - Disclosure - Legal Matters link:presentationLink link:calculationLink link:definitionLink 2474446 - Disclosure - Legal Matters (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2175116 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2376314 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 2477447 - Disclosure - Income Taxes - Domestic and Foreign Components of Income Before Provision for Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2478448 - Disclosure - Income Taxes - Schedule of Provision for Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2479449 - Disclosure - Income Taxes - Schedule of Reconciliations of Federal Statutory Tax Rate to Effective Income Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 2480450 - Disclosure - Income Taxes - Schedule of Federal Deferred Tax Assets and Deferred Tax Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2481451 - Disclosure - Income Taxes - Schedule of Unrecognized Tax Benefits (Details) link:presentationLink link:calculationLink link:definitionLink 2482452 - Disclosure - Income Taxes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2183117 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 2484453 - Disclosure - Subsequent Events (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 lpsn-20211231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 7 lpsn-20211231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 8 lpsn-20211231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Australian Taxation Office Australian Taxation Office [Member] Supplemental disclosure of other cash flow information: Supplemental Cash Flow Information [Abstract] Long-term liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities Legal Matters Legal Matters and Contingencies [Text Block] Federal statutory rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Convertible Debt Convertible Debt [Member] Current income taxes, State and local Current State and Local Tax Expense (Benefit) Released (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Net loss Net loss Net Income (Loss) Attributable to Parent Operating lease ROU asset (Note 10) Operating ROU assets Operating Lease, Right-of-Use Asset Schedule of Business Acquisitions, by Acquisition Schedule of Business Acquisitions, by Acquisition [Table Text Block] Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Payroll and other employee related costs Employee-related Liabilities, Current Income Statement Location [Axis] Income Statement Location [Axis] Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Statistical Measurement [Domain] Statistical Measurement [Domain] Other Other Intangible Assets [Member] Contract acquisition costs noncurrent Increase (Decrease) in Contract with Customer, Asset Internal-use software development costs not yet subject to amortization Internal Use Software Development Costs, Balance Not Subject To Amortization Internal Use Software Development Costs, Balance Not Subject To Amortization Security Exchange Name Security Exchange Name AdvantageTec AdvantageTec Inc [Member] AdvantageTec Inc [Member] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Convertible debt conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price EMEA EMEA [Member] Forfeited (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Accrual during period for cash awards related to achievement of long-term incentive plan awards Share-Based Compensation, Accrual For Cash Awards To Be Settled In Stock, Achievement Of Incentive Plan Awards Share-Based Compensation, Accrual For Cash Awards To Be Settled In Stock, Achievement Of Incentive Plan Awards Revenue from Contract with Customer [Abstract] Schedule of Deferred Revenues and Contract Balances Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Payment related to contingent consideration Payment for Contingent Consideration Liability, Financing Activities Deferred Revenue, Period Increase (Decrease) Deferred Revenue, Period Increase (Decrease) Restructuring Type [Axis] Restructuring Type [Axis] Cancelled or expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Operating leases, weighted average remaining lease term (in years) Operating Lease, Weighted Average Remaining Lease Term Foreign Currency Translation Foreign Currency Transactions and Translations Policy [Policy Text Block] Other assets Other Assets, Noncurrent Investment, Name [Axis] Investment, Name [Axis] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Segments [Axis] Segments [Axis] Dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Net (decrease) increase in cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Estimated sales tax liability, including interest, minimum Estimated Sales Tax Liability, Including Interest, Minimum Estimated Sales Tax Liability, Including Interest, Minimum Acquired Finite-Lived Intangible Assets [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] Entity File Number Entity File Number Percentage of principal amount paid if repurchase due to fundamental change (percent) Debt Instrument, Redemption Price, Percentage Change in Fair Value of Level 3 Liability: Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Stock-based compensation APIC, Share-based Payment Arrangement, Increase for Cost Recognition Intangibles amortization Deferred Tax Liabilities, Intangible Assets Subsequent Event Type [Domain] Subsequent Event Type [Domain] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Summary of Operations Summary Of Operations [Policy Text Block] The accounting policy related to summary of operations. Deferred tax liabilities, non-current Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Aggregate amortization expense Amortization of Intangible Assets Intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Weighted Average Amortization Period Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Fair Value, Expected To Vest Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Fair Value, Expected To Vest Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Fair Value, Expected To Vest Expiration between 2023 and 2026 NOL Expiration Period, Tranche One [Member] NOL Expiration Period, Tranche One [Member] Net deferred tax assets (liabilities) Deferred Tax Assets, Net Operating leases, weighted average discount rate (percent) Operating Lease, Weighted Average Discount Rate, Percent Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Recognition of deferred revenue Contract with Customer, Liability, Revenue Recognized Product development Research and Development Expense [Member] Liability Class [Axis] Liability Class [Axis] Subsequent Events [Abstract] Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual Deferred tax assets, net of valuation allowance Deferred Tax Assets, Net of Valuation Allowance Business Combination and Asset Acquisition [Abstract] Awarded (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Business Acquisition [Axis] Business Acquisition [Axis] Property and equipment and finance lease, gross Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] Award Type [Domain] Award Type [Domain] Estimated future amortization expense Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] Schedule of Carrying Amount of Liability Component of Convertible Debt Convertible Debt [Table Text Block] Local Phone Number Local Phone Number Assets Assets [Abstract] Total deferred issuance costs Deferred Finance Costs, Liability And Equity Component Deferred Finance Costs, Liability And Equity Component Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Options exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Accumulated goodwill impairment charges Goodwill, Impaired, Accumulated Impairment Loss Options vested and expected to vest (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract] Goodwill and Intangible Assets Goodwill and Intangible Assets, Policy [Policy Text Block] ROU assets obtained in exchange for finance lease liabilities Right-of-Use Asset Obtained in Exchange for Finance Lease Liability Awarded (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Schedule of Carrying Amount of Equity Component of Convertible Debt Schedule of Carrying Amount of Equity Component of Convertible Debt [Table Text Block] Schedule of Carrying Amount of Equity Component of Convertible Debt Convertible notes issuance Deferred Tax Liabilities, Convertible Notes Deferred Tax Liabilities, Convertible Notes Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Preferred stock, $0.001 par value - 5,000,000 shares authorized, none issued Preferred Stock, Value, Issued Incentive Stock Option Incentive Stock Option [Member] Incentive Stock Option Gross Carrying Amount Intangible assets acquired Finite-lived Intangible Assets Acquired Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Options outstanding, beginning balance (in shares) Options outstanding, ending balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Loss Contingency, Damages Awarded, Value Loss Contingency, Damages Awarded, Value Threshold consecutive trading days in analysis of conversion price Debt Instrument, Convertible, Threshold Consecutive Trading Days Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Trade names Trade Names [Member] Accumulated Deficit Retained Earnings [Member] Debt Instrument [Axis] Debt Instrument [Axis] Advertising Advertising Cost [Policy Text Block] Non-current liabilities: Liabilities, Noncurrent [Abstract] Operating lease right of use asset Deferred Tax Liabilities, Leasing Arrangements Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Contract with customer liability, current, Increase (decrease), net Contract with customer liability, current, Increase (decrease), net Contract with customer liability, current, Increase (decrease), net Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Long-Lived Assets By Geographic Region Long-lived Assets by Geographic Areas [Table Text Block] Accounts receivable Increase (Decrease) in Accounts Receivable Purchase of property and equipment recorded in accounts payable Capital Expenditures Incurred but Not yet Paid ROU assets obtained in exchange for operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Business Acquisition, Pro Forma Information Business Acquisition, Pro Forma Information [Table Text Block] Global intangible low tax income inclusion Effective Income Tax Rate Reconciliation, Global Intangible Low Tax Income Inclusion Effective Income Tax Rate Reconciliation, Global Intangible Low Tax Income Inclusion Schedule of Federal Deferred Tax Assets and Deferred Tax Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Germany GERMANY Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Principal payments for financing leases Financing cash flows for finance leases Finance Lease, Principal Payments Number of operating segments Number of Operating Segments Contingent earn-out Business Combination, Contingent Consideration, Liability, Current Basic Earnings Per Share, Basic Net operating loss carryforwards, subject to expiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration Lease expense for operating leases Operating Lease, Expense 2024 Lessee, Operating Lease, Liability, to be Paid, Year Three Revenue from Contract with Customer Revenue from Contract with Customer [Text Block] Thereafter Finite-Lived Intangible Asset, Expected Amortization, after Year Five Professional Services - Business Professional Services [Member] Professional Services [Member] Beginning balance (shares) Ending balance (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Balance, Beginning of year Balance, End of year Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Net assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Total interest expense Total interest expense Interest Expense, Debt Gain on settlement of leases Gain on settlement of leases Gain (Loss) on Termination of Lease Schedule of Disaggregated of Revenue Disaggregation of Revenue [Table Text Block] Amortization of tenant allowance Tenant Allowance, Amortization, Lessee Amortization of lessee lease liability over time which offsets lease expense. Restricted Stock Units Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Interest Deferred Tax Asset, Interest Carryforward Organization Consolidation And Summary Of Significant Accounting Policies [Line Items] Organization Consolidation And Summary Of Significant Accounting Policies [Line Items] Organization Consolidation And Summary Of Significant Accounting Policies [Line Items] Accounting standard adoption adjustment Cumulative Effect, Period of Adoption, Adjustment [Member] Accrued sales tax, including interest Accrued Sales Tax Liability, Including Interest Accrued Sales Tax Liability, Including Interest Shares of common stock available for issuance (up to) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Operating cash flows for operating leases Operating Lease, Payments Contract acquisition costs Contract acquisition costs non-current, opening balance Contract acquisition costs non-current, ending balance Capitalized Contract Cost, Net, Noncurrent Stock based compensation – excess tax benefit Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent Australia AUSTRALIA VoiceBase VoiceBase [Member] VoiceBase Property and equipment Deferred Tax Liabilities, Property, Plant and Equipment Fair value of contingent earn-out recorded in other long-term liabilities Business Combination, Contingent Consideration Arrangements Business Combination, Contingent Consideration Arrangements Federal Ministry of Finance, Germany Federal Ministry of Finance, Germany [Member] Aggregate purchase price Business Combination, Consideration Transferred Allowance for credit losses Accounts Receivable, Credit Loss Expense (Reversal) Expected to vest (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected To Vest, Number Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected To Vest, Number Principal Long-term Debt, Gross Goodwill [Roll Forward] Goodwill [Roll Forward] Entity Voluntary Filers Entity Voluntary Filers Non-deductible excess compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Section 162 Effective Income Tax Rate Reconciliation, Nondeductible Expense, Section 162 Business Acquisition, Equity Interest Issued or Issuable, Basis for Determining Value Business Acquisition, Equity Interest Issued or Issuable, Basis for Determining Value Purchase of capped call option Payments for Derivative Instrument, Financing Activities Assets, Fair Value Disclosure [Abstract] Assets, Fair Value Disclosure [Abstract] Finance ROU assets Finance Lease, Right-of-Use Asset, after Accumulated Amortization Net carrying amount Long-term Debt Match Step Two Matching Tranche Two [Member] Matching Tranche Two [Member] Total assets Assets, Fair Value Disclosure Level 1 Fair Value, Inputs, Level 1 [Member] INVESTING ACTIVITIES: Net Cash Provided by (Used in) Investing Activities [Abstract] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Goodwill impairment recognized Goodwill, Impairment Loss Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Weighted-average shares used to compute net loss income per share: Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Internal-use software development costs Software Development [Member] Entity Small Business Entity Small Business Gross increase for tax positions of current years Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Total liabilities and stockholders’ equity Liabilities and Equity Other Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Other Other Accrued Liabilities, Current Shares subject to outstanding stock options and employee stock purchase plan Shares subject to outstanding stock options and employee stock purchase plan [Member] Shares subject to outstanding stock options and employee stock purchase plan Total Americas Americas [Member] Deferred revenue (Note 2) Total deferred revenue - current Deferred revenue current, opening balance Deferred revenue current, ending balance Contract with Customer, Liability, Current Decrease in valuation allowance charged to equity Valuation Allowance, Deferred Tax Asset, Decrease, Gross Valuation Allowance, Deferred Tax Asset, Decrease, Gross Operating lease liability Deferred Tax Assets, Lease Liabilities Deferred Tax Assets, Lease Liabilities 2026 Lessee, Operating Lease, Liability, to be Paid, Year Five Issuance of shares of common stock in connection with acquisition Other Significant Noncash Transaction, Value of Consideration Given e-bot7 e-bot7 [Member] e-bot7 Exercised (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Restricted cash in prepaid expenses and other current assets Restricted Cash Additional paid-in capital Additional Paid in Capital Stock Issued During Period, Value, Earnout Payment Issuance of shares of common stock as earn-out payment in connection with AdvantageTec Inc. Stock Issued During Period, Value, Earnout Payment Stock Issued During Period, Value, Earnout Payment Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Liabilities and Equity [Abstract] Liabilities and Equity [Abstract] Accounts payable Increase (Decrease) in Accounts Payable Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Income Tax Contingency [Table] Income Tax Contingency [Table] Net Loss per Share Earnings Per Share [Text Block] Equity Method Investment, Ownership Percentage Equity Method Investment, Ownership Percentage Entity Interactive Data Current Entity Interactive Data Current 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Four Decrease due to settlement Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Common stock issued upon exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Minimum Minimum [Member] Proceeds allocated to the conversion options (debt discount) Carry amount of equity component of convertible notes Debt Instrument, Convertible, Carrying Amount of Equity Component Abandonment of property and equipment Other Restructuring, Property And Equipment Abandonment [Member] Other Restructuring, Property And Equipment Abandonment [Member] Change in fair value of contingent consideration Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 2023 Lessee, Operating Lease, Liability, to be Paid, Year Two Effect of foreign exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Conversion ratio Debt Instrument, Convertible, Conversion Ratio Total liabilities Financial and Nonfinancial Liabilities, Fair Value Disclosure Unamortized issuance costs Debt Issuance Costs, Net Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Unrecognized tax benefits balance at January 1 Gross unrecognized tax benefits at December 31 Unrecognized tax benefits Unrecognized Tax Benefits Income Tax Authority [Domain] Income Tax Authority [Domain] Total deferred tax assets Deferred Tax Assets, Gross Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Address, State or Province Entity Address, State or Province Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] Leases Lessee, Finance Leases [Text Block] Restructuring (Note 14) Balance at January 1 Balance at December 31 Restructuring liability Restructuring Reserve Loss Contingency, Damages Sought, Value Loss Contingency, Damages Sought, Value Deferred tax assets Deferred Income Tax Assets, Net Options vested and expected to vest Share-based Compensation Arrangement By Share-based Payment Award, Options, Vested And Expected To Vest, Aggregate Intrinsic Value Share-based Compensation Arrangement By Share-based Payment Award, Options, Vested And Expected To Vest, Aggregate Intrinsic Value United Kingdom UNITED KINGDOM Issuance of common stock in connection with acquisitions Stock Issued During Period, Value, Acquisitions Current liabilities: Current liabilities: Liabilities, Current [Abstract] Common stock issued upon vesting of restricted stock units Stock Issued During Period, Value, New Issues Operating lease liabilities Increase (Decrease) in Operating Lease Liability General and administrative General and Administrative Expense Technology Technology [Member] Technology [Member] Payments for acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Convertible Senior Notes and Capped Call Transactions Debt Disclosure [Text Block] Beginning Balance (in shares) Ending Balance (in shares) Shares, Outstanding Refund claims related to prior years Proceeds from Income Tax Refunds Schedule of Provision For Income Taxes Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Lease restructuring costs Other Restructuring [Member] Options exercisable (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Intangibles amortization Deferred Tax Assets, Goodwill and Intangible Assets Stockholders' Equity Share-based Payment Arrangement [Text Block] Noncash or Part Noncash Acquisitions by Unique Description [Axis] Noncash or Part Noncash Acquisitions by Unique Description [Axis] Level 3 Fair Value, Inputs, Level 3 [Member] Property and Equipment, Net Property, Plant and Equipment, Net, by Type [Abstract] Less: accumulated depreciation Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization Accounting Policies [Abstract] Accounting Policies [Abstract] Options outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Common stock issued upon vesting of restricted stock units (in shares) Stock Issued During Period, Shares, New Issues Amortization period for contract acquisition costs (in years) Capitalized Contract Cost, Amortization Period Professional services, consulting and other vendor fees Accrued Professional Fees, Current Other assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Current income taxes, U.S. Federal Current Federal Tax Expense (Benefit) Letters of credit outstanding Letters of Credit Outstanding, Amount Total operating lease liability Operating Lease, Liability Document Transition Report Document Transition Report Common stock, $0.001 par value - 200,000,000 and 200,000,000 shares authorized, 74,980,546 and 70,264,265 shares issued, and 72,234,303 and 67,554,435 shares outstanding as of December 31, 2021 and 2020, respectively Common Stock, Value, Issued Finance leases, weighted average discount rate (percent) Finance Lease, Weighted Average Discount Rate, Percent Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Total other expense, net Nonoperating Income (Expense) Accounts receivable, increase (decrease), net Accounts receivable, period increase (decrease), net Accounts receivable, period increase (decrease), net Weighted average recognition period of unrecognized compensation cost Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Beginning balance (in dollars per share) End balance (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Goodwill acquired in acquisition Acquisitions Goodwill, Acquired During Period Commitments and contingencies (Note 12) Commitments and Contingencies Total long-lived assets Assets, Noncurrent Subsequent Event [Table] Subsequent Event [Table] Accumulated other comprehensive (loss) income Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Emerging Growth Company Entity Emerging Growth Company Increase in valuation allowance recorded as an expense Valuation Allowance, Deferred Tax Asset, Increase, Gross Valuation Allowance, Deferred Tax Asset, Increase, Gross Amortization of finance leases Amortization of right-of-use assets Finance Lease, Right-of-Use Asset, Amortization Proceeds from debt offering, net of debt issuance costs Proceeds from Debt, Net of Issuance Costs Accounts receivable, allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss, Current Common stock as earnout payment in connection with AdvantageTec Inc. (in shares) Issuance of shares of common stock as earn-out payment in connection with AdvantageTec Inc. (in shares) Stock Issued During Period, Shares, Earnout Payment Stock Issued During Period, Shares, Earnout Payment Acquisitions Business Combination Disclosure [Text Block] Accounts receivable Billed Revenues [Member] Payment of issuance costs in connection with convertible senior notes Payments of Debt Issuance Costs ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Weighted Average Assumptions of Fair Value Options Using Black-Scholes Option-Pricing Model Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Other Commitments [Table] Other Commitments [Table] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Deferred income taxes, Foreign Deferred Foreign Income Tax Expense (Benefit) Auditor Name Auditor Name Cover [Abstract] Cover [Abstract] Goodwill [Line Items] Goodwill [Line Items] Total costs and expenses Costs and Expenses Schedule of Revenue by Geographic Location Revenue from External Customers by Geographic Areas [Table Text Block] Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Accounts payable and accrued expenses Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Net loss Business Acquisition, Pro Forma Net Income (Loss) Defined Contribution Plan Match Groups [Domain] Defined Contribution Plan Match Groups [Domain] [Domain] for Defined Contribution Plan Match Groups [Axis] Other lease restructuring costs Other Restructuring. Other Lease Restructuring [Member] Other Restructuring. Other Lease Restructuring [Member] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Less: present value adjustment Lessee, Operating Lease, Liability, Undiscounted Excess Amount Match Step One Matching Tranche One [Member] Matching Tranche One [Member] Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] Capitalized contract costs, period increase (decrease), net Capitalized contract costs, period increase (decrease), net Capitalized contract costs, period increase (decrease), net Hosted Services - Business Hosted Services - Business [Member] Hosted Services - Business [Member] Income Tax Authority [Axis] Income Tax Authority [Axis] Thereafter Finance Lease, Liability, to be Paid, after Year Five Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Financial Instrument [Axis] Financial Instrument [Axis] Operating Leases Lessee, Operating Leases [Abstract] Lessee, Operating Leases Accrued expenses and other current liabilities (Note 7) Total accrued expenses and other current liabilities Accrued Liabilities, Current Revenue Total revenue Revenue from Contract with Customer, Excluding Assessed Tax Non-cash compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Less: present value adjustment Finance Lease, Liability, Undiscounted Excess Amount Assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract] Net Operating Loss Expiration Periods [Axis] Net Operating Loss Expiration Periods [Axis] Net Operating Loss Expiration Periods [Axis] Stock option Share-based Payment Arrangement, Option [Member] Equity [Abstract] Equity [Abstract] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Comprehensive Loss Comprehensive Income, Policy [Policy Text Block] Net operating loss carryforwards, not subject to expiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration Cash payments Payments for Restructuring Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] 2026 Finance Lease, Liability, to be Paid, Year Five Common Stock Common Stock [Member] Other expense, net: Other Nonoperating Income (Expense) [Abstract] Foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Finance leases, weighted average remaining lease term (in years) Finance Lease, Weighted Average Remaining Lease Term Segment Information Segment Reporting Disclosure [Text Block] Loss from operations Operating Income (Loss) Common Stock, Increase In Shares Authorized During The Period Common Stock, Increase In Shares Authorized During The Period Common Stock, Increase In Shares Authorized During The Period Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Defined Contribution Plan Match Groups [Axis] Defined Contribution Plan Match Groups [Axis] Defined Contribution Plan Match Groups [Axis] Operating lease liability (Note 10) Operating lease liability Operating Lease, Liability, Current 2023 Finite-Lived Intangible Asset, Expected Amortization, Year Two Treasury stock, at cost (in shares) Treasury Stock, Common, Shares Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Document Fiscal Year Focus Document Fiscal Year Focus Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Customer relationships Customer Contracts [Member] Stock-based compensation expense Share-based Payment Arrangement, Noncash Expense Restructuring Costs Restructuring and Related Activities Disclosure [Text Block] Additional Paid-In Capital Additional Paid-in Capital [Member] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Litigation Settlement, Amount Awarded from Other Party Litigation Settlement, Amount Awarded from Other Party Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual Treasury Stock Treasury Stock [Member] Accrued expenses and other current liabilities Increase (Decrease) in Accrued Liabilities Schedule Restricted Stock Units Activity Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Purchase Price Purchase Price [Member] Purchase Price Business Consumer Business [Member] Consumer Business [Member] Aggregate principal from exercise in full of over-allotment options Aggregate Principal From Exercise In Full Of Over-Allotment Options Aggregate Principal From Exercise In Full Of Over-Allotment Options Other income (expense), net Other Nonoperating Income (Expense) Other liabilities Increase (Decrease) in Other Operating Liabilities Expected to vest (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected To Vest, Weighted Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected To Vest, Weighted Average Grant Date Fair Value Repayment of debt acquired in acquisition Payments for (Proceeds from) Other Investing Activities Purchases of property and equipment, including capitalized software Payments to Acquire Property, Plant, and Equipment Other United Kingdom, Germany, Japan, France, Italy, Spain, Canada, Singapore [Member] United Kingdom, Germany, Japan, France, Italy, Spain, Canada, Singapore Contingent Consideration by Type [Axis] Contingent Consideration by Type [Axis] Business Combinations [Abstract] Business Combinations [Abstract] Employer matching contributions Defined Benefit Plan, Plan Assets, Contributions by Employer Maximum Maximum [Member] Number of leases abandoned Number Of Leases Abandoned Number Of Leases Abandoned Operating loss carryforwards generated in taxable years ending on or before December 31 2017 Operating Loss Carryforwards, Generated In Taxable Years Ending On Or Before December 31 2017 Operating Loss Carryforwards, Generated In Taxable Years Ending On Or Before December 31 2017 Total liabilities Liabilities Unbilled Receivable Unbilled Revenues [Member] Schedule of Accrued Liabilities and Other Current Liabilities Schedule of Accrued Liabilities [Table Text Block] 2022 Finite-Lived Intangible Asset, Expected Amortization, Year One Award Type [Axis] Award Type [Axis] Granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price FINANCING ACTIVITIES: Net Cash Provided by (Used in) Financing Activities [Abstract] Schedule of Future Minimum Lease Payments Lessee, Operating Lease, Liability, Maturity [Table Text Block] Consolidation Items [Axis] Consolidation Items [Axis] Total stockholders’ equity Beginning Balance Ending Balance Stockholders' Equity Attributable to Parent Fair value of stock options exercised Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises in Period, Fair Value Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises in Period, Fair Value Billing Status, Type [Axis] Billing Status, Type [Axis] Operating loss carryforwards Operating Loss Carryforwards Common stock, shares issued (in shares) Common Stock, Shares, Issued Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued City Area Code City Area Code Payments Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Options exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Supplemental cash flow information related to leases Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] Developed technology Developed technology [Member] Developed technology Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Entity Address, City or Town Entity Address, City or Town Repurchase of common stock Payments for Repurchase of Common Stock Israel ISRAEL Useful life of assets Property, Plant and Equipment, Useful Life Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Schedule of Unrecognized Tax Benefits Roll Forward Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Software and software development costs Software and Software Development Costs [Member] Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Employee Stock Purchase Plan Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan Risk-free interest rate, minimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Operating lease liability, net of current portion (Note 10) Operating lease liability Operating Lease, Liability, Noncurrent Total minimum lease payments Finance Lease, Liability, Payment, Due Measurement Frequency [Domain] Measurement Frequency [Domain] Total current income taxes Current Income Tax Expense (Benefit) Loss Contingency, Information about Litigation Matters [Abstract] Loss Contingency, Information about Litigation Matters [Abstract] Aggregate principal Debt Instrument, Face Amount 2022 Finance Lease, Liability, to be Paid, Year One Purchase price paid in cash Purchase price paid in cash [Member] Purchase price paid in cash Unrecognized Tax Benefits, Increase Resulting from Acquisition Unrecognized Tax Benefits, Increase Resulting from Acquisition Historical volatility, maximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Net Operating Loss Expiration Periods [Domain] Net Operating Loss Expiration Periods [Domain] [Domain] for Net Operating Loss Expiration Periods [Axis] Total acquisition consideration Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Accumulated deficit Retained Earnings (Accumulated Deficit) Operating Segments Operating Segments [Member] Stock option term (in years) Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Convertible Senior Notes Convertible Senior Notes [Member] Convertible Senior Notes [Member] Restricted stock units Restricted Stock Units (RSUs) [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Common stock issued under Employee Stock Purchase Plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Entity Filer Category Entity Filer Category Present value of lease liabilities Finance Lease, Liability Total deferred tax liabilities Deferred Tax Liabilities, Gross Employer matching contribution, percent of match Defined Contribution Plan, Employer Matching Contribution, Percent of Match Operating leases remaining lease term Lessee, Operating Lease, Remaining Lease Term Business Acquisition [Line Items] Business Acquisition [Line Items] Reconciliation of cash, cash equivalents, and restricted cash to consolidated balance sheets Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract] Income Statement [Abstract] Income Statement [Abstract] Entity Registrant Name Entity Registrant Name Schedule of Changes in Fair Value of Level 3 Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] 2024 Finance Lease, Liability, to be Paid, Year Three 2025 Finance Lease, Liability, to be Paid, Year Four Remaining amortization period for debt discount and debt issuance costs Debt Instrument, Convertible, Remaining Discount Amortization Period Capped caps initial cap price (in dollars per share) Capped Calls, Initial Cap Price Capped Calls, Initial Cap Price 2023 Finance Lease, Liability, to be Paid, Year Two Cancelled (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] (Benefit from) provision for income taxes Total income taxes Income Tax Expense (Benefit) Expiration between 2030 and 2037 NOL Expiration Period, Tranche Two [Member] NOL Expiration Period, Tranche Two [Member] Accounts receivable, net of allowances of $6,338 and $5,344, as of December 31, 2021 and 2020, respectively Accounts receivable, opening balance Accounts receivable, ending balance Accounts Receivable, after Allowance for Credit Loss, Current Amendment Flag Amendment Flag Equity Components [Axis] Equity Components [Axis] Entity Tax Identification Number Entity Tax Identification Number Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Document Fiscal Period Focus Document Fiscal Period Focus Total current assets Assets, Current Joint Venture [Member] Joint Venture [Member] Joint Venture Sales and marketing Selling and Marketing Expense [Member] Total minimum lease payments Lessee, Operating Lease, Liability, to be Paid Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Forfeited (shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Receivables Billing Status [Domain] Receivables Billing Status [Domain] Summary Of Financial Information By Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Stock-Based Compensation Share-based Payment Arrangement [Policy Text Block] Common stock repurchase Stock Repurchased During Period, Value Deferred income taxes, U.S. Federal Deferred Federal Income Tax Expense (Benefit) Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Increase in valuation recorded Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Product and Service [Axis] Product and Service [Axis] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Reconciliation of Shares Used in Calculating Basic and Diluted Earnings Per Share Schedule of Weighted Average Number of Shares [Table Text Block] Allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss [Roll Forward] Netherlands NETHERLANDS Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Entity Public Float Entity Public Float Non-deductible expenses – stock based compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Unrecognized compensation cost - RSU Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Bonus cash payment settled in shares of the Company’s common stock Issuance of shares of common stock to settle cash awards Stock Issued During Period, Value, Bonus Payment Settled In Shares Stock Issued During Period, Value, Bonus Payment Settled In Shares Weighted average fair value of stock options granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Equity Component [Domain] Equity Component [Domain] Tenfold Tenfold [Member] Tenfold Business Acquisition, Value of Shares Prior to Acquisition Business Acquisition, Value of Shares Prior to Acquisition Business Acquisition, Value of Shares Prior to Acquisition Sales and marketing Selling and Marketing Expense 2022 Lessee, Operating Lease, Liability, to be Paid, Year One Common stock repurchase (in shares) Stock Repurchased During Period, Shares Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Bonus cash payment settled in shares of the Company's common stock (in shares) Issuance of shares of common stock to settle cash awards (in shares) Stock Issued During Period, Shares, Bonus Payment Settled In Shares Stock Issued During Period, Shares, Bonus Payment Settled In Shares Deferred tax assets: Components of Deferred Tax Assets [Abstract] Equity consideration in acquisition Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Debt issuance costs attributable to liability Debt Issuance Costs, Gross Accretion of debt discount on convertible senior notes Amortization of debt discount Amortization of Debt Discount (Premium) Statement [Line Items] Statement [Line Items] Property and equipment, net (Note 6) Total Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Deferred revenue Increase (Decrease) in Contract with Customer, Liability Issuance of common stock in connection with acquisitions (in shares) Stock Issued During Period, Shares, Acquisitions Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Net loss per share, basic and diluted Earnings Per Share, Basic and Diluted Remaining performance obligations Revenue, Remaining Performance Obligation, Amount APAC POSIT - ASIA PACIFIC [Member] Federal Domestic Tax Authority [Member] Internal-Use Software Development Costs Internal Use Software, Policy [Policy Text Block] Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Convertible senior note net Convertible Debt, Fair Value Disclosures 2024 Notes Convertible Senior Notes Due 2024 [Member] Convertible Senior Notes Due 2024 2025 Lessee, Operating Lease, Liability, to be Paid, Year Four Debt Disclosure [Abstract] Debt Disclosure [Abstract] Financing lease liability (Note 10) Finance lease liability Finance Lease, Liability, Current Furniture, equipment, and building improvements Furniture Equipment And Building Improvements [Member] Furniture, Equipment and Building Improvements [Member] Level 2 Fair Value, Inputs, Level 2 [Member] WildHealth WildHealth [Member] WildHealth Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Less valuation allowance Valuation allowance on deferred tax assets Deferred Tax Assets, Valuation Allowance Contractual interest expense Interest Expense, Debt, Excluding Amortization Deferred revenue, net of current portion (Note 2) Total deferred revenue - non-current Deferred revenue non-current, opening balance Deferred revenue non-current, ending balance Contract with Customer, Liability, Noncurrent Auditor Location Auditor Location Computer equipment and software Computer Equipment And Software [Member] Computer Equipment And Software [Member] Finance Leases Finance Lease Liability [Abstract] Issuance costs Deferred Finance Costs, Allocated To Equity Component Deferred Finance Costs, Allocated To Equity Component Corporate Corporate, Non-Segment [Member] Type of Restructuring [Domain] Type of Restructuring [Domain] Segment Reporting [Abstract] Segment Reporting [Abstract] ASU 2016-13 (Topic 326) adjustment Accounts Receivable, Change in Method, Credit Loss Expense (Reversal) Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Interest Finance Lease, Interest Expense Issuance of shares of common stock in connection with acquisition (in shares) Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued Capped calls Capped Calls [Member] Capped Calls [Member] Business Business [Member] Business [Member]. Use of Estimates Use of Estimates, Policy [Policy Text Block] Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Threshold trading days in consideration of note conversion Debt Instrument, Convertible, Threshold Trading Days Document Annual Report Document Annual Report Deferred income taxes: Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract] Title of 12(b) Security Title of 12(b) Security Current liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Foreign tax credit Deferred Tax Assets, Tax Credit Carryforwards, Foreign Proceeds from issuance of common stock in connection with the exercise of options and ESPP Proceeds from Issuance of Common Stock Total assets Assets Investment, Name [Domain] Investment, Name [Domain] Deferred income taxes Deferred Income Taxes and Tax Credits Deferred tax liabilities: Components of Deferred Tax Liabilities [Abstract] Original issue discount Deferred Tax Assets, Original Issue Discount Deferred Tax Assets, Original Issue Discount Common stock, shares authorized (in shares) Common Stock, Shares Authorized Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Geographical [Domain] Geographical [Domain] Document Type Document Type Product and Service [Domain] Product and Service [Domain] Product development Research and Development Expense Debt instrument stated rate (percent) Debt Instrument, Interest Rate, Stated Percentage Schedule of Activity in the Allowance for Doubtful Accounts Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Business Combination, Contingent Consideration, Liability Business Combination, Contingent Consideration, Liability Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Convertible senior notes, net (Note 8) Convertible Notes Payable, Noncurrent Aggregate Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Fair Value [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Fair Value [Abstract] Cumulative Effect, Period of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] Measurement Frequency [Axis] Measurement Frequency [Axis] Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Schedule of components of lease costs Lease, Cost [Table Text Block] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Deferred Rent Deferred Charges, Policy [Policy Text Block] Subsequent Event [Line Items] Subsequent Event [Line Items] Geographical [Axis] Geographical [Axis] Basic Weighted Average Number of Shares Outstanding, Basic Diluted Earnings Per Share, Diluted State State and Local Jurisdiction [Member] Segments [Domain] Segments [Domain] Threshold percentage of stock price if converted Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger Cash paid for income taxes Income Taxes Paid, Net Assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Accounting Standards Update [Extensible Enumeration] Accounting Standards Update [Extensible Enumeration] Subsequent Events Subsequent Events [Text Block] Other Japan And France [Member] Japan And France Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Intangibles, net (Note 5) Intangible Assets, Net (Excluding Goodwill) Employee Severance [Member] Employee Severance [Member] Cost of revenue Cost of Revenue Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Treasury stock, at cost; 2,746,243 and 2,709,830 shares as of December 31, 2021 and 2020, respectively Treasury Stock, Value Deferred tax liability Deferred Income Tax Liabilities, Net Vesting period (in years) Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Organization Consolidation And Summary Of Significant Accounting Policies [Table] Organization Consolidation And Summary Of Significant Accounting Policies [Table] Organization Consolidation And Summary Of Significant Accounting Policies [Table] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Loss on disposal Gain (Loss) on Disposition of Other Assets Expiration between 2022 and 2041 NOL Expiration Period, Tranche Three [Member] NOL Expiration Period, Tranche Three Schedule of Reconciliation of Federal Statutory Tax Rate to Effective Income Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Fair Value Measurements Fair Value Disclosures [Text Block] Loss before (benefit from) provision for income taxes Income (Loss) Attributable to Parent, before Tax Income (Loss) Attributable to Parent, before Tax Restructuring costs Restructuring charges Restructuring Charges Accounts payable Accounts Payable, Current Allowance for doubtful accounts Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss Depreciation Depreciation and amortization expense Depreciation, Depletion and Amortization Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Three Foreign Foreign Tax Authority [Member] Business Combination Business Combinations Policy [Policy Text Block] Proceeds from issuance of convertible senior notes Proceeds from Convertible Debt Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Schedule of Restructuring and Related Costs Restructuring and Related Costs [Table Text Block] Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Financial Instruments [Domain] Financial Instruments [Domain] Hosted Services - Consumer Hosted Services - Consumer [Member] Hosted Services - Consumer [Member] Conversable Dec 13 2019 Conversable Inc 1 [Member] Conversable Inc 1 [Member] Goodwill amortization and contingent earn-out adjustments Deferred Tax Liabilities, Contingent Earn-Out Adjustments Deferred Tax Liabilities, Contingent Earn-Out Adjustments Business Acquisition, Equity Interest Issued or Issuable, Value Assigned Business Acquisition, Equity Interest Issued or Issuable, Value Assigned Amortization of purchased intangibles Amortization Of Intangible Assets And Finance Leases Amortization Of Intangible Assets And Finance Leases Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Document Period End Date Document Period End Date Purchases of intangible assets Payments to Acquire Intangible Assets Entity Central Index Key Entity Central Index Key Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Threshold for five day period, product of sale price of common stock and conversion rate of notes Debt Instrument, Convertible, Five Day Period, Threshold Of Product Of Sale Price Of Stock And Conversion Rate Debt Instrument, Convertible, Five Day Period, Threshold Of Product Of Sale Price Of Stock And Conversion Rate Options Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Management Retention Plan Management Retention Plan [Member] Management Retention Plan State taxes, net of federal benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Deferred income taxes, State and local Deferred State and Local Income Tax Expense (Benefit) Total lease cost Lease, Cost Schedule of Property And Equipment Property, Plant and Equipment [Table Text Block] Number of shares of common stock covered by called caps (shares) Number Of Shares Of Common Stock Covered By Capped Calls Number Of Shares Of Common Stock Covered By Capped Calls Contract with customer liability, non-current, Increase (decrease), net Contract with customer liability, non-current, Increase (decrease), net Contract with customer liability, non-current, Increase (decrease), net Income Statement Location [Domain] Income Statement Location [Domain] Current income taxes: Current Federal, State and Local, Tax Expense (Benefit) [Abstract] Gross decrease for tax positions of prior years Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Contingent Consideration Type [Domain] Contingent Consideration Type [Domain] Supplemental disclosure of non-cash investing and financing activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Customer Relationships Customer Relationships [Member] Investments in Affiliates, Subsidiaries, Associates, and Joint Ventures, Fair Value Disclosure Investments in Affiliates, Subsidiaries, Associates, and Joint Ventures, Fair Value Disclosure Compensation expense Compensation expense [Member] Compensation expense Business acquisition transaction costs Business Acquisition, Transaction Costs Equity component of convertible senior notes issuance costs Adjustments to additional paid in capital related to issuance costs attributable to equity component Adjustments to Additional Paid in Capital, Debt Conversion Option, Issuance Costs Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing debt conversion option. Includes, but is not limited to, legal and accounting fees and other direct costs of issuance. Non-deductible expenses – other Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent Property and Equipment Property, Plant and Equipment Disclosure [Text Block] Schedule of Interest Expense Incurred Schedule of Interest Expense Incurred [Table Text Block] Schedule of Interest Expense Incurred Unallocated corporate expenses Segment Reporting Unallocated Corporate Expenses Segment Reporting Unallocated Corporate Expenses Other liabilities Other Liabilities, Noncurrent Disclosure of major customers for revenue Segment Reporting, Disclosure of Major Customers Non income tax Accrual for Taxes Other than Income Taxes Capitalized computer software Capitalized Computer Software, Gross Schedule of Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Debt Instrument [Line Items] Debt Instrument [Line Items] Purchase of capped call option Reduction to additional paid-in-capital related to called caps Adjustments to Additional Paid in Capital, Capped Call Option, Issuance Costs Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing capped call options. Includes, but is not limited to, legal and accounting fees and direct costs associated with issuance. Trading Symbol Trading Symbol Net loss per share of common stock: Earnings Per Share [Abstract] Estimated sales tax liability, including interest, maximum Estimated Sales Tax Liability, Including Interest, Maximum Estimated Sales Tax Liability, Including Interest, Maximum Supplemental balance sheet information related to leases Supplemental balance sheet information related to leases [Table Text Block] Supplemental balance sheet information related to leases Revenue Business Acquisition, Pro Forma Revenue Property and equipment gross Property, Plant and Equipment, Gross Accrued Liabilities and Other Current Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Balance, beginning of period Balance, end of period Accounts Receivable, Allowance for Credit Loss Other assets Increase (Decrease) in Other Operating Assets Revenue, Remaining Performance Obligation, Percentage Revenue, Remaining Performance Obligation, Percentage Trademarks Trademarks [Member] Options vested and expected to vest Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Severance and other associated costs Severance Costs Additions charged to costs and expenses Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) Other Liabilities, Fair Value Disclosure Other Liabilities, Fair Value Disclosure Options outstanding, beginning balance (in dollars per share) Options outstanding, ending balance (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Other Commitments [Line Items] Other Commitments [Line Items] Costs and expenses: Costs and Expenses [Abstract] Patents Patents [Member] Future Services Future Services [Member] Future Services Liabilities, Fair Value Disclosure [Abstract] Liabilities, Fair Value Disclosure [Abstract] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Year Ending December 31, Year Ending December 31, [Abstract] Year Ending December 31, Conversion option of the Notes Convertible Debt Securities [Member] Options exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Entity Current Reporting Status Entity Current Reporting Status Historical volatility, minimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Weighted Average Grant Date Fair Value (Per Share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Fair value adjustments Liabilities, Fair Value Adjustment Total provision Effective Income Tax Rate Reconciliation, Percent Amortization of purchased intangibles and finance leases Cost, Amortization Amortization of debt issuance costs Amortization of issuance costs Amortization of Debt Issuance Costs Payables and Accruals [Abstract] Payables and Accruals [Abstract] Schedule of Domestic and Foreign Components of Income Before Provision for Income Taxes Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Total liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Cash, cash equivalents, and restricted cash - beginning of year Cash, cash equivalents, and restricted cash - end of year Total cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents United States UNITED STATES Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Accrual during period for cash awards related to bonus Share-Based Compensation, Accrual For Cash Awards To Be Settled In Stock, Bonus Share-Based Compensation, Accrual For Cash Awards To Be Settled In Stock, Bonus Risk-free interest rate, maximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Unrecognized tax benefits Taxes Payable, Current Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Current assets: Assets, Current [Abstract] Consumer Consumer [Member] Consumer [Member] Gross Carrying Amount Finite-Lived Intangible Assets, Gross Shares reserved for future issuance Common Stock, Capital Shares Reserved for Future Issuance Interest expense, net Interest Income (Expense), Nonoperating, Net Leases [Abstract] Income Taxes Income Tax, Policy [Policy Text Block] Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Other Americas Other Americas [Member] Other Americas [Member] Money market funds Cash and Cash Equivalents, Fair Value Disclosure Entity Address, Postal Zip Code Entity Address, Postal Zip Code Common stock issued upon exercise of stock options (in shares) Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period ROU assets write down Other Restructuring, Right Of Use Asset Write Down [Member] Other Restructuring, Right Of Use Asset Write Down [Member] Prepaid expenses and other current assets Increase Decrease In Prepaid Expense And Other Current Assets Increase (Decrease) In Prepaid Expense And Other Current Assets Diluted Weighted Average Number of Shares Outstanding, Diluted United States Income (Loss) from Continuing Operations before Income Taxes, Domestic Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax Recurring Fair Value, Recurring [Member] Capped caps initial strike price (in dollars per share) Capped Calls, Initial Option Strike Price Capped Calls, Initial Option Strike Price Liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract] 2026 Notes Convertible Senior Notes Due 2026 [Member] Convertible Senior Notes Due 2026 Income Taxes Income Tax Disclosure [Text Block] Requisite service period Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period Noncash or Part Noncash Acquisition, Name [Domain] Noncash or Part Noncash Acquisition, Name [Domain] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Schedule of Stock Option Activity Share-based Payment Arrangement, Option, Activity [Table Text Block] Summary of Intangible Assets Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block] Deductions/write-offs Accounts Receivable, Allowance for Credit Loss, Writeoff Decrease due to expiration of statue Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Five Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Weighted average number of shares outstanding, basic and diluted Weighted Average Number of Shares Outstanding, Basic and Diluted Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Auditor Firm ID Auditor Firm ID Lease restructuring costs Other Restructuring Costs Revenue earn out Revenue earn out [Member] Revenue earn out Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Entity Address, Address Line One Entity Address, Address Line One Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Changes in operating assets and liabilities, net of acquisitions: Increase (Decrease) in Operating Capital [Abstract] Common stock issued under Employee Stock Purchase Plan Stock Issued During Period, Value, Employee Stock Purchase Plan OPERATING ACTIVITIES: Net Cash Provided by (Used in) Operating Activities [Abstract] Proficient Proficient [Member] Proficient [Member] R&D tax credit Deferred Tax Assets, in Process Research and Development Non-vested and outstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Fair Value, Nonvested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Fair Value, Nonvested Released (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Effective interest rate (percent) Debt Instrument, Interest Rate During Period Principles of Consolidation Consolidation, Policy [Policy Text Block] General and administrative General and Administrative Expense [Member] Entity Shell Company Entity Shell Company Description of Business and Summary of Significant Accounting Policies Business Description and Accounting Policies [Text Block] Expected life (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Total current liabilities Liabilities, Current Cash payment in acquisition Payments to Acquire Businesses, Gross Payments to Acquire Businesses, Gross Net carrying amount Debt Instrument, Convertible, Carrying Amount Of Equity Component, Net Of Issuance Costs Debt Instrument, Convertible, Carrying Amount Of Equity Component, Net Of Issuance Costs Contingent earn-out Contingent Earn-Out [Member] Contingent Earn-Out [Member] Operating cash flows for finance leases Finance Lease, Interest Payment on Liability Money market funds Money Market Funds [Member] Foreign exchange adjustments Goodwill, Foreign Currency Translation Gain (Loss) Cash Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Employer matching contribution percent of eligible compensation Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Options outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Amortization of purchased intangibles Amortization of Intangible Assets, Nonproduction Amortization of Intangible Assets, Nonproduction Current Fiscal Year End Date Current Fiscal Year End Date Sales commissions Accrued Sales Commission, Current Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Statement [Table] Statement [Table] Equity component of convertible senior notes Debt Conversion Options Issued During Period Debt Conversion Options Issued During Period Advertising costs Advertising Expense Recently Issued Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Weighted average assumptions Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] Carrying Amount of Liability Component: Long-term Debt, Unclassified [Abstract] Unrecognized compensation cost related to nonvested share-based compensation arrangements Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Statistical Measurement [Axis] Statistical Measurement [Axis] Accounts Receivable Accounts Receivable [Policy Text Block] Subsequent Event Subsequent Event [Member] Finance lease liability Finance Lease, Liability, Noncurrent Total Finite-Lived Intangible Assets, Net Goodwill (Note 5) Beginning Balance Ending Balance Goodwill Goodwill Foreign taxes Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Cost of revenue Cost of Sales [Member] Current income taxes, Foreign Current Foreign Tax Expense (Benefit) Schedule of Changes in Goodwill Schedule of Goodwill [Table Text Block] Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Finance lease right-of-use assets Finance Lease, Right-of-Use Asset, before Accumulated Amortization Operating lease cost Operating Lease, Cost Unamortized discount Debt Instrument, Unamortized Discount Total deferred income taxes Deferred Income Tax Expense (Benefit) Business Acquisition, Equity Interest Issued or Issuable, Description Business Acquisition, Equity Interest Issued or Issuable, Description Options vested and expected to vest Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Schedule of Receivables, Contract Acquisition Costs, and Deferred Revenue Schedule Of Receivables, Contract Acquisition Costs, And Deferred Revenue [Table Text Block] Schedule Of Receivables, Contract Acquisition Costs, And Deferred Revenue [Table Text Block] EX-101.PRE 9 lpsn-20211231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 10 image_0.jpg begin 644 image_0.jpg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lpsn-20211231_g1.jpg begin 644 lpsn-20211231_g1.jpg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end GRAPHIC 12 lpsn-20211231_g2.jpg begin 644 lpsn-20211231_g2.jpg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htm IDEA: XBRL DOCUMENT v3.22.1
Cover - USD ($)
12 Months Ended
Dec. 31, 2021
Feb. 25, 2022
Jun. 30, 2021
Cover [Abstract]      
Document Type 10-K/A    
Document Annual Report true    
Document Period End Date Dec. 31, 2021    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 000-30141    
Entity Registrant Name LIVEPERSON, INC.    
Entity Central Index Key 0001102993    
Document Fiscal Year Focus 2021    
Document Fiscal Period Focus FY    
Amendment Flag false    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 13-3861628    
Entity Address, Address Line One 530 7th Ave, Floor M1    
Entity Address, City or Town New York    
Entity Address, State or Province NY    
Entity Address, Postal Zip Code 10018    
City Area Code 212    
Local Phone Number 609-4200    
Title of 12(b) Security Common Stock, par value $0.001 per share    
Trading Symbol LPSN    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Entity Shell Company false    
Entity Public Float     $ 4,035,402,834
Entity Common Stock, Shares Outstanding   72,570,760  

XML 14 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Auditor Information
12 Months Ended
Dec. 31, 2021
Cover [Abstract]  
Auditor Firm ID 23
Auditor Name BDO USA, LLP
Auditor Location New York, New York
XML 15 lpsn-20211231_htm.xml IDEA: XBRL DOCUMENT 0001102993 2021-01-01 2021-12-31 0001102993 2021-06-30 0001102993 2022-02-25 iso4217:USD shares 0001102993 --12-31 2021 FY false 10-K/A true 2021-12-31 false 000-30141 LIVEPERSON, INC. DE 13-3861628 530 7th Ave, Floor M1 New York NY 10018 212 609-4200 Common Stock, par value $0.001 per share LPSN NASDAQ No No Yes Yes Large Accelerated Filer false false true false 4035402834 72570760 BDO USA, LLP New York, New York 23 EXCEL 16 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 17 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 18 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 19 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 3 36 1 false 0 0 false 2 false false R1.htm 0001001 - Document - Cover Sheet http://www.liveperson.com/role/Cover Cover Cover 1 false false R2.htm 0402401 - Document - Auditor Information Sheet http://www.liveperson.com/role/AuditorInformation Auditor Information Notes 2 false false All Reports Book All Reports lpsn-20211231.htm a2021q4livepersonex313.htm a2021q4livepersonex314.htm lpsn-20211231.xsd lpsn-20211231_cal.xml lpsn-20211231_def.xml lpsn-20211231_lab.xml lpsn-20211231_pre.xml normanosumiofferletter.htm lpsn-20211231_g1.jpg lpsn-20211231_g2.jpg http://xbrl.sec.gov/dei/2021q4 true true JSON 22 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "lpsn-20211231.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 3, "dts": { "calculationLink": { "local": [ "lpsn-20211231_cal.xml" ] }, "definitionLink": { "local": [ "lpsn-20211231_def.xml" ] }, "inline": { "local": [ "lpsn-20211231.htm" ] }, "labelLink": { "local": [ "lpsn-20211231_lab.xml" ] }, "presentationLink": { "local": [ "lpsn-20211231_pre.xml" ] }, "schema": { "local": [ "lpsn-20211231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd" ] } }, "elementCount": 760, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 5, "total": 5 }, "keyCustom": 0, "keyStandard": 36, "memberCustom": 0, "memberStandard": 0, "nsprefix": "lpsn", "nsuri": "http://www.liveperson.com/20211231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lpsn-20211231.htm", "contextRef": "i26def4914221494eb2c87c3c1d3a9aee_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://www.liveperson.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "lpsn-20211231.htm", "contextRef": "i26def4914221494eb2c87c3c1d3a9aee_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "lpsn-20211231.htm", "contextRef": "i26def4914221494eb2c87c3c1d3a9aee_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:AuditorFirmId", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "false", "longName": "0402401 - Document - Auditor Information", "role": "http://www.liveperson.com/role/AuditorInformation", "shortName": "Auditor Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "lpsn-20211231.htm", "contextRef": "i26def4914221494eb2c87c3c1d3a9aee_D20210101-20211231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:AuditorFirmId", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "country_AU": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AUSTRALIA", "terseLabel": "Australia" } } }, "localname": "AU", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesDomesticandForeignComponentsofIncomeBeforeProvisionforIncomeTaxesDetails", "http://www.liveperson.com/role/LeasesNarrativeDetails", "http://www.liveperson.com/role/SegmentInformationLongLivedAssetsbyGeographicRegionDetails" ], "xbrltype": "domainItemType" }, "country_DE": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "GERMANY", "terseLabel": "Germany" } } }, "localname": "DE", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesDomesticandForeignComponentsofIncomeBeforeProvisionforIncomeTaxesDetails", "http://www.liveperson.com/role/SegmentInformationLongLivedAssetsbyGeographicRegionDetails" ], "xbrltype": "domainItemType" }, "country_GB": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED KINGDOM", "terseLabel": "United Kingdom" } } }, "localname": "GB", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesDomesticandForeignComponentsofIncomeBeforeProvisionforIncomeTaxesDetails", "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofRevenuebyGeographicRegionDetails" ], "xbrltype": "domainItemType" }, "country_IL": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ISRAEL", "terseLabel": "Israel" } } }, "localname": "IL", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesDomesticandForeignComponentsofIncomeBeforeProvisionforIncomeTaxesDetails", "http://www.liveperson.com/role/LeasesNarrativeDetails", "http://www.liveperson.com/role/SegmentInformationLongLivedAssetsbyGeographicRegionDetails" ], "xbrltype": "domainItemType" }, "country_NL": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NETHERLANDS", "terseLabel": "Netherlands" } } }, "localname": "NL", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesDomesticandForeignComponentsofIncomeBeforeProvisionforIncomeTaxesDetails", "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofRevenuebyGeographicRegionDetails", "http://www.liveperson.com/role/SegmentInformationLongLivedAssetsbyGeographicRegionDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofRevenuebyGeographicRegionDetails", "http://www.liveperson.com/role/SegmentInformationLongLivedAssetsbyGeographicRegionDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID", "terseLabel": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/AuditorInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/AuditorInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/AuditorInformation" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r4", "r5", "r6" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.liveperson.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "exch_XPST": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "POSIT - ASIA PACIFIC [Member]", "terseLabel": "APAC" } } }, "localname": "XPST", "nsuri": "http://xbrl.sec.gov/exch/2021", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofRevenuebyGeographicRegionDetails" ], "xbrltype": "domainItemType" }, "lpsn_AccountsReceivablePeriodIncreaseDecreaseNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accounts receivable, period increase (decrease), net", "label": "Accounts receivable, period increase (decrease), net", "terseLabel": "Accounts receivable, increase (decrease), net" } } }, "localname": "AccountsReceivablePeriodIncreaseDecreaseNet", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofReceivablesContractAcquisitionCostsandDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_AccruedSalesTaxLiabilityIncludingInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Sales Tax Liability, Including Interest", "label": "Accrued Sales Tax Liability, Including Interest", "terseLabel": "Accrued sales tax, including interest" } } }, "localname": "AccruedSalesTaxLiabilityIncludingInterest", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/CommitmentsandContingenciesEmployeeBenefitPlansLettersofCreditandNonIncomeRelatedTaxesDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_AdjustmentstoAdditionalPaidinCapitalCappedCallOptionIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing capped call options. Includes, but is not limited to, legal and accounting fees and direct costs associated with issuance.", "label": "Adjustments to Additional Paid in Capital, Capped Call Option, Issuance Costs", "negatedTerseLabel": "Purchase of capped call option", "terseLabel": "Reduction to additional paid-in-capital related to called caps" } } }, "localname": "AdjustmentstoAdditionalPaidinCapitalCappedCallOptionIssuanceCosts", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_AdjustmentstoAdditionalPaidinCapitalDebtConversionOptionIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing debt conversion option. Includes, but is not limited to, legal and accounting fees and other direct costs of issuance.", "label": "Adjustments to Additional Paid in Capital, Debt Conversion Option, Issuance Costs", "negatedTerseLabel": "Equity component of convertible senior notes issuance costs", "terseLabel": "Adjustments to additional paid in capital related to issuance costs attributable to equity component" } } }, "localname": "AdjustmentstoAdditionalPaidinCapitalDebtConversionOptionIssuanceCosts", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_AdvantageTecIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "AdvantageTec Inc [Member]", "label": "AdvantageTec Inc [Member]", "terseLabel": "AdvantageTec" } } }, "localname": "AdvantageTecIncMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows", "http://www.liveperson.com/role/FairValueMeasurementsLevel3LiabilitiesDetails" ], "xbrltype": "domainItemType" }, "lpsn_AggregatePrincipalFromExerciseInFullOfOverAllotmentOptions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate Principal From Exercise In Full Of Over-Allotment Options", "label": "Aggregate Principal From Exercise In Full Of Over-Allotment Options", "terseLabel": "Aggregate principal from exercise in full of over-allotment options" } } }, "localname": "AggregatePrincipalFromExerciseInFullOfOverAllotmentOptions", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_AmortizationOfIntangibleAssetsAndFinanceLeases": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortization Of Intangible Assets And Finance Leases", "label": "Amortization Of Intangible Assets And Finance Leases", "terseLabel": "Amortization of purchased intangibles" } } }, "localname": "AmortizationOfIntangibleAssetsAndFinanceLeases", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "lpsn_AmortizationofIntangibleAssetsNonproduction": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofOperations": { "order": 6.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 }, "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortization of Intangible Assets, Nonproduction", "label": "Amortization of Intangible Assets, Nonproduction", "terseLabel": "Amortization of purchased intangibles" } } }, "localname": "AmortizationofIntangibleAssetsNonproduction", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperations", "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_BusinessAcquisitionValueOfSharesPriorToAcquisition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Acquisition, Value of Shares Prior to Acquisition", "label": "Business Acquisition, Value of Shares Prior to Acquisition", "terseLabel": "Business Acquisition, Value of Shares Prior to Acquisition" } } }, "localname": "BusinessAcquisitionValueOfSharesPriorToAcquisition", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_BusinessCombinationContingentConsiderationArrangements": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Contingent Consideration Arrangements", "label": "Business Combination, Contingent Consideration Arrangements", "terseLabel": "Fair value of contingent earn-out recorded in other long-term liabilities" } } }, "localname": "BusinessCombinationContingentConsiderationArrangements", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "lpsn_BusinessMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business [Member].", "label": "Business [Member]", "terseLabel": "Business" } } }, "localname": "BusinessMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.liveperson.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillDetails" ], "xbrltype": "domainItemType" }, "lpsn_CapitalizedContractCostsPeriodIncreaseDecreaseNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Capitalized contract costs, period increase (decrease), net", "label": "Capitalized contract costs, period increase (decrease), net", "terseLabel": "Capitalized contract costs, period increase (decrease), net" } } }, "localname": "CapitalizedContractCostsPeriodIncreaseDecreaseNet", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofReceivablesContractAcquisitionCostsandDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_CappedCallsInitialCapPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capped Calls, Initial Cap Price", "label": "Capped Calls, Initial Cap Price", "terseLabel": "Capped caps initial cap price (in dollars per share)" } } }, "localname": "CappedCallsInitialCapPrice", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "lpsn_CappedCallsInitialOptionStrikePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capped Calls, Initial Option Strike Price", "label": "Capped Calls, Initial Option Strike Price", "terseLabel": "Capped caps initial strike price (in dollars per share)" } } }, "localname": "CappedCallsInitialOptionStrikePrice", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "lpsn_CappedCallsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capped Calls [Member]", "label": "Capped Calls [Member]", "terseLabel": "Capped calls" } } }, "localname": "CappedCallsMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "lpsn_CommonStockIncreaseInSharesAuthorizedDuringThePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock, Increase In Shares Authorized During The Period", "label": "Common Stock, Increase In Shares Authorized During The Period", "terseLabel": "Common Stock, Increase In Shares Authorized During The Period" } } }, "localname": "CommonStockIncreaseInSharesAuthorizedDuringThePeriod", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "lpsn_CompensationExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Compensation expense", "label": "Compensation expense [Member]", "terseLabel": "Compensation expense" } } }, "localname": "CompensationExpenseMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "lpsn_ComputerEquipmentAndSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Computer Equipment And Software [Member]", "label": "Computer Equipment And Software [Member]", "terseLabel": "Computer equipment and software" } } }, "localname": "ComputerEquipmentAndSoftwareMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.liveperson.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "lpsn_ConsumerBusinessMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consumer Business [Member]", "label": "Consumer Business [Member]", "terseLabel": "Business" } } }, "localname": "ConsumerBusinessMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "lpsn_ConsumerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consumer [Member]", "label": "Consumer [Member]", "terseLabel": "Consumer" } } }, "localname": "ConsumerMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillDetails", "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "lpsn_ContingentEarnOutMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contingent Earn-Out [Member]", "label": "Contingent Earn-Out [Member]", "terseLabel": "Contingent earn-out" } } }, "localname": "ContingentEarnOutMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails", "http://www.liveperson.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueDetails", "http://www.liveperson.com/role/FairValueMeasurementsLevel3LiabilitiesDetails" ], "xbrltype": "domainItemType" }, "lpsn_ContractWithCustomerLiabilityCurrentIncreaseDecreaseNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contract with customer liability, current, Increase (decrease), net", "label": "Contract with customer liability, current, Increase (decrease), net", "terseLabel": "Contract with customer liability, current, Increase (decrease), net" } } }, "localname": "ContractWithCustomerLiabilityCurrentIncreaseDecreaseNet", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofReceivablesContractAcquisitionCostsandDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_ContractWithCustomerLiabilityNonCurrentIncreaseDecreaseNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contract with customer liability, non-current, Increase (decrease), net", "label": "Contract with customer liability, non-current, Increase (decrease), net", "terseLabel": "Contract with customer liability, non-current, Increase (decrease), net" } } }, "localname": "ContractWithCustomerLiabilityNonCurrentIncreaseDecreaseNet", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofReceivablesContractAcquisitionCostsandDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_ConversableInc1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversable Inc 1 [Member]", "label": "Conversable Inc 1 [Member]", "terseLabel": "Conversable Dec 13 2019" } } }, "localname": "ConversableInc1Member", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "domainItemType" }, "lpsn_ConvertibleSeniorNotesDue2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Notes Due 2024", "label": "Convertible Senior Notes Due 2024 [Member]", "terseLabel": "2024 Notes" } } }, "localname": "ConvertibleSeniorNotesDue2024Member", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails", "http://www.liveperson.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://www.liveperson.com/role/NetLossperShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "lpsn_ConvertibleSeniorNotesDue2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Notes Due 2026", "label": "Convertible Senior Notes Due 2026 [Member]", "terseLabel": "2026 Notes" } } }, "localname": "ConvertibleSeniorNotesDue2026Member", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails", "http://www.liveperson.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "lpsn_ConvertibleSeniorNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Notes [Member]", "label": "Convertible Senior Notes [Member]", "terseLabel": "Convertible Senior Notes" } } }, "localname": "ConvertibleSeniorNotesMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofEquityComponentofConvertibleDebtDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofLiabilityComponentofConvertibleDebtDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofInterestExpenseIncurredDetails" ], "xbrltype": "domainItemType" }, "lpsn_DebtConversionOptionsIssuedDuringPeriod": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Conversion Options Issued During Period", "label": "Debt Conversion Options Issued During Period", "terseLabel": "Equity component of convertible senior notes" } } }, "localname": "DebtConversionOptionsIssuedDuringPeriod", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "lpsn_DebtInstrumentConvertibleCarryingAmountOfEquityComponentNetOfIssuanceCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Convertible, Carrying Amount Of Equity Component, Net Of Issuance Costs", "label": "Debt Instrument, Convertible, Carrying Amount Of Equity Component, Net Of Issuance Costs", "terseLabel": "Net carrying amount" } } }, "localname": "DebtInstrumentConvertibleCarryingAmountOfEquityComponentNetOfIssuanceCosts", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofEquityComponentofConvertibleDebtDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_DebtInstrumentConvertibleFiveDayPeriodThresholdOfProductOfSalePriceOfStockAndConversionRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Convertible, Five Day Period, Threshold Of Product Of Sale Price Of Stock And Conversion Rate", "label": "Debt Instrument, Convertible, Five Day Period, Threshold Of Product Of Sale Price Of Stock And Conversion Rate", "terseLabel": "Threshold for five day period, product of sale price of common stock and conversion rate of notes" } } }, "localname": "DebtInstrumentConvertibleFiveDayPeriodThresholdOfProductOfSalePriceOfStockAndConversionRate", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails" ], "xbrltype": "percentItemType" }, "lpsn_DeferredFinanceCostsAllocatedToEquityComponent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Finance Costs, Allocated To Equity Component", "label": "Deferred Finance Costs, Allocated To Equity Component", "negatedLabel": "Issuance costs" } } }, "localname": "DeferredFinanceCostsAllocatedToEquityComponent", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofEquityComponentofConvertibleDebtDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_DeferredFinanceCostsLiabilityAndEquityComponent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Finance Costs, Liability And Equity Component", "label": "Deferred Finance Costs, Liability And Equity Component", "terseLabel": "Total deferred issuance costs" } } }, "localname": "DeferredFinanceCostsLiabilityAndEquityComponent", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_DeferredTaxAssetsLeaseLiabilities": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Lease Liabilities", "label": "Deferred Tax Assets, Lease Liabilities", "terseLabel": "Operating lease liability" } } }, "localname": "DeferredTaxAssetsLeaseLiabilities", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_DeferredTaxAssetsOriginalIssueDiscount": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Original Issue Discount", "label": "Deferred Tax Assets, Original Issue Discount", "terseLabel": "Original issue discount" } } }, "localname": "DeferredTaxAssetsOriginalIssueDiscount", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_DeferredTaxLiabilitiesContingentEarnOutAdjustments": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Liabilities, Contingent Earn-Out Adjustments", "label": "Deferred Tax Liabilities, Contingent Earn-Out Adjustments", "negatedTerseLabel": "Goodwill amortization and contingent earn-out adjustments" } } }, "localname": "DeferredTaxLiabilitiesContingentEarnOutAdjustments", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_DeferredTaxLiabilitiesConvertibleNotes": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Liabilities, Convertible Notes", "label": "Deferred Tax Liabilities, Convertible Notes", "negatedTerseLabel": "Convertible notes issuance" } } }, "localname": "DeferredTaxLiabilitiesConvertibleNotes", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_DefinedContributionPlanMatchGroupsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Contribution Plan Match Groups [Axis]", "label": "Defined Contribution Plan Match Groups [Axis]", "terseLabel": "Defined Contribution Plan Match Groups [Axis]" } } }, "localname": "DefinedContributionPlanMatchGroupsAxis", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/CommitmentsandContingenciesEmployeeBenefitPlansLettersofCreditandNonIncomeRelatedTaxesDetails" ], "xbrltype": "stringItemType" }, "lpsn_DefinedContributionPlanMatchGroupsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Defined Contribution Plan Match Groups [Axis]", "label": "Defined Contribution Plan Match Groups [Domain]", "terseLabel": "Defined Contribution Plan Match Groups [Domain]" } } }, "localname": "DefinedContributionPlanMatchGroupsDomain", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/CommitmentsandContingenciesEmployeeBenefitPlansLettersofCreditandNonIncomeRelatedTaxesDetails" ], "xbrltype": "domainItemType" }, "lpsn_DevelopedTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Developed technology", "label": "Developed technology [Member]", "terseLabel": "Developed technology" } } }, "localname": "DevelopedTechnologyMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/AcquisitionsScheduleofFiniteLivedIntangibleAssetsAcquiredasPartofBusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "lpsn_EBot7Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "e-bot7", "label": "e-bot7 [Member]", "terseLabel": "e-bot7" } } }, "localname": "EBot7Member", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails", "http://www.liveperson.com/role/AcquisitionsScheduleofBusinessAcquisitionsbyAcquisitionDetails", "http://www.liveperson.com/role/AcquisitionsScheduleofFiniteLivedIntangibleAssetsAcquiredasPartofBusinessCombinationDetails", "http://www.liveperson.com/role/AcquisitionsTables", "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows", "http://www.liveperson.com/role/FairValueMeasurementsLevel3LiabilitiesDetails" ], "xbrltype": "domainItemType" }, "lpsn_EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncomeInclusion": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofReconciliationsofFederalStatutoryTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 4.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Global Intangible Low Tax Income Inclusion", "label": "Effective Income Tax Rate Reconciliation, Global Intangible Low Tax Income Inclusion", "terseLabel": "Global intangible low tax income inclusion" } } }, "localname": "EffectiveIncomeTaxRateReconciliationGlobalIntangibleLowTaxIncomeInclusion", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofReconciliationsofFederalStatutoryTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "lpsn_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofReconciliationsofFederalStatutoryTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 6.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Section 162", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Section 162", "terseLabel": "Non-deductible excess compensation" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseSection162", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofReconciliationsofFederalStatutoryTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "lpsn_EmployeeStockPurchasePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee Stock Purchase Plan", "label": "Employee Stock Purchase Plan [Member]", "terseLabel": "Employee Stock Purchase Plan" } } }, "localname": "EmployeeStockPurchasePlanMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "lpsn_EstimatedSalesTaxLiabilityIncludingInterestMaximum": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Estimated Sales Tax Liability, Including Interest, Maximum", "label": "Estimated Sales Tax Liability, Including Interest, Maximum", "terseLabel": "Estimated sales tax liability, including interest, maximum" } } }, "localname": "EstimatedSalesTaxLiabilityIncludingInterestMaximum", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/CommitmentsandContingenciesEmployeeBenefitPlansLettersofCreditandNonIncomeRelatedTaxesDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_EstimatedSalesTaxLiabilityIncludingInterestMinimum": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Estimated Sales Tax Liability, Including Interest, Minimum", "label": "Estimated Sales Tax Liability, Including Interest, Minimum", "terseLabel": "Estimated sales tax liability, including interest, minimum" } } }, "localname": "EstimatedSalesTaxLiabilityIncludingInterestMinimum", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/CommitmentsandContingenciesEmployeeBenefitPlansLettersofCreditandNonIncomeRelatedTaxesDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_FurnitureEquipmentAndBuildingImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Furniture, Equipment and Building Improvements [Member]", "label": "Furniture Equipment And Building Improvements [Member]", "terseLabel": "Furniture, equipment, and building improvements" } } }, "localname": "FurnitureEquipmentAndBuildingImprovementsMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "lpsn_FutureServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Future Services", "label": "Future Services [Member]", "terseLabel": "Future Services" } } }, "localname": "FutureServicesMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "lpsn_HostedServicesBusinessMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hosted Services - Business [Member]", "label": "Hosted Services - Business [Member]", "terseLabel": "Hosted Services - Business" } } }, "localname": "HostedServicesBusinessMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofDeferredRevenuesandContractBalancesDetails", "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofDisaggregationofRevenueDetails", "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "lpsn_HostedServicesConsumerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hosted Services - Consumer [Member]", "label": "Hosted Services - Consumer [Member]", "terseLabel": "Hosted Services - Consumer" } } }, "localname": "HostedServicesConsumerMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofDeferredRevenuesandContractBalancesDetails", "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofDisaggregationofRevenueDetails", "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "lpsn_IncentiveStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Incentive Stock Option", "label": "Incentive Stock Option [Member]", "terseLabel": "Incentive Stock Option" } } }, "localname": "IncentiveStockOptionMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "lpsn_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) In Prepaid Expense And Other Current Assets", "label": "Increase Decrease In Prepaid Expense And Other Current Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "lpsn_InternalUseSoftwareDevelopmentCostsBalanceNotSubjectToAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Internal Use Software Development Costs, Balance Not Subject To Amortization", "label": "Internal Use Software Development Costs, Balance Not Subject To Amortization", "terseLabel": "Internal-use software development costs not yet subject to amortization" } } }, "localname": "InternalUseSoftwareDevelopmentCostsBalanceNotSubjectToAmortization", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/PropertyandEquipmentNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_JapanAndFranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Japan And France", "label": "Japan And France [Member]", "terseLabel": "Other" } } }, "localname": "JapanAndFranceMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesDomesticandForeignComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "lpsn_JointVentureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Joint Venture", "label": "Joint Venture [Member]", "terseLabel": "Joint Venture [Member]" } } }, "localname": "JointVentureMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/SubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "lpsn_LesseeOperatingLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee, Operating Leases", "label": "Lessee, Operating Leases [Abstract]", "terseLabel": "Operating Leases" } } }, "localname": "LesseeOperatingLeasesAbstract", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleoffutureminimumleasepaymentsDetails" ], "xbrltype": "stringItemType" }, "lpsn_ManagementRetentionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Management Retention Plan", "label": "Management Retention Plan [Member]", "terseLabel": "Management Retention Plan" } } }, "localname": "ManagementRetentionPlanMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "lpsn_MatchingTrancheOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Matching Tranche One [Member]", "label": "Matching Tranche One [Member]", "terseLabel": "Match Step One" } } }, "localname": "MatchingTrancheOneMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/CommitmentsandContingenciesEmployeeBenefitPlansLettersofCreditandNonIncomeRelatedTaxesDetails" ], "xbrltype": "domainItemType" }, "lpsn_MatchingTrancheTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Matching Tranche Two [Member]", "label": "Matching Tranche Two [Member]", "terseLabel": "Match Step Two" } } }, "localname": "MatchingTrancheTwoMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/CommitmentsandContingenciesEmployeeBenefitPlansLettersofCreditandNonIncomeRelatedTaxesDetails" ], "xbrltype": "domainItemType" }, "lpsn_NOLExpirationPeriodTrancheOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NOL Expiration Period, Tranche One [Member]", "label": "NOL Expiration Period, Tranche One [Member]", "terseLabel": "Expiration between 2023 and 2026" } } }, "localname": "NOLExpirationPeriodTrancheOneMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "lpsn_NOLExpirationPeriodTrancheThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NOL Expiration Period, Tranche Three", "label": "NOL Expiration Period, Tranche Three [Member]", "terseLabel": "Expiration between 2022 and 2041" } } }, "localname": "NOLExpirationPeriodTrancheThreeMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "lpsn_NOLExpirationPeriodTrancheTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NOL Expiration Period, Tranche Two [Member]", "label": "NOL Expiration Period, Tranche Two [Member]", "terseLabel": "Expiration between 2030 and 2037" } } }, "localname": "NOLExpirationPeriodTrancheTwoMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "lpsn_NetOperatingLossExpirationPeriodsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net Operating Loss Expiration Periods [Axis]", "label": "Net Operating Loss Expiration Periods [Axis]", "terseLabel": "Net Operating Loss Expiration Periods [Axis]" } } }, "localname": "NetOperatingLossExpirationPeriodsAxis", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "lpsn_NetOperatingLossExpirationPeriodsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Net Operating Loss Expiration Periods [Axis]", "label": "Net Operating Loss Expiration Periods [Domain]", "terseLabel": "Net Operating Loss Expiration Periods [Domain]" } } }, "localname": "NetOperatingLossExpirationPeriodsDomain", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "lpsn_NumberOfLeasesAbandoned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Leases Abandoned", "label": "Number Of Leases Abandoned", "terseLabel": "Number of leases abandoned" } } }, "localname": "NumberOfLeasesAbandoned", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/LeasesNarrativeDetails" ], "xbrltype": "integerItemType" }, "lpsn_NumberOfSharesOfCommonStockCoveredByCappedCalls": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Shares Of Common Stock Covered By Capped Calls", "label": "Number Of Shares Of Common Stock Covered By Capped Calls", "terseLabel": "Number of shares of common stock covered by called caps (shares)" } } }, "localname": "NumberOfSharesOfCommonStockCoveredByCappedCalls", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "lpsn_OperatingLossCarryforwardsGeneratedInTaxableYearsEndingOnOrBeforeDecember312017": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Loss Carryforwards, Generated In Taxable Years Ending On Or Before December 31 2017", "label": "Operating Loss Carryforwards, Generated In Taxable Years Ending On Or Before December 31 2017", "terseLabel": "Operating loss carryforwards generated in taxable years ending on or before December 31 2017" } } }, "localname": "OperatingLossCarryforwardsGeneratedInTaxableYearsEndingOnOrBeforeDecember312017", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_OrganizationConsolidationAndSummaryOfSignificantAccountingPoliciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organization Consolidation And Summary Of Significant Accounting Policies [Line Items]", "label": "Organization Consolidation And Summary Of Significant Accounting Policies [Line Items]", "terseLabel": "Organization Consolidation And Summary Of Significant Accounting Policies [Line Items]" } } }, "localname": "OrganizationConsolidationAndSummaryOfSignificantAccountingPoliciesLineItems", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "lpsn_OrganizationConsolidationAndSummaryOfSignificantAccountingPoliciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organization Consolidation And Summary Of Significant Accounting Policies [Table]", "label": "Organization Consolidation And Summary Of Significant Accounting Policies [Table]", "terseLabel": "Organization Consolidation And Summary Of Significant Accounting Policies [Table]" } } }, "localname": "OrganizationConsolidationAndSummaryOfSignificantAccountingPoliciesTable", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "lpsn_OtherAmericasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Americas [Member]", "label": "Other Americas [Member]", "terseLabel": "Other Americas" } } }, "localname": "OtherAmericasMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofRevenuebyGeographicRegionDetails" ], "xbrltype": "domainItemType" }, "lpsn_OtherRestructuring.OtherLeaseRestructuringMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Restructuring. Other Lease Restructuring [Member]", "label": "Other Restructuring. Other Lease Restructuring [Member]", "terseLabel": "Other lease restructuring costs" } } }, "localname": "OtherRestructuring.OtherLeaseRestructuringMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/RestructuringCostsRestructuringChargesDetails" ], "xbrltype": "domainItemType" }, "lpsn_OtherRestructuringPropertyAndEquipmentAbandonmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Restructuring, Property And Equipment Abandonment [Member]", "label": "Other Restructuring, Property And Equipment Abandonment [Member]", "terseLabel": "Abandonment of property and equipment" } } }, "localname": "OtherRestructuringPropertyAndEquipmentAbandonmentMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/RestructuringCostsRestructuringChargesDetails" ], "xbrltype": "domainItemType" }, "lpsn_OtherRestructuringRightOfUseAssetWriteDownMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Restructuring, Right Of Use Asset Write Down [Member]", "label": "Other Restructuring, Right Of Use Asset Write Down [Member]", "terseLabel": "ROU assets write down" } } }, "localname": "OtherRestructuringRightOfUseAssetWriteDownMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/RestructuringCostsRestructuringChargesDetails" ], "xbrltype": "domainItemType" }, "lpsn_ProfessionalServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Professional Services [Member]", "label": "Professional Services [Member]", "terseLabel": "Professional Services - Business" } } }, "localname": "ProfessionalServicesMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofDeferredRevenuesandContractBalancesDetails", "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofDisaggregationofRevenueDetails", "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "lpsn_ProficientMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Proficient [Member]", "label": "Proficient [Member]", "terseLabel": "Proficient" } } }, "localname": "ProficientMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "lpsn_PurchasePriceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase Price", "label": "Purchase Price [Member]", "terseLabel": "Purchase Price" } } }, "localname": "PurchasePriceMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "lpsn_PurchasePricePaidInCashMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase price paid in cash", "label": "Purchase price paid in cash [Member]", "terseLabel": "Purchase price paid in cash" } } }, "localname": "PurchasePricePaidInCashMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "lpsn_RevenueEarnOutMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue earn out", "label": "Revenue earn out [Member]", "terseLabel": "Revenue earn out" } } }, "localname": "RevenueEarnOutMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "lpsn_ScheduleOfCarryingAmountOfEquityComponentOfConvertibleDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Carrying Amount of Equity Component of Convertible Debt", "label": "Schedule of Carrying Amount of Equity Component of Convertible Debt [Table Text Block]", "terseLabel": "Schedule of Carrying Amount of Equity Component of Convertible Debt" } } }, "localname": "ScheduleOfCarryingAmountOfEquityComponentOfConvertibleDebtTableTextBlock", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsTables" ], "xbrltype": "textBlockItemType" }, "lpsn_ScheduleOfInterestExpenseIncurredTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Interest Expense Incurred", "label": "Schedule of Interest Expense Incurred [Table Text Block]", "terseLabel": "Schedule of Interest Expense Incurred" } } }, "localname": "ScheduleOfInterestExpenseIncurredTableTextBlock", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsTables" ], "xbrltype": "textBlockItemType" }, "lpsn_ScheduleOfReceivablesContractAcquisitionCostsAndDeferredRevenueTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Receivables, Contract Acquisition Costs, And Deferred Revenue [Table Text Block]", "label": "Schedule Of Receivables, Contract Acquisition Costs, And Deferred Revenue [Table Text Block]", "terseLabel": "Schedule of Receivables, Contract Acquisition Costs, and Deferred Revenue" } } }, "localname": "ScheduleOfReceivablesContractAcquisitionCostsAndDeferredRevenueTableTextBlock", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerTables" ], "xbrltype": "textBlockItemType" }, "lpsn_SegmentReportingUnallocatedCorporateExpenses": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Segment Reporting Unallocated Corporate Expenses", "label": "Segment Reporting Unallocated Corporate Expenses", "terseLabel": "Unallocated corporate expenses" } } }, "localname": "SegmentReportingUnallocatedCorporateExpenses", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_ShareBasedCompensationAccrualForCashAwardsToBeSettledInStockAchievementOfIncentivePlanAwards": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation, Accrual For Cash Awards To Be Settled In Stock, Achievement Of Incentive Plan Awards", "label": "Share-Based Compensation, Accrual For Cash Awards To Be Settled In Stock, Achievement Of Incentive Plan Awards", "terseLabel": "Accrual during period for cash awards related to achievement of long-term incentive plan awards" } } }, "localname": "ShareBasedCompensationAccrualForCashAwardsToBeSettledInStockAchievementOfIncentivePlanAwards", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_ShareBasedCompensationAccrualForCashAwardsToBeSettledInStockBonus": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation, Accrual For Cash Awards To Be Settled In Stock, Bonus", "label": "Share-Based Compensation, Accrual For Cash Awards To Be Settled In Stock, Bonus", "terseLabel": "Accrual during period for cash awards related to bonus" } } }, "localname": "ShareBasedCompensationAccrualForCashAwardsToBeSettledInStockBonus", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesinPeriodFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises in Period, Fair Value", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises in Period, Fair Value", "terseLabel": "Fair value of stock options exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesinPeriodFairValue", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestAggregateIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Options, Vested And Expected To Vest, Aggregate Intrinsic Value", "label": "Share-based Compensation Arrangement By Share-based Payment Award, Options, Vested And Expected To Vest, Aggregate Intrinsic Value", "verboseLabel": "Options vested and expected to vest" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestAggregateIntrinsicValue", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAggregateFairValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Fair Value [Abstract]", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Fair Value [Abstract]", "terseLabel": "Aggregate Fair Value" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAggregateFairValueAbstract", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "lpsn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAggregateFairValueExpectedToVest": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Fair Value, Expected To Vest", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Fair Value, Expected To Vest", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Fair Value, Expected To Vest" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAggregateFairValueExpectedToVest", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityRestrictedStockUnitActivityDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAggregateFairValueNonvested": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Fair Value, Nonvested", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Fair Value, Nonvested", "terseLabel": "Non-vested and outstanding" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsAggregateFairValueNonvested", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityRestrictedStockUnitActivityDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsExpectedToVestNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected To Vest, Number", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected To Vest, Number", "terseLabel": "Expected to vest (shares)" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsExpectedToVestNumber", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "lpsn_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsExpectedToVestWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected To Vest, Weighted Average Grant Date Fair Value", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected To Vest, Weighted Average Grant Date Fair Value", "terseLabel": "Expected to vest (in dollars per share)" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsExpectedToVestWeightedAverageGrantDateFairValue", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "lpsn_SharesSubjectToOutstandingStockOptionsAndEmployeeStockPurchasePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares subject to outstanding stock options and employee stock purchase plan", "label": "Shares subject to outstanding stock options and employee stock purchase plan [Member]", "terseLabel": "Shares subject to outstanding stock options and employee stock purchase plan" } } }, "localname": "SharesSubjectToOutstandingStockOptionsAndEmployeeStockPurchasePlanMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "lpsn_StockIssuedDuringPeriodSharesBonusPaymentSettledInShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Shares, Bonus Payment Settled In Shares", "label": "Stock Issued During Period, Shares, Bonus Payment Settled In Shares", "terseLabel": "Bonus cash payment settled in shares of the Company's common stock (in shares)", "verboseLabel": "Issuance of shares of common stock to settle cash awards (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesBonusPaymentSettledInShares", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows", "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "lpsn_StockIssuedDuringPeriodSharesEarnoutPayment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Shares, Earnout Payment", "label": "Stock Issued During Period, Shares, Earnout Payment", "terseLabel": "Common stock as earnout payment in connection with AdvantageTec Inc. (in shares)", "verboseLabel": "Issuance of shares of common stock as earn-out payment in connection with AdvantageTec Inc. (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesEarnoutPayment", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows", "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "lpsn_StockIssuedDuringPeriodValueBonusPaymentSettledInShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Value, Bonus Payment Settled In Shares", "label": "Stock Issued During Period, Value, Bonus Payment Settled In Shares", "terseLabel": "Bonus cash payment settled in shares of the Company\u2019s common stock", "verboseLabel": "Issuance of shares of common stock to settle cash awards" } } }, "localname": "StockIssuedDuringPeriodValueBonusPaymentSettledInShares", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows", "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "lpsn_StockIssuedDuringPeriodValueEarnoutPayment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Value, Earnout Payment", "label": "Stock Issued During Period, Value, Earnout Payment", "terseLabel": "Stock Issued During Period, Value, Earnout Payment", "verboseLabel": "Issuance of shares of common stock as earn-out payment in connection with AdvantageTec Inc." } } }, "localname": "StockIssuedDuringPeriodValueEarnoutPayment", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows", "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "lpsn_SummaryOfOperationsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The accounting policy related to summary of operations.", "label": "Summary Of Operations [Policy Text Block]", "terseLabel": "Summary of Operations" } } }, "localname": "SummaryOfOperationsPolicyTextBlock", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "lpsn_SupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Supplemental balance sheet information related to leases", "label": "Supplemental balance sheet information related to leases [Table Text Block]", "terseLabel": "Supplemental balance sheet information related to leases" } } }, "localname": "SupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "lpsn_TechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Technology [Member]", "label": "Technology [Member]", "terseLabel": "Technology" } } }, "localname": "TechnologyMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/AcquisitionsScheduleofFiniteLivedIntangibleAssetsAcquiredasPartofBusinessCombinationDetails", "http://www.liveperson.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "lpsn_TenantAllowanceAmortizationLessee": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amortization of lessee lease liability over time which offsets lease expense.", "label": "Tenant Allowance, Amortization, Lessee", "negatedTerseLabel": "Amortization of tenant allowance" } } }, "localname": "TenantAllowanceAmortizationLessee", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "lpsn_TenfoldMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tenfold", "label": "Tenfold [Member]", "terseLabel": "Tenfold" } } }, "localname": "TenfoldMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails", "http://www.liveperson.com/role/AcquisitionsScheduleofBusinessAcquisitionsbyAcquisitionDetails", "http://www.liveperson.com/role/AcquisitionsScheduleofFiniteLivedIntangibleAssetsAcquiredasPartofBusinessCombinationDetails", "http://www.liveperson.com/role/AcquisitionsTables", "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows", "http://www.liveperson.com/role/FairValueMeasurementsLevel3LiabilitiesDetails", "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "lpsn_UnitedKingdomGermanyJapanFranceItalySpainCanadaSingaporeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "United Kingdom, Germany, Japan, France, Italy, Spain, Canada, Singapore", "label": "United Kingdom, Germany, Japan, France, Italy, Spain, Canada, Singapore [Member]", "terseLabel": "Other" } } }, "localname": "UnitedKingdomGermanyJapanFranceItalySpainCanadaSingaporeMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/SegmentInformationLongLivedAssetsbyGeographicRegionDetails" ], "xbrltype": "domainItemType" }, "lpsn_ValuationAllowanceDeferredTaxAssetDecreaseGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Valuation Allowance, Deferred Tax Asset, Decrease, Gross", "label": "Valuation Allowance, Deferred Tax Asset, Decrease, Gross", "terseLabel": "Decrease in valuation allowance charged to equity" } } }, "localname": "ValuationAllowanceDeferredTaxAssetDecreaseGross", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_ValuationAllowanceDeferredTaxAssetIncreaseGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Valuation Allowance, Deferred Tax Asset, Increase, Gross", "label": "Valuation Allowance, Deferred Tax Asset, Increase, Gross", "terseLabel": "Increase in valuation allowance recorded as an expense" } } }, "localname": "ValuationAllowanceDeferredTaxAssetIncreaseGross", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "lpsn_VoiceBaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "VoiceBase", "label": "VoiceBase [Member]", "terseLabel": "VoiceBase" } } }, "localname": "VoiceBaseMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails", "http://www.liveperson.com/role/AcquisitionsScheduleofBusinessAcquisitionsbyAcquisitionDetails", "http://www.liveperson.com/role/AcquisitionsScheduleofFiniteLivedIntangibleAssetsAcquiredasPartofBusinessCombinationDetails", "http://www.liveperson.com/role/AcquisitionsTables", "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows", "http://www.liveperson.com/role/FairValueMeasurementsLevel3LiabilitiesDetails", "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "lpsn_WildHealthMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "WildHealth", "label": "WildHealth [Member]", "terseLabel": "WildHealth" } } }, "localname": "WildHealthMember", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/SubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "lpsn_YearEndingDecember31Abstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Year Ending December 31,", "label": "Year Ending December 31, [Abstract]", "terseLabel": "Year Ending December 31," } } }, "localname": "YearEndingDecember31Abstract", "nsuri": "http://www.liveperson.com/20211231", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleoffutureminimumleasepaymentsDetails" ], "xbrltype": "stringItemType" }, "srt_AmericasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Americas [Member]", "terseLabel": "Total Americas" } } }, "localname": "AmericasMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofRevenuebyGeographicRegionDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]", "terseLabel": "Accounting standard adoption adjustment" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Axis]", "terseLabel": "Cumulative Effect, Period of Adoption [Axis]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Domain]", "terseLabel": "Cumulative Effect, Period of Adoption [Domain]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]", "terseLabel": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.liveperson.com/role/SubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.liveperson.com/role/LeasesNarrativeDetails", "http://www.liveperson.com/role/RevenuefromContractwithCustomerNarrativeDetails", "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.liveperson.com/role/LeasesNarrativeDetails", "http://www.liveperson.com/role/RevenuefromContractwithCustomerNarrativeDetails", "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofDeferredRevenuesandContractBalancesDetails", "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofDisaggregationofRevenueDetails", "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofDeferredRevenuesandContractBalancesDetails", "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofDisaggregationofRevenueDetails", "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.liveperson.com/role/LeasesNarrativeDetails", "http://www.liveperson.com/role/RevenuefromContractwithCustomerNarrativeDetails", "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.liveperson.com/role/LeasesNarrativeDetails", "http://www.liveperson.com/role/RevenuefromContractwithCustomerNarrativeDetails", "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]", "terseLabel": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.liveperson.com/role/SubsequentEventsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesDomesticandForeignComponentsofIncomeBeforeProvisionforIncomeTaxesDetails", "http://www.liveperson.com/role/LeasesNarrativeDetails", "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofRevenuebyGeographicRegionDetails", "http://www.liveperson.com/role/SegmentInformationLongLivedAssetsbyGeographicRegionDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesDomesticandForeignComponentsofIncomeBeforeProvisionforIncomeTaxesDetails", "http://www.liveperson.com/role/LeasesNarrativeDetails", "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofRevenuebyGeographicRegionDetails", "http://www.liveperson.com/role/SegmentInformationLongLivedAssetsbyGeographicRegionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdateExtensibleList": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Standards Update [Extensible Enumeration]", "terseLabel": "Accounting Standards Update [Extensible Enumeration]" } } }, "localname": "AccountingStandardsUpdateExtensibleList", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Billing Status, Type [Axis]", "terseLabel": "Billing Status, Type [Axis]" } } }, "localname": "AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofReceivablesContractAcquisitionCostsandDeferredRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]", "terseLabel": "Accrued Liabilities and Other Current Liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AccruedLiabilitiesandOtherCurrentLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableChangeInMethodCreditLossExpenseReversal": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Accounts Receivable, Change in Method, Credit Loss Expense (Reversal)", "terseLabel": "ASU 2016-13 (Topic 326) adjustment" } } }, "localname": "AccountsReceivableChangeInMethodCreditLossExpenseReversal", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesScheduleofActivityintheAllowanceforDoubtfulAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "periodEndLabel": "Accounts receivable, ending balance", "periodStartLabel": "Accounts receivable, opening balance", "terseLabel": "Accounts receivable, net of allowances of $6,338 and $5,344, as of December 31, 2021 and 2020, respectively" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets", "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofReceivablesContractAcquisitionCostsandDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/AccruedLiabilitiesandOtherCurrentLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accrual for Taxes Other than Income Taxes", "terseLabel": "Non income tax" } } }, "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AccruedLiabilitiesandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/AccruedLiabilitiesandOtherCurrentLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accrued Liabilities, Current", "terseLabel": "Accrued expenses and other current liabilities (Note 7)", "totalLabel": "Total accrued expenses and other current liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AccruedLiabilitiesandOtherCurrentLiabilitiesDetails", "http://www.liveperson.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/AccruedLiabilitiesandOtherCurrentLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accrued Professional Fees, Current", "terseLabel": "Professional services, consulting and other vendor fees" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AccruedLiabilitiesandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalesCommissionCurrent": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/AccruedLiabilitiesandOtherCurrentLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accrued Sales Commission, Current", "terseLabel": "Sales commissions" } } }, "localname": "AccruedSalesCommissionCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AccruedLiabilitiesandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive (loss) income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquired Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Weighted Average Amortization Period" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails", "http://www.liveperson.com/role/AcquisitionsScheduleofFiniteLivedIntangibleAssetsAcquiredasPartofBusinessCombinationDetails", "http://www.liveperson.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "verboseLabel": "Stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash provided by (used in) operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Advertising Cost [Policy Text Block]", "verboseLabel": "Advertising" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Advertising Expense", "verboseLabel": "Advertising costs" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accounts Receivable, Allowance for Credit Loss", "periodEndLabel": "Balance, end of period", "periodStartLabel": "Balance, beginning of period" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesScheduleofActivityintheAllowanceforDoubtfulAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)", "verboseLabel": "Additions charged to costs and expenses" } } }, "localname": "AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesScheduleofActivityintheAllowanceforDoubtfulAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableRollforward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesScheduleofActivityintheAllowanceforDoubtfulAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff", "negatedTerseLabel": "Deductions/write-offs" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesScheduleofActivityintheAllowanceforDoubtfulAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 22.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofInterestExpenseIncurredDetails": { "order": 1.0, "parentTag": "us-gaap_InterestExpenseDebt", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Accretion of debt discount on convertible senior notes", "verboseLabel": "Amortization of debt discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofInterestExpenseIncurredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofInterestExpenseIncurredDetails": { "order": 3.0, "parentTag": "us-gaap_InterestExpenseDebt", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Amortization of Debt Issuance Costs", "terseLabel": "Amortization of debt issuance costs", "verboseLabel": "Amortization of issuance costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofInterestExpenseIncurredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Amortization of Intangible Assets", "verboseLabel": "Aggregate amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets", "http://www.liveperson.com/role/LeasesSupplementalbalancesheetinformationrelatedtoleasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure", "totalLabel": "Total assets" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets, Fair Value Disclosure [Abstract]" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Assets, Noncurrent", "terseLabel": "Total long-lived assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/SegmentInformationLongLivedAssetsbyGeographicRegionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AustralianTaxationOfficeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Australian Taxation Office [Member]", "terseLabel": "Australian Taxation Office" } } }, "localname": "AustralianTaxationOfficeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails", "http://www.liveperson.com/role/StockholdersEquityRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BilledRevenuesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Billed Revenues [Member]", "terseLabel": "Accounts receivable" } } }, "localname": "BilledRevenuesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofReceivablesContractAcquisitionCostsandDeferredRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails", "http://www.liveperson.com/role/AcquisitionsScheduleofBusinessAcquisitionsbyAcquisitionDetails", "http://www.liveperson.com/role/AcquisitionsScheduleofFiniteLivedIntangibleAssetsAcquiredasPartofBusinessCombinationDetails", "http://www.liveperson.com/role/AcquisitionsTables", "http://www.liveperson.com/role/FairValueMeasurementsLevel3LiabilitiesDetails", "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails", "http://www.liveperson.com/role/SubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails", "http://www.liveperson.com/role/AcquisitionsScheduleofBusinessAcquisitionsbyAcquisitionDetails", "http://www.liveperson.com/role/AcquisitionsScheduleofFiniteLivedIntangibleAssetsAcquiredasPartofBusinessCombinationDetails", "http://www.liveperson.com/role/AcquisitionsTables", "http://www.liveperson.com/role/FairValueMeasurementsLevel3LiabilitiesDetails", "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails", "http://www.liveperson.com/role/SubsequentEventsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Business Acquisition, Transaction Costs", "terseLabel": "Business acquisition transaction costs" } } }, "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableBasisForDeterminingValue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Acquisition, Equity Interest Issued or Issuable, Basis for Determining Value", "terseLabel": "Business Acquisition, Equity Interest Issued or Issuable, Basis for Determining Value" } } }, "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableBasisForDeterminingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Acquisition, Equity Interest Issued or Issuable, Description", "terseLabel": "Business Acquisition, Equity Interest Issued or Issuable, Description" } } }, "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned", "terseLabel": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned" } } }, "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails", "http://www.liveperson.com/role/AcquisitionsScheduleofBusinessAcquisitionsbyAcquisitionDetails", "http://www.liveperson.com/role/AcquisitionsScheduleofFiniteLivedIntangibleAssetsAcquiredasPartofBusinessCombinationDetails", "http://www.liveperson.com/role/AcquisitionsTables" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Acquisition, Pro Forma Information [Table Text Block]", "terseLabel": "Business Acquisition, Pro Forma Information" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Business Acquisition, Pro Forma Net Income (Loss)", "terseLabel": "Net loss" } } }, "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsBusinessAcquisitionProFormaInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Business Acquisition, Pro Forma Revenue", "terseLabel": "Revenue" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsBusinessAcquisitionProFormaInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Business Combination, Consideration Transferred", "terseLabel": "Aggregate purchase price" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails", "http://www.liveperson.com/role/SubsequentEventsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable", "terseLabel": "Equity consideration in acquisition" } } }, "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability", "terseLabel": "Change in fair value of contingent consideration" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High", "terseLabel": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Business Combination, Contingent Consideration, Liability", "terseLabel": "Business Combination, Contingent Consideration, Liability" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails", "http://www.liveperson.com/role/SubsequentEventsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Business Combination, Contingent Consideration, Liability, Current", "terseLabel": "Contingent earn-out" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Acquisitions" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/Acquisitions" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual", "terseLabel": "Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual" } } }, "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual", "terseLabel": "Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual" } } }, "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "terseLabel": "Assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsScheduleofBusinessAcquisitionsbyAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]", "terseLabel": "Assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsScheduleofBusinessAcquisitionsbyAcquisitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "terseLabel": "Cash" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails", "http://www.liveperson.com/role/AcquisitionsScheduleofBusinessAcquisitionsbyAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets", "terseLabel": "Other current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsScheduleofBusinessAcquisitionsbyAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities", "negatedTerseLabel": "Current liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsScheduleofBusinessAcquisitionsbyAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "negatedTerseLabel": "Deferred tax liabilities, non-current" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsScheduleofBusinessAcquisitionsbyAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails", "http://www.liveperson.com/role/AcquisitionsScheduleofBusinessAcquisitionsbyAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "negatedTerseLabel": "Total liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsScheduleofBusinessAcquisitionsbyAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]", "terseLabel": "Liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsScheduleofBusinessAcquisitionsbyAcquisitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "terseLabel": "Net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails", "http://www.liveperson.com/role/AcquisitionsScheduleofBusinessAcquisitionsbyAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities", "negatedTerseLabel": "Long-term liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsScheduleofBusinessAcquisitionsbyAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets", "terseLabel": "Other assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsScheduleofBusinessAcquisitionsbyAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "terseLabel": "Total acquisition consideration" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsScheduleofBusinessAcquisitionsbyAcquisitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]", "terseLabel": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations Policy [Policy Text Block]", "terseLabel": "Business Combination" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Description and Accounting Policies [Text Block]", "terseLabel": "Description of Business and Summary of Significant Accounting Policies" } } }, "localname": "BusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Capital Expenditures Incurred but Not yet Paid", "terseLabel": "Purchase of property and equipment recorded in accounts payable" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedComputerSoftwareGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Capitalized Computer Software, Gross", "verboseLabel": "Capitalized computer software" } } }, "localname": "CapitalizedComputerSoftwareGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedContractCostAmortizationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Capitalized Contract Cost, Amortization Period", "terseLabel": "Amortization period for contract acquisition costs (in years)" } } }, "localname": "CapitalizedContractCostAmortizationPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_CapitalizedContractCostNetNoncurrent": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Capitalized Contract Cost, Net, Noncurrent", "periodEndLabel": "Contract acquisition costs non-current, ending balance", "periodStartLabel": "Contract acquisition costs non-current, opening balance", "terseLabel": "Contract acquisition costs" } } }, "localname": "CapitalizedContractCostNetNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets", "http://www.liveperson.com/role/RevenuefromContractwithCustomerNarrativeDetails", "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofReceivablesContractAcquisitionCostsandDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets", "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Money market funds" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "verboseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents, and restricted cash - end of year", "periodStartLabel": "Cash, cash equivalents, and restricted cash - beginning of year", "totalLabel": "Total cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]", "terseLabel": "Reconciliation of cash, cash equivalents, and restricted cash to consolidated balance sheets" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net (decrease) increase in cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Supplemental disclosure of non-cash investing and financing activities:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 12)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, Capital Shares Reserved for Future Issuance", "terseLabel": "Shares reserved for future issuance" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails", "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common Stock, Value, Issued", "verboseLabel": "Common stock, $0.001 par value - 200,000,000 and 200,000,000 shares authorized, 74,980,546 and 70,264,265 shares issued, and 72,234,303 and 67,554,435 shares outstanding as of December\u00a031, 2021 and 2020, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Components of Deferred Tax Assets [Abstract]", "terseLabel": "Deferred tax assets:" } } }, "localname": "ComponentsOfDeferredTaxAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Components of Deferred Tax Liabilities [Abstract]", "terseLabel": "Deferred tax liabilities:" } } }, "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Comprehensive Income, Policy [Policy Text Block]", "verboseLabel": "Comprehensive Loss" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "verboseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidation, Policy [Policy Text Block]", "verboseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContingentConsiderationByTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contingent Consideration by Type [Axis]", "terseLabel": "Contingent Consideration by Type [Axis]" } } }, "localname": "ContingentConsiderationByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ContingentConsiderationTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contingent Consideration Type [Domain]", "terseLabel": "Contingent Consideration Type [Domain]" } } }, "localname": "ContingentConsiderationTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]", "terseLabel": "Schedule of Deferred Revenues and Contract Balances" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Contract with Customer, Liability, Current", "periodEndLabel": "Deferred revenue current, ending balance", "periodStartLabel": "Deferred revenue current, opening balance", "terseLabel": "Deferred revenue (Note 2)", "verboseLabel": "Total deferred revenue - current" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets", "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofDeferredRevenuesandContractBalancesDetails", "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofReceivablesContractAcquisitionCostsandDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Contract with Customer, Liability, Noncurrent", "periodEndLabel": "Deferred revenue non-current, ending balance", "periodStartLabel": "Deferred revenue non-current, opening balance", "terseLabel": "Deferred revenue, net of current portion (Note 2)", "verboseLabel": "Total deferred revenue - non-current" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets", "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofDeferredRevenuesandContractBalancesDetails", "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofReceivablesContractAcquisitionCostsandDeferredRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Recognition of deferred revenue" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtFairValueDisclosures": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Convertible Debt, Fair Value Disclosures", "terseLabel": "Convertible senior note net" } } }, "localname": "ConvertibleDebtFairValueDisclosures", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Debt [Member]", "terseLabel": "Convertible Debt" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofEquityComponentofConvertibleDebtDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofLiabilityComponentofConvertibleDebtDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofInterestExpenseIncurredDetails", "http://www.liveperson.com/role/NetLossperShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleDebtSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Debt Securities [Member]", "terseLabel": "Conversion option of the Notes" } } }, "localname": "ConvertibleDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Debt [Table Text Block]", "terseLabel": "Schedule of Carrying Amount of Liability Component of Convertible Debt" } } }, "localname": "ConvertibleDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleLongTermNotesPayable": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Convertible Notes Payable, Noncurrent", "terseLabel": "Convertible senior notes, net (Note 8)" } } }, "localname": "ConvertibleLongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Corporate, Non-Segment [Member]", "terseLabel": "Corporate" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSoldAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cost, Amortization", "terseLabel": "Amortization of purchased intangibles and finance leases" } } }, "localname": "CostOfGoodsAndServicesSoldAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperationsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 }, "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cost of Revenue", "terseLabel": "Cost of revenue" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperations", "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost of Sales [Member]", "terseLabel": "Cost of revenue" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperationsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Costs and Expenses", "totalLabel": "Total costs and expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Costs and Expenses [Abstract]", "terseLabel": "Costs and expenses:" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Federal, State and Local, Tax Expense (Benefit) [Abstract]", "terseLabel": "Current income taxes:" } } }, "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Current Federal Tax Expense (Benefit)", "verboseLabel": "Current income taxes, U.S. Federal" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": { "order": 3.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Current Foreign Tax Expense (Benefit)", "verboseLabel": "Current income taxes, Foreign" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Current Income Tax Expense (Benefit)", "totalLabel": "Total current income taxes" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Current State and Local Tax Expense (Benefit)", "verboseLabel": "Current income taxes, State and local" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerContractsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Customer Contracts [Member]", "terseLabel": "Customer relationships" } } }, "localname": "CustomerContractsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Customer Relationships [Member]", "terseLabel": "Customer Relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails", "http://www.liveperson.com/role/AcquisitionsScheduleofFiniteLivedIntangibleAssetsAcquiredasPartofBusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Text Block]", "terseLabel": "Convertible Senior Notes and Capped Call Transactions" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofEquityComponentofConvertibleDebtDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofLiabilityComponentofConvertibleDebtDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofInterestExpenseIncurredDetails", "http://www.liveperson.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://www.liveperson.com/role/NetLossperShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofLiabilityComponentofConvertibleDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Long-term Debt, Gross", "terseLabel": "Principal" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofLiabilityComponentofConvertibleDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component", "terseLabel": "Proceeds allocated to the conversion options (debt discount)", "verboseLabel": "Carry amount of equity component of convertible notes" } } }, "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofEquityComponentofConvertibleDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Convertible debt conversion price (in dollars per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleConversionRatio1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instrument, Convertible, Conversion Ratio", "terseLabel": "Conversion ratio" } } }, "localname": "DebtInstrumentConvertibleConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails", "http://www.liveperson.com/role/NetLossperShareNarrativeDetails" ], "xbrltype": "pureItemType" }, "us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instrument, Convertible, Remaining Discount Amortization Period", "terseLabel": "Remaining amortization period for debt discount and debt issuance costs" } } }, "localname": "DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days", "terseLabel": "Threshold consecutive trading days in analysis of conversion price" } } }, "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger", "terseLabel": "Threshold percentage of stock price if converted" } } }, "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instrument, Convertible, Threshold Trading Days", "terseLabel": "Threshold trading days in consideration of note conversion" } } }, "localname": "DebtInstrumentConvertibleThresholdTradingDays", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Debt Instrument, Face Amount", "terseLabel": "Aggregate principal" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instrument, Interest Rate During Period", "terseLabel": "Effective interest rate (percent)" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Debt instrument stated rate (percent)" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofEquityComponentofConvertibleDebtDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofLiabilityComponentofConvertibleDebtDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofInterestExpenseIncurredDetails", "http://www.liveperson.com/role/NetLossperShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofEquityComponentofConvertibleDebtDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofLiabilityComponentofConvertibleDebtDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofInterestExpenseIncurredDetails", "http://www.liveperson.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://www.liveperson.com/role/NetLossperShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instrument, Redemption Price, Percentage", "terseLabel": "Percentage of principal amount paid if repurchase due to fundamental change (percent)" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofEquityComponentofConvertibleDebtDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofLiabilityComponentofConvertibleDebtDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofInterestExpenseIncurredDetails", "http://www.liveperson.com/role/NetLossperShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofLiabilityComponentofConvertibleDebtDetails": { "order": 3.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Debt Instrument, Unamortized Discount", "negatedTerseLabel": "Unamortized discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofLiabilityComponentofConvertibleDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredChargesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Charges, Policy [Policy Text Block]", "terseLabel": "Deferred Rent" } } }, "localname": "DeferredChargesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Federal Income Tax Expense (Benefit)", "verboseLabel": "Deferred income taxes, U.S. Federal" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]", "terseLabel": "Deferred income taxes:" } } }, "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredFinanceCostsGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Debt Issuance Costs, Gross", "terseLabel": "Debt issuance costs attributable to liability" } } }, "localname": "DeferredFinanceCostsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofLiabilityComponentofConvertibleDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Debt Issuance Costs, Net", "negatedTerseLabel": "Unamortized issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofLiabilityComponentofConvertibleDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Foreign Income Tax Expense (Benefit)", "verboseLabel": "Deferred income taxes, Foreign" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Income Tax Assets, Net", "terseLabel": "Deferred tax assets" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Income Tax Expense (Benefit)", "totalLabel": "Total deferred income taxes" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Gross", "negatedTotalLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred tax liability" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Income Taxes and Tax Credits", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxesAndTaxCredits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenuePeriodIncreaseDecrease": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Revenue, Period Increase (Decrease)", "terseLabel": "Deferred Revenue, Period Increase (Decrease)" } } }, "localname": "DeferredRevenuePeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred State and Local Income Tax Expense (Benefit)", "terseLabel": "Deferred income taxes, State and local" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetInterestCarryforward": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails": { "order": 9.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Tax Asset, Interest Carryforward", "terseLabel": "Interest" } } }, "localname": "DeferredTaxAssetInterestCarryforward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Goodwill and Intangible Assets", "verboseLabel": "Intangibles amortization" } } }, "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Gross", "totalLabel": "Total deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails": { "order": 10.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, in Process Research and Development", "terseLabel": "R&D tax credit" } } }, "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net", "totalLabel": "Net deferred tax assets (liabilities)" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Deferred tax assets, net of valuation allowance" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Operating Loss Carryforwards", "verboseLabel": "Net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration", "terseLabel": "Net operating loss carryforwards, not subject to expiration" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration", "terseLabel": "Net operating loss carryforwards, subject to expiration" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Tax Credit Carryforwards, Foreign", "terseLabel": "Foreign tax credit" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsForeign", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost", "verboseLabel": "Non-cash compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities", "verboseLabel": "Accounts payable and accrued expenses" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Valuation Allowance", "negatedTerseLabel": "Less valuation allowance", "terseLabel": "Valuation allowance on deferred tax assets" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails", "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Intangible Assets", "negatedTerseLabel": "Intangibles amortization" } } }, "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Leasing Arrangements", "negatedTerseLabel": "Operating lease right of use asset" } } }, "localname": "DeferredTaxLiabilitiesLeasingArrangements", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Property, Plant and Equipment", "negatedLabel": "Property and equipment" } } }, "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofFederalDeferredTaxAssetsandDeferredTaxLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "terseLabel": "Employer matching contributions" } } }, "localname": "DefinedBenefitPlanContributionsByEmployer", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/CommitmentsandContingenciesEmployeeBenefitPlansLettersofCreditandNonIncomeRelatedTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay", "terseLabel": "Employer matching contribution percent of eligible compensation" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/CommitmentsandContingenciesEmployeeBenefitPlansLettersofCreditandNonIncomeRelatedTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match", "terseLabel": "Employer matching contribution, percent of match" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/CommitmentsandContingenciesEmployeeBenefitPlansLettersofCreditandNonIncomeRelatedTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation", "verboseLabel": "Depreciation and amortization expense" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows", "http://www.liveperson.com/role/ConsolidatedStatementsofOperationsParenthetical", "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.liveperson.com/role/PropertyandEquipmentNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofDeferredRevenuesandContractBalancesDetails", "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofDisaggregationofRevenueDetails", "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofReceivablesContractAcquisitionCostsandDeferredRevenueDetails", "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofRevenuebyGeographicRegionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofDeferredRevenuesandContractBalancesDetails", "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofDisaggregationofRevenueDetails", "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofReceivablesContractAcquisitionCostsandDeferredRevenueDetails", "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofRevenuebyGeographicRegionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of Disaggregated of Revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement [Text Block]", "verboseLabel": "Stockholders' Equity" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Domestic Tax Authority [Member]", "terseLabel": "Federal" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EMEAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "EMEA [Member]", "terseLabel": "EMEA" } } }, "localname": "EMEAMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofRevenuebyGeographicRegionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Net loss per share of common stock:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic", "terseLabel": "Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic and Diluted", "terseLabel": "Net loss per share, basic and diluted" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/EarningsPerShareReconciliationofSharesUsedinCalculatingBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]", "terseLabel": "Weighted-average shares used to compute net loss income per share:" } } }, "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Text Block]", "terseLabel": "Net Loss per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/NetLossperShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Effect of foreign exchange rate changes on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofReconciliationsofFederalStatutoryTaxRatetoEffectiveIncomeTaxRateDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Percent", "totalLabel": "Total provision" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofReconciliationsofFederalStatutoryTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofReconciliationsofFederalStatutoryTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 1.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "verboseLabel": "Federal statutory rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofReconciliationsofFederalStatutoryTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofReconciliationsofFederalStatutoryTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 8.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "terseLabel": "Valuation allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofReconciliationsofFederalStatutoryTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofReconciliationsofFederalStatutoryTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 7.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent", "verboseLabel": "Foreign taxes" } } }, "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofReconciliationsofFederalStatutoryTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofReconciliationsofFederalStatutoryTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 5.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent", "verboseLabel": "Non-deductible expenses\u00a0\u2013\u00a0other" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofReconciliationsofFederalStatutoryTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofReconciliationsofFederalStatutoryTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 3.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent", "terseLabel": "Non-deductible expenses\u00a0\u2013\u00a0stock based compensation" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofReconciliationsofFederalStatutoryTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofReconciliationsofFederalStatutoryTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 10.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent", "verboseLabel": "Other" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofReconciliationsofFederalStatutoryTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofReconciliationsofFederalStatutoryTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 9.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent", "terseLabel": "Stock based compensation \u2013 excess tax benefit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofReconciliationsofFederalStatutoryTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/IncomeTaxesScheduleofReconciliationsofFederalStatutoryTaxRatetoEffectiveIncomeTaxRateDetails": { "order": 2.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "verboseLabel": "State taxes, net of federal benefit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofReconciliationsofFederalStatutoryTaxRatetoEffectiveIncomeTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/AccruedLiabilitiesandOtherCurrentLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Employee-related Liabilities, Current", "terseLabel": "Payroll and other employee related costs" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AccruedLiabilitiesandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized compensation cost related to nonvested share-based compensation arrangements" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted average recognition period of unrecognized compensation cost" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized compensation cost - RSU" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeSeveranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Employee Severance [Member]", "terseLabel": "Employee Severance [Member]" } } }, "localname": "EmployeeSeveranceMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RestructuringCostsRestructuringChargesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Stock option" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Equity Method Investment, Ownership Percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/SubsequentEventsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueDetails", "http://www.liveperson.com/role/FairValueMeasurementsLevel3LiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueDetails", "http://www.liveperson.com/role/FairValueMeasurementsLevel3LiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liability Class [Axis]", "terseLabel": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails", "http://www.liveperson.com/role/FairValueMeasurementsLevel3LiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value by Liability Class [Domain]", "terseLabel": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails", "http://www.liveperson.com/role/FairValueMeasurementsLevel3LiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "terseLabel": "Change in Fair Value of Level 3 Liability:" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsLevel3LiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of Changes in Fair Value of Level 3 Liabilities" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements", "negatedTerseLabel": "Payments" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsLevel3LiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Balance, End of year", "periodStartLabel": "Balance, Beginning of year" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsLevel3LiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring [Member]", "terseLabel": "Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FederalMinistryOfFinanceGermanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Federal Ministry of Finance, Germany [Member]", "terseLabel": "Federal Ministry of Finance, Germany" } } }, "localname": "FederalMinistryOfFinanceGermanyMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinanceLeaseInterestExpense": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/LeasesScheduleofcomponentsofleasecostsDetails": { "order": 3.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Finance Lease, Interest Expense", "terseLabel": "Interest" } } }, "localname": "FinanceLeaseInterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleofcomponentsofleasecostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseInterestPaymentOnLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Finance Lease, Interest Payment on Liability", "terseLabel": "Operating cash flows for finance leases" } } }, "localname": "FinanceLeaseInterestPaymentOnLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesSupplementalcashflowinformationrelatedtoleasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Finance Lease, Liability", "verboseLabel": "Present value of lease liabilities" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleoffutureminimumleasepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finance Lease Liability [Abstract]", "terseLabel": "Finance Leases" } } }, "localname": "FinanceLeaseLiabilityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleoffutureminimumleasepaymentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/AccruedLiabilitiesandOtherCurrentLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Current", "terseLabel": "Finance lease liability", "verboseLabel": "Financing lease liability (Note 10)" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AccruedLiabilitiesandOtherCurrentLiabilitiesDetails", "http://www.liveperson.com/role/LeasesSupplementalbalancesheetinformationrelatedtoleasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesSupplementalbalancesheetinformationrelatedtoleasesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Noncurrent", "terseLabel": "Finance lease liability" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesSupplementalbalancesheetinformationrelatedtoleasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesSupplementalbalancesheetinformationrelatedtoleasesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Payment, Due", "terseLabel": "Total minimum lease payments" } } }, "localname": "FinanceLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleoffutureminimumleasepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleoffutureminimumleasepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, to be Paid, Year One", "terseLabel": "2022" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleoffutureminimumleasepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, to be Paid, Year Five", "terseLabel": "2026" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleoffutureminimumleasepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, to be Paid, Year Four", "terseLabel": "2025" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleoffutureminimumleasepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, to be Paid, Year Three", "terseLabel": "2024" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleoffutureminimumleasepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, to be Paid, Year Two", "terseLabel": "2023" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleoffutureminimumleasepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Undiscounted Excess Amount", "negatedTerseLabel": "Less: present value adjustment" } } }, "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleoffutureminimumleasepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeasePrincipalPayments": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Finance Lease, Principal Payments", "negatedTerseLabel": "Principal payments for financing leases", "terseLabel": "Financing cash flows for finance leases" } } }, "localname": "FinanceLeasePrincipalPayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows", "http://www.liveperson.com/role/LeasesSupplementalcashflowinformationrelatedtoleasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAsset": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization", "terseLabel": "Finance ROU assets" } } }, "localname": "FinanceLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesSupplementalbalancesheetinformationrelatedtoleasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.liveperson.com/role/LeasesScheduleofcomponentsofleasecostsDetails": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Finance Lease, Right-of-Use Asset, Amortization", "terseLabel": "Amortization of right-of-use assets", "verboseLabel": "Amortization of finance leases" } } }, "localname": "FinanceLeaseRightOfUseAssetAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows", "http://www.liveperson.com/role/LeasesScheduleofcomponentsofleasecostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Finance Lease, Right-of-Use Asset, before Accumulated Amortization", "terseLabel": "Finance lease right-of-use assets" } } }, "localname": "FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finance Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Finance leases, weighted average discount rate (percent)" } } }, "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleofcomponentsofleasecostsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finance Lease, Weighted Average Remaining Lease Term", "terseLabel": "Finance leases, weighted average remaining lease term (in years)" } } }, "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleofcomponentsofleasecostsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Instrument [Axis]", "terseLabel": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedTerseLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "verboseLabel": "2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "verboseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "verboseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "verboseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails", "http://www.liveperson.com/role/AcquisitionsScheduleofFiniteLivedIntangibleAssetsAcquiredasPartofBusinessCombinationDetails", "http://www.liveperson.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]", "terseLabel": "Estimated future amortization expense" } } }, "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Gross Carrying Amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails", "http://www.liveperson.com/role/AcquisitionsScheduleofFiniteLivedIntangibleAssetsAcquiredasPartofBusinessCombinationDetails", "http://www.liveperson.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.liveperson.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Total" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsAmortizationExpenseDetails", "http://www.liveperson.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinitelivedIntangibleAssetsAcquired1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Finite-lived Intangible Assets Acquired", "terseLabel": "Gross Carrying Amount", "verboseLabel": "Intangible assets acquired" } } }, "localname": "FinitelivedIntangibleAssetsAcquired1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails", "http://www.liveperson.com/role/AcquisitionsScheduleofFiniteLivedIntangibleAssetsAcquiredasPartofBusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Foreign Tax Authority [Member]", "terseLabel": "Foreign" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Currency Translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GainLossOnSaleOfOtherAssets": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Gain (Loss) on Disposition of Other Assets", "negatedLabel": "Loss on disposal" } } }, "localname": "GainLossOnSaleOfOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows", "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnTerminationOfLease": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Gain (Loss) on Termination of Lease", "negatedTerseLabel": "Gain on settlement of leases", "terseLabel": "Gain on settlement of leases" } } }, "localname": "GainLossOnTerminationOfLease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows", "http://www.liveperson.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofOperations": { "order": 3.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "General and Administrative Expense [Member]", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperationsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Goodwill", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Goodwill (Note 5)", "verboseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails", "http://www.liveperson.com/role/AcquisitionsScheduleofBusinessAcquisitionsbyAcquisitionDetails", "http://www.liveperson.com/role/ConsolidatedBalanceSheets", "http://www.liveperson.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Goodwill, Acquired During Period", "terseLabel": "Acquisitions", "verboseLabel": "Goodwill acquired in acquisition" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails", "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.liveperson.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "Goodwill and Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Goodwill and Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "terseLabel": "Foreign exchange adjustments" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Goodwill, Impaired, Accumulated Impairment Loss", "terseLabel": "Accumulated goodwill impairment charges" } } }, "localname": "GoodwillImpairedAccumulatedImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Goodwill, Impairment Loss", "terseLabel": "Goodwill impairment recognized" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.liveperson.com/role/GoodwillandIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "verboseLabel": "Impairment of Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossAttributableToParent": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Income (Loss) Attributable to Parent, before Tax", "terseLabel": "Income (Loss) Attributable to Parent, before Tax", "totalLabel": "Loss before (benefit from) provision for income taxes" } } }, "localname": "IncomeLossAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperations", "http://www.liveperson.com/role/IncomeTaxesDomesticandForeignComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "verboseLabel": "United States" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesDomesticandForeignComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "verboseLabel": "Foreign" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesDomesticandForeignComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperationsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperationsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityNameAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Authority, Name [Axis]", "terseLabel": "Income Tax Authority, Name [Axis]" } } }, "localname": "IncomeTaxAuthorityNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Authority, Name [Domain]", "terseLabel": "Income Tax Authority, Name [Domain]" } } }, "localname": "IncomeTaxAuthorityNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxContingencyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Contingency [Line Items]", "terseLabel": "Income Tax Contingency [Line Items]" } } }, "localname": "IncomeTaxContingencyLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesDomesticandForeignComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxContingencyTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Contingency [Table]", "terseLabel": "Income Tax Contingency [Table]" } } }, "localname": "IncomeTaxContingencyTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesDomesticandForeignComponentsofIncomeBeforeProvisionforIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Text Block]", "verboseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 }, "http://www.liveperson.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Income Tax Expense (Benefit)", "terseLabel": "(Benefit from) provision for income taxes", "totalLabel": "Total income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperations", "http://www.liveperson.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax, Policy [Policy Text Block]", "verboseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Income Taxes Paid, Net", "terseLabel": "Cash paid for income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Contract with Customer, Asset", "negatedTerseLabel": "Contract acquisition costs noncurrent" } } }, "localname": "IncreaseDecreaseInContractWithCustomerAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities, net of acquisitions:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Lease Liability", "terseLabel": "Operating lease liabilities" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Other Operating Liabilities", "terseLabel": "Other liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangibles, net (Note 5)" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofInterestExpenseIncurredDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Interest Expense, Debt", "terseLabel": "Total interest expense", "totalLabel": "Total interest expense" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofInterestExpenseIncurredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebtExcludingAmortization": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofInterestExpenseIncurredDetails": { "order": 2.0, "parentTag": "us-gaap_InterestExpenseDebt", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Interest Expense, Debt, Excluding Amortization", "terseLabel": "Contractual interest expense" } } }, "localname": "InterestExpenseDebtExcludingAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofInterestExpenseIncurredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNonoperatingNet": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Interest Income (Expense), Nonoperating, Net", "terseLabel": "Interest expense, net" } } }, "localname": "InterestIncomeExpenseNonoperatingNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InternalUseSoftwarePolicy": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Internal Use Software, Policy [Policy Text Block]", "terseLabel": "Internal-Use Software Development Costs" } } }, "localname": "InternalUseSoftwarePolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Investments in Affiliates, Subsidiaries, Associates, and Joint Ventures, Fair Value Disclosure", "terseLabel": "Investments in Affiliates, Subsidiaries, Associates, and Joint Ventures, Fair Value Disclosure" } } }, "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/SubsequentEventsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCost": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/LeasesScheduleofcomponentsofleasecostsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Lease, Cost", "totalLabel": "Total lease cost" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleofcomponentsofleasecostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lease, Cost [Table Text Block]", "terseLabel": "Schedule of components of lease costs" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_LegalMattersAndContingenciesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Legal Matters and Contingencies [Text Block]", "terseLabel": "Legal Matters" } } }, "localname": "LegalMattersAndContingenciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LegalMatters" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeFinanceLeasesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Finance Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeFinanceLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Schedule of Future Minimum Lease Payments" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid", "terseLabel": "Total minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleoffutureminimumleasepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleoffutureminimumleasepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleoffutureminimumleasepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleoffutureminimumleasepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleoffutureminimumleasepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleoffutureminimumleasepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleoffutureminimumleasepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedTerseLabel": "Less: present value adjustment" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleoffutureminimumleasepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Remaining Lease Term", "terseLabel": "Operating leases remaining lease term" } } }, "localname": "LesseeOperatingLeaseRemainingLeaseTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LettersOfCreditOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Letters of Credit Outstanding, Amount", "terseLabel": "Letters of credit outstanding" } } }, "localname": "LettersOfCreditOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/CommitmentsandContingenciesEmployeeBenefitPlansLettersofCreditandNonIncomeRelatedTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Equity [Abstract]" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:", "verboseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets", "http://www.liveperson.com/role/LeasesSupplementalbalancesheetinformationrelatedtoleasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueAdjustment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Adjustment", "terseLabel": "Fair value adjustments" } } }, "localname": "LiabilitiesFairValueAdjustment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsLevel3LiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure", "totalLabel": "Total liabilities" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities, Fair Value Disclosure [Abstract]" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Noncurrent [Abstract]", "terseLabel": "Non-current liabilities:" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesSupplementalbalancesheetinformationrelatedtoleasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LitigationSettlementAmountAwardedFromOtherParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Litigation Settlement, Amount Awarded from Other Party", "terseLabel": "Litigation Settlement, Amount Awarded from Other Party" } } }, "localname": "LitigationSettlementAmountAwardedFromOtherParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LegalMattersNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-lived Assets by Geographic Areas [Table Text Block]", "terseLabel": "Schedule of Long-Lived Assets By Geographic Region" } } }, "localname": "LongLivedAssetsByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofLiabilityComponentofConvertibleDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Long-term Debt", "totalLabel": "Net carrying amount" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofLiabilityComponentofConvertibleDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-term Debt, Unclassified [Abstract]", "terseLabel": "Carrying Amount of Liability Component:" } } }, "localname": "LongTermDebtAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofLiabilityComponentofConvertibleDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofEquityComponentofConvertibleDebtDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofLiabilityComponentofConvertibleDebtDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofInterestExpenseIncurredDetails", "http://www.liveperson.com/role/NetLossperShareNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofEquityComponentofConvertibleDebtDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofCarryingAmountofLiabilityComponentofConvertibleDebtDetails", "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsScheduleofInterestExpenseIncurredDetails", "http://www.liveperson.com/role/NetLossperShareNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingencyDamagesAwardedValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Loss Contingency, Damages Awarded, Value", "terseLabel": "Loss Contingency, Damages Awarded, Value" } } }, "localname": "LossContingencyDamagesAwardedValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LegalMattersNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyDamagesSoughtValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Loss Contingency, Damages Sought, Value", "terseLabel": "Loss Contingency, Damages Sought, Value" } } }, "localname": "LossContingencyDamagesSoughtValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LegalMattersNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyInformationAboutLitigationMattersAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loss Contingency, Information about Litigation Matters [Abstract]", "terseLabel": "Loss Contingency, Information about Litigation Matters [Abstract]" } } }, "localname": "LossContingencyInformationAboutLitigationMattersAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Money Market Funds [Member]", "terseLabel": "Money market funds" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "FINANCING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "INVESTING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "OPERATING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.liveperson.com/role/ConsolidatedStatementsofComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://www.liveperson.com/role/ConsolidatedStatementsofOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows", "http://www.liveperson.com/role/ConsolidatedStatementsofComprehensiveLoss", "http://www.liveperson.com/role/ConsolidatedStatementsofOperations", "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.liveperson.com/role/EarningsPerShareReconciliationofSharesUsedinCalculatingBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recently Issued Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash or Part Noncash Acquisition, Name [Domain]", "terseLabel": "Noncash or Part Noncash Acquisition, Name [Domain]" } } }, "localname": "NoncashOrPartNoncashAcquisitionNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "domainItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued", "terseLabel": "Issuance of shares of common stock in connection with acquisition (in shares)" } } }, "localname": "NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "sharesItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionsByUniqueDescriptionAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash or Part Noncash Acquisitions by Unique Description [Axis]", "terseLabel": "Noncash or Part Noncash Acquisitions by Unique Description [Axis]" } } }, "localname": "NoncashOrPartNoncashAcquisitionsByUniqueDescriptionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense)", "totalLabel": "Total other expense, net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of Operating Segments", "terseLabel": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/SegmentInformationNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossAttributableToParent", "weight": 1.0 }, "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperations", "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/LeasesScheduleofcomponentsofleasecostsDetails": { "order": 2.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Operating Lease, Cost", "terseLabel": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleofcomponentsofleasecostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Operating Lease, Expense", "terseLabel": "Lease expense for operating leases" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Operating Lease, Liability", "terseLabel": "Total operating lease liability" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesNarrativeDetails", "http://www.liveperson.com/role/LeasesScheduleoffutureminimumleasepaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liability (Note 10)", "verboseLabel": "Operating lease liability" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets", "http://www.liveperson.com/role/LeasesSupplementalbalancesheetinformationrelatedtoleasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liability, net of current portion (Note 10)", "verboseLabel": "Operating lease liability" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets", "http://www.liveperson.com/role/LeasesSupplementalbalancesheetinformationrelatedtoleasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Operating Lease, Payments", "terseLabel": "Operating cash flows for operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesSupplementalcashflowinformationrelatedtoleasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease ROU asset (Note 10)", "verboseLabel": "Operating ROU assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets", "http://www.liveperson.com/role/LeasesNarrativeDetails", "http://www.liveperson.com/role/LeasesSupplementalbalancesheetinformationrelatedtoleasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Operating leases, weighted average discount rate (percent)" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleofcomponentsofleasecostsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Operating leases, weighted average remaining lease term (in years)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesScheduleofcomponentsofleasecostsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards", "terseLabel": "Operating loss carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards [Line Items]", "terseLabel": "Operating Loss Carryforwards [Line Items]" } } }, "localname": "OperatingLossCarryforwardsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Loss Carryforwards [Table]", "terseLabel": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/AccruedLiabilitiesandOtherCurrentLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Other Accrued Liabilities, Current", "terseLabel": "Other" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AccruedLiabilitiesandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Commitments [Line Items]", "terseLabel": "Other Commitments [Line Items]" } } }, "localname": "OtherCommitmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/CommitmentsandContingenciesEmployeeBenefitPlansLettersofCreditandNonIncomeRelatedTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Commitments [Table]", "terseLabel": "Other Commitments [Table]" } } }, "localname": "OtherCommitmentsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/CommitmentsandContingenciesEmployeeBenefitPlansLettersofCreditandNonIncomeRelatedTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax", "verboseLabel": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Intangible Assets [Member]", "terseLabel": "Other" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Other Liabilities, Fair Value Disclosure", "terseLabel": "Other Liabilities, Fair Value Disclosure" } } }, "localname": "OtherLiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsLevel3LiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Other Liabilities, Noncurrent", "terseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income (expense), net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other expense, net:" } } }, "localname": "OtherNonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OtherRestructuringCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Other Restructuring Costs", "terseLabel": "Lease restructuring costs" } } }, "localname": "OtherRestructuringCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RestructuringCostsLiabilityforRestructuringChargesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherRestructuringMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Restructuring [Member]", "terseLabel": "Lease restructuring costs" } } }, "localname": "OtherRestructuringMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RestructuringCostsRestructuringChargesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Other Significant Noncash Transaction, Value of Consideration Given", "terseLabel": "Issuance of shares of common stock in connection with acquisition" } } }, "localname": "OtherSignificantNoncashTransactionValueOfConsiderationGiven1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PatentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Patents [Member]", "terseLabel": "Patents" } } }, "localname": "PatentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]", "terseLabel": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Payment for Contingent Consideration Liability, Financing Activities", "negatedTerseLabel": "Payment related to contingent consideration" } } }, "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForDerivativeInstrumentFinancingActivities": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Payments for Derivative Instrument, Financing Activities", "negatedTerseLabel": "Purchase of capped call option" } } }, "localname": "PaymentsForDerivativeInstrumentFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Payments for (Proceeds from) Other Investing Activities", "negatedTerseLabel": "Repayment of debt acquired in acquisition" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchase of common stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Payments for Restructuring", "negatedTerseLabel": "Cash payments" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RestructuringCostsLiabilityforRestructuringChargesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Payments of Debt Issuance Costs", "negatedTerseLabel": "Payment of issuance costs in connection with convertible senior notes" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Payments to Acquire Businesses, Gross", "verboseLabel": "Cash payment in acquisition" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails", "http://www.liveperson.com/role/SubsequentEventsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedTerseLabel": "Payments for acquisitions, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Payments to Acquire Intangible Assets", "negatedTerseLabel": "Purchases of intangible assets" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property and equipment, including capitalized software" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.001 par value - 5,000,000 shares authorized, none issued" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Proceeds from Convertible Debt", "terseLabel": "Proceeds from issuance of convertible senior notes" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Proceeds from Debt, Net of Issuance Costs", "terseLabel": "Proceeds from debt offering, net of debt issuance costs" } } }, "localname": "ProceedsFromDebtNetOfIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConvertibleSeniorNotesandCappedCallTransactionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIncomeTaxRefunds": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Proceeds from Income Tax Refunds", "terseLabel": "Refund claims related to prior years" } } }, "localname": "ProceedsFromIncomeTaxRefunds", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from issuance of common stock in connection with the exercise of options and ESPP" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]", "terseLabel": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization", "negatedLabel": "Less: accumulated depreciation" } } }, "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.liveperson.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization", "terseLabel": "Property and equipment, net (Note 6)", "totalLabel": "Total" } } }, "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets", "http://www.liveperson.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization", "terseLabel": "Property and equipment and finance lease, gross" } } }, "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.liveperson.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/PropertyandEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property and equipment gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Net, by Type [Abstract]", "terseLabel": "Property and Equipment, Net" } } }, "localname": "PropertyPlantAndEquipmentNetByTypeAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "verboseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Schedule of Property And Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/PropertyandEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.liveperson.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Useful Life", "verboseLabel": "Useful life of assets" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "terseLabel": "Allowance for credit losses" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesBillingStatusDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Receivables Billing Status [Domain]", "terseLabel": "Receivables Billing Status [Domain]" } } }, "localname": "ReceivablesBillingStatusDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofReceivablesContractAcquisitionCostsandDeferredRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]", "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]" } } }, "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofOperations": { "order": 4.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Research and Development Expense", "terseLabel": "Product development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Research and Development Expense [Member]", "terseLabel": "Product development" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperationsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Restricted Cash", "terseLabel": "Restricted cash in prepaid expenses and other current assets" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows", "http://www.liveperson.com/role/LeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted stock units" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails", "http://www.liveperson.com/role/StockholdersEquityRestrictedStockUnitActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring and Related Activities [Abstract]", "terseLabel": "Restructuring and Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring and Related Activities Disclosure [Text Block]", "terseLabel": "Restructuring Costs" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RestructuringCosts" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringCharges": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofOperations": { "order": 5.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Restructuring Charges", "terseLabel": "Restructuring costs", "verboseLabel": "Restructuring charges" } } }, "localname": "RestructuringCharges", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperations", "http://www.liveperson.com/role/RestructuringCostsNarrativeDetails", "http://www.liveperson.com/role/RestructuringCostsRestructuringChargesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring Type [Axis]", "terseLabel": "Restructuring Type [Axis]" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RestructuringCostsRestructuringChargesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RestructuringCostsRestructuringChargesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/AccruedLiabilitiesandOtherCurrentLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Restructuring Reserve", "periodEndLabel": "Balance at December 31", "periodStartLabel": "Balance at January 1", "terseLabel": "Restructuring (Note 14)", "verboseLabel": "Restructuring liability" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AccruedLiabilitiesandOtherCurrentLiabilitiesDetails", "http://www.liveperson.com/role/RestructuringCostsLiabilityforRestructuringChargesDetails", "http://www.liveperson.com/role/RestructuringCostsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring Reserve [Roll Forward]", "terseLabel": "Restructuring Reserve [Roll Forward]" } } }, "localname": "RestructuringReserveRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RestructuringCostsLiabilityforRestructuringChargesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 }, "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Revenue", "verboseLabel": "Total revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperations", "http://www.liveperson.com/role/RevenuefromContractwithCustomerNarrativeDetails", "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofDisaggregationofRevenueDetails", "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofRevenuebyGeographicRegionDetails", "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue from Contract with Customer" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomer" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from External Customers by Geographic Areas [Table Text Block]", "terseLabel": "Schedule of Revenue by Geographic Location" } } }, "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Remaining performance obligations" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue, Remaining Performance Obligation, Percentage", "terseLabel": "Revenue, Remaining Performance Obligation, Percentage" } } }, "localname": "RevenueRemainingPerformanceObligationPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability", "terseLabel": "ROU assets obtained in exchange for finance lease liabilities" } } }, "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "ROU assets obtained in exchange for operating lease liabilities" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]", "terseLabel": "Schedule of Activity in the Allowance for Doubtful Accounts" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of Accrued Liabilities and Other Current Liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AccruedLiabilitiesandOtherCurrentLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]", "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]" } } }, "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]", "verboseLabel": "Summary of Intangible Assets" } } }, "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/EarningsPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/NetLossperShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsNarrativeDetails", "http://www.liveperson.com/role/AcquisitionsScheduleofBusinessAcquisitionsbyAcquisitionDetails", "http://www.liveperson.com/role/AcquisitionsScheduleofFiniteLivedIntangibleAssetsAcquiredasPartofBusinessCombinationDetails", "http://www.liveperson.com/role/AcquisitionsTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]", "terseLabel": "Supplemental cash flow information related to leases" } } }, "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "verboseLabel": "Schedule of Provision For Income Taxes" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "verboseLabel": "Schedule of Federal Deferred Tax Assets and Deferred Tax Liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "verboseLabel": "Schedule of Reconciliation of Federal Statutory Tax Rate to Effective Income Tax Rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Schedule of Changes in Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]", "verboseLabel": "Schedule of Domestic and Foreign Components of Income Before Provision for Income Taxes" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "terseLabel": "Schedule of Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RestructuringCostsRestructuringChargesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring and Related Costs [Table Text Block]", "terseLabel": "Schedule of Restructuring and Related Costs" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RestructuringCostsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails", "http://www.liveperson.com/role/SegmentInformationLongLivedAssetsbyGeographicRegionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "verboseLabel": "Summary Of Financial Information By Segment" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails", "http://www.liveperson.com/role/StockholdersEquityRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Schedule Restricted Stock Units Activity" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of Stock Option Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Weighted Average Assumptions of Fair Value Options Using Black-Scholes Option-Pricing Model" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]", "terseLabel": "Schedule of Unrecognized Tax Benefits Roll Forward" } } }, "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Weighted Average Number of Shares [Table Text Block]", "terseLabel": "Reconciliation of Shares Used in Calculating Basic and Diluted Earnings Per Share" } } }, "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/NetLossperShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Future Amortization Expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/GoodwillandIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.liveperson.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillDetails", "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureOfMajorCustomers": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting, Disclosure of Major Customers", "terseLabel": "Disclosure of major customers for revenue" } } }, "localname": "SegmentReportingDisclosureOfMajorCustomers", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails", "http://www.liveperson.com/role/SegmentInformationLongLivedAssetsbyGeographicRegionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 }, "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Selling and Marketing Expense", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperations", "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Selling and Marketing Expense [Member]", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperationsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_SeveranceCosts1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Severance Costs", "terseLabel": "Severance and other associated costs" } } }, "localname": "SeveranceCosts1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RestructuringCostsLiabilityforRestructuringChargesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows", "http://www.liveperson.com/role/ConsolidatedStatementsofOperationsParenthetical", "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period", "terseLabel": "Requisite service period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Vesting period (in years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Forfeited (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Awarded (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Awarded (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Ending balance (shares)", "periodStartLabel": "Beginning balance (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Restricted Stock Units" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "End balance (in dollars per share)", "periodStartLabel": "Beginning balance (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted Average Grant Date Fair Value (Per Share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedTerseLabel": "Released (shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Released (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]", "terseLabel": "Weighted average assumptions" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityWeightedAverageAssumptionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails", "http://www.liveperson.com/role/StockholdersEquityWeightedAverageAssumptionDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum", "terseLabel": "Historical volatility, maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityWeightedAverageAssumptionDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum", "terseLabel": "Historical volatility, minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityWeightedAverageAssumptionDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum", "terseLabel": "Risk-free interest rate, maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityWeightedAverageAssumptionDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum", "terseLabel": "Risk-free interest rate, minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityWeightedAverageAssumptionDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails", "http://www.liveperson.com/role/StockholdersEquityRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "terseLabel": "Shares of common stock available for issuance (up to)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "terseLabel": "Options exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Options exercisable (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Cancelled or expired (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average fair value of stock options granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Options outstanding, ending balance (in shares)", "periodStartLabel": "Options outstanding, beginning balance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Options outstanding, ending balance (in dollars per share)", "periodStartLabel": "Options outstanding, beginning balance (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]", "terseLabel": "Aggregate Intrinsic Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value", "verboseLabel": "Options outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "terseLabel": "Options vested and expected to vest" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price", "terseLabel": "Options vested and expected to vest (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails", "http://www.liveperson.com/role/StockholdersEquityRestrictedStockUnitActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercised (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Cancelled (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement [Policy Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period", "terseLabel": "Stock option term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected life (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityNarrativeDetails", "http://www.liveperson.com/role/StockholdersEquityWeightedAverageAssumptionDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value", "verboseLabel": "Options exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Options exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Options outstanding" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Options vested and expected to vest" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/StockholdersEquityStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares, Outstanding", "periodEndLabel": "Ending Balance (in shares)", "periodStartLabel": "Beginning Balance (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Software and Software Development Costs [Member]", "terseLabel": "Software and software development costs" } } }, "localname": "SoftwareAndSoftwareDevelopmentCostsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SoftwareDevelopmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Software Development [Member]", "terseLabel": "Internal-use software development costs" } } }, "localname": "SoftwareDevelopmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "State and Local Jurisdiction [Member]", "terseLabel": "State" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.liveperson.com/role/GoodwillandIntangibleAssetsScheduleofChangesinGoodwillDetails", "http://www.liveperson.com/role/SegmentInformationFinancialInformationbySegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows", "http://www.liveperson.com/role/ConsolidatedStatementsofOperationsParenthetical", "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.liveperson.com/role/RevenuefromContractwithCustomerNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows", "http://www.liveperson.com/role/ConsolidatedStatementsofOperationsParenthetical", "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.liveperson.com/role/RevenuefromContractwithCustomerNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Issuance of common stock in connection with acquisitions (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "verboseLabel": "Common stock issued under Employee Stock Purchase Plan (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Common stock issued upon vesting of restricted stock units (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedLabel": "Exercised (in shares)", "terseLabel": "Common stock issued upon exercise of stock options (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.liveperson.com/role/StockholdersEquityStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Acquisitions", "terseLabel": "Issuance of common stock in connection with acquisitions" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan", "verboseLabel": "Common stock issued under Employee Stock Purchase Plan" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Common stock issued upon vesting of restricted stock units" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stock Issued During Period, Value, Stock Options Exercised", "verboseLabel": "Common stock issued upon exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Repurchased During Period, Shares", "negatedTerseLabel": "Common stock repurchase (in shares)" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Stock Repurchased During Period, Value", "negatedLabel": "Common stock repurchase" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets", "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/SubsequentEventsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/SubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/SubsequentEventsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/SubsequentEventsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosure of other cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/AccruedLiabilitiesandOtherCurrentLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Taxes Payable, Current", "terseLabel": "Unrecognized tax benefits" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AccruedLiabilitiesandOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounts Receivable [Policy Text Block]", "terseLabel": "Accounts Receivable" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trade Names [Member]", "terseLabel": "Trade names" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsScheduleofFiniteLivedIntangibleAssetsAcquiredasPartofBusinessCombinationDetails", "http://www.liveperson.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trademarks [Member]", "terseLabel": "Trademarks" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/AcquisitionsScheduleofFiniteLivedIntangibleAssetsAcquiredasPartofBusinessCombinationDetails", "http://www.liveperson.com/role/GoodwillandIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Instruments [Domain]", "terseLabel": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Treasury Stock, Common, Shares", "terseLabel": "Treasury stock, at cost (in shares)" } } }, "localname": "TreasuryStockCommonShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Treasury Stock [Member]", "terseLabel": "Treasury Stock" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [], "calculation": { "http://www.liveperson.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Treasury Stock, Value", "negatedTerseLabel": "Treasury stock, at cost; 2,746,243 and 2,709,830 shares as of December\u00a031, 2021 and 2020, respectively" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Type of Restructuring [Domain]", "terseLabel": "Type of Restructuring [Domain]" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RestructuringCostsRestructuringChargesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnbilledRevenuesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unbilled Revenues [Member]", "terseLabel": "Unbilled Receivable" } } }, "localname": "UnbilledRevenuesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/RevenuefromContractwithCustomerScheduleofReceivablesContractAcquisitionCostsandDeferredRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits", "periodEndLabel": "Gross unrecognized tax benefits at December 31", "periodStartLabel": "Unrecognized tax benefits balance at January 1", "terseLabel": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails", "http://www.liveperson.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions", "negatedTerseLabel": "Gross decrease for tax positions of prior years" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities", "negatedTerseLabel": "Decrease due to settlement" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits, Increase Resulting from Acquisition", "terseLabel": "Unrecognized Tax Benefits, Increase Resulting from Acquisition" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions", "terseLabel": "Gross increase for tax positions of current years" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations", "negatedTerseLabel": "Decrease due to expiration of statue" } } }, "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Use of Estimates, Policy [Policy Text Block]", "verboseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "terseLabel": "Increase in valuation recorded" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted", "terseLabel": "Weighted average number of shares outstanding, basic and diluted" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/EarningsPerShareReconciliationofSharesUsedinCalculatingBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Basic", "verboseLabel": "Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.liveperson.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 2 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r4": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r5": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r6": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r7": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r8": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r9": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" } }, "version": "2.1" } ZIP 23 0001102993-22-000035-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001102993-22-000035-xbrl.zip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

?*ZI$!TE@:"N"KBJ* M(&5^(N4&"!D#DY 0;*JKE,1A \:].M 2Q!MI0AC^T)=1R4P2246KA BZ4K!N ME/^D3&>12.("/E>)YERC4LV'*-M3=CNAV$F0I)D%3#_!QBVP?P12I>I8;9E, MCBA4E:4,G>>HJR)2UWD.NSX0?K&,:*!Z'PG! )PB.$I@OE3V$D/$^(?4JN<']8\:9BK]\I!O?\@#O61 M7XP:<&WND*W#D0\RMRA66Q> 9LLRIN63Q!Q3W3/TV#]HJ%" MRF7XY)+T++,)4&X!EG@PYW%RFEHP\L+R0&W'P@RZI5BW*_H.T#@U53V79C.R!<+\E<-0+XAAMJ.V#95@$(>9N-BE#MK2O=VJ>F< MZ']QP18+J-6UPQH!)]$N@B]EK8#QPJ0BAWTS CJ DUDDLA;E:9&:%X,USF0. M'2' YCV9P%JG%L.JP9C"<#0M%MFM(HC)TT)XKG >'&T@ZD.,SH)AX*U;2 "< M5G5<01!4AI2>IZP25[]PHR;L%)U[ 4Z_X#57+3%47FRA5:O9+LWP?^@YQD.8 MLQ0OY.) EHB8M^C,0#-K&T..87HQF]3$P68@P!)E8B['&,F)(S=*-QFY;$@R M/A ^5MP,W+L!]M="[9M3I02N:\X'Z&:!7\WG551!IB*WT4/ 6C!CX.XB:<,6 M27-B5^%]'ZBVT15E64B5(%(_S:%.K_ 3:Q_^A22M#)6'P]!O1V*9@G1/LY:' ML^I;$6/[0HNK*(,V:"*8R#"=R'XH.ZAK)( JZU@R4_.6^5N23-3**EU($A(:('KA(^-E2$;9?E"//@%XP M(UA#[&9&8\^ 685%;38KJ*.H2ZLJ1D,1KEQE#T@W"Y()77C!0)=&Q\8>H@66 M@L37%6^BP(<8X7*7RE5]2!;J]QERN30^MB M:_2PJMY9:G:&:F&E8#=0\SG99SE??KS49*BP+LE8A8$5,<=X*M7^BOQ?7FBZH03!5'A5:3/B MI>GHJ11>H$'^#:M22"#Y%J-W1ZXT%]NL36=).I.7KM3Q6U9]N](3+C7.D0MS M3MRR 'MH@X)(E[1PL&BNJ=.EVTITOG+4(L)$Y,-\:QQ[L!+J@)&:;47*2;QJ M74=:/0).O!M=Q'*0H_C$IY>-YL+&HRZ/S3?)#2ZV;T9].K1IK5R)J];)%;AW MU3H,"!VB,(^*,3I*B(0/07L9Y\==(#IY0P<\\L;X;]%%!)M' 9. ):"A6K$,O*K5REPXJ5D4]GXQ(B(I *>0S51="7]+U%]H<>]N'.4+"+B M)SXRAGBJX_NZ 8@N&P9JF4U](M[ET.,Z-P/+\C[6XG1DAV136Q7>3O0II\L= M(4MZ+)*[NLCZM'W\ AZ?8'!* (Z"6/628(!1(A&ZE0D'W,M4)UEBX#W4>T4[ M'-BI+,SC6;?0=&FM"[3\\E#HJ:"T2+"Y3W04=]YX7G58>FK]9B]PZABBTM2" MO&7UC#S_RTPK9R#!:@["X*PA(CQ+&4FXAAR2B^ O.1^0'IJ@YIJL[K=?,EEVGNFH+R:7&37E&,%2$7>):)NLR8DA-RB^8"^S17CF=PU1:IZ7,G[[JF M3[C2A1"&T7:XS.U4Z-NFO=$BZ-+#D+S.\F"F1X;>B16AG!AC')%[!]NL%8R6 MW*1;"1BHMFRR%@=>,@ZF(L JY70NX*5.=)7](:60_.UD$(K/"#*YZE%01*'7'E+(UEW3BB >FQ16AKEX^NO%#^=5S5I#."G*?LX(>R T5PF,:,D]@[:R6 M0C0Q)8>3D?PVV\,$I*6JV\IZ%XNV#9)!:+]RQ/ =C-"Y&T M&:U_>Z%PR'/A,>$5UU,NDE0.^5-GS@=&]2ME&,.ZDR7)K>L##"7CPDV6@U"? MCXS@=T5LB,1N5@(]]4(E0Z]D0:]SVQG9T2\I_Q0V<) H;]J *W:,;4A9&@M@ MGX1%(TV[6(+!HH):5G"O@LY#AE6.P %_X*@IF!9: BT[?M KBI1%WOUJLV+9I M$L!YPF51^ENQ3%,FF<":1?F48F,F1EY)_>>OA@#\#M4<@0TA=(BPO MQR++IQ#*P0)!2KXOUH&1&,U_)]S4,EUJ*0&@D,XD/!H.I=DFP2@0#;:I;[/( M&OJ[ 3]PN_+P93[_TH:K@WNJ2,;U6K56OUK?UX@3J1!"7+/0>^R?]/*G&YU<^N@>]$/(M M\##PGL9R/K,$U/_4.ER F,7^\4^*ZK;!#O3CT6T=U0V"GUV1^&;DVT"U$PPS M3V89/Y75'<-\GA@!=LX[3X-/?#S8/[3^$%C9MT9Q=[NDKQC:34^?&,6] T.O M^S0.Z!#56^N(>^,(WC(BO]%36-?769RPZY/=HVYU]L=L<#B-R]C[$USL7CR1 M3N#W83Q@H?6",EB2<&$=?M[[2VS"3M*UP"4XN?J3+'/,FBD$6O MNB,D?!AJ+)N5I X,:E :J8Q-@ ;]SXS"2D5$#QVT6 JQ8XS7S\;E4*<%?%,C MZ)B>8FP@Y>@]I@I+''(!B8@F%8Q@&+:KR:"WFXU'(DH/$#%II;[.?9X2O MX(!0D !!7'V6Y 6G.E.V^'3*,7%0/5Y%K$;I*8]B8[,7!AC"G"<8B?)Y(1&' MDN>P/0M\2(5L,@B"3E *BEPS7_S1N$]K]6K7N7F4]R<[[,TJV;=HK)9#:@*M M/RJ3^P* <7FS&7%)$AS;W"-(!*L.#( B)R_^?15]Y8DLUWTBR_W-ZFD11Y\9\2TPXKT8P\76AZKU/N$\ @UY]*LP8^>96SQO[V/=WF=F?,N=H/1* M;RB"KG>85IE!2P(?;:=>K;HF?'/W_.,+& MFQ?NRZ+[_OG^/;.W']_>>N.!28^?9S(/8V/[KWH/M?/9_7#<7LC/&<$.'4[A MRS!\3$RW=FVF^_,G^8"YQC4< #="T3?/M)_T\5Q#9CZ,X[E]/O@P#J94**Q- M%#.:'A'B@UB=C2Q=I%]=4DEJXX]N9'7+N5[E242&:GHWKRQN2:?:;.-Z]Q*I MU.N":Y&8X\N&SJ(.AQ'5'LP1Z2T M 'U*(:-#6ESEC/:]#(/,QA']$:2%+"E5:$P_+ZMB%5VS$6.60'=D-L)*WL7- M@6O>87KB(IF!SS*(TP0&<#(!92PO69;,%'R MO-J^.$@ELK( B%#HS!(R$UN_8UJB";V@4.K4-L-O=/-E^DN4:U.WY6*M-H$Y M#P-@_9C N*A(""%*@!2X[:)9D.K?ZL4)+)0XF$:)>.JX(ST!_R!/B"WB&<+T M$2"@!FJ@UMU<(35,$V[S%.5I0+"K1CL0$YA&[V !D>:B%A@%X$:SOS;2!1WO MY<=5Z.2T!E-*0E5(K-9)/(NR.SCE7P]7JO:,*_5P<]$+S4[%52A"X5#?X'/J M="9P-XCC(T4Q@=UC*@)XQ2E1VF0,%S>Y#Z)R%,.^T>--J _+F>CB=8C#BBTY M$,M$?@RR( #U!?0,A?X#S\W"[.+^0(0?GL-1F0".08X,J;K#$A\23",U\\<+ MWQ=WDC:&I1)D(]V\5-.]C$@>3;)X"YYTUZ=8_VCZM=NIUAM7 \6X]K#-YZSN M*ZQ"");[7(?)Q=X2^Q+_(5Y,W.HW9!Q+Y4-/9K&TS.7T[>=\YR>8,>K^4.#H M,6>+/MVS?!#)U?>4=G!=:_<_;# M<^+K$Z6N>R2L9T9QPXSB(239/B=E/E@5Z/KY08_Z.M2?5:"GSYI6G@4B;)7RD*4TZL_BBRWAY.(*+UY MY0D>9O*20O7R1=.+1O,WC!DWX7]$8EIOF@2AY:ITMZ.\KXD8*Q1]I47[DX1C M<)Q@RS!N/0A%U^22[!+XC/HI!A%F*U&C6WJD\#H#!VU]-LICI).'DPWY,PFK M063DK-)QB:RFA ]C[/"#Z0BK!(=/3I-8]$/";$G7M28P__$%>64/_T3K#^9$ M5_);+SI&U2M%-".*$]5JBU+=AD /*3#OPN$6TN*(5$0.(3;M%?EEXOBI[Z_N M4XV7/']2]9K%%!9,@95I+K(93)XP1]"%TUF2SI:Z[YI=K0KMPD4S.)!47O"D M\Q3=6IYM6\Q3Q!REO$UE,4TQ3TLL9 ?*@R7MF]);L7E\'/IY!@\U<3T/)K-) MX7Q$6ZJ\<:8:]/HI3]@3F;[)*71G/T]10E+5>*!!AAFSP019BJ0+Z@^/"Z;> MUJ"Q6+A;JCW1B[QQD9$)6<&J+*YMZ(IQKAJR.$0XVI_=8+^>'_9^];F]M&CD7_ M"LKQGI*K()H W_9)JK2ROV: 0E2 M%$5*(#B5BIWKZ44S@H?4 &\H;3H&I .8C[T!E&M3J3(15JRV?L!U5 MDL:9F_*BIFZ48!.W-(9]<,M"QF*[_\Y\?M3D#]$D?#4A/.4ZR110C#0/YG44-"5U_[L.:EL2K,-JP MEUEL>-%]^'#X((<:3)LPA#0V%),;F4=(R?Z2[#*R'.("R&HP8>G)8@#*LH#M M(7I3P^JU*<1)R"WJV G<3HTYFZL,R +Y<^H'6)07>,[AG4<5F0&" <&R27 ) M0;4J5&2)WRHNH*!2GM6"232R!R1)GIQ#\M;7LL$WGPEI$HZ&&+;)-X;]);@B M(;T/K$,'4$JOF,VG#K6GX]TQG21#-8>B)MI%PL8X\_YFI"NAD!6$@X2B!P^!$M;^7D9KORQ#:ET!A;@*U>"R$P 9, [1H[ ;$+6\UR;\CHU>R5PV5EIN&F>R;K@Z"09* MY[,KJB=1C9#;Z#R-SD5\M?+VFY;QZR;1+SJ4JI#DG0X%"!7FDO0J9"(*3&$6 MZ1>4EC!8A7B;4U$&2@T/QQT7^6)DV2"-4W?)N%B :T@X26 MQR!RZEI)G7)\U2A!4$7Y M.?\;]U0H?NJ0FP(-3FXK4=?.,9ELZA1"T0C>SU7*H_CX"-CV!ITO+NEV*<"2 MJ3^ATQDB)Y>BQ%7R$83NLGB7+$\'" ";STE-Z7 L#)&\SRG:'60#E0 OTA-* M.?9E003#;=O9^@CF A9><1J:)KJI*?9KYW3C-5DGMN[)1;$XB= MDG%-&T/=Q5>1Y_ 9$\?GY?=G=(#@O5T1')4R>2)=+^!?#GVY#+:R)_2 ]"(W?Q& M8I_4WHT\/KT5?Y/])/[XPOW\(IGNRQ.;H=1D\Q>*Z?P[)5#OLK]2K[UC!<45 M-Z%_,128- +'G%W!YKE )^0MVW&#JPT5'YT]RGH,5E@?.;TNM!P,/&$T[IYK MN+K7&D=%#7=*,ZQ$Y_$%P#V=;.NQPVX/;-^WW7Z_9;WMM7NMT>X[?C#-NR8[ M[H]:O7WMJ]/X[7;[3[#4#E)J@^"R%PA4)#I5 4$7NMB.5$:G M+-Z:A4IK>,*H/(1SZ4BLLYLH=0**4OB4!Q1^X0&%.U.^6.BQ4/Y.!]"*/1XY MZ6]%QEMXUILU3K-H?;2+E#]14M>VZU/J+G ?]9&HQNI[JC7!;Q=YJFNN-@-# M7-9=Y46FMZ?"1P)OB1NW%X!/0Y*>9\_S;%/FX!%T4'?%LVN%@T>"H!F*Z6F5 M'E;/+FM+-]0_7;L>A1IN*O*%U"AO7NN?_72#S!-1GK*8_X;D#!D/+B/I*#3\132IX?DE#RZ.Y^B@CN*KE E VRW328S7]JAE&P#C M -3A_GH>U3B$=XW^]X#E,&4^9G>8MX 9SU\_?I,9P$4&Q)I$T4A-75"SNWEZ M:SH5Z1MYS8>6\1D3\-WH-O1EH'V282@_/%5*.PA!G@*X_ F(.<"[0@-$6Z4L M5$R%B".,^,6, >-?$4]%5$L.+%>-P)0C03J4?31WXM0T5FM3L DLB4_I@7$) M!(PCP[0_V$+9.P4VST4##0 2A3MO3#M8D[FRG*HB4VC7("!/IP4H(++QG=5- ME-(8BJPWD< Q92'/W.)Y&[AF3'$0CU-;'TQXVIA1;ZXD?RBSY0OBF5^2VTM1 MY8PGWXCLCG+I%NP5Q7-I^!=YZC^2JMS.MJ5::M++8S1J#=J#74+&N[U6?W" MGAO]5K][@ XA!QQV.R <*+!Y7<&\@YS>D-#W9SJ\>(7T(PGPW++9Q['N[".7 MJ0W?&=]8T8>&XW,?[5KV'G!;^W8M1Q5V^X06'WN)O6TX>'N]MMGO[.*"U^ ] M5#3",0>--[[<^_%VO#FQW)A;#4):-+=A/8< M;%Z#%C3-!:\UU.#50OBYA?#SAM;H9D[/U\_DD6BL,>L^HD/07LAY_Y*SV>BQ M!N;0.D0 CD;/7KAG*X_@BZ#F!37CENUF\&Y:1S$]OND$14Y0YP=J.E$N_X_1 M'Z)8ZYK^$H_J(/&8.(/ZX[(^+6$NF]8Z:'UAT/J317WZRNRS4Y"YOE70AO9 M&+$F&Q@@I>4R92F(L?V+J48ZY<6NMX[=,D7L)*QNS6]RM[$"0A^33 M2Q1*M6N)=X6FZEPK^DHV")(=?&#C,CQ1UB.VV]:H7$<; PH]$" K%+0#J-H^R68E1+BBCTBK8Q6-S]G(J[\X+NO.H[=NL8,] DH2 $ M(-TV-90HUT7%TM@8M>B[/@R-D:TLI$+/24+] S"0\*>/]<]A<\/N+P7',-XE M18V;'2_-Q"O2YU$-(XX 85PO/4RL4GXJK4QEF T5U8IR) MGB\\Q.3[]1^):/?R1E1)EV6=72 #/\S@]>6BL"152[V&9&\9N6@5O*#6 0&B MGQ"H\FPVYOQ5K(!C7<0Y4JSKPB#V5$!11'^J88="#PC3@BILBQ+Z''TPC6,D M4VR%!!_S)44S$"0"+$)G2 &6L!2L#$G5O.6 7"<75F&D-D\!737SLYD,%%4C M-A$68MG%( 8 EU1;1;WU8FIL&8"K3C#6,P_;%>Q S8NFCL=+FO,N*:C]>.E_ MM>7/WJ.HUZC)AW7B(QTL5G>KH*+?D5MOD%L_R[+DB7%NB'98'_^=@7%RSMLG M7-P[L9?L*IB/I/>&V+%H*,-_J@4 M@!F)>30;1 ,(; '#=T@M![R9'Z*E&2]%HN>R16TF5;0>VK"SF;/@#"VV4)3' M3Y0F1LO3D&Z\)NF3TZUQ%7 .5T6YD%!SWBWD#%M3_1O R#N=< #)UTN/OA$] MLDCCY(VTZ"B>F"N:P2SI:2%WBH98:KY68("!1HFQHY0[95Z&I\(98]0WR,0$""?E M]"%2'J@P_E(@/SP5@FI-$K!$N5POC!"J9;\I46"*EBQU#2-!4R(;3-M@]T@] M.'HNW"]!K14PI3Y4:-4@*93UI>,!$AFG_9CR%A $YS-^U+G-?(^\Q(E(%4"^ M0!."VB_F21.B'87:JH(WA:!64)(N 3"4.3&1C>"B.2J4V"'%>P^R+[J7Y@'" M+Z'6-*2W8H^();?Q=>>$O'-"5W=.J(DZ7):[GP7MWP@*O\+VH N2#%(K\D9Q MOFA]0N2M=GDJ%"*EZ,B$(:E/V$\X#&+2%@@9WLQQ&GFPP=L%#5R2T8UO! ;2 M[8L3@XAZL-T+23CL$,5EOM#JBA5M9/S\9,S\GZMZ$<4J:AP2J#26P <@HC3D MQD5(R8BZA!\AX$B _6=NX54<4 Q5$O9BJ93]Q+/?L.?09 +8C\EH4MK\T,<0 MN]$^V#%160L=#)2D.\RI$\WQQ/F$ (0)4)00)YJ8/=A""!.X^(IY[ERY:R0= M(D#P4E?8HDD9/X-&U-LO$$FIL IE8 Q"\D*HPG VE) ATR$.KKQI'\S914T MNN9$+JD?SWQS,DVYV[(P8RO[OG'3H[#:5QLS$9'(_E,D?UA\!Y0I;#GT$PAW MQ@3->8:F9='F*4D!QSRWLW!]B,,R]_G!HYA\B1:47"6WA?$L?1(XGA2]#D4G M+]X,CQ]NRN)LYGBL)-.9Y[];#;*->SNV=X^FQ,VP-!P?IV&*W#Y"'>:!A M.ZU1;WA,J^UOA[(C[UNC9G;NEG.W0QVGQYY9GIR0]T_I(/TF551J_$;B^^SU MFV?.;+5U9BM'"G<*28SP/,F_D,5+7IEFI(+FE,?=1 K9-6)[N"L%]?5XW"V3]\&.'/6),UU-YSVB4-,'$\F>CJEGI][J&+#7-H;7 MX_\/V">F)GL=VN;@%/9Y2CCM#$\$I]U*G+Y0,O)C?0W[UC!45F@I3_EYM0NL M8%?M8CQ=O3R,P;J0[>")@NAH=FJ/3F.?IX-1JV/V3V&?KRVSJU5+2;54I#,_ M\^GE"?KEE-0+%OMTQ!$=L?LG,(^7W?:G=/ :,_LG<(V7X_:W1WURM-Z/1RKWKD( MV$^' O#SA.3C43W=1ZN>O2.Y+G0_?*R-W%1(='JFK>&@*4(Y5?4?I_N:"@E+H<*2-2+C%?( [, M^Z"(]+SK;#;#H.=2"/\-Q=YB0J#G3R9@>(R9ZXC\1GQIQMRI$_JN2 L(B6W$ M6CT,S8W+8.%%+91\:9&8%\F47W:N]*LI5FX:<92%E+%03GG+2RV$>4ZVG+]Z MWV+A106$E;44*8Z4^NP2"$1:,[Z X>RN/P_8AE3DY^?$[=*]CJ1:2Y^V_FU- M;R>>\9)2W%:.U+Q/#T=[WN)(X;@B'P7(C9=3&9FE%D4B\Y[J]$1 Z\#[:>R/ M,\QDZ/&F1ZL9$.*'/%D'V"!DO&Z+R"3T13Z$61$>;RX5$!!$F&14 ('IIV1 M(,F)?3DG*T^V5Q?'.Y IE0KR)EN <8RQKR4S()7L0'1,F$^/IW- 5THRSR&6,=\."J,I>9YPQ/? MW!1#1PW;W@L"-R=-;951=7K9VCV=K;V?6.DM2[8 G=MEPUDI@2$2%S]0V0[C MCSG*N=6:+?7/#:2&F@D(@812_I:+IT7GK'*.;^T(M%-MF4\)L.SW@F= MEDVY-TXL$V(1SB;!J@#-:H47M"4IE?/>#P*T@?TDR7@F+U8KHWQ:D;&^C%)S MV5*CYJH\/U?8QW_*VAJ2,F1KU=6QTOOH'&QG5$W"RJRBD:)BHR\6CQM<+4R2 M;T>92.0,Y_4^Q&$B#!9 #X"Q_TBM1Q9GN0P?'E7Q#*VNFYJQXKQOJ101+Q]) MBC4G4&YW;U7#*E1*>HTZU[([U?[=VZU_SVU? "^FZGY85 M8'O^F&KY=:8)?(<9YDF7D%X.:&DHNH9XJY"5%#% +![TVG, MV#F6)JNN#)C79[QU,/_<(.<1-4)F6/D)J52TG^:>DD1VF@5>32/X BF82-0I M*CGF1SF:EU9"G\1(',>E]7#^[W">=$*UVMOJJ+F(Y,E1UVB\BV(AWQE8?J$X M'L^ P#,LZ$ KH%/Y)FA@7=Q"%G75FJF\I!<"1M3X25*E3L#F46E'6)T!"4KR M,Q51Y(V2T6>#=:CP.>RFC.4D1"6+LC!4BZ*(<^3-M%!#O/ 6@ M 0\6^J," MK)!!+H.9\].? 2D:P#^ ,&$P/JAVEJLX3K*@7,+37;@!X3#)2-[)M2? /0[Y MRHI=W,;1/0(@[Y+=,D2?RE49ZT^P%;=IN($_F9PC5RR5,'X0^D6M+-[]&@N1 MS0K^4J7SJM3;+"Q\[Z^O_&Z_[78GK#/ILF[7Z[H.Z[8]:^+:_4YO- !99PW[ MG5?[-ON6#UO59A]W4)7LOBM1M!!@2X5X>+$1@.5O>8VKS5)1UHNP6[V'*D8\ MHX$K4GAE]='#5\&H66?[/U$@Q4X54R'Y5"93^Y;R+6 M"*7ZR\_JKI(R=_0J2:J M SF,MB,S9%X\!(G,")%SO? M>VB8;X;YM_RX\LZPJT&OBQ(6;JZ^=G-IUML3ZWVM5'LD 65!5"?!BN%D;\<[ M5*%^#HA>B^OT>S3WP2BGZKC&65=S#D'(5-=7SNK:KGA'\Z0T_$/.JWFE$ M 0VH@!4C!-T>=(4:%)5VDR3"$KWR.):%RFSFFJEH%5DH+S=E13EYV>I%U#.E MM!*L/QCXY;*MW-AI&<;G%,T6+)V(I>MYL78XWF"9/W&TJ;"! M\IT4 !#&C;!G>'@!F$H@3ZD<+9O Z1&/89\G59"CLRMN+'<5* ,I]YQH&_%3 MF+(N>0BKW(PHCSMF)=.-&Z*PR1!.VP)=PL='SJ[\;GFE)B55VU,KR3] .DAX MW.3$FUQ3E"!6^BM0:>!BA[AO44[12)V?<(0%-G)X\6<#HR\"?EU8&+T(NAG; MT"NGQ.S]=FO04P0C<0=QUD/GEGJ=QDHGSN_,1>_+0A1^;7B!PL_**:==76/: M$0) !/)09(&V+$ M^#@B^)R??K"H5XN%R]Z6.!Y45JCO+5( M/&.51T@!9_(9B9/<7'96P1^XPU)$QU4CX!X;YW!)SD6%:*@R!P$&DB+=X)57 M@2H]:QAAAZ\GV3B!/<.3<(C'L+5;?JL1D([W@A8E'/F98@6M>!-9&W_*%9P7S(7Q,C%DV$:#Y! MO,NKZ[:MLQ]OA,.>\U&IB9"4]B!>@?7A"^P50#%ZQ96C>.:,A$90+(?N MAOT)6GA)%G/W.E5_OF4E@ F[GRX#L?M!(JIO\SO%TG J_+E/[ =^RGNT4:@4 MV*LB[B:_9R$$I+ZX[,X]Q]O4N>9WJ)[H]Y4_)F[H_;$?<&6Q9)U5DX0 ^I2* MQE\[ )O_<>(Q2+0K<6]B5K5(^/S]VHBS8&G%'#,P,QZ>R_&!'=X;"IC'E[7# MBZ+C(I)2O$"!SO;ZYTTU0A(74G3J.$"'H)<5<1]DOY'R30.@IC&Q"M*VL]M6 M;V-!>VGDX2/KX=(R+EE,3FF\[\LETY)IIXJ54A^@&<.PQ?R"D!2I28(OIT7J M$R?%&9/";/V*EIJQH W! D&^U$]&6 8N\^:Y#[ M*Y0@G$2Y6]Z$/3@I6-DPF4.B!^\4R<02B0%I' 74Q::PT*88=4A7!%RM^")6 M8CE^&H"7A=A'$0Q9.B:"-14#*-T%YCE$(FPX%*UT5$N5$#IU[AB'-==5*)O) M\.)M?/ 7D3\;R*IFY*,6_"!"K.+"L;':_22M'[7CR]#T DU,?T']?R8J8). M7*N:%*,Y%;UH/=PYZ..4@^*0%M^V-[*#]@O=R%Y%24J]TX#*I.0HZYBUEF+] MY:.4:4H[4N<6CEGBB"2C'BH.9>5^"6CKD.](GJX0+KD]0Q*!NG;=10&($*3K M5(%HJ1\JL71,<1%"*L#?(@W@-HHPZL%)HE"&_Y]1_L.$ A:D@TONX$VI 2J( M#[E;Y8(5);#2,5E&&8!A @P>E^Q*?M"G.&9\K6HW:(/)U=/"E157"B(ITOAO M*-):QD411^.A;SA(E.XJM) ML56RY-EB/;(0D2KP@2@H,)AQ&0KOZB7$!#WNTX1Q9@B0^%K"X*& A M@_:^.F"K&Q]S\OTFR#=OUA7F UU%*8X-0+^2H/@#UZZR/HQZ2?@" 7=^*? E MQJJ#C.R_E(R,HRF<#PA&%R(H[7^8=RL["DHQ(RIAWP#));P/==./U]^ "->T MTYH+H.$A,$H4T:IHYVLA+*R^XM(C,XF%M\ZMB'R;"E"CV0:KO.-!8:D"95/T M@4PDM:/'#HY9.2-0TQ-T 'GB%L0H&YX&WOSOD%B1(3LLZ"YL$J02!R0==9S1)XLI6Z"@ZQQ60*\)+[ QN7*8M7 M5\H%.76#^AW@=@43YIEJLG<@WGEP*0Y"#7OU4L(JQ@/*/>$M")J%1>LQ(Y. B4Q+V"%#()#6KF@YEJ]/7DMQRQ6I=B)V!(20<8PC\'%&'LL( MBZ4.S=*M@KX83"=0A\N]&(4/&^;W9Y3\N1R]NT3I@F7_ZR]6O_W>ZI^Y;R3X M/OX4ROX"F!N@#;!, E4.K F?*B*F5DB=]L5!V#*^J=#/?6K+G"*S*.'M@MR% MRWZ><5^\2^S*+04=')('APQT<$A-U*JBG7)A(3@"Z=L+A)M2*JFTPN*H6"MC M]L#N[GFM>^P1M-V$,GJ:7^7)7&CI0R\)5WZ;[Z"?!L[[,X;G_J4FTE*5D$,; M RCR6T/N,Y"SY4'FL9_\D(W\>!HHJF\9H$ A"TY8Q!/0Q5S$%077$MQ441=J MEF0]7S1(>PQ0)]E_QX1.0_V6!ZFCN4,:*=7#C$/(M!A23JI05_ M1:;)AV*6_'1,BM)'5$5Q#$B>9*)/N!A*Q/^J!\6*8ZJ(W^#F_&)I;ME+NPY> MHJ']0B>@&^[1ZV%RSZV(-*3^*YPJ@"$^D27F,$AT!#(UO(%J<@>VS66Y,?Y9MW[^+K+?+R*.#BC4:]JDJ MBC/C #M+BTI,^)"0C6]$7D22)P++%T1M%V3IRTR<$_X>C1.RVV$&NVT-\'HB MI,O0/)S&QY@<3I4".\)Y*=V.)<22&Q*(EE#^VFJU#0!70,0E,^]DI,R*V[+4 M.1E.@-D85%:P.$?3A^'1/9Y'L> XDM^@*W&R^;(_=27&KG '*$L]BXJJ.?Q> M@RA:'OBYVP<,?Y]-WDC-6D::BH_RS:X,C21H>N2D5$$G2L<4:\%M,%)3)9CQ M:C7(4$I+:&FQ%'?:ZKV,N&;.0G2#\..QLAO\<3WRB"LQ;9E?93E)1;1B^2IZ M/@\69='#PWZ-*5 Z' *3'[ 3-29'6E"S?')QJ<_=O(0189C$F^40'G&=#* 3 M8Q;AZCYR.542*P)2R\PGK*E[#.;T)R!;<['/1# '66]E4L]#N,8\.TEZ2"H\ M/[R]MF*IG89P2PQ[V/Z-(- =C48%9#R6W[00=*MBMK@'"(SYJ8C$5?N@+^6& M<;*21,W)B)/@>8XS5F38B[GC1(:H*;Y)N-')_C]%MCRY*>/-G8*FP8L7E$7B%NE4X(Q*5 MLY!\V9.WO&6Q@N$_M^+.0W@ 14 [B(9%$6)>B@*%1:J+)A<>G:$H8APO43P> MC+ @^8L5T)S\!BX&Z^L\FTM%D7M48^;/QEF<\+A$&9 M93A22."+>WR^4CS0 MH6,.!!2/EKQGI"646$8E6EU>'97XQ13,$O-]-%Q4W&QK.R\'C&ZRD0&DO PC M8JM$6Q[#$Y^L2%<$CI*)*DE:I3]Y?A79[IX?4*""HO5"X+DID[&Z"9-VO;"X M9@D+[J1_F=82H'5#,3%9()(45M97BV/G\-43J.4P)](UI/*=KI%.EU7PHH ' M7S)/>-<3-TL2$0!6>NL#_TG&>5R Z%XDOKAI!UO/X:3/K\S52HA\ G7XHLS@ MFG5A*/ULEA_Q"G]22:,]N#3*,J+86$^F@5_P7#..>%SA)S!4#:M]_H^\R.,$ M1H-'Z-3!E_ !U#@5VNO(HGG;U1C8/1M_O^1!H[SS4Z! =QLS+!L3'M3"GE58 M6I/(09AZ;C?OACQU%26][K,F8/X=A??OS@(.1F")GEU.'3]^4\>%7N&YQ?@U M (U5Q^7] T0(4%X+8'GW4%3NRZSP$YJC7\ <#%ANGHO1+3/,-1YO1N[X?K;^\?8^N/NKFM M?SJ7_L]X;EG?-.#XI?>#LEHI9D[1LXDHWB?<.&57.*_ 1BZ6()"N)#S=A)[, MHE./^GA>QX.U Z=X+A-E*KVLA>DDJ'>\4/+_CNL.7/_<*[$ MPR#SP%F\\T-:,[VT2Y%-D"RM-I<\F^]EDT-PJI_;K>L M]:]N&+;;ZK1'>Q_5@A=[@YV&W?Q;9[A_$!QHL7:KV]GMS>8LUFKUK=VHJT%D MT!OL-NI#B^UWMAKV@6:+N_9+W+]*6+$^2%!BP@B=:ZYX2QY,!Q&F[A8=Q.K4 M!*QZ?_\+&KT1&[FFI%6R+OWG$EMJXH5>[[GZ'IIZ//?4\!31*9=5'U0-_ MKJ5=\(#0_;E**UJ,5E=HV['%J/6 [_+@<%S3!N;U]JU/3X?POSV0L: I7U-^ M,RD?2TV*Y$JE30P6B2BY48Z'^NSUU+?1I_6<]-A^&7JLB0%V$03&:K7Z9S?( M7AX:W'E'72TJ=R].1$N.=XM7?US:;QS=+^^]NNNP\+T^4FS-?$R->K4WE^YV ME/(=F[>EQE7+^#VZ=!+7C[:K='D0?KV<^FRR6A'@L8WD'XT.*@SZXCV@,9)C M+6O:C]]DVZCM5ON690[M-L_#7=[S#LBDG;:WW^=3:6BM6&P6FFRSW;;-3F=X MM(C:P61\+@NL_00+K/.07=,\.K3,3E<+C)HCJM=KF_TC%AO>TA'K/M$8]LST8O2P=/N8$N'%-XS[^[RB.&>V=CQD5FZPQB>U^S*A& MYL$%W=*T.ZNCXT*39?:MCFD/K*-%5$,UTI./&4=)AR,M,&J.J)$U, <=C::: MH\D> $/9&DOUQE+7' P[YL#>Y3RX1T2=H!UNC;0=KB5!?=!DF7:O;;;M74[D M&E'/CBA[)Q>>1M1S"K[AT.RTM0E4N:PV]58JCF6S&&G;]H[72_MWU!= MAS&9'X8-BC;C5C_9]">KSS1V>V-TV0Y,6]OHLK]'T]#XT#(NHP!^7->$Z?E" MRS[EW6Z.(1IJW/FC5'TZ#=,?O]X[6Y](U/,ZC0,H=: M6-0=3;9EFWV[I]%4;S1U1J:U4SA//;#44)'^Y+"RXR)"V[3: ]/NU\-+L-71 MKRE'C%,)*^MV+;!=!TC;=>:HZG3 M[IB#GCX)UAU- W-@Z6OOFF/)-MN=H=GO]FMA@[_T+9!^LOY/5A_7.IMOZ@YC MS[W,3=V7*(0U&+^WC-]BQL(QBV]7:S4]GP0I:D#\$ULP7<4,V^>$J6E<44,] MT0F6J@'^QD+J\7<992%8F?I*KVGJ!+[55WKU1U.OUS'[U@O[W?1Y^\3/V[V> M90[Z6EC4'$W64,OT8T#3R.P/CS=^N:$B_<2N]$"@MWMF^Z6%^IH,M:Z^TCM^ M$M-'C*- 4Z]MF7;G>&]>&ZJ/3NV( <)BU#_>0*<3$18=+=./ 4UXQ!AH+-4= M2^; MLSAH!Y7>J=D@Y],E8C.J*VCO.N/)GO4,WM:K=8=37UTF6@TU1U-M@UH MLH\W#^YDT&0.C]@/?B)8LLQ>9V2V.R\<\ZWCSO23CXL[>PZGXLO$E7W%[MNA M\:5E?$NRF?_B%2 N7#?*PA3@)DM /'/CM:?X67O;MS,[]E/OR02WV<.1.1QH MTZ+F:,+\D&-.X]$W3TV@PCZV01KH_)>:H\FR!N;0TKZ7FJ/)[ILC+=+K)M)/ M+KBMTQF9W9>^]] ^"_WDDW+E'MLSF9.?2LW"_W#\/H^+@/UT0MB$<3V''X/@ M)=T>GZ)X!BOY+8C&F"-'3I ;YDY#F/-V<81.D+YV@C1."78Z U"#+QQ;H@WF MA] T['7,P1&?:QIJ,3\H$9M&A98YW*D7M*9"387[HL+_^LO0MNSW1TN%)Z*R M.FVSU]74:P[FOH#'<)_!&CJV"#2=0!7S;$$2.J-S-%+MQS:W0;?^X59 M3?#RJ 3'IP.AQB3Z"!M^+\2P?TGSM&5M+XD:30:]D:7)0)/!P.YK,M!DT&OW M3;NWE=6BR:"Y9-!MFZ/M3NR:"II+!;;9L;JFM5WOJ9Y MO)D3W_JA7%X?-B[F/$=7XCMK6(;\O[(D]2<+_I4?8A7X=^?XT%[@/GP([C;" M_ I/Z2Q M)WX"2#86S(F!YV;S3/SFN"X0D1.ZS+CWTZG26%M)L+Q.87PG]A+CUPC^0S?F M@_=)]2.7D>=/@*)P&<9--/==8V -30,6?W%]J7Z#BZY8PO7'2R/. I:T9$> M8&%N!2 _X8\1=.&CP^%Z"?MUPH7!?LZ9"\!*(_H8)@RG1_!-\ETG*8PY8XB< M"%B#CW>O;OH.,( [3MPI\V"9+>-F"C@4LR).)P%,H\Z E!O3.(_@&ED@SNVD&B^*[H_W<^T%@C!G, DSU'\#A>$%/?OWXC5,!_!$3 M),+(<)(DBPFP$A;)&M E?&"&6UXS>LNXRN(DPY=A=3F23 7DB9%,H_L0]N8& MF8@W0$A3YB?9K!;@QS\C'8,_'7GN^P<_?E>#F<7X$%W M ;""3T!$R$_X)\#%#R>8E4R4%G$ZQ]WP+W#S,\$,1%<(6T(,ARW! 98/^$(\ M1\;7"$!B6;C4W_T[=L7B) ISU,$R2+[R#531"SR1.L#^1-11!N0>AHB][VP> MQ2DN$$-X#:M]_@]B95P$AH8"SQ%O_B_P)C %4F, @]":\1D =6LE[OC1,OBE M!*Y="X$++&K,64SD$DH20PE$&/+AJY":E(RC,$N *@$5 I&$(62LN>/++VS# MB9ED]$+&PJ:R&5 _#)4B!I%V[/;[KU%X_O'?F9\NC,_Y1%-D9@]23SI%U\BJZ-2%R!4]))0* MT'8NB[D> 5I88T5(FP%$U1&90IR!_KGWW3H&_C>XR2!PWK,]1,4N?"W MY^/(XPRU2P:*>S.!ENB3\R(1*2<60:KTE!3>\*#"QSD]T0HQ2L0T[J<^K%-" M 1E5@&"93Q_%GBW!GXTBVVXMR%8:PP)-[XPS_XWQ>H"X?-WO@IWXNM?%S[U! MG]N,K[OM(6$>Q<_OT:63N'[$A=%E!)(H3,J2"?Y*E'98?!!\@"J9F)*V .]H M:.+ 8)7/_&S&Y15*/*#2"1*2L*=,6",NLF]:5M527EN8#=@!-0*D2#^K"UB> MG_8$;_3;;>6-8C?Y\[FHQ0? [G&GPD#B+$>F#O!@MVV=_7ACS(&&$SXZK!:7 M:V-/[1XLCQ)F+5SGT.PB-[\>F(-!1RZE9UJC[F$A/ 4+,YV"& '"=P+3N.,2 MA*QA/W'&?H ,F0-\#P90C?BN5PN^R_&3V[@3/T[$T0#M]=D\B$@"%[:H/$JA MKO_$QG'FQ L#R$HH!40?G@;0] 9YB_:"F\&A!H:(HP!_P(&Y)A$O;; $ZH_( M?FT0*3DQQV7@$"H7VV#RFYM&P+,!# M@Q*,V"P41@#C:M:YWQ_4'G2W$:+0,6$*!8,B$P&PM2>%GB4SMC@0"",#C N0 M5FX0)=QJ2A%(PJZXSF8SY [5BC!NT)4F;0ET'$AG14R'Q,)&D8/02BZD P)? M$M:+%['DZ09>/L]N.%3X6D^=M_C^.W?SO\0(*BNQ@!N1H?>>][ MZ51XE]6WA&)L%Z\XXP1 EZY_19&R"$D6;R]2;_P9D.57=F]\CP"E:YC6:F_% MM4H\"0_F5/[%Y?K>7U_YW7[;[4Y89])EW:[7=1W6;7O6Q+7[G=YHT+'^SQJU MVZ_D:].X0,LM.Q_'S/EQ[DQ@C^^EJT+,"W$FGI=6/0ZD*U:(:NJ M:CLL/W&DS8GIC\R2MY9UTDJ:/.'I8Z%>+F[!!N1 MK(7 TK>[F[+,&L!MZ?: 33*.Q_L5]_= DS?4<>FQE5A43^W&C0)(9+CA44IEH,C46N03"!!C ^12?=W)R13$#2)-1J-6OQ: MZQ.<%:)[5+@.73K$; J2&(D@9G<^" GA7BZI2/ACYJT5QT-GLKADF&>I,8FCV8;I-KT!N$]8.%(_.8\: M<-#SV9U@%@408)29FZ#B,6Z%H<\@!LT85/C-H,CW$/O@^K*I$*!PH0U63"#X/Y4>,#V%7'P?A5;0-2QLWYG%TYWMXXP)F$=!Z M1)2&Q,"MUN*BA!^Q%?R4B'?NN#] ^:V<[\L7/.GR_&;I8;QARAW=94>ODS C M<0(4!X#:UWT+,V7 I$NR\;_$_8LP#@5[@2DE(T&3<"(4C"'R&QU"'X_K08E>6+"U/\2X8IV@"(;C@N=4= M;+EL?C)V0&S]]&?9S)A'*0(/!A!&,:[$%BOB4[?XZ8!? (I#@F#GTH8(T\8M M[#CDM[L^^8#&)4%16AV_7D-G2R&!Y-!@3K([I #5*K^- ,BT@QE#JS_!JSP0 MPWXR+<9>)\/1IY.OV$E\<6&(EZMX-BQNTM09E^06G<2122/B'TS('#YK&/,FE9_/R*L,Y%CW'!A?Y] MC%.!0 O$01F=&R6/F>0B>A].H'@N AH[0Q\CG/=\?FL9LVCR!HAC@6B3MSRE M\Q:L&B]+49' !G$;_(A:AM/4N>/*EBYVA8[D9T)%3>%;?H*,#I#&(SD\@23@ MTNXNT2,:!<:9DW"Z(1",?AHM8\V UM"1XE%S29 -PW CIQZ>68U5O MSU"W]UYJ&FE@+*]:OEE>0;$R>GH%&5-Q/3AF,)\BFX#CHCC7.,NOF4OP(W3R M#>986"?H2&S00WQ>(P#:P3UQ[ L %6*4QL:]$)V&D2!3BHQ021%&BD#ZW%DN2N4$F19QQ ME<:A1-QT =QD XC#=)J46+[DCXP-E T5SDG)[AR==!6^]D62"54L'+V'\4(2>*/(2Z27!L!JNUX!+?X7-#%]Z,X_?"-I)^496;4'%-)*^ M07YJ@F4Z%$W%I6(8A62,ICZWBTAHA3RVQH6C='G#C"7".BR.9'3=Q2T ]7(+ MQJ!CSP2T:1Y*Y@+11S.&3[J!SRC>!^A/7D85OQ/<^!.@W?,(HV"QJB>6"#CW M:@KUK0"B"',R*'+/C;(Y1R$Z:$'QQEQB!,-2+7 MS(A^@-FN_WF%#US!"T+87\61E[DH8[GP0N$?\S-:E9=":I5B*4#:TAC$'X!C M9E$1:":C(81?*7<]K+H<.CS_4ARZA9U7!/F5O"'P?+?2$P!Z (4NM].Y_>E+ MJYI//%X*R:/;&;;S^.VJBV(% M=644+_D'9Q0L+EU(/'":H@9RF41X-BN0+))LS:VQW-OD[U$Z26RTY1('U.=_Q^OGH,\8K@"@K_+_D\UW #][7 SK*0,YK' MO8W5P& 57OQR/-L6ILW+&3#:;MG TVNZNNV1GQ^Y('./!(EWS131$M)R=9 MUO=.>%YC8;)5VP1^;MK6,%@QB[Z9I5=B-C=QM5.^ARUEW6QF MZ^[C3D/R^:VLDJI=K#5*'K)&I)^\9?PY]0/V$(P4O.07%JJ4T(%TDA.4XJDK M@72G$Q%7"[]@KKI$Z!*;^*F\L)\Y'I.7@#E_DXJC(S%(CC3.N-A9\H="%NZV2@\QL1ASI7PUU$>O4"&FC&PDCPLYGU4(JOX!NMU],K SM6#V'6I M_@? /'#F"7LG/[R7W;S\D*!(+[TOSU=1)Y?FXS\+L3T:M;I6#R6WZ!@G)A9" MO45"?:DH"?]MV!JUU__:;EEK?].CZE%/;]3J>T5-I W5/[GH.&!% MHP>5&X$ P_S7EO\\UDV1QB8=^@',HL9MKPB6O,#8QSLP/#;N<[3-WAXJ([^' MP]&3-_XQ+T7S*:/XC"MG 49R8OR!5L0VAM>S+WEM@ELM5RNLVGTVH[2WF'A= MWP"[-=S8-L#:HA7E47(XUI#Y1D'32B9I\L[XFM&=/E[PYY'%_ DXO_U!N9PD M]L[^\J9Q4J^ "6WQ&[EOZ:. #GW.(41_73,WBX&R6$)_DI@(%G@P4,9(&@NR MCS]9[/H)X[N-!.3P ,L_7<4^C]I7H"%HC M?7V?,$?@GY0<4,OUY1()#_*U7*&@\UJN[<@4L/VFEE \>UUE&%2?Y>S.H]NO M"3=C_>7_S11LA&D4>$*:;Q3E#=DRW5F=SGZ_\-3$R@VO(?CV1N?%TR%3I>5A MD/U>:V\$ROJ4_:<2PMHZV/L:YZ&F/Q7@KW&][$Z[9XYV:EA>369/+HO>+/"* M'&T-WL. US)MNV/V=VIU?B UTUV]';S%B\Z=E=JQ;+3[ M=K37C>Y,?L\]3K-:_U$0F/V^/AT:FP7>H6T.ZM2EM%G0[5FMP0OWK&PN<&VS MW;;,SDX6UN&;@FH+XN@WJBV(1LB)SE"K.&V?:?!J\%;;$+;9Z0QK84.LD^8R M]#>,\.)LD]S73Q[^R8/Q[+=,0<];<\<2B-T!V9/ MFXL',\8'EFG7B7KK)JSJ,(YV:6B71@/(N+E25)\*#VL#4(T3#5U]*7)TP!VT M+7/XTK2K[0=M/]1$[VO[H=*'T,'&LUH&:^M,@U>#=]F" .'0?V$#35^('-&3 M)WLALJ$ZLC9HGM>@:;?UD?V #A$-WL-F.M4,O'435G481SLUM%.C 63<7"FJ MSX6'M0'LEWZ^E+DD,#M6>:@KR]%M/V@[0=M/ZSW(>@\$6V=:?!J\%99 M$!VS;^DL$?WD,UV*['3OL:?6%MM=?BRUD=M4=O"1\_=:P]X3Z@YV6E9%(P2E M\&!GB\J_VLXZG"P=Z02+ UJQE@Y>/21X!\-Z46_=9%4=QCDY5TOWK6V=BJ]E MSSNM-2$W5X[J\^IA+VLZ9J=.6JI9T.WU6M9 _= =6FQJ->@4PM7B[8@]$Y? M7O-K"Z)2"-?K'-8LX&KS3(/W>,';:7?,;J=7"Q/BI>\A])//<%LCB$FT85;H MZ2D-3Y[U-N=MXD_G@N=KK[0>=G(T)Z^C1Z-GB4+KF,.MFO$_7+HT==M1_0D(>MMZHP#)N]LX!_YQLR);_U0 MTE(?:%00R#E>EKVSAF4F^5>6I/YDP;_R0X^%Z;MS?&@O+#)\B$5L9)$SZ\V& MZ[(#3%D&R;#5&^!^+V91%J:)D4RC^]"(V3QF"8##2*?,2 &J+#6)S!HF#F!X83BWD\"_46C,63RA;#.7&3.6QKX+(USPQ3LQ*QX4ZRJ]X"3PCI-D M,=]-S.Y8F#&"PX6'M /??_SU\\V'"_H.M^>X4Q\>FR'HH@EL"XC3]W"'I8%# ME'ZQD[);WS6B\;^8JVP.E\+"Q,'[3/QCYJD)/X.>V*S>1 M8 B 9PY)(YOCWQZ@VX2Q;P$D 4L27#5A%=:; M1&&.)P%Q/@>\E\R9ZT]@]6X4SR/@1C))HT #S@0NWV^Q+L/@"DLB2A M^1!GL(A%XBM9Z3\!VW+1$?XDD7Y@:#W?T)@&3?V$3V<1L$L":^&.X0C'] M=38#$;0HH_ &A96< ZZ0]M41Y+L@$[)9V-INW?<, MUBD7CE,B\!&"\"PN'/@;480?DS1R?Q@(^L3$IP.?9?BD8[A.,H5!%@AK$_EA MDL4P%I - R+TQ_ R8!+6+.:X_/!?SFS^_J)5OE4_<@EMUTI"EV6S.'QMW3I 1UM>@6D@A_#N:(YDE?(B"J"? /T!C"^1$%^@Q$[\Y M+C"]1WQ^[Z=3XY,?PA\^/'H!O\ B8>W&=0KCDYS]-8+_Y(*D\I'+R$-A(O@E MFH-<&5A#$P7-Q?6E^@TNNF()UQ\OC3@# =8LRNO4@O*^Q#)3.V8N V'#=1WC M@DN8 B "*-?CI/X8Z-8& WETU;U3<&H9!U+VC[EN77 E M ")@PGQ\.IL#>Z$"]1CB*L,?XVBF&F9H"WUSTV@,0MZV31JO9:Q%X /HLKLY MMO[VW^/X[=\>,5 UEA\9/V9U'XH>(S1_=>*8PL;(9@@BM/G0>OH-P4PV$2KE M\U_)6KPH _L3EY+_"U*R/F#:]VF>H'21*'H?MN^A11J4+0!IJI7-,@)4R2BZ MBB.@X1F^]H$/0QH"K)S?(Z#^&P;&RN?"N)$_7O#C K>92O@PI94$MJNSSH:> M,4::![Z\F, M7'2:Q5$C-YV5TT$:I? OS<,5-TQP/_7=J;#G$WD8XC,07SLI:/4Q*>5>^Q=< M75F;HZH4/WR__@-L\<\AJ/$P%!@BO4GF-.V6S+LELXZ#)+N 0/1 MO22<210$T3U^CV]Q,*S\B\OUO;^^\KO] MMMN=L,ZDR[I=K^LZK-OVK(EK]SN]T:!C_9\ULH:OY&O3N#"';MGY.&;.CW-G M GM\YP3WSB)Y];9LR((5*];40_6V#F2K!N^N6'[B2,^F[)<-K&IE_RU+$SQY M(*>+P[?T"*7&1V"S:+*_ /:5-563U1Y#YK>$PN-LET<;*BLD\XQVR@UY.W)A M3H(X85R'@D14_5"@#UT6AV03*&11UOM3%I #D)2=JNB=1/[)B&SHXS)@"ZDK M5E*Z]@ X!,X\8>_DA_?2Z^V'M#-ZZ7T9G!4Y#80E_G,A$%IM+A3$Y8:86?S< MHI^6+F/$;[U6UU[_<[MEK7]UP[ C.,W8>Q_5@A\[73WLL0T[W&K8!R[G'A&S M\N"CEKWR;,7%*K<^GO%FM3KKZAN9A4)QK8U ZA_1CJ[)W*W8T)8DL&6&7+ZO M=4ER!]G<5V?&-NGX1TYZZ+0X:_NTN/H3%CEQC ]P@-LY4V"W9$R5U/9PCGDZ M$>8'^6OF9C&_:?L#KV:#!5H]?X3RZ.YM7Z/G+HD95W M/+QN/S4%5C-''=9?=^;(X:?9HZ9Z4IB4'Z7[]HJ\L&>OWQQ0;=9MZW,_%K$C MVEQ0)"+W^T60(2Z(CX^\DEO9N!["]. M_(,!"BEHY/$H?WU,**\L^K$FSZN[L8Z+91V$.-)G[47\'2_[4^.J9?P>73J) MZT<'%'SUB$L?O>V^M=N6O7:C#R525FRTQF'XN_P:_!N ME2#7&NW2/^= P&V6#+1/109J)FT^>!]CPVU8D%BJ[,S#Q]7.N% MES.K)0MK\&ZC;UMVC2K%-$L"VJ'=WC&;B M8V'BYH+7:K>L%^ZQTV A:)^*$-1)J6&W-3H1)AX,S'Y[H'GX0)V4 MAN:P7:.;CV9!U^ZU1MJ..90(M$]%!-9"T6KP:CMFOTY5B[RJ[1-AXD['M'LU MW1*=Y==DS-C3NY*J19D MIL&KP:O!J\%[8N"US6[?UL ]4$&5@3GJZF0X?9&E!:0&KP:O!J\&;[/ :_7- MGO81'TR3#T=F9_C"X#U!^TG?HFD>UN#5X-7@U> ]K/G4,?O:?#I8NL.P9PY& M+^S'%IGXCM:/=TB)!6 MOD<*7JO?&@WK ]QFB4#[5$2@9M+F@_?D7&"#MU2.O',B/-S7S>$:SL'-!>^H M5:=J%,T2@/:I"$#-H\T'[\D9,7 ,P3@HJWLB3&S9YLC69DR3>;BYX+7:+>N% M T4;+ /M4Y&!FDN;#]Z3,V1Z;\F.&9P(#W=&9D_;,8UFX>:"=]#JUXATFR4! M[5.1@)I'FP_>D[-B[+=6'\V8X8DPL=5KZ^"80SH,-'0/Z4MLU:E':,-DH'TJ M,K 6FE:#5QLR^_6I6M8I52?20;X:ND<+W5&KI^V80XE W?!"X)VC*[7HWEXGQU(M3]& M=[TX0A&HNUYH)FT,>$_.C#FU:Z5:4)D&KP:O!J\&[XF!5]\Y'_*>83!\^:J. M)V<^G=IMEI:0&KP:O!J\&KPO4K9YH",)#N8(&;5-NS?0]I.^1=,24H-7@U># M5X.W2>"UVN;@I?TCS85N9VB;=ON%+]EWZGJQ@@<^IKI$T:AB5U/KY9MB?(WB M&*V+^0T.C1Z-'HT>C1Z#DV]/3,WG:' M1(V<%_#^COIF=[LBN2^''F'>KC-E/3^9!\[B71B%;//)53]9?E(#5@/VN)XD MP+Y-G7' X+^>?_>W_X9_Y!LS)[[U0RFI^B !A?@YQ[N&=]90BF _]%B8OCO' M;_8B;8V9]4;*V.>9LKS_8:LWP/U^B5O&]1P>#0*?C*?!^\0(G"0U M/&=A1!.#S>9!M)@!B(Q[/YT:Z909E]$,EKPP[IW$^.:FT9C%AFV;!IZR6X8Z MI#&)X@GS4^893A#@>%,_,:(L35(GQ-48T3SUHS Q#<#4U+AC"3T;>D86\C], M@TTFS$W].[8RF4E/PI)B!A,Q8^IX1AB5QF?_SOQT83CW3NPE!BP8UH![8/"B M^(@C&9_\!'2.\;_,B5NY\MN9J+CJ^E>6I/YD\;)T9M>"SOX( Y8 \!%7]W[" M $V$6X1_&J4 ^0BTOQ_"AS";(8X!.)[?7SN!&8'C#*>+%VGHA/,/%CX! G M#($HX\2)%W)P_I3GI(QX9V64,WP(^/HSL_ M05D!0Z8H6& \0#B]OKH 16XYMS%C_%-B>"QQ8W^,0F8,^,81!#X^%F]BU(+J^JU=*>W?L+D4'B)9[$S@8[.D:*<64O1FD[3, M0C]=%9: KS3V720P3B7X&%>'&Z0FTA>) F,!"A&T,W&O0AQ\,LFUCR0V_&KL M!$[HLGP(Y&0@H@!?Q__X(:CP($ F3'!\VLS&H=<3G(!KMX>D%B4D5=_%+'"0 ME=_?^UXZ%6=@]2U!G^WB%6<,!]HL7?^*0K4N+)S%VY/HC3\#SOK*[HWOTXXNO.[W6P%[/VZ6=='8B.]_[ZRN_VV^[W0GK3+JLV_6ZKL.Z;<^:N':_ MTQL-.M;_62.[^TIY;1^A:=8RLE9BTX@^N&V!UD?L@NVY(#]OKK?]9'?8! M]Z+TN;?1XU[E8^NO/%IQ0<&-F6>\H:B.T15R\(*X;&TXQS'MB OQB@UMB=8M M0ZGS?:W36P?9')Z9C?T9-KW6L+?%O!46/EY'G7=:5H5$1.,%1R@Y9(4=^=BP M1Z'\ZT]U7W.=>,UUXH74B8J589S]YEEBV,3*??<7_%.;7\8B>??KHMX-1/3&GBIQ#R>!CX+E5J71\-+U/ MC^E1T_3K-T8%43]@X!V$NI_NL-ANR]_QDC8UKEK&[]&ED[A^U"1#8F/DH=YH M8S8Z&)K#P?JJ98W99Q>VV3/;0^LQ!]!])OH^NWSZ>S0-C0\MXS(*X,?UGH2G M;[9O%=BV,^@U?Y\@H7J6.1IT=Y!0SU)'Y=DEV$7 M?CHAK#\/ ]Z>"O8.D9I0R:,-$PV(A@-B:.&Y2\.A9]KVR&RW>ZOR\^G)'36* M\:I/O@<5N#(\'W,E4AD/0P'7(D1&B6XQHO@)X2Q'@)9ZI$=\D\&L49*LABS% M;![%(D1<)L58;=/NVJ:!%8\[IM$U>X,!3X?IF)UASS3N60EZ/W$Q&:9Z3.3_YJ%/ DG3$@C(=784 \$I'T[)KTE_"DP!^)G'N]/%D;J?@<(8=;W2;M M-\"T.WSU!"@<)O;T\N,WX\I9&-^1_8T/?H(4D<7L$= I\:G=S=GT@7C3%\7^ M'W1^06+]$'G>^2<@U!_&GYC#>)V">$N-[YAQ.",!=QF%H%'A\:LX2E&V88R: MFZ((-D!^ Y^)@ F0NAX'(*.A9\SS83N"G43B \_O %Z:LS#A,A<>P%0,GM+$ M6&)N]SR@+D^0-"B+2DR%T]]'AC.+,A W^"2"^_K\'^8* MC 5>!))*Z)%B$%DKC3AJ 2@SFE?0A,0UY=@Z\WD<_:0'@H71[>);U@;EV0R\ M_9EB$^=\#8];)8/K<<*T_94I*[ MC/MIQ*TG\1593UE2F:+0,FXPH]D/W2#SQ#(G61"< SZ9"1/'*7WD0>+,22B? M4^%D)5_+A9.8@WE0/UTFL@F15(J%^40[ */0^!=L)O%\ES]6RFLD>FX9 #[X MY+,[E#68L;<&-C%?U!@H*V:3 -:2J.)EDR RYM%<,L%]% ?>/2",9N9H$?#P M\9R)VYX[BQ@,10X+'\@$(!\S9#+:&YUC24@R> '?WXQ0R3L*? 06<##X1;(S MPJAE?-H*EB2UW2C$8S%:W%Q&\@F5=]PLCEGH^HSR)O]H7;<,#V/SXP0H19(9 M('+JA+%%CC$LC8N FU6JM8 >B,TBIQ?#G00 M]#] "O)CH&7VNFT%^BC9I\X=JAX6%B">Q-%,*!4G6"0^::PYRO@T+5*NKC]> MYF=)+S]H&'$6H**\G_H!-YM7D(WBUQ2?_@&?/B>QPP+3N #:C 'R#JWK-X85 MWA=+I%&L5M4>ZEH?>3Y]WOPMD".M-IW;>[2]N5[ML]RZK>& M0_NE%[!="MON^3@'=[,_>(XG\O@]-7$U$#Y*W>5EC)])%,T,&FB%EVH2T'V0.[I+T(6>30\:E(K<[ '8#Q4_;X"&'4N']JR=NG_48WQQ]8&?:Y-_E+',,2#[!0]WBY[ M!I8_ECX"VX3L/97CCZM@,-C'HQ=K=J$Y?M\[_0RFT4(S?)'_HQE^A>&[+]=< M6S/\OG?Z=P(Z>>.K\U[)2%5,_RJ Z^C&7Y7 M"N=XM5MVKX[,GXW30UUM+T%'K+_V_-_?IK[ 4P5 !3!J+ ZK5%_!P%0C?&C M$@!+H:U8R^[5DX3"V@++AX@A:<**3BNPQ]]7$$F?1UDTJ0CJ@C)UH=4);!,7T*MP,1J=7;A>GU. MK2?7\_0,S?2%9ZJMF7Z%Z3LM6U]!-8?I_PBI"_0_8(U>--/,KT2=Z)NHE9-/ MJV]IWF\:[U]CSKH./%&NH'LCS?K+Y0![K<%0\[Z^E#J-2RG+[ Z>0P@ U5B2\/H8 MVXB2_1#.$C-5%F5D4@!.U(I=?+":;.PM1?Q(0+4M$-AVSO&@4KQ"E!E3D F 9 M7FJ13_Z,D^:_YL6GUO.[$P31/54ZABV*XG\SYX=" #!'DF0S4;\1YY,X2D0Q MU@CK>0*A.,:=$_LL7?"X#RDG?%%&BXIG)30*K5(49\1M^?%2-<38<4&[L&2I MZB-3J&(>1W< '1A;7:M!&Y*!(E%&6J&1LJC3\,*7.8!5CQE=5+J-;U+G,%[I:Z*W\>RZ;Q\ G!*:" M^7 B;&$P%J"(B::!P=8,X8RC.Q"J(&RK1J)*<)X_F8#T!1A7%*&-B8J*" IYPH0OHA181=!?Z,0Q%6]5 MV4]6$*8G_ITYI$AY)40XXB TE[4A5M>@DP]),'B,5BEW %H6+312XW"F(_@2F/): MP8O"$(#_&*\[O=; -B8.;(-W9!#P*'5,.%/[+>2-%E8>6[NO-QLJ@I]>!=]N M&1:G7<'W1>61TA_&\") ,:ILDA=HNQ#S@G)%@YM<)2I&0'GA^S MD$VP0TF&4CXM2WDA#H!CI#A ,>9P>S?)@M1$DPRGSNN\(E.+$Q\OVBHJIV^) M%LN&[8NOT#?46X>FHZD(:W5:_7Y_VX*L6P]K]UN]SOI7=QUVU!KVN_M?;,ON M;UV35J_U$6OM]?8_ZN'@.MIJU-W+ C_S74QU5LI7C0+4X'3=C5M1. @7S^G7%WC#SWD UP]OK-([:X1798[:'Q:Q1F MR0HPC!.%QH7KLH!AJQ&/(/#/HM/;QW]G?KK@@+FX=[#?RHD"Z1LY?GX5EN13 M@5"=3-H=5B63QM$]_]P]2,8>#+(7W\N6TC6"XV=J7!5]('=N]'TD"8JJ4^G, M?T.'ARA+#=?)$CC_G_GP'2J;VRCRA(<=CR7P/?PP7N2=-^$$(D[V813&0(?W M25;_(ZK%F/:TV*]-O9 W,P4YI/_M)]GMN.J:SYM.!VVL->UO M\() MA-LY[[2LBD,F=@3%$4I=C(6KH=E4.+1[YJ@WT%18+RJT3XL*NV:[TS6[[5V* M]6@Z/" ==DZ,#OMF?[1+7*XFP@,28;>*"*M/)IW14\O<'(-Y/E[D!OB$;'6/ M.>E4V.B>GSAC/\#C<&Z>5]KD,(K:Y]Z@"R(5 MG4,A4O;[%\O/>6HJV%H71K/0M+O96@\T-512/]EL/2XJ?(K9JNFPSF;KD='A MKF:K)L*:F*WM4S!;2QYE-$Z7WE0F]K:U*XG$3["U,:@YF::VI?+=O*)F,G:9:O1I-&T MMU*MYJ#?->V^-OAKIN-ZIV5H-4ITF 5G#3.7#15@J)T M ?-,2C8N"C%4W-2G]EB3O,>,(=O+ M;-T7XUA09M<.9:V>D5(3'+7P6(XJZEWTR4] ,1K_RYS8&&/Y:^\,X?7HW:PE5<@6V(J'J_M2TY3OZVBD0[^0A7U\/NBG![O@15F)#3@ MD2R\8PG6Y4^F#KP(?X,!%N2=.<7N<(S2WI2>8M2D[QXA0]V"Q'"R8\]]9"R0 M"^: W,A3.YZ5NX<5W;W>$R3/Q@\ 9CN@\.WR%J%/W?3Z!G_'R:O=NO%J21G* MKIF$2'^<<92D$:(">)#-_&Q6])U"4IDR)Z!6S$G&NU*Y$?:G GH@_!J7WW[] M?M$T)/;JAL2:"]Q>^QJ& MJ.=B^X+)5WAU=>XC^[F[/? M ZVN7Q0S5TN=X"\_?C,N9 MX4[J:V!TUG9\ @2_YEBK]M$H[>6$PRMYO2+V7 M%&!V!F*1Z!@'1'[RV 16EWNW2@MY8Y8[47 6&K,2$Q+S2A_8.VI[,?71%B7V M+DGD$"L*^[,Q;)XZ4[.?\>X;CNG&&EG#>BIL; M16*#\P!P01/,X^@V=F:)\+E1FPTTPOP07U^RJ9!H9J$_\5T.64?NG(\E1_=\ MD!AI%"<"U/1CQ%O6YM\%OFSO<89?V>WW'_[+FJ6YYX+("]Q6S%UV&2!)\"1W;"Y:22LC)#] 8 M!-*%+(Z,ZKE/539ER@DM82FWBU><<1(%6;K^ M%67%+BR1Q=L+]QNZ"?O*[HWOTRK_3N# T;]GY&*C[ MQSEU^WGG!/?.(GGUMGQN@$.#&+P'$%^[]]7SQ5I=]P"ZGCA2O73N@Q+QD4I5 M2LE+WHAU67(AESY&@"YKWATDI[JZ,Q25)KPF-,7_*^Z=7.D5(DXU(H0N%_UPQ>9^Q0=XBW( 0/& W!X.>?<&SPEQ=$Z-JJO7 M1JM:DL(X.8EI#S@2(!/_P(,#G 'JDCW(*U5&2LFK52#Q+-=(XB ' M8L"7ZJR855B"3DB7L/GVWAAGBMG#9[T2;K1+Q<>F8/R.3*C%DM*-L)5: L^[ MA4+.0C0"JNY:-JGG= DEU=?$:Q2T/'ER]0ZOY:=/TOK^; 9$ I,&"QI7F!-W M?N6>:F=(/&Q];B%KBU9Z4Y*6XN+_0]%'[Z5L4MZ1;X\&:>+,6'&TD1(AF^.1 MQ*B6W":@P&7SE),A#K)."'+THW0=D_RY\SWF/8.M5Q]EOPZ&1N2Z0 BDR07) M6#9G!QG=H3*B6LGB,J]D<2G#,NJG0==1A%"':R< H,0X'DVQI.GPMEDPNU1V MI3$<-X4_ %I/57ZDL];*>46^%[=@!Q+T39#(#6?WFV4#&D[=222E'7<"5[G5 M*MA8$#@*=@G#-12&!)#_]!1:P\4O+P3O=(%&)ED@",X$UAC_B[GILLNH2GWB M]30J1IR"M#'Z[#GU; 6$TD.D89#&I6DI#3QRZTNE)13+\CEDV;_%!2,EN?HI MG."E23=W8H X?B&'%Z9<;N1?Y4]H0$:S3LFQ1M"$/C/DKV)CQ4')40[[E\5Y#")3'=]*?.3Y 8 M\PB/#MS5*!?3'8U&.=)I[IA@Z^/"4)JB=<)@A:G/N&9"TIJ+*0BIRAQG:SV# M'_E#-\[/8N'PLZ"+55@*>W_F>*L^24Z*8Y:+:^:3<7YFH5.3:)1Z&MMO$(!R MF1C_ \YLPBD%1Q@?/B.@TV$<_H8"ZJ>6]8M;&CBB]VP@!3#I!_DB)K(IZ#"&][_-"-9@1Q MQME^>0%\1PENJ9(UZ<9I3GP) I'LQW/$'QPN?5B;6#4(+Y@7-2J'&8HAX)1H MYKO+CN^*2P/0_D@NL/;0XR$@R+8<-0DN?QG2^9 S9U%!RL7^:J0]GNE"ZB)@ M/QW.MW/X,0C\^H#@( H4J59NU?# 9RK#* $UOF8I M4@!,ARPI^U7IC+]TK%?H*+^P>X-2;F5LH0O75R?,;8QM9T$56K+$P'IWX41" MA\*8!0R/7!C_%3C^#"1[LCYJH70:+/B+GPN+TY#">2M1#N68LRG7"V%^?E/\ MIF9Q%R6>!!#GJD):M'0L >4(^XBE!APSTGWJ*84<$[GC17(XF44;SC4\3$X> ML-73#2U$4-Y]5L74'"9]KAAC_3(9$3#17F5 S*4E=A/-C&?))?(9D@0B,K,E_"1S$<4N>2'43F07&\5RHT$0N+&_A@='V,@IL+AQC8Q M9SZA9%(E)O A+M4WL >X@>VOOX'%Y?K>7U_YW7[;[4Y89])EW:[7=1W6;7O6 MQ+7[G=YHT+'^SQKUNJ_TQ>V>#25K.>"PVBY"<<7")#"]K(/@A;8Q>>E\&<$6Y(IJ/_UQ(JE:; M2RM1ZD+,+'YNT4]+]5KX;[UV:]3MK_VYW;+4W[:O^+#U D:MWL#>=OY'_-;K MK)]STYN;UFK!L*.>7NQ!%MMO;T<&#U1TJ4^9_C5U-L&>W:*XYO:%5)Y0D6T/ MIN"3X?&)@2GY*-GZ7"O[Z,2A4M6S3DN#,]Z5X]=S;7A-Y2336J[M[/6;G-:> M/F=%,<*J:7\/1[361[(#*EWI&FLQR+W\CE M6DL"X\1?RZ4=G/;W6^T5:5\I(/5,Y,^Q\N*6Z U6*Z##/F"M9))N5P1_J62F M<"WMT?X^2)W[*X:QH;\&H$7V8(8_U%.D BC-*/.Z%?(/WE5D:=J=&Q =%YKL MWL#L#[L:3?5&D^:FHT!3+;AI)XV[_\:4!]&X'^,08^8NLV?0MXTMJU[++EXG MTO#/LD!"V .-IOJCJ=<[WB:N)X(FN],SK<$+T_V!WZX%O&[\Z=$VJE MN]R^%:3$$;=Z/A$IH4VCHT"3C8W3K5T.3QI-SXDF%'HOC:8FZ]R_8U#Q[\YB MXK-@?2/0DU6Y6[<$U4+B!<]/(,LM:Z31= 1HZO0TFNJ-)AN$GMW3*O=@*O<3 MEO[Y$B5)P&*M;GZG[=.E@D>.R1H;GTCN8C:\4*B@7<_%C68N6_3O# M'4TA33 M[,'T*TH#RHQ^3,G'IJNI>)<%O)39.RILB*R!KY9J?II4Y%#^]/WZCX3*L9YU MWE#=T.7'J>EWTD>5OVDNE0 LX8@5 6M5:B+I.@I4H4ZQ6'LO*!0A!JNQ&DYFE[T3! M1[',$G50S1T)HJ4J.P)$O!(5[&TA2BC 2H"L[WR7T6YD34R8B%=9SP%#^VR4 M*+!K(0INIG#D0@V9S4*L;R':\/$:FK>W,;O%BF%$KKRR[<0!G-TY04:LM\H7 M:RKFT@B- M@37DE<8J'KW^>&G$6<"PT!4+L2BH+*_ZT%9]WO-55/#,B[/+BEO8\LKEU59% M]RN<'O<]\4.8'VN(4/5146'W3M3Z)#[.RXEB/6 J&N=.F0?+1*9![(ABIP#: M"6=F4?9%[?L@:I_BZW(%" 0OHI*/ 9DK2C,2Y?P@MYB=[SG@>#IF &3_* *)LP/\VPMZY2T$7(H7,NTR0N0(-QN0HK^(1% M?868I?*Q1?47(0)Q?Z)L'H!CEM??*Y?[Y45A':I?"SAE5/#]:P1 LBQ5*1H>_$-5-$45E-S9*5#+ )TP27\=X8%8G&!GU"$6^WS?^3U MVY?YC"HE3_R ^E7 FO$9 /5ZN5M_*=NIA92]J.Y:RJFWZ/R\VO Y"V6;Z>4R MY8A#DJ2Y\+P'9GR'A8JYQ4_)BB:0E&U:[<%[JF!\F1E=LS=JOR\>HW!/7$[7 M'&'#.ZP"*$-2X.VN9;:M@?*\N#LS!@,X8XJF>?F/TG\'X]GT8N-+,]Y4].!9 M)S%CI5I7M2YSC F\(N4_EZ0^&9,QZ(Q2%?958[VE5%"[GT8T']7+1VD@UY/D M=B#*[$*8ED0BTO(CQW*8LH[ MATD9=H/:="H2>V3\72>FY'$PMN,?+*6O,+'\_[?WIMUM*U>Z\%_!=9)>4BY$ M$2 XV9VL)0GX9MS6*D?)UQ:4XJ: M,A\5*>+:GX9Q.+]>F#7*8^%QX!J5WR_/222^K&#J7H&@C!.I0V%!?L1>'U8& MJB:N@8AK/A4_R=8"LKJ*PEN<9.3^1F,MB*RN6(<$4L&<^&466E6*#S@";!:1 M2%$K%5]MGD9$=5*/_N_IB=7]TW'6I4$ )7.3+^I<$AQD];XE>)(VM+G*N)# M5Z*K"A0N-?1YZ+;L356_?J\UL#N/7Z5MT+*&@T#;C5\C-IOSU68XDF< MO%++Q]I9H.JS'^>AZ+%5L*]"MQ M:CSHSEY&\D=6=7%I,9/L(EJW.C!C1[\I-(W!1+- MZ;Q1@?=)!;;6%IDO107>3Q6WVAWZT)CIE\)K^Z&?OJ Z%H=L;7X)N:\::F?! M&)@QFH?4W.T7#"X(R)FY)H]2/MS&2%J#;3#:YK6KV^:=GC= MSW;L5NM[R1A?MMV?SCIO+JX:@[TQV'?!B-@/@]UN#/:]L!(:@WW_#7;K!97! M>LF\]H@6><.".\:"]Q5W>\N"+]-I=AE2UL1'3@HA+DVGF C2N,H:5]GAN M:*A&96/"#4,U]B!_=#=2R;^(6XRHG\]#G_(["TG<>9*%\ERY&' -ITJY:WDZ MDTP4%+]C!)W*4"SD?&_TVIXS$9V)(QQG['BN<-IC:^+9O4YWV.]8_[*&O?:KI1(U M)>;=L#Z>5<;+I0)Y=KT7#TX>> J3?)E /P:QCVF.%RXJ1O[<7;<3\1[C&MZ9 MS?)0UQ4IF_(RC;61<1HI:;Y4:@*SJ M)T,81W4<:LRP5NG1E6G1 MSY#4N6.7FN_J=_KU?:NY=*I7]41:U'KKQ)Q5NR"A2KP/Q.2T*CX^F/?C7P1OVEV?<6N M7[L@M*04-:@>C?PW5@Z)?"KZ ?_ QI28-PI;G(!@CUU/I9*RC-2/@@[2F"M0 M#I),9Y7%9/S@)IQB)_M/A^[1#/BFH5_!1>2CG0DM9CTA1R=:.D MCD^!0G9+]6\R*@,5E+_(,MA7KD0&=U3087/PV78Q^V2:\#.> ?+I>F;] MR]OU%\=N)2H*)&FY[Q'6K:X84>#NI##SMM "QV[<^1'\]%A*X$XZT(!/ >ZDK\/9M" M;@"'-!-2_?DFRZY1LO1U.$6[];,+R!'%.V#H=[9EZ+]G/T]!(%U,8?"/>:FY M@S,AOQ>\?3(F-9W!+.$=<;F"&M.F7ZRB%J9)G #=T;\WJU69E\'%!!RXX(D5'Z]24KN9S_&>H8>2$*::E79/^GX*PA@Z05T MJTO*+8NS/8KCM9V6-;0?/8[7MEN#?N\ 7GM'U/&@?M -HHZW%^1Q)X@2U1%@ M>B!>KL)HL48CD0?4RDJST+\&A"896 MQ'<4!(PX0&P\WL5@MV6OL9JZ*W_@B,V+,[S(T_X'_2'&)RY,%#2J_%SG$5Y5 MO\33K8SGV/AT^:BVCDZ5[+JFHB#UA"JE "0WZ#1'7/J8:DCK;Z>RT5QQE"M] M&T?N\?$&V/CP(-X]R4IY7[NW>@W66%E ;+K$:^SD?7?ERB(30:>!"'O MWID=82?+= 9#K*WQ\I?Z1P<38U_^.F4[Y'VV(9\: IW[0V!M[/KNH&"U"O\= MJWVO3_T;QNC+*>\^=PQ,I],!'6(#E?!A6U';UN]@MOP>*MN=7+9!O90F2^*^ MT>VRVP'7]) 7$$EHS-/(NP8P58U?Y(4\7J.',@:Y<--0>5\A+P1DZ?NL@Y<* MNR-G#P5=>Z"]1:O&HF!B+0Z7^@W<:?R:AA\HKP/'^;7;L@KRQP 9!^_CT2F+ M%Q3M8BM/1;S(,>CFHVS;[[:'9 MM^V:JZ"Z';E3WRUORL=@G'I\_TG^Z:,\2'HDIN'ML;G>\GK8VK7?O6MQO)\# M4$@[=K=N;4TWO:?HIF?<2A>M4>.B]6,#1(B7\@TXA]$#-&-C$AEOHWMP"\<* MY)@8XU"PO96X/V2:BVS^QJ'X3!GD,T0_(GG_53>SDGMX%9Y@^.-<1'3OC+Y' MC7),&>9X[7(;H>("5R33["-A[48#,5V ..9P,#"[@W8.%-7NXY+?F,&Y!F() M,/I.WW2.1AS M, -F5\)F&AQ:[N>_(9'&;_OBQF/W=VJN:'1[G>Z1=PSK;QFU'>R _V=A0:W0 M50I)0X2&=Y!0:0T;B*?'"OOI;2GL)P_\,)$K6\A-@_)^O/!,GJ^!\3 M'"L8D#WHXJSOI\Q&Q A;*>LG9?V1_T055W@^>WKYVMA-!("!926[A(50L*U? N3 M[19CM0:I?TTX^V3-]]A'G0[9@<5Y"&I<'-=7"I*L98"K%P"//@JQ_.CS9IO< M!9IE[8R4\VP_BGLE=T=1P@N']H^2"&_P9"FJ?R$!(9Y/_03A RRE6!0_Y#]H MDT&!HFQ" 49\=*G"KIJ,*YHO==<:DE*?+S$4")4P3&1'9D^KDCO'XN.&S)**9^].?I3/E/B 66,R%YD?(UZH%B&'V M!.:(:V%B]=KD>N/H[]1": FPM/0WF3@'-C#6%8@HV[O@X*EXM>;GT.U7Y?DB M\BH%0D6RIDAE7)2*H)D@4&G^"L'7UE1?!O]^KQ9,[G@& MQF&,\)IUM^6,FD*K=JH!(:)97"/C3/UPM0((4_=6YP:DJ[&8BBN43I[,-7!3 M0&5RN]42+Y%,0/1 9HJ75U/&SL+I2/]@H@U(:4+Y[[*$HI(HPUOP>$)1YL7) MQRWC,E\8.0Y1LL2JCD8MH_'PUS*P?![>NFNWMMR5J26V@N"E,BMPJ.IMB MMHNLE.441^VS9^&8K&;&# W9-%3+E0#8$6">P&#!)#=%*E%C B'4W' JOX+: M0CDP0-+\5'8,<%+L>(=/FQRRS&@:EBZ;#[I\_59E F"9)\;I2B^4K#P37@7P M7E!Q4,\7@2SW@@AIDIN)5+8K=(?+%%'#@^6$+## @+C.6.HWT%[BL2]S24D< MJ[L9A%CWIZFI.* ?IA&.!P9<9C>.*#DMR7%JQDEGARC"YXB*29P[!.0%P>,[ M LR"I%C2O1KG0(5S8'<(?R5JDKU3&:#? Q[4W+D-=I&>N55/>B1")G&@LJJ5)J*JHT0?Y= MFC5 GLNL+2>YG*=3I !I-ZO:;K+(@30]BA7O7AM'_C'[#5!87@M$WB,?/AM% MX0\TH&-:'./I%/UO:G1Z#AY<%6]RY-\<@SV0I?9N?/E R8L#C\="RB9< E7WPR_D M?C(M+C?'D&U M(A&9>2O_,J9DF)6NOE\XD)VA/@UK9R[/O6NR3FJ%<"S@3U;F4-J"V>;A;S!$ M >C!*MN7BFTJ\2KZ2S6^/E N2X5Y$03$*_!L051)NW M?'KD4"_S6\@B%)"P!W MJAT&V 96"];BQ/'Y_0BFS(M\ I5 MQ;1*(UARR(]$KBRRW6F/; M5 W$LBM2#!=65JT>+L]SBQIA_?FCUI;#7FF"5&@V'Y$FI-2T@I]1H2A6G+J] M%OD>ET]"B7VS:@BVCOF!57.6VMO<]3G)5NIF^05,A:8S@NTC\[%FCS"$E,LW MAE-TG\2@V/ \EL27'HEZUQVG6>FJV42!JB>G3*-BF53[W)-I6+LH*K[E/A$B MH(.2$'R@.5Q5.(CJ143]K]P\X(QN'6]414[/"Z,QN9DR9;02GVJMS3J>RY=% MT%9UJ2!O198G>RNY60\(7W4Y0TY/WKE[ 71^CX(W='AIJQ1F$ M:B5(> H\) M]P\V? Y\.F'A:R[Y5ZO7)?VP,H 9U7'IP),AQZ:&Y:"):NK]\@R &!)_RA+< MCV)JTX V)]W+RE\4%,<\^I"NU4,L6W3MT M,%9R&_)8\=J#\=3N&JME_&/-C2?*'X>D:-/VR4,H5&:?NW&,0>C25MKH. JS M7^]$L"BDJ=0PS^7(IMR7FWM3A="K:?D3 ]L*^$)& JAW%@9&=^U,"/)37V-A M;KK>69[#,7%KG%._BGZ//6!W=.2H7&#&<;I5](0-?Y)Y)\Q$4@. *:XL*'1SA(":@76-=%'5%K@>7Q(KUY!'* M5^+4\4H=4]>G HE%KUV8/[A#'ISGT4;H%OJPK%:ZU&>TRE3.:M7$7VW#GM4D MT&!P#*CWX8\?0LR1J>$GT:*8FHO7AU[RNY:$G3.WG+@378 _C;/C/,Y(BN[,-3P(SOZX.;:]6 M#?/,J'IVR^+(Y-.P*=P%7&1^X$VT(S;3Z+"D$1\MQ43=J2:AMYDU2\S%A%]S MC%+F'3$3Q0-+6;(D/.]:Y]<2.6S:P\7%S& M1-SU6NG;SMW:I@JO'XNYD!6#@ZH ?/QL0;.9">3>91S+:9Z=L3R>^X+CUJXBAOG M^ZF_W\_Z@@HW3A&8C_@AZ4L.0*>[QDHP*GN,'-W4AIC?3"B\*'4/54ZR/.N$ ML3H/RJJ\&/%*D7'5CH_,\2K]:7JXB[8RM?#"S6S&&YAQLUU!.,)&Y:"KFEKV>I$_F$"%=&A^7@G=6JO?EE;.GYB'*?>V= M<4G'Y_GNW[6HCKR_X&D>@*RJZ3I(O7HS,-?)J$#.4Y "4U(562(0%>-E3!JS M'I<]3694/4AK*9NAEJQIJF[ \"\VY$R5&ZHJ=E!!(6(5MK"*AJ $?JE]*CN[ M9*I)GF"$RV8LH2Z[NJH7ED>NKO1Q\2R92U^U<5E3=]JA95A?:F=<3/HK1MY* MA.)EE6?V&HNJ4^ L2)P0K]J.1L>D(, O8QAC0J^,Y+45"K40?<&TOW/ID*7" M89RQ;F)&"][7C(460"$%+.PQ0(?*A#[RCM4K8)* ^)CCLN: ]$8Z.A[M:'P, M2$?1SD="_A,H)+Q% _IHHJTH^_!*1B-/L*NW-%D,Y1>$[Z^/\=D8?97HN\(W M8PPRJ>84U0$?_':L/-Y$FO#)CV.DQS3"(U$SHPI]Q@*HTAR N 94#,JWAP<>W937$4DR_DADOU8"P!> M$!P#+2?P3IJJ;%_%$! M7CXA/[ZC-,5<;(-M@\U-?,_,3Q'FDNE\1.C\J);GHI.KE+-9?).>82OA8H=L MI:="X[A*9\9-D/T2#.705NT'86]':0ROBF-V:.D_1S8SE->THAFSG4R@F)I=GT^2;4SS3E*%%5T)4OVD#\#L(-[:5/PG.1Z5:0"P 6$ M^(QRSDM;J623?\SN%]R3T6*I(;$D&I6ER6EL^5]L&[_A;7_JG)CD1:K>4+F021!&LNL]SH7\61D1 M25-+3I+IS"^%>;WA?5:Y,$QBL/]Z &4%X;KH'J?+42);4G8\]C+'UPJI:1Z, M)C[6T',!!9!G8$E2J[F3.9C8#22/K!9C.M>*72AC84FAJU*ZPAZ;)=^SI#83OCOPI ?_D,-QI9\4*!_6)W7D,&=(+ M1AH ^R1RUU"N:+5N1M+FE8B Z76$L:#"J_270A4=+#NJ6PRR:B%R\!AT,M@3 M+Q=4!A6Y;AGO&!II '^2R4H-,LPL[SC*@IKS:\#1DCU>OAVKC@O-+LU@%9I_ M2%DOFH^@G,L FYR #AN"[:8V3F:GL5V"XC?*GL[RUEE69$E !I^][&YOJC]! M6L1:DKO47_28UXH7ES%661I!W7#XBTC@+PL9D7GN'A/0!\ (X_)DH-'395Z( MZ,R[*_WG,=CJ\&(N9;Z),+H"#5KJ:N\Q&>^%2Y*EDF\ V85-D!F) MY)E9*LR5.642(,V$N[?G=FIFH^I%UCE<'>\2\I0@D[4T&J,0G VJ=CICKQ;& M#N214GEB,,=,H6(*T)DFN?HH*QJBER.,YF$D1Y(I7EK073F+5JZ@$+E=M?64&8I5AM5&";U& MN!Y@CO(RRX,MQ0=6'VM>H=Q-@7_=1*;S8BJ0>-ZR\%GP1!F,E#B7/JB%/DPU:^[*"WV*;^] M5&'4>"\O';N2&PN;)S,R3:,B_#_C 582/++Y?-)DS$(2IGJ__FJVH;(%E',S MLZRT;$99ME[IME3/>R!]50^.):#1CL;4CXER#4:+HH7+I63RA]04*'EP,1>Z MAT3N!^EY7$&M9?PZ5\7^/5FG2'+4U(=IC;/:DV,LJS!-]1NV++N>PR!*ZE>L M)?'D@56YA\:OB<^OBIO0PK:R['EU,R7C7K*/U4&Z2ZZ%PIQQRPI\7"[%%A0> MR4,XZMJUYV %@^NBA ,%"PA$":D"H5_#8729JC2$3531?8@(.8.C&6=E!K[G M4N0-JN7JBI@TDI=NW!;-.1[R[\A,LY?&Q;JI&,-?C2L*!]8HVF93%51A:=0H"+B?=#].^7AE8$_<\G! M3'(<%9 QE>S%O\C]R9C"R=!4K$6+G;E'B?^72'+*XRWKWY9A-?,H5M4+4177 MI.2.93PSV>X5E? RZ9W[-G/G!(@\OIDRE>(A==@\: 2^F;JW(U>)!2],YS3) MM%IJ*7]'[FPE%86C&.)1$WK MMI 8=+;40N*KGLZ6NU=JO*B/9WX_%QOE5_!<"!NO@9$\@/#]@+S0N<9\R.7_)?. *S!R26UY7PFH[T]]5]Y#JOJ,,^-6&#^"\)8#2]2^ M3ZEDOY8\/<$+!OB=IP)'2G'5;PYMA^4>!"[JIF#<>"E=+69%IS$G)F%DE?J[ M[/QQF?6'-;!U,'1>_16[#KM_/53RR!+FZ?IRO89:>[ADRFXOK5B& M_2\Q!F8V,"J]=&7R3,&P'V=&+$7ON4L2+DLGR:]9X!-UD^XFZDW7M'M+#4(K M!29*5D"07ML8NXM8.B^KY&,>;DU3J,^=*52C5X[+S.58N**+\BH(^+I4ODEY[!>BP30BH()M,VBO[4=HZ91X71ISU! RG>5E>PU79@9 M)DAK2N$,M0P'DJ/+E=?J'V\P0&[J+E[[ 1$1_>A-D9@1T4KMT6D\_EKRZG#0 M&G2(7;'/>#)6 TM.;M%7JJ=YX;MNKS48#&J_;K>L>W[7[0SO]7M^4_L*:]C&ZJB9?)@RE@%W9TGTDJ77"@D M0KZX?*FIH2)Y51ZQ-V2W->C>A:(K#JN-1_5JK4?A)9U&3:TK^;4]85D)\JX/]GDP=66B\1RQD M-RRTSK$6U;4]H<5SU@^Y[MF>S/FKIL;NR92/_E3%0W^Y%%Z,>_G_WIHM:UK'A)?(3 M'-$N.Y MNTXEW?!:;SVZ>CMUO1_?J"L+-0)?(48W'+]"C%9-X=YBM+.^&%WK MA.]->G=3"N/C,V)(E;[RZJ^69;9[CMD9#.X-'X>W9TYK\*?"=C5H4H\F>(_^ M=S>X2C$RY!>Z,]DC1'$:1-F0._IFIS\ZQ\3Z+I?N: MQ=(%8^.="KC;-0[>Z?W+Z%(UB!<=$R/H7G;NSYX1ZI /U&!=A8!>@, M++-O-RK !BJ W9@1Z\+)W\+KP'C7,LY#;-L>[Q&6#!HLV9 Q.HYIM9T&2-;= MKS\W*+(FBIQ-Q4^7TI(OY_ E0,D> -&S!L4MMT[&:R]8&1AX=1BXP?=-X.]6CW/< 0C;(O&A8@B'$MANS M9F\Q9)L0\3X*1)P8Y^D^ 4034[XIO??,OM.H&/L)#SNM8ORWN/$#X[QE?')O M8,0] I$FC'QCAX=E-_>Y#8P\R64N%FGZY"XF/A9>V2,4:<++-[95G($YZ#0H MTJ#(XT>68VGASV$<3U<7:]DU$&GBRS<'$=MT[&X#(@V(/#:(_ -4$=^=&;^T MC'^(6,S<8*_,FB90=>.8D*%E]KN-0O*D6")Y75NN9)R#QIIWA:K&59D8655C MX\BR5(W)XWT"I,VC71]&*^OSWZ/3Y([P9]]L]RRSU^^L#VG-EC]O K"JHTJU M[U=NW.X]24L[I=*O?[VK ED]GC[V,5 =XS_759)_O+*#Y2XLU1/Y1&V8L,.% M]:?Z.KQW-"F@CB_/5K%_O85IE46?9\CBE@Q:W3ZN5Q9C#L)$;VG'A9A5.WGL M+!11R>8)-S=VTC7YR;9S=B""%UWZ8AF%D M?+9,JH;^OV'T(_^7 0A@#5[6(=L[<V1\J(C174V#?M :6V>U;!9KE M=]=2[:!G#JWNBR39[OZ1[+L[2-;*27:Y"%@%R?;[?:!"'QY2FI,U@/>2^E2K M._5;%2^_&S^1VNI)4Y:PDH3V9FD$_/77.0Z!K8,7L-X88V4_I/#YIV3\L.$= MLSVT37MHKSW\)55$>M"@W6$/;/[^VD.>/WB7.R!_[%[]'G][P AE)>RNL5:> MYX-7:G<[ ';UHS_]"-^,7RXVH9'*07I6WW282VK M6/PB EW?GX/=4 U\OR?+.U M<(K 60N4Y&GYT!_A]52DX5O+^.R=8TJ3]Z-ZB#7>G;\35!P0-RY,_2H541B7 M7AFK::]YOI;9T2@5G_Q?5TR-_WM)G5:IOM?M_L]'MK&ZU96< [#8## MZX_8*5V3-?T1]PQN^CL!-U\94Y(P<;/>@-3-$/#B@N,%87IU;7Q\0?\#,60:TQ]4%6P';@;)5J7=>XZ6_BQ'[-S M%2&#/+PM])VQDW9@=32%WTBQ1LMT@1#$#6+CO$.LET81G#C,KM0KEIZH:!BK M7+^U/6/S'W+C6#]@H>RY>,D WX51N9EL99-X7(_Q-S<@X 8!;9L(FB"'77X%Y,)FF721KL")2-F1SE* MH9?HVAGL!&MGO %F7*>][ZSQH@ADN&,$8MMFU^XV%+([%*(5V-D&B71:0Z= M(O8 [YL:$-DE$MEN;,42B?1-NY$R.T4@VXW+6"(0R^IAV8F&1':(1+8;N;%$ M(E1XH"&0'2*0[496+.LA;<<=@D/'"# MH4]T48(7(^-">J#(T@/#+#T0%J8N9Y;2&^*\J>\2L=U)6IU6-R.NNKL_?_R7 M5[[3:WO.1'0FCG".YPFF/K8EG]SK=8;]C_A_97R$+9GC M?4G@B?ONI^T\UF8.>X-7:XW_*%FL5IE+JS?Z[OV]<*-D4=CE)]S*#?=D0^!: M+Q/M+%@82;Y*+.]>7>&-6@+_FH5ID&!Z2CB]$R@"QIU.510,3$/P,4X_G1UXZBQ-,[N%/ M^,>)^P-Q#Y:*R3^P2R;N%J(^9H+1"P T,2Q&T =T(:X=AA]C1 TF$6$*F4&I M9!/W)HP(]REMC[^\ DB-Z"+6O7']*7\-HP8@:EP X:GO!M]^*QQ ++=) MIHXA7X@9[ 4>5T;K=)3X5Y6 YE/V(\.?S<08R<7@N^ M1Y%H\.H)_#LA3%(D9BJ>Q-]D"HA9MS@QFT_#A< @$]2.@-Y28 *@/(XD4_ES M!!* %[A^8'-!(\SHHZ>*02@BD*"&1-:*806\:8JSD M7%L?Z7!.V\%Y?!-7*2L8QN7)?Y.(8>R"3VM6*[="C245^:HG>3&")EV8YD@D MMT(P+L+C<,8+YOB T'T61F(UGYA Z+^A'- #>4-D9!0Q-"'F(OTU((1O!4P% MA3$,R((M$\HK=C4S>'PD:7_BRRQ99 X_'/N>%GR*^Z#_F+;40]* .5)H<_U( M+-++NTCFD'H#*P!2&N-*X-&Q$+!H#0XTSC:)FP'+.(3,S8=!3$/#C)8N=1X1 M:&'4)*[A5=I?M F_I10CQ126"672<'2).7,!<9F&W6BFQ"Z8G<$5P(LD9\HM M)QN+;#N"8!\U,_7A$7R*6:#X9"3"R;%"/TDV_ H?_HU\%6C"61/TN;&AA#' M)?+"DG: K*S+=YA\C9#!7IAF 8AJCY6;LZM(D%HLU=N[JH1MKJ7NLG;[%922#Z"98/F5&<\=K/S<"K:K"+U)DTO";%Z*7MP2O=3/$DM:@L8*@AN$ MXQCML'#./P0>SJ8&_\&_J2(7KDMMSJK58V8<'"(N/;/OX'>)#$3/O2)37./7 MW'9FM7M,/I7YF X(;)(9"^J:=2IO%IP@)TN1E@Q[?NV/_,PLLMN699P% >H" MW]@:Q3PJ?+G51OL!T_'N'BN-\]-38(A&N8M-IVEKXESQ5NZQ-"ZZI/ :X IU MGU"CJN7]K#*RKW @T&"DCW7JLXJ%KL0C]7*W^+D;P9Q@[$D4SDC="7!-K!+] M",);E;4(AM. -6\I+7P4VVZ2QM*S>8.Y MBW ,Q36%E4X15$%IXJ2"^NRIRER@BXS>LMDZ>&QP8O1,TK+E]L*/YK)Y#1M!A[Y8T8B)PLQ M)MX9B:D/Y,V[P_F9&@F0 IHS(_)2(#Q,5HW()^(F"6JY]%PDZ#B1:4!/_QV( M5-EJ ,3^&/ZF2>$>")WV:!KD*2)@"$?X&N8?6% :T9Y('X^'#B.2\/6NO"H-U/:'?(N*P7?L^L#U$.U F!$LY^!Q4"X\;4J MM;LSC?/4Y)XTIJH(SP:BJNG,?WV.6WG;":16M#3M]IO<#D_H$^N-)L*^N/'8 M_1T0-Z:46$G@DN>E6Q_D&K @@2L7(V.>5PXLO3A9RSB+29]6G^G>]YA!*R8) M/7-_X(#,HG(/I)>$-)0"[RH8'9/QZTB1BYOG[ MK[2H\VO7IXZL^@F9Y( ),A>X.OM(3- GB,;2,C6U)#DUSH',.="M=PYL8MFU M7S4NA4<62!O%63@MK1S*&=_+(FQ\$!+]+EF=>\J;_W5I95@0Z\\HNVDSWH)Q MR?J0#GL(O&J+P%Y!:8.%U%)2X/!!S343&^_)KGT'VB4Z>!F[.AQ19-%NPS_: M]X[_V9.+L+?OOAJ_7IZ!H/]TP9HRF8+:KE8XUM%(N_)CMJ?GZ0C$M HC()L) M@)[.@JQYWO(%;;DH;+FQM-N;1']6@2]55,X!G>IA4V;W/!:OU3_>J(K,?D#[ M03]Z4QR@HB [C<=?2W@;#EO]=A\13E:IE@-+\&L1^*G*T(7O.E:K[SBU7[=; MUCV_ZW8Z]_KERYIL;ZW75M87M[JOND:" M^1YL2GFY#UCEO1N1[,UNE6\LFIW;8.?:M3OW1"RV8<<6?'_GN;H'T*9P, .I M:(\7YU[17Z5J]/OW5WEHOZ<[:'_30V\;FQ[]WU1 M=*>F95<>9R6[[P9O.-; M/JK.>/IP/;E[2=Y;NPW3[Z?+QA,OKL_]PU".H<, M(<]%\LU^/BN$W-7Z<)\AYFPZ-;[2G>Z> 8WS>%U)-V"<34AASQEK0ZI_?,.S M.:^=.Z]-.H?N28V4G:C[*L-,GFXJU9?9N;_TN=NKJI@LRC3C3)X)RI\)ASU- M1!QSP&NL+M0C=:%>42";XK5H+3*\IWQYC,,@,Y!1[G)$\<0/W( RTBBLG**_ M3!ELI#=W6+Z(QCBK&;YSC'&KX^+;JUZK:-% M+R)Q4;)B#ILL MLQ!CJO[!BB_N,F5OQEPH!4C[A+_)T-*H>AW53DB3ZS"":8VSS%%4+63%'TZI MS ;E\4S^SXG,F&;,QCDLCVOFF1UYQE:61ZF2YJC."QHB>B\YS$Y=KGR2T.P" M.!B8HEBMM+^,P.&S& X&;2@7\VLP9YU3=50)1RWN5Q;MV"A\6)Y/EA2\M.-& MK%K^274SISG.D,GDNDHT5!7>"OFX7 A._:F%BN/$F3RS@8 >L)DN9KC*?$=\ M, #;,,IF@459J )/3FJ%CU$5,;59CC&'<9I/.B"K M98@UE# 5S9^)93XJ%:[:F*V6N>IQF8HROL=QB;DP_UCQE\9>V8>\"[@[!('9 M] )QJR:^_8Q<:]BY(R%W52[;TZ0_79Q]^VY\_/LZ>U.8W(,KP6ZUK&ZW9;SG M>@NLD7[(7'^7RG&9-;9]AF*O&V34/9>B.0FG4ZZU, Z]-"\)D)6LR'-^ 52H M5 GMVI>P914J59R>O;ZO9ZG7>4Y3?;V]R;M,/\^()5];NS6@]580+!7 4^5D M6,!% M./J692F$F[G]RT%R8A8HTPA:S!H4)W/SK,D0: M98QL>HGGE-%[C)1ZN]T]X)1ZV'OO!-Z WH'7<3J#]R\JTW8?G_FJU:[W__RO MCV\_@J;YY=W[?]ZU#1@$U:W;@V=/-!YT._=)-+:<5K>W7CKL)J^UX:WUW][W MK?UAJ]M?+]'X_B''U=F#<-C/F#KX)44OYAJIEAMD4VX8 OF\"WXG8B_RJ9_, M)FF2.W.,U3%A=LO:@3.\IQ-L,GG4W>"YCH4G"S&^YD9"%"GZGVZE1)"U!M]L M95+&-:A6H-GM[6T+IM:Z"F].SR+O&I2:^%2,K]SH%(P3]]2RVO9P MV#F%*5J6X]AMI]UKV]V!99_>M$$+Z W_)7[:)U;K.IF]^FM6?)3OF:9<].BS MB*ZP@I8,@:(PB;^E@3!L&ZM@M'NJW.$G&/V"JKV:J ^V3.,RO Z-,RU\ BM> MPN<748C=BLA/L(A!/8_Y%S3N+Y&XNC(^1,*/KQ-TQH'BCBV29/ETU9KBFY#N M/E+EC"-_E0:JM$^@?/PSGVD6Y''./:+*U2(')_\MC7;XI+!JX^@#?$[J*.SN M2:=M.=;Q\7^>NF7M0L.+DE;*\=J/QGWW?73?P)\17 Y_]@@:)S]I*F4R]*9X!OX6UR#7_"9Q\_&O]SP8\\!X!EJ[-L M7MZZ(';?PM(-^#TM^'5:UI%[W.#?H>%?>VC9[6Z_;0'Z]>$C%S0[:] 9_%O\ M/.G\RVHE/]$'>M]*ZJNA2/?F,?W5(%)]_>W")7MU<;5VFR;,T/79A>TP.FWZ MPFHTK]T!G]%VP:3>4"4F$UG%N*2_20UGN*9>Y;3L&A3[1F$M7)H$J_ZJC1,ZCJ M=#HG=L?I]7L-5FT#JQHK\>!0:K669+.6M%F[F#7AI%,+)X^G%,%O=;W(:O2B M'<$:IW&O'R[6P/_90\?1/CH!7N0/)>!@S"B@2:%;KZ'I36NK+'6NH#M5%JL( M:87GE:XR[/4&PP8^M@$?C:K2P$<]?*S05PJ,_ TG'.<=!4LW>"[H(='"L/NL M6)B(,Q0'O^3OIK L<4,MZU1KU>YD>R9& MP @[D#ZJ/XLH MQ@:0P\Z6#,)4V_:E2SO\\M?698[=MAT"&4T4PR=%G)2J#NSQC*(>;CL$J5:.D;('WNPWO'RCO MVQ;.MV.A&]EN_^Y,X2=L#BDPZ,IP(RUJ6&5]*5N#>XJ2=@"&7!JQ ?4M3YV^ MT%IN7LHZ59:=M0S-?_/^IW?M!E?"./,HD] :=IP[-);'=D?;E>[H@>R-MJ3+ M=!IO]%8@J]=6/QTK)4V5<;D#O/X M'IE5IV@.[>WICVY;5 M&0 =@J6KR1_2?W]!*SV_-HT-F@!)F(?2*B)A#:W^3U;;?=D6_Q_=Q%X8OF>@Q6YPY6!QI=UVNCTPI&^LH6/;G0*N+'GH@&_;QOO9?!HN MA)"(MM3USC2:S7;CI-'!S<'"S?F JPPLQ?5YO M8?G.0 _]O&AET9_5T:F6"2 Q7#>);X5YU<2&KNY3ZGH_KJ(0Z.5$DN>$_F]5 M@](= 26G :6# Z7T"6[ 1_5+M<4 D:IWQ_J?P4O(N?9W #[ 3$4&@'PD/$W+P?1H\KHUY MO1W%O#5:#C];9>C'KB;\N.6B^Z6-T_[W\ H_-Q64]Z:"? PH\4F-U/O(SBFO[M!F,+_7]1@/HA1Q#53 MLNK9Z^).79N5/84_R("*NOT34P%A@+57Y7Y8EIY6Y:5O&5\ZF]R7W;TMJYT^)JX MN#QX$TBT#V!EM1NT.EBT&N!\.^U35Q4!3T)O$F:]6VSQ4[J<]"+A3X1>F4K' M #+8P)*L,R4?YI7JF^5R"E973:WQ2NT*?%D-?!T\?$5Q^B_@R^[/Q)^)0?%J M'@MR1KZ'$,*QUK\&@!IGMVXTUN!K?:QYDF+B#=;L!=8T.1X-UDBLZ?_T1'@? MI$$PN%^U7:3 3H,^!XL^3=H "=W8,/"A.=>S9)IZ*':HGF&@)'OD7%6G6Z6087, M^MC BVT]3=I' U;[ %9-BL:!@U7?/L4[-BN< #I,10)4"?LO?L9S&&/-R,DS M>-ZXQ!],IWY-&JR]L0YUOXLU"4R_\U,2FV27.0:F@9G%3"YD19"GAJ0[DU.W MCU5[G#]K-2'?#8A1L)0.8MYUY,> 7/Z:(':.SV/H-TPKJKECV]P2O&?8U-.B M6!,\L&7 :H+"#QNPK$Y'-Q&1=Z>)/R=%3-8_PA9VWP4 0BE07+JF4D .A03; MT:FHH)ILW+M<&*G7(-)>(5(3@-X@DHA@=F*.SBHM]/PA<4LK0M$Y%R7#CZTH M5 4(,QL,VW,,&S80=J@05FIJ!VK4";#\+)QX[GPNQG!*Q:"#<_H8_C.=&M\1 M]ESN4W4>!A,_FC'<<2D-T,, <1 \-FJ(]R!][,XFFX0^!WV0"I(/?B<:F;3# M,LEN-S+IH&52QUYF8#Q#:C!6E$EGZN/IOHHGRSD,^;3.H1Z&?%IC)QKYM,OR MJE7Z6!H">'H!Z#0 U )0#D/W(<1N/"D-UNM*CPI#1X- V<*B_ M51QB'T0#10^#H@"XS@W".)WY6K8J(\I7_,#X1)_4I51\H=\;GUO&5WQ'=;8] M=RBRK5;#I\_-I[#I5J,N[#>/WMM;@GU^X(\NWCG;UN^.?N=L6])PN4Q'L3_V MW<@7Q+2H RA/1E5-U9<:0;C69F5JSD'O@J[C(< 4=;R#WAJIX![T'JPNU:5T M^SS&A,I%V$V7P%U1&3J-RM"H#'(5=L?RPB &L@PG/HPR%P$S^3E_2B[/=U^- M7R_/3./3IPL3K )JI#['$"XR\%&5H.[I%^EHZGO&F>>%:4 NAP\^P,)ZO@2D M2OS[Q2/K71N_867$!FYW'&X[C876P&V5/M51^M0YGM<$3HS\M0"0\P@@TY\# MRV,UUY2BXL()/"$B8YY&<>IRCY_W/[UK-[@2 +D Q"EPN]5Q3RSGR#TVT47C MCL,Y8J[^FTO!/N).VU;6X*4;C=Q Q"=??T[%@EX&W\#,[36QN\,VPHN'[E6' M^/(%UZK5-T+KQ0DMNQ%:C="JX'C[3J$%^JP+_X1_[;C0L@_"X%AUB@UNOSC< M[C2XO=^X7NX\H MY>PQPCH-PNX;PMHMZ\]-"MB>8^S3V*UVGV%UI91^LM+(/6EHU]P,O4EIA.O/'+Y=XF+;SYMFDEI1"VUW[1ZJ#8_SS M[;=/QD>L,8IH]R[T4JKB<&)\!\CTU>=C]?DX%+$1A(F!N99N!$\0MOIXEIAN M";;&.V P@^A[)#PWC>';).9Q$O<*X#H2!J8YCK'FW:V?7,MWZ!-2XQ6.I&&$ M)V6$R_/_.GA&^.[^#(-PM@"9GX@@ILHFWK68N1EG-!3Y?!1Y?O:IHWYDQ_\&&$-CH8^GY\^W[W_T-#G,GV^$Q,_\!ORW#9Y?CI[VY#G,GE^ M1E4[\G(B/EVFRMKKSNTWR__[V0U@M\@AXL%;<,>,,()_S^; RB[U:IECD4WXT(TBC(,I M[^&-CDD:!'U\S_10N?ZE/L>Y?=SW<13=8D$_H:^3#QKA3 MS:MZ?R\_CA5?8W4P=&"-A#'&)A)C@T01[ ^Z:^G?UAN\ \"WG MQEPU)+N#&&3C"B^-0.D5<3'T";ZVAAV'+RIFU.BA]9+H0,KQ.F*XT$[+G<^G M0!)4K#O?K:E[&]/11.)*6K6Q62[+XL?JL. ]URZ@$U+)U)<>1'H\(A<\YEF' M(]B>ZG)O<3J:^3%)6S@9W6V)]P+DLD>$@^>\:T->:/#T?/9[P@M^@\/']TU] M=^1/_61AT#6$@80"D_5/)I&;CHUY%-[X,=&_I)&)&%/?[J75PW]#F"/\M[3N M:_AHYHZ%X1I783@V)BZN%J%X-J)WU,_(N#A%<"$X%?P--%A MO.2XU7: :LJC_S::YM^BT3:[=9-6/8'+3#>;40A=S7#^%*&-0W'=YF0)L MZ$;$52X23%Z .,X+$$>XTG@.IY3&=9P;&Y:%3UIV!0/G?-O1^=:LGM.C8H-) M)Q7"KZ);'S8'1[R#[!+:1;6N>G!IVBM0@,*P=,56ZCO@C__RRG=Z;<^9B,[$ M$8XS=CQ7..VQ-?'L7J<[['>L?]EM^]5?#[TI0_7[-CW=#210O_)$+S_^\N7L M^Z_?WE_6;L F$2"/+B%U$O1F(T^I9 MC]]BQ'%:EF-OTF+DWL9X[\%E5Y_+&/_T\>_O+]Y_N_SZQ30^?CEOK>'UL9R' MN'V6M^8^OIPG+'C[7#O_=O%Z [_/KJ[B-#ZMZ'=8147/ZRB4H(DH"\\:H$+Z M8T-MP:YOZA<0LJ]W>^^\D4MJXF'V$#]^$=;@_;R;P>&RG#PP>HU<]F M4.V*[>2TZVVGTU$X7L!_KI/9]*__'U!+ P04 " !ABZ)4RR(R=),9 !Q M(P$ $0 &QP'-D[3UK<]LXDM_G5_#\Y6ZKHEB4Z%=J MDBWYE?6N$[ML9[+W:0LB(0D[%*$A0=N:7W_= $E1(@D^)"?/]P:E]P.Y]03QH5/B:".\<+$S/CNT.!W8^+SN?&=^[^S9]+K?9) %WRQ M]-ET)HQ!?S#8?.M_( /SA%J#?F]\1&C/FDQ(;VS;9SV+G)SVC\]LZ\0\?C?] M,#ZQ"3&M8<_JGS@]RQQ,>F='0]*;D%-G8@V<(Y-.)-+7X$-@S^B<&- Q+_CP M&GP\F FQ^'!X^/+R\OYE^)[[T\-!OV\>_O/+[:-L>A"U=9GW^UKKU['OQNV' MA_AZ3 *:-%\$WEISESW3!0PE]][;? Y ],<#,VX/6)C&OS,"P3Q[ 2_(_R> M6"YHD \#KP_Q-=+I]_IF;[!&R1$)6)K,T:%Z>6 0(7PV#@6]YO[\DDY(Z )( MZ/T1$I=-&'5 $UR*LEYKD'HMB#^EXBN9TV!!;%II+#[]8A@H)#9?<%\87@9X M0H*Q9#;PA03#KN$@*K'>"L?[U\ Y.*S.01CT MIH0L&G"1AE2<1$_J_BS9P[JD2U2S^JTX:]> M#+<+'E93L!X/,=R6/.1.N2*-*(.4?P<5V%Q(#/HF>+1;,FW#U !ZAMGZ(5?:!3F*KGEF?X K7BTWWOUPR?@^H_03_#>8,['@PL.COF!@<^^/=SHW"M)5#6/\<485ZQ\ZH/7"_\9O947 MWS,DU*^'FVTWL(0!=>Z\3_+WIFY'P%$3#>"&4E2&6Q_-7+#H83Q\FD$=A0X3 MW+\!@^O/)2_51S@'5C?<5G]@;0YWA,)(X>C0X%]P+^ NHC B7H9#M92*">^)#KV94,.!S!P):QZ>7 M%IK2ZM(R_F<-]U\Z*KUDM (^N0.Q2-8:3JT"7'JI#?M]2R>U%5*#3XP5VKV\ M4F.\@VE7!;%>DA9$BDTDN9^)&0%<\#ET;$:] *1VRX,=3,@L2KTTC_K]X^K2 M7,-N(/J]%">/@MN_S[CK@(BN_@B96&XOQAR<>CD>]_LGU>681O_?AB*PE^3D M@@2S:Y>_[&(>)JCT&)DRX0B\Z;W,(0VQ/'51;DE'8VXXXLF>E[&XU+ M>.FD_CS09^J%%,NR(-P0/K$%5FM=A('@\SH[2V6(]%[QL9FU*1%&53(6XU2U M9#'6O:#BD:CKKE1#I_='3H:-A-9%9Z-DN%=K]26=4-^G3@2 )C4&B/8SZOL1 M;T%<;[!/+9GDKZ\9Z>4_YB:&5+8]@8PY^LO>;FMER@(RG?IT2M1:'0&^H1+I M">H5Y\R2>PI;*LX:!_@D0K%7%:WDHH;CY6?*ISY9S)C]0*? Q-LI2RE)K;J8 M?4MN6FRG+C' >&FLN# 4&WN-*1&?3=FS7,WCAB/[CY %DI,+'@A<0S:6E;?4 MIBW8T6N::'OW0H@Q:(A>7PG%[K-Y6^OBCFR;Q[ UD6L5P_T>1JI M1T*GF^+]2@5N'H-P'F?$I]7%MPFH#2_-H9E-( &N7%M Y#(NGNN->-'O/! MM=&B:0VKR*"+P>$5\3WF38/[:#AAF>">S5P6>=#R8? -L#/O(F;8FYZ3 /-: MSB5S0T&=32RU+>+;LJ&WGT?@^F\J1XS)N%\IQSI/,L$GN3*0+Q-R\S$7?FR1X(]2=%0)'-3HGL-D+PT]UPJX-)+%/R7 M2M:YZ[4-GSEW7ICK0@1X YWPI@P6*Z79U:6E0Z+U9V 9S>YEQ=AD5+K"%\VW MO6QP%.KZ..6HM,[.P!K6E5,7_1[-**]B]HL9O* !\^+6M8WC=F3T=O/(,NL* MNK<>^D>$,=$4 W8S,-2(:?/O7:I $6Z]W(\M,[-+7"KWG$F_EW-Z[$=S[@OV MIV3PZG5!O:"^*]0,O5[:)Y:9V:DME7::FA&1VPM\72+-/=XZ2/7"/;7,S#YK MN0GO>!;O7MUELX3QP1.>"PP4J@LO%UKO^9Z9V;*<&(V44H*HXU*HZ^IJ<&A] MW&%_6%4B7?1M\X9UY6WFO:UM IN3T!K$H6F9F8W3 L%N^++YK?86,AZ)YLM= M)6QZL6+.MK)8NYWE&=FV'U+GEI$Q<^5.+(S/G9A1_R+T\9Z1U)L:UWC5P:I= M#8=#,ULZ&*$W4EBD6"4%(R*1?KL7:.[0UUU &^#6+ZS6< ?"[>*:6T<2M2UP M$^1Z@WQD#3(% PWDW$'[?,&]9[Q)$Q3\D7J,^U^Y4$>+R&)!X?^N^^03+R V M$JQWXTHMQ'HK?6QF*WA3% Q%PI TU$$D204+SEPC36/-0E\Z:C.1[ YI/8)BZQ2HY[%)^ED%_2F4QK4%F'[^ILG0]=Y8@M%$5!,W9 M]*GSKIN^E92ND0"5-="9@A0$ ,^!X"7I8B50 M\&''S",[5)7=,*'7HR-KD).W+M0CQ5)4')ZML8C9,DA@(&-KJI?BK?.:EF,% M[GV.'T\DJ-"'9=^2#";N/R%K8RP3UW\GH 0&Q=VQ)M0T1KJ([ZUK!0F&EZ!A(T MD**1(FE$- W!#46UFZ5,D7P29]*.4ZP!G\AQL?&*J:9BKXA6+VC3&F;VTA-! MIYS.%0W\2U(Q))E.2S8U$\;1%9CX@;,WG>+U".FEC]5ME:9Y1-205/=3O7RJ M3T(!PSD' O-P+@=F09;RDS%;3_=RU'JA8T:JRI17=(R(4#3G8U)=EG+ST*$ M7B\ORQIF]F-B>77\-,4U8?YOQ WI%Q@/G!2HFM7%D0^N#2:.CLSL;36(QY"( MC#2FK@NB;K"A0Z*-/8Z.AY6%TL5@)'=@5;J0>.G*S.B]0T0"4MO&[8*8WB"> M6,/,GF.1M'MQ6A3W'M/EGS%U@X@T\-Z*1B-W2Y^I.]RF\+<>6KW(3ZUA9JNE M6.22B#'L?+EOK@2:>R_5T.D%>68-,WL=Q8+L=C+T@L_G3,BQB+[^P+PI]>I] M+D^'1.OI'/?-[$55*6S)%R 2?'O1X"AS<>"(D^J/CYB;PV,+%ORX9V)A^;UC"G>ENC'GB=9\24$7%E2+;> M&1%CLO)0LJ:N70?N>HH](^+/D QVTAIL\T7C>E\NAKF/]W1GKK7J]O>)LV-8 M^P+((@S:X.9X.,RY,#!'%EV,;+)#*I_BMI66X]'(\L:QJJVK7HU!IL$);A#YX\O*;2'4^[).!U?N=IV;V.M4U M).JK3)T>_OJ?%RW H'<[SX;9$"!'%%WT.K,CFISYG'!__>V,^--&WPEM2D)K M]D[ZX)!6D6IO=8H5/_"]T411W)M#.59O)._F,C8MJXH1S3[=BS4U_MM\SJX4 MEUZ >":@F@"[[9KTNQ!#@G=SI.NZXUE0K1]^ M^B YX:PTOX$0CYU<-K[E,V]2Y2Y="JX3D%'Y;>^_R9!< _)%& M4->$O05QO>4#TY?9-%]3 7@7<2+WS2)>5E=Z!.K^!0FA^#$2AJ1_OZY0W3:= M:U?![EIC*B/7:\2I964V7S?4EC5R[VZQ0?+U0!>1E^6A[=)C63JV3;U=[LEJU6HT[YUE-D TRA4K#TQ M2:D?J4+-M>==K^++E>,WSX=).?78GU)@43W-CI2D!+E>%4SK*+-!IE&%-"TI M[IA:UV7=/,;6(='+#H^$EQY7O,M' M\(2JLZ12F.XB\/YUB?2H+%KUV3C$ME@-^H4(>_;9Y^$"HVO"O .#C /A$UM\ M/!!^2 \,C\SIQX/J\!Y^[FCLTAC^=>R[[ /H!>,.]N/C@1/ZDMD#(P!1"B8D M.HGEXX%JS@2='QA"-1=^#W\%'QQ)X@;>(:*#P\+>ID_3GJO#M(]XEC9U)4M< M@LM3ERX\T5=Q[G+[]_0H3(@;),.P/>(W'!X14ZDP0E_O;J]>%TQ1NE?4?>C. MC#[-?$J_T/F8^D7*4!&X#9J0[V8GE=+BBOC>72A&SK_#0$0'&@MDWP15^1 P M+Q $OTJE7D5'OS\>V+(RN^+ J"=S[H'M\Y=5)LB,^'C0??QOB!R?.+"-7#C0 MD53M93#RG+B&7#Z^#WU[!DHM9[Y60W:'OPU*))F["8*0.I=R1U#IO#Q$@U+G MH;A7)[6+#4<-%'6Z_&.U)HHD[HJNO*UJ1>OB:8G1_(TSFYZ#@NJ5/].L#3J< M?S'M94@'_<&QOC^50%O21\G^=R9F%V"$(9+R5W?:JZ^2@(KYN#!?4O7O5UH\ M:1OC:^T,OL2SFGP!,XS:,X^[?+K4RUX#T :)8SDW=?X!]A1 /E-PP;SEW\F" M>-?HC] ;<-.6CPO =4$\XI!':$@6W"^9P-MB;/(Y !Q[PEST-!( M6>''(=1JC-N+RHM&IS*9F87"WA'VMBH LG[C8/D\Y+.O?"[G;_%X(:#4X MH95&<)WKF)S #2#XK&JC:>M>H52#"%$23XZ"BO> M(Y^(%U+F0U2!;(/9D9$Z!BL.<@Q!F)(;?N"/N-?6\>S(GC'P#Q$AAG(V_,N>9?2N((H#P#":ID N)NH?,D]<.@_ M\=3KPA%L@JJM5D<6+#0L5N@FJMBJT9!2\JV\! MC4U^%$_\^Y\5 YA4+Z2UMS-V0J4EFQU5,\3M3 RC15$&965&1A'_13W1 MP^R\5^H)WD\"KLT6.]EQ'D+NRM3?O=X ;ZM/59Y2B#.6VZ8F-O"T-II,8M_4 MEKI^JNH@VC!I,[44I?N2^O\CH[LR;_GG\/*SO?#59[R#&ZS?)JYB M^A$0_$[O?3#PN@WW\#+]>XFWP)E#;_[0..2OY28E/IX MVC#+\DI>,%JP55WW-I4S.C0MS:&D9W?D2);O?!8 M$&Z!96X:MMLNVK>?!QO M9;(DL7HFJT1PV89M$%A>64J0'7QMX48E^-9&^J5[@J-7%C3>4%3 .Y"T(SXX M##C'8;YIOL1^#5'W[B;*S1Z-B>? 4!7+M[#]&TT\Y@DZI7Z5N 0+&JKL:!:' M)-4QM#5QE_5ZX$E=1VD%T@K_J$H&YK/+88174>0M?X%V"D"*+]#M\^Z00BM2 M/=H5\YQ[81"MEZMB'_FJV1*L1?BSU^,DM$:%Q@+,&P_KG?1K\F=] 9S)_(4PS1I"YVG+= V59/^I%.\<$#7> ^A3?]YI$XG73! M?7@(OZ*$B\9OJH6DK5LJ?B!L M7"AMU&5K:^%HJT_]A7A$Y5@>J, ZT<@K+CF+IP5J@X#1)#.;P;-RT[W>K@W< MZRZ.VF'>O!Q?:QW!U?&+DI/X&.XD:P\N2K7/=VQ+H"5'.S*+SIW/I@P\%JD7 M>-DF=J_ZFE4 WM*%JS3%?%Z08HX21+_),T]X]Y\N"'.B)!1T4&;RH^2M4CC-\=A&V%IKV^JS@Y8QZC: MF@E-I:UBB<<+U2@4,^[CI49J>7N:T9+ZH&;(?G9B;&1+*QNLCAS6OP&J%HZV MNJUQW@#$.(9%")&O#@;A60OF4'_3MA9;D*;HVCH\?^?,$[_!H[#LQIJ\EFWP M@*M<7;7*6>_Z4JP2S&T5>[;R&L(;8"NYLT_=2:2*Y>:EL5%C=&U0H/C 5;4\ M9%'K-O3D%OBA=%7.&54\Z@]JE #][!,53]2;<-W^%3\WKR3;NEX[NGG#9516.<)<=+M?TG"<&+@F; MTQ3I0U)V>;Y^$B0E4Q(E421 ;7LZJF7QHKT7D&LG,A.)S+_^^Q]GDR>?<+X8 MSZ9_^X'_F?WP!*=IEL?3]W_[X?=W/X/[X=___J<__?7_ /SGCV]?/7DQ2^=G M.%T^>3['L,3\Y/-X^>')/S,N_O6DS&=G3_XYF_]K_"D _'WU1\]G'[_,Q^\_ M+)\()L3U3^=_"8);5()!U %!E1(@IN1!!>N8\4E9;O[O^[]$FT+@2H)B-H/B MHH#7,D )+A=C*?_^DO]$<,"G]#@IHO5R[_]\&&Y_/B7IT\_?_[\ MYS_B?/+GV?S]4\&8?'KQ[1\V7__CQO<_R]6WN??^Z>K3RZ\NQKN^2)?E3__S M'Z]^2Q_P+,!XNEB&::HW6(S_LEB]^6J6PG(UY_?B>G+K-^HKN/@:U+> "Y#\ MSW\L\@]__].3)^OIF,\F^!;+D_KO[V]?7KGE9/P)/Y+X9],_I]G9T_J5I\]G MT\5L,LY5OC^&287^VP?$Y8(&L+K@\LM'_-L/B_'9QPE>O/=ACN5O/TP^+J8$ M1' NUC#^[?:+/?V*,(5).I^L)N05O=Y7?5IG["E.EHN+=U9S"(QOA/EO5^^_GKIC1_'\ M?#ZG)WFD-,N)-@-C"NCFF+$,_FZ$\1+/+OZ^JJVCI;R#.?$:CEES>D*I?/IOFG_W\^_EA7=/K] MY_&TZL]=8)^5)/HZ783+^;\QD'RSG M(2V?SQ;+7W'YZVR:-DHY:YLETPJRJ0:GB1F\=!DP&252R";&/AIP'W3[$$U] M.T1K+I!F5'DY)=O\_3A.UM1>$*2?_DB3\^H!_3*;Y<_CR61DE)=6YPPR*@=* M\P@NFD3C)Q6=K$XYLBY4V0?=/E31WPY5F@ND&54N[QZ,B-QI#4%:2^8<<308 MINI F2Z,2Y-S%SH\1.3FVQ'Y01/;3*POL" IH/QR2DXEO@M_7/)NA)I;XX2$ M:&(!E5* Z!AQS00M;?+"^M1%T+=CVD?T]ML1?:/);^L@$>LCKP@0.@"6,Q:^RB*0NQ"A/N0 M-1SYB!6&T1D#W)6J>SV"2ZF 1*FCQ)!MZ6/M;($84CBH*2NNL__0B6_G*\W. MSL;+ZO35T57KG PMG*8**',M0DR"'F:1:&"T,D?F&?ER(A:5<@Z^DXMT.Z@A MA8BZ,J.58)HQ9*\?._80#]DA2FIW3 MH_1#-<.C$UDVA5I(0J"F(31WNJ2D/6).=V- M:T@;$HVITE @[5:X(9D?+7C26NI] A7C(*33,:5 MZTC2H^$FB,@,I%)2$2-,/@XP[&WGH M%;W?"^"0%LI6'.DAFY;$^83S936;OG^'\[-?9TN\"+&-O"!W)M<-)UMW M<1EZ<-7=$9XCS]XC$Z878>X"-J25LB%1FLFB;?;#U@BW",N45Z3.+/!< R0R MU1TGZ4$F,OR<"8GK/MRX'=- 0Q)'T:*1!'H'J[9@R9!%5"R!P!+(6+1Q351E MO&8F%6]=GV2X>Z$-*3&R&3^:RJ-?#MTVA9&X*XQC0A&>'#TH7QB$A#6DYER* MQ6;'^6D2Z:X"&U(B92N*M)1%S]R!R)5#)=3*K21])E;6#P/#94#.F$*TCY([ M<% H8CWGJTNOHV6+4><\KF,/DS=A3'IW<]IE9&UDZ)P&ZS(EFL)2<8&6VJ!!J6Q()9%5YER,RAO25K+/ M:G 3RP/=)OB6:'#DS#=CP%M1=%T;6J[6N^[ ._ M4?$7DN17L8Y(B+9(3VHB$W\4.O(O3":?0W CBF 231'4,,O79 M:KX%T -]W+Y&;6M*'#?][?<"M@:G,3C&/0,A%0-EHX!HR,267%KAL3#G.F>K MMM.%;_$33L_Q9Y+GKFW57<,PX6)UGF_S0"]&62K'DE<0,W.@0O3@&#D> M11EC6''T2/?9&KF.9% JM#4_CIKVQJOIK2N\L4DBMQ9\U#1 YA "TP:*IF5" M>!J_[Y.M^!!KJ\VZX:PNIIYX+#+62A\"P>=>-Q]6)# MAMRZ=7R@&)H]!;_.IK.K6#9/Y2@)4X03!FATII9YK?4>,AE-+G.;;+"B4[KN MK9"&M'?2D1MM1'("AKA4I*I)YE'91"!X(F Z :+R24@33>SCD.[)D$/6A"7. M<;&\Q>X-DE)8*Z0J8+H(-3SK[*HQ,F!T!Y[K0SWHQN2_FS#G!TU MR=K*J&W&WNV#-E+RP(N&4FL"*![I.4Y&@_!,"*9R\KSTR]K[)K1J'\8TE$M' MUP.M4RXA&+.NVA0@TK)/+[7W@:MH91_G_6[7X["1O2X;'W"D&9GSE@QZ)@O) M32@/WL5Z(+0422N6=KK/::G^1]A_B^L MS]?%DZ6-<5Y*0ZX\)RLHU\HX!4T)4A+@33,S5@@7:8>>'Y!2FPR6U6\OH#$11&92;+=0JZ=1AB#R$6LQ4B3 M,=QJ:_L<#;P3UI"..C1E2#MAM.3'EN=STF?//X3Y>QHCCU(QP1"PU#XU M:",$-#4K.SM/GUGG^IPTWX5F2/DYK=EPW-0?38*:U3#:+F _*S<*4L^F'^>S M3#!K?7O41MJZ:\ =V>]$T4A+7F%@(K.>LY1,N):(!4^:H$\$[ Y01X-V]V2,?CS;$ZS.UW7&$A?WLW#=!'2IKG*ZM5&(OF_SA>K M K&7L^*TE,*$ DG17*B0!/C #)CL$W,9M8Q]S)0^XQF6Y]R'C -@PF.MD&'Q MX>?)['/;E?'RHIU7Q-W@VZ6:UAN\F<\^C>EJ/W[Y?5$/=%YNX3XC$GQ:'Q75 M$7GR2@'+I9829K5[1@R04_1:/(3<66LL6>)_&M>$MJ=<7 ML_.X+.>3B_)F(S2VZ.@=H"ED S"R"[Q1$;(EF,J;:&R?HCEWH1K2.G@B^C03 M4KM-AP]ACC^&16UA=E:=W0V%K4<:I ;-@P>5.9F/ICA(FM63^C3,3B=Q=N,9 M4BSY1%1I()CV<:/7-R(8UWHJ+D9<\)"=MR!XK3YLA*$QAP2.1QJM9'A"535U]+ (R\D\RPR6'5S7&T"!(\( LDT MRZHX[?I8T?N@>V +Q>^45D=*K2.?5A&QKQ.P[C"8O!!,\@S+X83W&Q(/O9UN>5/+FLXT5!V??E*@R1.^VJUEQQK==^=,WM'A$C9*XF\200#CDH3L.-9$* \2B4<(HFH ]M[@"U%VM.65[B%+1I M):1FK-F.T[VM$_VZT,A7B*YL*ND[%IN\L1M]#=OVJ5Z_:]M*_S^G-<562(/IM,9I\KR[<9_:J6&\&1B=D6SC)(7]O6 M9AJZ]PIKNAG:Y)PS]III?XMS>>^M]J*$_D[6J@ZSWS=0>JU_[0B]5%ZS0BMG M+>04:0T-J$1=5Q,KVF5^/>C0,U!Z#=U>5#I5HOEC!DJ/D=J)=WQ[Y4K.HD\NZ .![L4R^[VSK)TL>T;F=WEB=,ZZ MIE 747N.* C!>.#6&Q^%]3GU\=GVAK@7R=SW3K(6\FM7Y.5*%KXH*44F2(?R M4'M."@:!D_6O9"U-9%,NHE/IGP>??O#?%TT.ET.'>%#M@[8)D[XN*Y:.?%': MH:\=C*K)AJE *&@ 8T$FM2+SN$\YA[M0[961R;X3*[NYF$ZV>;QMM+FL'9.U MR JW]6 B8^ \\Y Q:.9=DAS[./$/ +D7K;ZS\'0O&7;:Y7B!IX6WFU*[]$ M0Z__KZT'/H4)KG)O%LOY."TQUP^>3?/5-[:^.>(V!RT#@@NU>X"CQ3G*P.BW M5.AA,)P$TH5B1\%N4HOA\L(CSEST]>Q_2):,DRRKW$2&VL5'"TE>4J?CC5=Q M#.DTS^E8M;-8PV&R:?I,T0"O#>L9J9GY_ MIE'4+(*VE2HS7XKY(EJQRY-[D M[$$DY:4C7*97G;-]X WI<,_CL:F])%LZJKN6K9?33S035Y>M%$W4427PLA ^ MS!8<+2I@6#&^9&YE[E,]:'^,1Y^>"U]6*2KO9L\2"6J.=$]:P)=?WDQJ%'Z: MJ_A657Q&M5>I]UY!+K2X*B,<1*[)M8P^\:(++;1]S*+],3Y0E3^*&WLCP7;G,Z_CN\BAPG4SI96J6'^21XE'Z9(28(Q4M2A\ F?1 SH5.#F>7'=J M0/$0E(,JK?]8+&LEQ7X\NWXV;"2]"YDA@I:UEW;V&;SA!3Q''W.@IX#U"1G< M"^V!QSR_3T8=):_F-/IY-J<92(AY4=N0K((8NZ: !F!B['.2[X% !]4G],04ZR'+WO;H96+G%CY7G,U")[!UZ58J%HC&(606 M)-,Q,YW[5#S='V/+K, W\S%=_6-M KR6X\AP03+P!:1BJQX_FLC@&!DPDA?& MM..BCWEP)ZQOP>H\EDYW90 >)Z<>FOLM?CR?IP^$K2;;7S85'Y&;&9)G-$1- MXU1:6XCDV))?FQUCUI?"^T2<[L?V+1B5K4G46&(M2\I<+A8O%XOSRO2KL+S* MA=L0H'CI0;EUIUD/B:Q>C<:$4OKT@K\7VC=0,:0YC9J*JPN+GL_(W)@OJW%; M=S!&.A>AI/"@F:UMS+4'%VO'.JX\^FQBTGW:Q-T!ZANH)-*3.<>(J/D:MM[H MNB#S^FR/T=$JM ;0XBJ9WD#T:&E1U8'';-#HON[K#E /K!;R7:U:Q\JH-6EH M%;WO8.&NJ2A,AR1XJ"5Q5@>Z(SA5(FBK"]TK\" [E4@[!O:W4$RD$_%.(.<> M-OD+G(\_A>6J(FJM"[\:R@Z<1OO"DLR@@K1UK2:7JHN3" M0!7+P'/GP'M7;-0\A-RIH/E)Q]DIV+4K9\B7Y&*)DEAI.2@9:4:MP7J4$"U+ MQ-'89UTZM!+N-YPYTI?O.U*4>Y#@,3($G%?,E>* -!O-1:D9#((I\A10T9IJ M"Y=] DJ'9@A\PPDI@R#IL21XC&T#CTIP):LG6TNG5J>DGO>'F+EP,9'#$H:U M;?#(/=.^>9(>2X)F)%T/\779'O;KZ7%I:4PZ+@U*D-K1?*&1$%520%-%+@[Y M,:Y3&*3#8(84,W?%]=J9?3,INO1;=YH,-DZ[WX9?.]%[@, MX\E!;3<.O%.;7APMAMFH0<>EZ;G=2$AZ'Y67P')M)+1J:\!X+3B>M8^<'-=. M9_EW@#D^\7[5WG<3YKYQ,IF>H_5S6A-OZ+]:?F-DE?;25ZLF(;GNBB(IGD7!*\DAF(4AC+(@EES%[$>,A=![6CW909W>:^LSOTRVR6/X\GDS#- MU^E\_?41KM !=VGC!AT[O$8N$/E>Q,57!/ &C%]Q.8K(10P! 3%84(RT1% ^ M@F7:$OVX$)TZIM^-JT&Z\6U7?Y;2^5F5*5YMOOY_MQ:(1O2)M+C$.GA GJ\97&;Z9L5O<_*>,>-NB^.^P[R M-.NCEYZ7:!%B36]1.B,$[R3(S*T6&)/A?;(5'F]]O#G_O]) 'FMAW MB"@?DW5$(QQ%J9)66,LO9IH>Y15-5.20O2K,AVB#ZU,RXT# 0TK#&!;S'BS. M1^3>S[/S^2AX6P\]$3ER_!PGQ, MXM%W1XRYXKT3M6H#N4@Z!IJHG"#II)G/RO/0IR#"87B'U.]X6,1[J# ?B7C/ MRA+GEX MQBR8E<2/&M=Q04'@V0'3*/V+3JW'A(EV2CCR+J+&6KD(B>"$?UV7%55&9D:77Y_19][$U.,]^ M",(?LH4A0,W+7!O+GXT7"YJWBVE(G%NO2L M(>U1=:10$ZFT.TY)2];L"])"N5JJ=PRX:)TES[HV?,N@I"QD-N@ )6KMI$(K M.[6NN1?:D+:6^A"FK72Z]%F_+!!TB<@5&JZ2P KWH(P,X*VHYS&YR\&B*;Y; MVLJMJ(:T%]2'*LUDTHPEJQ7R]L$FGU6H/99+J:=U@Q,0C4P@=91&"F&1]XG+ MW(UK2)LW?9C24"[-N+(Z1'V>EN?S\?0]O<#Y)QPA.AJ>9Z!#;:*&[$(SI!V5/KPX6@;-V+ RIM^$+R%.\"LMM30%.83:W4>):,!A MB*!+#"EXX;CM4Z=[!Y@'%FG[!KEPK 1:.S)OYK."*VN9/##\.D;I<\'D"XC@ M.2CO#2ULM4)F">C($+*]6G;>C6L?@IRJEW175Z:%7#J'];:*\/Z&T_%L_NML MN8I\/0\?/]:B'9/)NWF8+L+J ./BZU;D16.Q9V>U,^2L?+6J9F3'0B9Y^1 MN3YG@FX!-*A#90?3X+J*;#'[S=;155WIRY*J5Y^\D7!!.!H,6.US[,-XGQ',7JB&% QMRHI$8.A'C]VE8[\YAOFB)/&(QVI14@,BY!B5# MAN #K>J&7$&;N?&=SNG>"VU0Q318B0S5NGHY7>*>5JZ1"(_T-!OJ7#MZA%6T<=FV 'F M:*?RWO[OH8:ZD@P@K2?7*)&O&Y6I*?*F%&&CP$Z5RNZ%-J2-UF-YFG/P(5C@26=)[V'IE"F^+\(AV52MR=-% M2NWB6%>H?5E-=]WB)>E4A+.!:,P5*%X4>)$],%=J?R#KE.JC6^]"-:3=U;Z* MY@AI=+:N5KMY6[9 N@B,+&9E4C]+%?$1-M/#;M#&$CIB4*TB/?4N5=BCFO[( MLQ?U !SI JT4A+K9E5-)7,40?>R39G4)H>5>_/44S&VM%Y+P)B0/0@H:;C(, M(BN,J"VY$;DHUBGG9T^ 0[)K#N/'73ORK233;G/^H@S7U)UKJ^K(J9(E1@0:"2U\3'@B M(C/@#=.2,\5%Z59:Y3900[)"VJN%8R30V?3X.8SG_Q$FY_@/ GI.[E==H-=' M*\-T>S=Q\WD.R\L_.<(@:7';-F9*\PEHE3V_@O#U5N0A3V85P$CS&+ 4"YK) M&G0T-=,X"7K@T$52-(&;/BD2MT)JT7'MV?1Z8X5=8P]6JRBB!$(=DX+3AT(WBX5VDU6SIVWID=V'R'KUV28)C$@D3\^"U MM>"423GRJ /V.>EV-ZYC1_WC^6(\Q47--X^T\E1RW-?J\S+AQX50DN%DH-2R MAT$SH-3;]2?M1$+M;&)LG9RY4@#@T[@F%)79 M?.L+1Y@4A]RFC0EQ] ";[>=L;K.Q,W_$*9;Q7&DIEW9=B.XF,%G*TB=:OO.J]YR)"2)7!@I&00-&S[!/]M1# MU,K!H_X9JRDQN3ELBTX:2\\M"P1-16W 953 4'CE:>Q*=>K&=#>P(:G3ALRY M1:LV$4_K)^6W95@B>8*OZ ]V0*,'6.L0Z:EEY&BJ(FKMKRAI 6#HI3.<^SZ; M+GO!&Y**[<^?AJ)JS:*?9W.:X^D.4,9S*0@4#TR2Q: R>&$-2=W9DIU!['0N M[!Y@0XI5GT#SM!#/R0RZJ)Q3@88II:J)DDZ#9X*\;<-=\$XYZ_OL;3S(H#LB MQ7^]#MPV_,PS.<1DCD43R&Y"F@//":\LVBB7A&*^3VAX/WQ#6K-;,NG6(P'M MI-7\";JR(MPZ"35&;$J!C#&"$JS:^%Q"])S)7(Q5I8\*?@C*(:WDIV!5<\DU MY]9FS;@-&Q.&^1@*:,R&L'E!JY*-4(S)]"04^MGY7-*=^(:TOI]$2[63UF-$ MDM]BFDW3>+(N/+>8E8W6K8_).?'U"WV_MGE?SM;-W^FZE]>I[[<..;?"TS$V MW67*&@6Q=]]QO>UQ/IZ^WV38$.P1IF1L[59<1&T]RGR&4,LI<9T\><,&3>JS M&;P_QJ/K-NV\TU7Y/5M>%]^5+X\<^0 E:0/,Y!IY5?0 ![W:E+566N-CI\+$ M#< /R6+LQ,P;Q:!.+/)V-<;V +[;=L'%R*'(C$=+\U0K"41I(&B:L8$P. IG5P%$5451.IE/5SO9C&9*Q.R *=R1$FW;H^PSB ME\DLU@?PHF/&J]EG^M[Z#^CGY+RF)XP2)_M>,%=;N3/"7C3$:#R05U&3P31' M+^XSA-M"&E(5O\ZT++:EDK7_*@B''#!97"VF&3[ M;,$?!7M(Y0,'KC8?+N;3:L!M%5(9TQ_6_;9QF(R$=(%4-I(YH>K# M@@D3%]:'RRH MJ<"[/!="HBU'@@0ZKL." 2 M]Z+":6-0._VXG_Y(N%C0'VSV/=[@/*UK:DOX< MN@19H4A.:&&=>#3B7D>[5YR?_>\CYU%2?8S=V,V^Q(T%(DSSUGMM6FRU!=!Q MO[7-I#3:8+V!XI?Y;+$8%6*CI\>%J%MC\X54G'/%@U)\:U+&53RM M4E$NKTJ_7+RW<16WU?VS:=XH^L4=8=ZHG!(\::#'3M$<60$NL0A11:69=%[F M/AO./48SI*W5!IR\+;OET0C0)HIU8QBOY^/WXVF8O%PLUN=,5Z5"LZW-/,AO MY*L#,[7B610L$8^,4UH4KZV_3YT^X'Y#VOALR)U>,]X\P6Z;U,_I]7A=8[C, MYI_#/"\VL8:1YR1@2W.@,$M0J9; TP*AH#:%:\%LI^KF#\,YI#W($VFB1D+K M1ZQ?9K/\>3R9D%[\NNFT_FBD A/:ZPQN5=D\,@]1DA84Y-6C,SPY[+/]_1"4 M0]I$/ 6I6@FLJZZZM@!ON@\M:K?@==O-Q67\B!Z'%[/SN"SG$_JLJMS%B/.B MG78&G%;T?!AE(/(0(12532I%FTYQ\?9C&=(&XN-87SV%WX_$7PN\T11=T=\C MGZ6K!YKA;E:4\<5,@Z+*"BXRIU:5ST Y)"V$4]!NT;B>FRE>*.WTXCL M *,=H>N:T] M1S5[(DMA(26IR**T%CSI4+()^ MA-^19V.4%ZGH"(S5"D N,H)8$(PN3'.G2V!]$E0:I5%M[1/T[=S6GRE'2J8#A"LHA]:168C M8N_LC_O)0(>H:(]FU1U:MKGPFL<2MQ!^+6+^4YA/7Y\OMS,<;?$B M<([@8ZU<5+R">C8<:KN5K"+/3%VKLWI_<''/>P\QK:49:4XACQX6[!;.&B"M M;1[G\WH,80TOU@: K"BPM"JL6X4ZG2U$EX53J*+![KMN=T,<8GK+B531L0+K MK(0N.C6O>C2/M!=>DPJ$X@V9I[5U:!3DKR6B>;&2'$1[I.*Y(TC'(W%N;$9FTW9WHPZ /,??D1 JI MEX#W/&JQ>;_^B&&!?__3_P!02P,$% @ 88NB5.,QC.5*C@ @$ & !4 M !L<'-N+3(P,C$Q,C,Q7V1E9BYX;6SLO5MS6SFV)OC>OR(G^W50B?NEHJL[ MG'9FMF=<:8?M/*?GB;$ +-@\19$Z).6TSZ^?!5XLB2*E37*#NF54E%.69.X/ M:WT;6'?\C__U]6STPQ>3=+%&8[G/[R<(LPQ__#GAOD^FGGR3GZJ?U;_^X^O6O-W[_ M3[7X;1%"^&GQT^^_.AMN^T7Z6/'3__GGFP_I,YX!&XYGIL^/?9XM^_F228+]1SYQ)^V/D;]6]L_6NL?HL)R93XV]=9_O%_ M_KRP_K+[\X_WKFTB'X_E/>7CVT^IW?H+1B! O/F'^[1S_ M\>-L>'8^PO7W/D^Q[$2_7G(%92J<_UX_[:>C,7TF(--T$9'1=W%<"=XCQFV? M?CSF[Y_%,A:X&,U[1'SSLWO%.SF#89\"OO'1/:!=?! [P[.(TSZA7OO<*SC7 M(#<1UH\<#;\@46@V&?\M3UM]Y0W]=/:?B;KLN M_#K'<<;\XP_#_(\?ARG'"-$:ZX2AXZ)$*Q0&90-BTD;ZP;X/JPM<+W$T2=>> M/:I;[^0[5T80<;3X[N!BQCX!G ^^/X%D@J_IR]E R*$G!D!%$S'DAA$GEF" M',"I4%ST-YDV6S.WP"PNN+9ZQ$]5?S_A:#Y;?V>A4<;%:OO^[[NQ+-5WQ.H^ MDZA^IA,COYR1:<1 IW'@#!&-M#P6RU.;%6[%:E16L://TRF&:?_^)$?J_Q7>#[%-%Q@ MH:]'N)#I.+\XFTSGP_]:8DQ2Q2"Y83& 85J")8P\L*A*$,K9C+X-%;J@>_3$ MZ%T%-VDBCJ7)R\EL_K;\-IGD&2'[@-,OPX2S#Y/1=92T6.FQ>%:X*TQK2Q:\ MUI$)#X .=)*\-"%*-WR/GBH-U'"3+/+H V6]Z(\01S@PW@I-KAU#$RW3"B0+ M0"Z@E0L2M8F?ZA?'\N'UF(Q$O)3+RM5]\74X&X!5'%(-#20Z^73T MG@%/COF4@A4Y%;(!FY#C%E ],N46__06YAR@ZDD;D3[784#N!&VSX MS:?@Q:LK_FD_!\BN*,!-7O2FS&XD.4(3)Z=+XEI$;@Q+F"73":J!I#DKR42@LV4S2#S#"V3\7IMC 9>E5+L@*N,2TY<"B%YSY M4JR.SO%D;4,3] J4TUN;/:IJJ^%YJ)P;^*T?<$0_^D16\#]A^B]RF<:??OE: MO6I4^-*_ M/AJXK^]QAO2!GPGE*_R"H\EYE<)UB$&F9)++S$;AF!:@F:_[H+.H 'C6O(@F ME.D [BD1IF]=W*2+6F4_?MJ2_N@_R?-A/DG_^CP9T:-GO_SGQ7#^K<_\SI9/ M;YK:N6LU&UF=J)Q HPV7,N@ ,5I>0/OD,)-9BK SJ[/E.;TG=%21(GM(3$IR MN;4RDL52X_!%:@Q2\:C#(TGHT.LX19CA*US^]_7XI@#?3T:C7R?3/V&:!T$9 MJZ("EGT03 ,G[Z!($H(4BCLEG!/-8C#[ 'T0X=M]>++%E6JFF!8V=LU8S=Y> MS&ME2RT6&JA (')V#(33M)4'8,%+6?,1RJ64#:8VEM(-*/=RR+53WK9PZY9XL&8Z3?9,$#R%Z M/9M=8'YU,25ZOL/I<)*7K%W\\.WYH@CCEZ\X3<,9YD&) KQ*I$],!-NGPH*3 M==N,)F8;I%2MDD#[8GT&;&JGNYT&=N]L^S<87>!VP#D24C2"%9-HL[3"LX#! M,&^PH')! ,2<+06Z&+1!9% M\4P&'BSYLQ*Y/OUF]AW?LR35,3JZR233NQ MGC2 YV37G7RC>MX\.D)#-VEDCZ71B_P?%[/Y(@SR2UFPXQU65T')U[S%-/BVUN%CH0 %D5VQAT69/?H6VS'.M MF,DA*9,2%(Q-&-AZ94^;O ^*%S=Y[YH>Q+^;,RQP/@/DOB]:C!F[0+O=#N/9ZO(&UY90;. M>A^YM$PE%Y@.&AE([1G9)CD4%*"P(<=NQ?8,"-6?;K9$:(^/UM\"<7FF9YU] M#JXP0E3SZIEVU$*Z3C[PJ%5Q0K1)6M\)[?F29W_-;.'.P>']FEH>O,(X?SD9 MK_K#5R&9FYOGP/E8C 7-5%%D$AJ"&TO(S$ET0>>9,ZT]-6UAV<)Q_ ?]VKQ2FX\G%_!U\J^L; M"&<@:S+J>/:%)),"N008F(DI0Q0V&5TZ\6F/ASYAYK02_1:.'!S!OPWHTH&\ MCM-:)5T&P4PPD6F%M&.&# RY4AREU#JK8RBRY9G/CR''"GX+00Z.S=_-Y)\G MXXO9"N8'G,]'F$E@*S?1<6UC<-WE%L0/#_R M]*N4+50Z.-Q])^5O VTU#RHDQ0J44,=E.1:5-,PHY,+06T#NPM$;SU]$:J62 M+3PZ.G+](J7)Q;BVX7RHA8,D@]D?Y[6<^I=:B3T;QA&^&<[F@\*M,SF33(PG M*Q],9A$RTDX:$QEBQCO9)A+4$>#3I%9++6UA4S\!Z5W;Z8NTS"/6R,4 E.8V M.LD\SY;V3Q=8"+2=@L\F!9%<4?>0=KL*\6DSJHVFME2.]A.EWK&S7@.:7'8\ MUH8A4(J 1L.BCYY\@*0%.@T%Y4-C4.E_@6_1]=B_YV_AFGM8W^FULR49&)9AW*=&V)A(AKB[NATZJ5UQTH4 MSA9@,D9D.AA@7GK.9/8^1EMK8QN6G=[2NG/(ZJ[-3"J@D]$JLJRK P:*-"8$ M9Q%E=K5O3\C&8SGO>];8,?V)1PCSHR+RQO=2]BSE'B[U!\^(&IM58@BZ@FDX: MVPKK?B:,]:B^22O9GXP8)=,9Z$QB&!59M&@C"]%K!KEX="9&H=H<_2@M*/E7&#]WQ'H\QZCI#*)3MEF(W5R^6D*:^D8SZ@U0JE4INU0[VU M0MT"ZRE0H3^Y-QGW-:?U8:[5!>1NK^<;:ATB9JN9\5$R[4AS@#8P9ZUW-D>> M6@FF^S(Z\+2_RY/S[U-U, MADS(I3"9*CY?"Y2X$ZPH@%2L]X"=QE#0 Z]PA?ZVR9.NB!YQH*&)T'L\3;K@ M6[T<71#N$WCHA1[W$7UHH],]"'.$0GJT3O= ZK4)6OC,R#(B([H@,"_(;5)6 MB*)/&5VQ"<>"F/VT<.)F7)9G+\Z)2,::T+RK'I>3,>-J1BZ:_A"*]YJK$$A-Y*&[G>-K+C^]]*JU#*\@) MMHR;0(8TEY%%BXZEZ#/M8MQAHPNU^I]*^SO.JZ#>32=?AB3TG[_],:N5LZL; M&\>?7B1Z;9 M$^N#F$V[#UNV5/6T5$^#(.[U.J3L5.'6%Y:X#'5HO&6A7H#,@_(V:TS@VZ1V M[[GRJ[7>;BW^VD?H3>*Y5Z8@U1%&XS0L M!# K8RU&;A%@V7'W$,X_F+$7G1=4K$ M59:_08*' V\U>>5.U)IESS04QV*(D>62G,,(#OS&S.4=W:YW/NH9TZ2!+GI, MO"V'CUR!\[:\'L]A_*EV3"Y)3#ODK\-QA?VF-C;,!CJ =-HN^@F0:<$#\]Y8 M!D%JDP"L0M^)-OL]][ESJ*&6&@SKO@KF_?#3Y_G;0K)98+UVWMH2C7>6SMO: MJZ*5]BQFS9E#)9)Q18%JTS?1$> S9EU+5;:8ZWWM_5B")F$LIR-)R:WA AB6 M3.OW7A(V[AC7&4(*W*!H$_2]#=5?W.I/:0T&9E_'5N>\O1K.%F,&WDWQ;'AQ M1LX"67>A1%:LR+3R>H-4CG4^J469HP%?V@33[X3V%[5Z5E^#F=@_7\R&8[+^ M7D[.(A&_XGPY63BS@O%Z/5Y)?9H(!7P.M-M=("TYR<)S*!-4L) 1-)L32ZG?PV M5']QLS^EM9CP?1F\^8C3L]6K\[8L;-U!3H;G6DO"BZ7S@7M@/CAD@0<@N\1F MX=ITK=V&ZB]&]:>T/N=^7T:9"TZG=?E5.!_A*U;?G/[[DKXY),I'(+,CUZF; M&&HW>2HLQFB8X9AYB2D+VR:K?A>ROYC5K_+ZG!Z^!GASS,AW4:PZ@+[+(6JM M%7+-B@2H$47.?%95&$D8*S"GS>ANLRNH=V'\BW&M%-KG'/'=4-?'. D2AU\6 MC0B+(<*")Y:4LO6VR+Y*GWFI5!0I,5I]'=F8ZC'N.!-1 MH[32>=J$.V4:#GK\DV/+B331("U^$W3U5:L@_GTX__R2MG3:O)=)UP$8[>H9 MS:Q2KN[&D7GE"O,F"%/H)]FV*+U^F1M.(O<(\M:^,AKW9%K$SWKAN\9,>EH]32XW7KWP?L.OBU.7>>YEQD< MD\61<1BL8%X+RXK* 91QB3>:DW@GM&=$G6.4TB YOA7@] +S.M1*WL4@Q "Y MYB2PWMBABY4L:.\60ZN5\RY*YNK#JAU\8MZCPX(Q.. MH+IB&?>A&)ZM,J%-QF4/D,^)4;THJD$BN'M'U(#\2D@0!9.+*ZU\O?.LT*XJ MBLF1]E$0NLWAUQWCD^\H:Z2N!D&!'4A?C[_@;(=@LE(A !W1R093[Y5)#"+4 MN4DV.<$S1-7&P=L?ZU/MJ.Y+/0TZQU:W6LT^3A97?$R1L!/MY]_>C6I'P#C7 M:5_GB\OWN$KU3W5)>8MC;2%]9DV<:8ZH[QP>Q4O6E\LUBEC;I. M0:QU#1@N[X"H4EO]) ] *S( LV*F'M):%'(HK#=T>DOD(00TLHU=M0_*YT>N MOE36(.-R ^MFP\F &P=%2U7-@$P LV$>D).3&IT73H)M-,_Y3FC/CTA'*:>! M&;4&^.MD2C))B'GV*PEMX4]L$CTD#[G1*.KN M&)\\NQJIJT&&9@?2[PU*6P2CBE8AZNH1QYK.IJ\@>,VDS*C %V4;W0"U/]:G MZ@?VI9X&]M35)LIWTR&A/*^CVY>[[<"J'*2(FJ$#VD9+MK2A1L6"$>B\#SPT MNAKM5E@/9C_J3:^W=+8>IY2&#AX=Q>_Q_&*:/A/*VJ3S_>*/ :"PF".P& ,R M>I<<(32"E5R"]"8G42Z$]O3ITZMR6KAP5P"^G)"%-IU7_[+VT0Y< MDM*(8IE2/#$=M&-!QL0,)LA!2?( &D4J=X-Z5HPY1B$-W+#U7KALLU[3>=G$ M3U0%'H1@PF8Z17F]&!7H*Q4X2A^3D+)MF&@+J*?/E9X4TL"S6D&C8_.N=N,M MPADD+I+C!5A)Y QJ5<>S<:=8YI&#"SF :Y/-/0KV<^';"93:H)SNBB7W"J?# M+XMQ\Z_')):+Q:*V():R\&Q*(EF)P+07A4'F=#9G!9%[#]RVR?GNC_6Y<*^5 M^AK4UW47T"";6*)%PT2(]7)X\D;)*LPL2I41I$Z&GW1<^W,D6"-U-2BU6]Z1 M\;;\\C4M1GN\ASF^'5?P]?\U=?T%1KCH"B2Y#-,<\R+G.,[7OW'E-P\;P4W\#./ K^\#N9FX6(:761Z M,Z^*:2FZ02$'214>F5&JUFJ@(O\Z2[)^C:U=C!P:1>E/N\Y'S_0'3(L&#O1Q M;[ $5[#8PE+UXP@\,E#2,A^#BT8&K46;20_/>S,^G=(:N.''@>>YY*!SO6L< M!-,ADHE3D#,9?,04;,#Z1\:=6&;?35$+2H,D89DHC*IX],KL8$'N<*YB8[\E.GT&YUP_P:C"QP(S74.$EB0SC.-GBP[ M'6H&(::257')M6/:G?!.SZ1[4/T6\O6KMP:)Y^LB&-#NKK/3R(Q,9!HEM:C) MX4QE*Q3I/Z?0IG#J.H[G2)O#@.QCFWW$^$ +J6'W)K/#TXDBL M'7'D*)@Z+,>@]*[;9<-[4^,FEGM@00NUW>Q[/4;F#4[@U^,Y3FE+6L-Q02OM M$C*?:S$L6L4@@ MK7XU36 Q"3 /YX1L1IMC'028?[Z8_SZ9_W^X>$L&CB>.BDPX9[*D5P04"QXX MRT4*9WE*H5$!6%>$]^,MG$[W-XC70'$M7,OKUP>]C7,2;4VFKD/ROTZF.\>8 M@$;-A6#62$W>3T0ZDWEBWF=T)"!Z/=ML:T> ?F8T/)5Z&YRZ7:!?;1>X!*ZC M]I9.#?+*:^K(@V6>F\*,35SH C;'1O&10R'_Q+Z2WL&;4? M"CUZ3)TOQJG.60%Y=3$F"RUJ3Q7OZ"TS'DXOYJB!UD%5*6+1F1HA:#,@- M Q")%9=!)8DIP,90@QW3Z[L_\YF0K*4F>BPPOPWFDM$;.%,R)GCA64'!B=@Q M,X@RL&0-MR%BB-$>PYAM#_V+,L?KHL<,_YW4_GDROIBM0'[ ^7Q4+=GE"HCG M7/G$->,9"7,DD\ [\J8RM]E:@FPU'KWCW +@+R[UJZ,>$TQW\_\VT#(*[4+6 M-1I.)VY(CEX&$5B1 JP5$8V1QV],?S'K=%KJ,7J\ 'W8#:0#F;1#R)8)XCW3 M!CWST286B[-<0]32YD[$.NSYSXE6)]!0BQLZOZ=H/BYN;M#)(8;LZ]U[2' D M,H^TD08>M$S%*%X:%4I9)PTQ;:-FD8#0 M E-200LG?+<)4 M=#$RV@F<.#GZ0:CQ'>SBJ%__'3AHC>T%\7/UA\OXK@/98?ZG__ M>/_ZN[C^_///OXV&7Y"\W]ED_+CN8R,399[SR1@C:6@)8H:7S MJ=-&TB.HH\.SRZC>>SR?3.L#+B/6;\L_X3\FT_7MEK,!**F@EAW[!+2GQ$R[ M.T!DPCMMDE IQ#;N:W>,I]N2[Y5<-\+";938H\^S1KKS.J8_9E@N1F^&!0?9 MUQLO1;V$(M*1(Q,R*%XQ[Z464KL^ M'N%*3"_.ZCNQ%&&]E"FA)%!DG&:R9I#<0D=_372$I9R=S:E-$J$+NF?*K=X5 MUZ2G;]&?,_POS"\G9^<7V?!RD7* MUT?Z0W!&QEUA4>@Y04(@6"V-ICJK.J,76U9\24E8R&XS>KEOGBS&]1S)4]/:FHP;?U%7MQ< M,5O,X3S'\0P'WB@G-9#E;S499X%[%HMRK':$>J*X-ZE-J]I-+,^4+T(_+H#9^P.F78<+E>2L&&%S MVL&9DRQ,B^29E[6 S@0Z:JT1$-K<,]ID.<^4K/=/C;[K\H^7[+)8KZ !P24P MX3BGK5V3EYM-39VYY*2Q:/W&6-9F >:35,D^"%K>FP;ONR)W-IT/WM=W;E%- MI;$$>E>JP$)M/HBV7E4.3"7'199.BM)I)#!]ZI5ME?ZVN:5>>^RIJV3O3]F3 M8X7>8\ST.XA5DK<+C'WJ8+MSH/],^MW5K4>H8%.)1\BOH3I1<;2J1":RDG04 M2K+Z>=]'?MT:>S2(\2_J0/R?68W5P @:]7@#@%,7HR M1+SPFFE5KV>)1C)4"9S5P2)V"N%V4^'51S]"%1XLN1:W-N_*=/[\[2-]Q&*S M@:RM*SFQ@IX6ZCQG8-QB$EM&RQV":79]ZEW@GIU!U4IQ;2YTW@ZQ EP5[G6! MV+0EJ0/(^VE&ZEW!70ETI'9.N4E=@1J]];'4OE*3ZG@I1:]1IG#WP^![F@S>@C\V4[GW7ZXNG>]3-I)]P&E7=K-%> O<(O.)J<+Z=US>:S=>], MU+6>5S&G:X.Z++Q.*!#,^Y+0F)0BMKFSM#/$IT.>MMIIY M) 6*_M)F'NKC8>\=QOL#)^\^"FY VE_.SD>3;XB+R6-O%VU7*VNA6$Z'BXDL MU8HAG:5C/I1:"B),B<9I<&T*)G9"NH=+0NY=XYNW@/>BKA8^PGIVT+IE;]58 M-%N\=:@Q.4M+=J&.$DK&D',<+<,HR;6QO(X3:K.+W0;KV1I__2FK06GR"LOJ M9>D"IJT5=Q7._9A?/:IK>_??$;)N84== Q5")C@B,8-),:TKQ9W*3&0+21+1 M\^;\T<>C^#LLEU/I?1\1]QU:7"]M':((NEBC;&TJ)?.L3I\#17BLUW6:0,AY MLY3HCJ&@]V8Y'"[A;9,[#Q#/SD.^YY$*[_$+CB^PBJ .%:V32O\\&55YG,0G3"<#MH >C(!MSA##Y]FN*GA2'TMJP>^.9[<:8HQFA+ M.QQW=;RQ,(G%9,F)BYR'X)30HDV/Y%W(CNX.7(=D!W^JVU5[;,%K'T_O B-3)*%*[[Y;1ZU2XN W!?6T9>D]:6'20H1]3Y*^#JQF(R[( M9EW'FK)!)65A)@0"9NMM538!D]Y+:7/4LN, V]N>\L1T>X0(^WYO::V%6$:R MA-$:W@J6 6Y<,IY%GQ83=LE]S2ZP! A8!*TUQ4Z:W?V,1Z_7GL2WLQ7@WH*P MUVS5R=I6/4G@]?9'GSC8NH<<-@*LB-8'<*B*TEI($Z3*(%(QJ(&\P[Q'@/5V M$(V#JB@U9",UX[09,:U=9 &%9E9'FY/@L?!&$PT;!U57G_?K%?E?C2D9ZH4Q70)DOD2JC"P5N]GPU.;P,(^60<\%R4I-&PPNO=-;Y8!JB0<04A:H[.;CK;+GJ>,'V8XBA[:6%[C&T/41X MTAB:UK0L99'9DB+3.1H&H OCP4?Z/[F+I=M]>X\AAM:3;H\0X0EC:,&)A+0D MYI(A6$'7"] MIO?X:5CO(&@?1;OSX:>-H^TGBXU(FLO9!J^=\%IH3AX@3TD4BPDETH]D]TC: MG3 :Q]+ &P%(5I8$"$Q+2?9*%ID)0V]/L(6?2T9%4K+>M=&][2Z>\$ M9RGH5$SD!76G>79/,Y9V#%-Z$_M#B*5][Y2YW/YAM.SWU4B+D99YJ"5[:(!Y M8P79'1P*SRJ9;IV'G9SJG3 >9%1M+R5/^A9VSV&55;_-54CKZ0 =0/4>6ML) MY_2AM9[4-6DEZY,1P4FABW6160#)-"=WP^?$F381 F!.(NO'2H!;XFNGU/\^ M(NY1[XL.Z>FWP1\?!LIQ;@,M@@=MR)@A.\9S[I@!RQ6Y%USX<(N29YC^]FGR MY:?5)R[UO/K+0LT+!5\^[[0^>D^"GQPEM;X#:,L+:L@XI>6LPP,E*F$E3TQ) M7F58IP<$#0R$,:PD M(84#YR._K3=P?4[6#URID[ZZ/"&_/^@QZ^TP:?4X$F5]0O_V\R#K:*WV@0G- MZVSSF%@HGJ@#L4X/,(8<_M[LFM]^?LQJ.U!J-_5V\)6):P2_OQFX0-NUJV>R M-Y[I"*E>N:=94#I #"AI ^A-;[^_>0IZVU-J-_5F[SL]E'#XI8989NM?7%P! M.QLN9S[-YG62PL9PA=.DCHX =NJT4E\RW$@Y!=JVZY24X#340D0HTD@'Z)*R MD%S<)^5T!,3F\S+H+3,:R96'VF)>!(M!>$:68W8^::_+2;_@CNN^]#GP@/FLJZQ=#QV_@:T(%'# Q]G:N?@B4KQ2L6E54R MF.FT4\)]\P M]E_Q2S@?SF$T_"_\/JVI'D;T@"LS2*0+66 R];YY,K" 2T9GH",[.6CCO2]H M;W,GCA@-TP'=$WE5FBFDQX# \@:*[0!GNU]J$W*P&AR]U+7]QHO$O"0/BXPK M:]$%KG7NM('N_>@GPHT3R+W!:-9.3+8A.4P\,.ZQYA*0,$8!+$NC1>'>N$9W M@.R_M1P@@2[CP9*.3B7NF!6VNKRZL*"C9)8';Y2-=6QO&PD\UGEM1VRN?2MD M9SCAX+N3[@:X[56/F1NGM68VU&M)3?3,VUQ8LHI>=9]KT+';%GL8@"?"DY/I MX"9OW$DV&]3H5* C@3B312N[;C.G??[/I60)7SISD'<\1 M%T(@ZXFC7][\Z9WU,AHM1:/RV\<\Z;#1IGN@6FZ^/Z'=ODL8;WGM05E)5@QG MJ"6YK"K4:NY(1[L'BZ\_LO;6.U%@93.T/0E/KQZ4FUY5;(--?%QE<(1?V M&==H'[//]B;V^Z[1WHQ[_3Z9X^S-!,:UW>S7X1C&:3C^="6C\O.WGXBT(Y$ MP$E4V2 P?!7A57SK2YHZH&MZ[\SM^.[I'L"3ZOQ&:U/O"KL'6O$D%;>*>5DB MTRYP%KCWY+)%D8R207:;[_(HZ'37Q7P/F4U[Z*D!BRJDRWLW5C6#KJ@8M "F MN%3D36G-O$9)SI6V@) 3VC9GWS8TIW=0^M38I&=Q-VB+_&,+ 5@I M0=1QL8J6:32=VRE@M%K12IN08#N>)T6#'D2^;LB\] WKQ>NI MNH4A QU;RDGFLQ,L&Y5<025<;#.!\R:6^Y@3H)/76I#G(;V(U>D(S-<&5'IU M3409Z]B11L;0(Y@3<"1?^I@,L(^"6MQSU"7=K+VS=" +!B[623)UKX]:L%"G M[0O+D;[_0-+-CY UO:N@@;&\ ^.+L\ETOKIH=UE1,>#<&1M%9B9YRW0&RZ)* M@67/BP)KHM$GYFT[P7OTG.E?"3WV#7;*ZGYG?9I\ M&M=SENROHF3VJV)+;>DXC39F%B)RX[7@1C4JYMX+YZ/G3D.U]%AU>&/QRUP? M< XHM6%@ RW<*QI^6 M.1-O(T?G.,-21^ESX_MC[RO[?8S:)L>*K^?]#2ELKL9;9I'UJ\5]Q-:S]OY)DCJ[.%M/7RH*L9XLN2SJQ TR4)#I M*ZZC+-S:;K=F=]+?M4>?=M[#P<*?]"&Y'B/,"R#P]0H0E;(IO" SWO,Z0(LS MCSHPY9V-17J92Z?08#<57GWT(U3AP9([57KT%YC6@$#MI/OP&:9X.;7AQ7@^ MS,/11G5_,5S?R;7[0$?G4YIAZ2<">5G(;&=ND M0!7O1"Z(.A8/(,EB,V"RDJF 'C1'=V1YZZT@?KT.XNT-$%=ULFP04PJD?!)C4,"T")KY%%,= M2N1B3I(VIS:!D5[@GSY>FMW=L3'7LQG7L?#3YAKCX]KN+:?H,,WPW@O$Z(!B2KDB9UB(S79/NT47. MK!;&^%@B@+HKTM(KHH?BA1VJZ,E]:ZF!=_4>9_/I,-5+0RO /T@CL_2\M&G/O8GE+U_P6 4U MI\R5UZ0+KJ:NVRYD]^.R':NY6XEPI-@;G#<[\E@YW>%2G8L,^TN[; ;IRUGW \7 R74PU>'6!I""].N]H&X2B ME6*EU)Q$,)8%1R -B"*EAN2@=/)M.CSL'@:(]:*624.9]CUR_C9\]KNG9$6. MGEQ\71?O/%G""A*30HJBZ[WGTAZM<_L\='Z(3$]5#*LLB]'+VF&93##.MIH%VQGB?6]1A['D=@ND+XTT")1=![KTR#A 21 U MR[R6O@OOZ,3,FH5DM%->IH"G\'%/.Z6Q.0GVE^U#2=)OLJ9'W$8Y&CMWAW+V$?*IW1:N^!ZWK&,O337U7L]1.RG MI(6&& O2#BDR!J9S)*O;2NBQC"9LV$?:]Q'+B-Q:4%JP MO&BF#.2!!U-' Q7N-*$S08F[')Q'&,O82RW[QC+VD6D#8_'-9/QICM.SNOCO M,S9=QA3K@)8HC6(Z>2)W!,-,T?4B(A6Q40GU-C1/Q1@X6M(-4AN;F-:G4@=4 M38V![;CNQQ0X7F]W$.$(H3-:^,>;H5S M>NN@#UW=7BIQ@*!W&@0]![I7=[Z_'B]&+=7/6XWLAM&5[\5OJ]\[(OY]X)-Z M"8OWL6'OO#,#)8"$)!BK1 MXNNAX='2>2$4BAR+,K'-Y.-K,)X@,PX7

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